Query 008621
Match_columns 559
No_of_seqs 324 out of 2161
Neff 6.9
Searched_HMMs 46136
Date Thu Mar 28 14:28:40 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/008621.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/008621hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0456 Aspartate kinase [Amin 100.0 2E-111 4E-116 849.8 37.6 550 2-557 1-554 (559)
2 PLN02551 aspartokinase 100.0 2E-103 4E-108 858.9 52.3 499 41-541 12-510 (521)
3 COG0527 LysC Aspartokinases [A 100.0 9.5E-93 2.1E-97 759.8 48.7 439 80-541 1-447 (447)
4 PRK09084 aspartate kinase III; 100.0 1.2E-88 2.5E-93 734.9 51.2 440 82-540 1-447 (448)
5 PRK09034 aspartate kinase; Rev 100.0 2.9E-88 6.3E-93 733.3 50.8 440 82-542 1-452 (454)
6 PRK06291 aspartate kinase; Pro 100.0 9.1E-87 2E-91 724.4 51.2 450 81-541 1-464 (465)
7 PRK09181 aspartate kinase; Val 100.0 1.2E-85 2.5E-90 712.1 47.9 435 79-541 1-467 (475)
8 PRK05925 aspartate kinase; Pro 100.0 6.8E-84 1.5E-88 693.0 49.6 436 80-544 1-438 (440)
9 PRK09466 metL bifunctional asp 100.0 7.4E-83 1.6E-87 726.9 48.0 439 78-542 8-456 (810)
10 PRK09436 thrA bifunctional asp 100.0 6.1E-81 1.3E-85 716.0 49.5 445 82-541 1-462 (819)
11 PRK08961 bifunctional aspartat 100.0 1.7E-79 3.6E-84 710.5 47.8 449 78-542 5-463 (861)
12 TIGR00657 asp_kinases aspartat 100.0 2E-76 4.4E-81 640.6 48.8 434 81-540 1-441 (441)
13 PRK08841 aspartate kinase; Val 100.0 1.1E-73 2.3E-78 607.4 43.8 378 80-542 1-380 (392)
14 TIGR00656 asp_kin_monofn aspar 100.0 1.1E-71 2.3E-76 597.1 46.4 394 81-540 1-400 (401)
15 PRK08210 aspartate kinase I; R 100.0 3.3E-68 7.1E-73 570.4 44.8 388 80-540 1-402 (403)
16 PRK07431 aspartate kinase; Pro 100.0 1.2E-67 2.5E-72 590.7 46.4 395 80-541 1-412 (587)
17 PRK06635 aspartate kinase; Rev 100.0 7.9E-67 1.7E-71 560.1 45.1 393 80-540 1-403 (404)
18 cd04245 AAK_AKiii-YclM-BS AAK_ 100.0 2.5E-66 5.5E-71 528.4 31.7 281 82-376 1-288 (288)
19 cd04258 AAK_AKiii-LysC-EC AAK_ 100.0 3.2E-66 6.9E-71 528.6 32.2 288 82-376 1-292 (292)
20 cd04244 AAK_AK-LysC-like AAK_A 100.0 8.7E-66 1.9E-70 528.7 31.6 290 83-376 2-298 (298)
21 cd04257 AAK_AK-HSDH AAK_AK-HSD 100.0 4.5E-65 9.7E-70 521.8 31.9 286 82-376 1-294 (294)
22 cd04243 AAK_AK-HSDH-like AAK_A 100.0 1.3E-64 2.8E-69 518.2 31.3 285 82-376 1-293 (293)
23 cd04259 AAK_AK-DapDC AAK_AK-Da 100.0 1.6E-64 3.4E-69 517.7 31.7 284 82-376 1-295 (295)
24 cd04247 AAK_AK-Hom3 AAK_AK-Hom 100.0 1.8E-64 3.8E-69 518.0 30.9 288 82-377 2-305 (306)
25 PRK08373 aspartate kinase; Val 100.0 5.8E-61 1.3E-65 498.3 36.0 323 80-444 3-327 (341)
26 TIGR02078 AspKin_pair Pyrococc 100.0 6.3E-58 1.4E-62 473.1 32.8 288 82-401 1-291 (327)
27 cd04248 AAK_AK-Ectoine AAK_AK- 100.0 5.2E-58 1.1E-62 464.5 29.1 279 83-376 2-304 (304)
28 cd04261 AAK_AKii-LysC-BS AAK_A 100.0 2.5E-47 5.4E-52 381.5 26.2 237 82-376 1-239 (239)
29 cd04234 AAK_AK AAK_AK: Amino A 100.0 1.8E-47 3.9E-52 379.7 23.8 225 82-376 1-227 (227)
30 cd04246 AAK_AK-DapG-like AAK_A 100.0 7.1E-47 1.5E-51 378.2 26.4 237 82-376 1-239 (239)
31 cd04260 AAK_AKi-DapG-BS AAK_AK 100.0 1.7E-46 3.6E-51 376.6 26.4 237 82-376 1-244 (244)
32 cd02115 AAK Amino Acid Kinases 100.0 1.4E-36 3.1E-41 304.5 24.7 237 84-375 1-248 (248)
33 PRK12314 gamma-glutamyl kinase 100.0 2E-32 4.4E-37 277.7 21.8 227 79-377 8-264 (266)
34 PF00696 AA_kinase: Amino acid 100.0 9.6E-33 2.1E-37 275.7 12.5 233 81-364 1-242 (242)
35 cd04242 AAK_G5K_ProB AAK_G5K_P 100.0 3.6E-31 7.7E-36 266.8 20.7 221 83-375 2-250 (251)
36 PRK00358 pyrH uridylate kinase 100.0 1.2E-29 2.7E-34 252.5 20.3 212 81-375 1-230 (231)
37 PRK14557 pyrH uridylate kinase 100.0 2.3E-29 4.9E-34 252.2 22.1 218 80-379 4-240 (247)
38 cd04239 AAK_UMPK-like AAK_UMPK 100.0 1.2E-29 2.6E-34 252.3 19.8 210 83-375 2-228 (229)
39 PRK14558 pyrH uridylate kinase 100.0 5.1E-29 1.1E-33 248.1 20.1 212 82-377 2-230 (231)
40 cd04254 AAK_UMPK-PyrH-Ec UMP k 100.0 2.6E-29 5.7E-34 250.2 17.7 213 81-376 1-231 (231)
41 TIGR02075 pyrH_bact uridylate 100.0 9.3E-28 2E-32 239.4 21.0 213 81-376 2-233 (233)
42 PRK13402 gamma-glutamyl kinase 100.0 9.7E-28 2.1E-32 252.6 21.4 226 79-379 4-259 (368)
43 cd04253 AAK_UMPK-PyrH-Pf AAK_U 99.9 5.4E-27 1.2E-31 232.1 19.4 202 83-376 2-221 (221)
44 cd04249 AAK_NAGK-NC AAK_NAGK-N 99.9 1.5E-26 3.2E-31 233.3 18.4 224 83-369 1-237 (252)
45 TIGR02076 pyrH_arch uridylate 99.9 2.5E-26 5.5E-31 227.3 19.3 202 83-375 1-220 (221)
46 cd04250 AAK_NAGK-C AAK_NAGK-C: 99.9 1.1E-26 2.4E-31 237.6 17.0 230 81-369 15-263 (279)
47 PRK05429 gamma-glutamyl kinase 99.9 2.8E-26 6.1E-31 243.1 20.3 228 80-379 8-263 (372)
48 PRK00942 acetylglutamate kinas 99.9 4E-26 8.7E-31 234.0 18.5 237 80-377 23-282 (283)
49 TIGR00761 argB acetylglutamate 99.9 4.5E-26 9.8E-31 226.9 16.8 215 82-359 1-227 (231)
50 TIGR01027 proB glutamate 5-kin 99.9 2E-25 4.3E-30 235.7 19.5 225 82-378 2-254 (363)
51 PLN02418 delta-1-pyrroline-5-c 99.9 3.3E-25 7.2E-30 252.2 19.5 239 79-380 14-286 (718)
52 cd04238 AAK_NAGK-like AAK_NAGK 99.9 3.7E-25 8.1E-30 223.6 15.8 222 83-368 1-239 (256)
53 PRK14058 acetylglutamate/acety 99.9 2.6E-24 5.7E-29 218.8 20.6 173 190-377 67-267 (268)
54 PRK14556 pyrH uridylate kinase 99.9 3.9E-23 8.4E-28 205.7 20.3 214 81-376 16-247 (249)
55 cd04241 AAK_FomA-like AAK_FomA 99.9 1.9E-22 4E-27 203.5 21.9 148 203-368 80-236 (252)
56 PLN02512 acetylglutamate kinas 99.9 1.7E-22 3.7E-27 209.3 21.8 235 81-376 48-308 (309)
57 COG0528 PyrH Uridylate kinase 99.9 2.1E-22 4.6E-27 195.6 19.4 214 81-376 6-237 (238)
58 COG0548 ArgB Acetylglutamate k 99.9 1.4E-22 3.1E-27 202.2 17.5 230 80-369 2-247 (265)
59 CHL00202 argB acetylglutamate 99.9 8.7E-22 1.9E-26 201.9 20.2 234 81-376 24-283 (284)
60 cd04251 AAK_NAGK-UC AAK_NAGK-U 99.9 7.6E-21 1.7E-25 192.3 19.7 221 83-369 1-244 (257)
61 cd04255 AAK_UMPK-MosAB AAK_UMP 99.9 2.7E-20 5.8E-25 188.3 20.9 212 81-375 31-261 (262)
62 cd04256 AAK_P5CS_ProBA AAK_P5C 99.8 3.8E-20 8.1E-25 189.4 19.5 245 80-375 8-283 (284)
63 TIGR01092 P5CS delta l-pyrroli 99.8 4.1E-20 8.9E-25 210.9 19.5 236 80-381 7-279 (715)
64 COG0263 ProB Glutamate 5-kinas 99.8 2.1E-19 4.6E-24 183.3 20.2 230 79-379 5-261 (369)
65 PTZ00489 glutamate 5-kinase; P 99.8 5.4E-19 1.2E-23 178.8 21.6 228 80-378 8-260 (264)
66 TIGR01890 N-Ac-Glu-synth amino 99.8 2.9E-17 6.2E-22 178.0 19.1 235 81-379 18-281 (429)
67 cd04236 AAK_NAGS-Urea AAK_NAGS 99.7 1.8E-16 3.9E-21 160.6 19.8 207 78-364 33-253 (271)
68 cd04237 AAK_NAGS-ABP AAK_NAGS- 99.7 1.6E-16 3.4E-21 162.8 19.5 223 80-368 18-263 (280)
69 PRK12353 putative amino acid k 99.7 3.1E-16 6.7E-21 162.7 17.6 123 253-377 177-314 (314)
70 PRK05279 N-acetylglutamate syn 99.7 5.5E-16 1.2E-20 168.6 19.1 233 81-378 26-292 (441)
71 cd04252 AAK_NAGK-fArgBP AAK_NA 99.7 8.5E-16 1.8E-20 154.8 18.6 212 84-364 2-230 (248)
72 PRK07431 aspartate kinase; Pro 99.7 6.2E-16 1.3E-20 173.9 18.0 146 382-540 426-582 (587)
73 PLN02825 amino-acid N-acetyltr 99.7 4.3E-15 9.4E-20 162.5 20.5 197 80-340 17-236 (515)
74 PRK12352 putative carbamate ki 99.6 4.1E-15 9E-20 153.8 17.3 239 80-377 2-315 (316)
75 cd04240 AAK_UC AAK_UC: Unchara 99.6 1.3E-14 2.8E-19 141.9 16.7 97 258-369 88-187 (203)
76 TIGR00746 arcC carbamate kinas 99.6 2.1E-14 4.5E-19 148.3 18.5 179 194-377 74-310 (310)
77 cd04235 AAK_CK AAK_CK: Carbama 99.6 1.5E-13 3.2E-18 141.4 18.2 120 254-375 174-307 (308)
78 PRK12686 carbamate kinase; Rev 99.5 7.6E-13 1.6E-17 136.3 18.5 121 253-376 175-311 (312)
79 PRK04531 acetylglutamate kinas 99.4 1.3E-12 2.9E-17 139.5 15.5 110 258-379 126-251 (398)
80 cd04915 ACT_AK-Ectoine_2 ACT d 99.4 5.9E-13 1.3E-17 106.8 8.6 64 476-540 2-66 (66)
81 cd04918 ACT_AK1-AT_2 ACT domai 99.4 4.8E-13 1E-17 106.9 8.0 64 477-540 2-65 (65)
82 PRK12454 carbamate kinase-like 99.4 1.8E-11 3.8E-16 126.1 21.5 119 255-376 179-312 (313)
83 COG1608 Predicted archaeal kin 99.4 2.1E-11 4.6E-16 119.1 20.7 156 203-376 81-251 (252)
84 KOG1154 Gamma-glutamyl kinase 99.4 3.3E-12 7.2E-17 123.5 13.2 156 196-370 91-259 (285)
85 PRK12354 carbamate kinase; Rev 99.4 1E-11 2.2E-16 127.5 15.5 123 253-378 167-301 (307)
86 cd04937 ACT_AKi-DapG-BS_2 ACT 99.2 2.4E-11 5.2E-16 96.7 7.8 62 476-539 1-63 (64)
87 cd04920 ACT_AKiii-DAPDC_2 ACT 99.2 2E-11 4.3E-16 97.0 7.3 62 477-540 1-63 (63)
88 cd04917 ACT_AKiii-LysC-EC_2 AC 99.2 2.8E-11 6E-16 96.2 7.8 63 476-540 1-64 (64)
89 cd04919 ACT_AK-Hom3_2 ACT doma 99.2 3.3E-11 7.2E-16 95.9 8.2 65 476-540 1-66 (66)
90 cd04922 ACT_AKi-HSDH-ThrA_2 AC 99.2 5.2E-11 1.1E-15 94.5 8.2 65 476-540 1-66 (66)
91 PRK09411 carbamate kinase; Rev 99.2 8E-10 1.7E-14 112.8 18.7 116 254-376 169-296 (297)
92 cd04916 ACT_AKiii-YclM-BS_2 AC 99.1 2.7E-10 5.8E-15 90.4 8.1 65 476-540 1-66 (66)
93 cd04924 ACT_AK-Arch_2 ACT doma 99.0 1.2E-09 2.6E-14 86.5 8.1 64 476-539 1-65 (66)
94 PF13840 ACT_7: ACT domain ; P 99.0 2.2E-09 4.8E-14 85.8 8.0 62 472-536 2-65 (65)
95 cd04933 ACT_AK1-AT_1 ACT domai 98.8 2E-08 4.4E-13 83.1 9.2 75 395-471 1-75 (78)
96 COG2054 Uncharacterized archae 98.8 2.8E-07 6.1E-12 86.5 15.8 83 287-377 118-210 (212)
97 cd04892 ACT_AK-like_2 ACT doma 98.7 4.3E-08 9.4E-13 76.3 7.9 64 477-540 1-65 (65)
98 cd04923 ACT_AK-LysC-DapG-like_ 98.7 4.2E-08 9.2E-13 76.6 7.8 61 477-539 1-62 (63)
99 cd04921 ACT_AKi-HSDH-ThrA-like 98.7 4E-08 8.7E-13 81.2 8.0 66 476-541 1-67 (80)
100 cd04936 ACT_AKii-LysC-BS-like_ 98.7 5E-08 1.1E-12 76.2 7.7 61 477-539 1-62 (63)
101 cd04932 ACT_AKiii-LysC-EC_1 AC 98.7 7.9E-08 1.7E-12 79.1 9.1 72 395-472 1-73 (75)
102 cd04934 ACT_AK-Hom3_1 CT domai 98.7 1E-07 2.3E-12 77.9 8.5 71 395-472 1-71 (73)
103 cd04935 ACT_AKiii-DAPDC_1 ACT 98.6 2.8E-07 6E-12 75.8 9.0 72 395-472 1-73 (75)
104 COG0549 ArcC Carbamate kinase 98.4 1.6E-05 3.5E-10 80.0 18.8 116 252-376 175-311 (312)
105 cd04868 ACT_AK-like ACT domain 98.4 6.6E-07 1.4E-11 68.2 6.8 59 477-535 1-60 (60)
106 cd04912 ACT_AKiii-LysC-EC-like 98.4 1.2E-06 2.5E-11 71.9 8.6 72 395-471 1-72 (75)
107 TIGR00656 asp_kin_monofn aspar 98.4 1.6E-06 3.4E-11 93.6 11.1 113 411-541 212-326 (401)
108 cd04890 ACT_AK-like_1 ACT doma 98.3 1.7E-06 3.6E-11 68.0 7.1 49 397-445 2-50 (62)
109 PRK06291 aspartate kinase; Pro 98.3 1.3E-06 2.9E-11 95.9 8.8 113 411-540 271-386 (465)
110 PRK09436 thrA bifunctional asp 98.2 3.4E-06 7.3E-11 98.6 8.9 112 411-539 265-379 (819)
111 cd04937 ACT_AKi-DapG-BS_2 ACT 98.2 7.2E-06 1.6E-10 65.0 7.5 51 395-445 1-51 (64)
112 cd04912 ACT_AKiii-LysC-EC-like 98.2 9.5E-06 2.1E-10 66.5 8.4 63 476-540 1-67 (75)
113 cd04891 ACT_AK-LysC-DapG-like_ 98.0 1.9E-05 4.2E-10 60.5 7.3 57 477-534 1-60 (61)
114 cd04933 ACT_AK1-AT_1 ACT domai 98.0 2.7E-05 6E-10 64.5 8.3 63 476-540 1-70 (78)
115 PF13840 ACT_7: ACT domain ; P 98.0 2.5E-05 5.4E-10 62.4 7.7 53 392-445 3-56 (65)
116 cd04913 ACT_AKii-LysC-BS-like_ 98.0 2E-05 4.4E-10 63.2 7.2 61 477-538 2-65 (75)
117 cd04919 ACT_AK-Hom3_2 ACT doma 98.0 2.8E-05 6.1E-10 61.5 7.5 50 395-444 1-52 (66)
118 cd04922 ACT_AKi-HSDH-ThrA_2 AC 97.9 3.9E-05 8.4E-10 60.5 7.5 50 395-444 1-52 (66)
119 cd04890 ACT_AK-like_1 ACT doma 97.9 4.2E-05 9E-10 60.0 7.5 59 478-538 2-61 (62)
120 cd04934 ACT_AK-Hom3_1 CT domai 97.9 4.4E-05 9.6E-10 62.4 7.7 62 477-540 2-65 (73)
121 COG0527 LysC Aspartokinases [A 97.9 9E-05 2E-09 80.8 11.6 114 411-541 257-373 (447)
122 cd04932 ACT_AKiii-LysC-EC_1 AC 97.9 7.3E-05 1.6E-09 61.5 8.0 61 477-539 2-66 (75)
123 PRK06635 aspartate kinase; Rev 97.8 4.6E-05 9.9E-10 82.3 8.1 111 411-537 211-325 (404)
124 cd04911 ACT_AKiii-YclM-BS_1 AC 97.8 6.2E-05 1.4E-09 61.8 6.3 64 396-466 2-65 (76)
125 cd04924 ACT_AK-Arch_2 ACT doma 97.7 0.00013 2.9E-09 57.3 7.4 51 395-445 1-53 (66)
126 cd04936 ACT_AKii-LysC-BS-like_ 97.7 0.00014 3.1E-09 56.4 7.1 49 397-445 2-50 (63)
127 cd04923 ACT_AK-LysC-DapG-like_ 97.7 0.00016 3.4E-09 56.2 7.2 49 397-445 2-50 (63)
128 cd04935 ACT_AKiii-DAPDC_1 ACT 97.7 0.00025 5.4E-09 58.3 8.4 61 477-539 2-66 (75)
129 cd04918 ACT_AK1-AT_2 ACT domai 97.6 0.00019 4.1E-09 57.1 7.1 49 396-445 2-52 (65)
130 cd04916 ACT_AKiii-YclM-BS_2 AC 97.6 0.00024 5.2E-09 55.9 7.6 51 395-445 1-53 (66)
131 TIGR00657 asp_kinases aspartat 97.6 0.00016 3.4E-09 79.2 8.3 109 411-536 251-362 (441)
132 cd04915 ACT_AK-Ectoine_2 ACT d 97.6 0.00032 6.9E-09 56.1 7.8 50 395-445 2-53 (66)
133 cd04868 ACT_AK-like ACT domain 97.5 0.0003 6.5E-09 53.2 6.6 48 397-444 2-51 (60)
134 cd04920 ACT_AKiii-DAPDC_2 ACT 97.4 0.0005 1.1E-08 54.4 6.7 50 396-445 1-50 (63)
135 cd04892 ACT_AK-like_2 ACT doma 97.3 0.00075 1.6E-08 52.1 7.0 49 396-444 1-51 (65)
136 cd04921 ACT_AKi-HSDH-ThrA-like 97.2 0.0013 2.9E-08 54.0 7.5 51 395-445 1-53 (80)
137 PLN02551 aspartokinase 97.2 0.0018 3.9E-08 72.1 10.8 100 343-445 380-496 (521)
138 PRK09034 aspartate kinase; Rev 97.2 0.0011 2.3E-08 72.9 8.7 98 346-445 325-437 (454)
139 PRK09181 aspartate kinase; Val 97.2 0.0028 6E-08 69.9 11.6 111 411-540 279-394 (475)
140 cd04910 ACT_AK-Ectoine_1 ACT d 97.1 0.0026 5.7E-08 51.7 8.2 61 396-466 2-62 (71)
141 cd04917 ACT_AKiii-LysC-EC_2 AC 97.0 0.0028 6.1E-08 50.0 7.0 48 395-444 1-50 (64)
142 cd04914 ACT_AKi-DapG-BS_1 ACT 97.0 0.002 4.4E-08 51.6 6.2 48 396-445 2-49 (67)
143 cd04914 ACT_AKi-DapG-BS_1 ACT 96.9 0.004 8.7E-08 49.9 7.6 56 477-535 2-57 (67)
144 PRK09466 metL bifunctional asp 96.8 0.0068 1.5E-07 71.0 11.5 110 411-538 268-380 (810)
145 COG4747 ACT domain-containing 96.8 0.051 1.1E-06 48.1 13.9 119 397-537 5-129 (142)
146 PRK09084 aspartate kinase III; 96.8 0.0033 7.2E-08 68.9 8.3 107 412-538 258-368 (448)
147 PRK05925 aspartate kinase; Pro 96.8 0.012 2.6E-07 64.4 11.9 96 347-445 316-421 (440)
148 KOG2436 Acetylglutamate kinase 96.7 0.0078 1.7E-07 65.2 9.6 123 199-339 170-303 (520)
149 PRK08210 aspartate kinase I; R 96.6 0.0066 1.4E-07 65.7 8.5 100 343-444 283-388 (403)
150 cd04891 ACT_AK-LysC-DapG-like_ 96.5 0.01 2.2E-07 45.1 6.6 46 397-444 2-52 (61)
151 PRK08841 aspartate kinase; Val 96.4 0.012 2.7E-07 63.4 8.7 94 347-445 269-365 (392)
152 cd04910 ACT_AK-Ectoine_1 ACT d 96.1 0.023 4.9E-07 46.2 7.1 63 478-540 3-66 (71)
153 PRK08961 bifunctional aspartat 96.1 0.014 3E-07 69.2 8.4 108 412-539 274-387 (861)
154 COG3603 Uncharacterized conser 96.1 0.025 5.5E-07 49.9 7.4 67 468-537 55-122 (128)
155 cd04913 ACT_AKii-LysC-BS-like_ 95.9 0.03 6.4E-07 44.5 7.0 48 396-445 2-54 (75)
156 PF01842 ACT: ACT domain; Int 95.8 0.028 6E-07 43.8 6.0 54 485-538 7-65 (66)
157 cd04888 ACT_PheB-BS C-terminal 94.5 0.23 4.9E-06 39.9 8.0 55 406-468 8-67 (76)
158 PRK11589 gcvR glycine cleavage 93.8 1.1 2.5E-05 43.4 12.6 107 393-511 6-128 (190)
159 COG3830 ACT domain-containing 93.6 0.16 3.6E-06 42.9 5.5 62 476-539 3-66 (90)
160 cd04888 ACT_PheB-BS C-terminal 93.5 0.49 1.1E-05 37.9 8.2 54 486-539 8-64 (76)
161 PRK04435 hypothetical protein; 92.9 0.8 1.7E-05 42.6 9.6 63 395-468 69-136 (147)
162 cd04911 ACT_AKiii-YclM-BS_1 AC 92.9 0.33 7.2E-06 40.0 6.1 60 479-540 4-69 (76)
163 KOG0456 Aspartate kinase [Amin 92.2 0.4 8.6E-06 50.8 7.1 70 468-539 385-458 (559)
164 PF01842 ACT: ACT domain; Int 91.5 0.78 1.7E-05 35.4 6.6 27 405-431 7-33 (66)
165 cd04908 ACT_Bt0572_1 N-termina 90.7 0.75 1.6E-05 36.2 5.9 53 485-537 8-60 (66)
166 cd02116 ACT ACT domains are co 90.0 1 2.2E-05 32.0 5.8 49 487-535 7-60 (60)
167 PRK13562 acetolactate synthase 89.7 1.1 2.3E-05 37.7 6.1 52 406-467 10-68 (84)
168 PRK06737 acetolactate synthase 89.6 1.1 2.4E-05 37.0 6.0 52 406-467 10-67 (76)
169 PRK11152 ilvM acetolactate syn 88.5 2.4 5.1E-05 35.0 7.3 51 406-467 11-67 (76)
170 PF13740 ACT_6: ACT domain; PD 87.9 2.3 4.9E-05 34.7 7.0 58 477-538 3-62 (76)
171 PRK08178 acetolactate synthase 87.6 1.7 3.7E-05 37.5 6.1 51 406-467 16-72 (96)
172 COG4492 PheB ACT domain-contai 86.4 5.8 0.00013 36.1 9.0 65 406-484 80-149 (150)
173 cd04889 ACT_PDH-BS-like C-term 86.2 2.6 5.7E-05 31.8 6.0 50 485-534 5-55 (56)
174 PRK13562 acetolactate synthase 85.7 2.7 5.7E-05 35.4 6.2 52 486-537 10-68 (84)
175 PRK11895 ilvH acetolactate syn 85.6 19 0.00041 34.1 12.7 90 406-509 10-115 (161)
176 TIGR00119 acolac_sm acetolacta 84.8 20 0.00044 33.7 12.4 90 406-509 9-114 (157)
177 PRK04435 hypothetical protein; 84.3 6.5 0.00014 36.5 8.8 55 485-539 76-133 (147)
178 PF13710 ACT_5: ACT domain; PD 81.2 3.8 8.1E-05 32.4 5.1 51 407-467 1-57 (63)
179 CHL00100 ilvH acetohydroxyacid 80.6 8.5 0.00019 36.9 8.3 57 479-537 5-67 (174)
180 cd04882 ACT_Bt0572_2 C-termina 80.1 5.9 0.00013 30.3 5.9 53 485-537 6-60 (65)
181 COG3830 ACT domain-containing 79.0 2.3 4.9E-05 36.1 3.3 46 394-442 2-51 (90)
182 PRK06737 acetolactate synthase 77.0 5.4 0.00012 32.9 5.0 40 486-525 10-53 (76)
183 PRK00194 hypothetical protein; 76.6 5.1 0.00011 33.4 4.9 35 477-513 4-38 (90)
184 CHL00100 ilvH acetohydroxyacid 76.3 47 0.001 31.8 11.9 38 406-443 10-53 (174)
185 cd04870 ACT_PSP_1 CT domains f 76.2 4.4 9.6E-05 32.7 4.3 44 479-524 2-47 (75)
186 cd04870 ACT_PSP_1 CT domains f 75.9 12 0.00026 30.1 6.8 30 398-430 2-31 (75)
187 PF13291 ACT_4: ACT domain; PD 75.5 11 0.00025 30.5 6.7 62 397-470 8-75 (80)
188 cd04883 ACT_AcuB C-terminal AC 75.3 14 0.0003 29.0 6.9 53 485-537 8-64 (72)
189 cd04893 ACT_GcvR_1 ACT domains 73.4 12 0.00026 30.5 6.2 34 478-513 3-36 (77)
190 cd04909 ACT_PDH-BS C-terminal 71.3 12 0.00027 29.2 5.7 52 485-536 8-64 (69)
191 PRK13011 formyltetrahydrofolat 70.9 1.3E+02 0.0028 31.2 14.5 34 396-432 8-41 (286)
192 COG2150 Predicted regulator of 70.0 27 0.00058 33.0 8.2 80 455-534 69-155 (167)
193 cd04878 ACT_AHAS N-terminal AC 69.2 32 0.00069 26.2 7.7 53 406-468 8-66 (72)
194 TIGR01693 UTase_glnD [Protein- 68.9 2.1E+02 0.0046 34.2 17.8 125 393-524 666-827 (850)
195 PRK05007 PII uridylyl-transfer 68.5 2E+02 0.0043 34.7 17.4 126 393-525 699-857 (884)
196 PRK08178 acetolactate synthase 68.4 12 0.00025 32.4 5.2 38 486-523 16-57 (96)
197 cd04908 ACT_Bt0572_1 N-termina 67.9 10 0.00022 29.6 4.6 26 405-430 8-33 (66)
198 cd04869 ACT_GcvR_2 ACT domains 67.8 29 0.00064 27.9 7.4 33 479-513 2-34 (81)
199 PRK11895 ilvH acetolactate syn 67.5 14 0.00031 34.9 6.1 54 485-538 9-68 (161)
200 PRK11152 ilvM acetolactate syn 67.3 13 0.00029 30.6 5.1 51 485-538 10-64 (76)
201 cd04887 ACT_MalLac-Enz ACT_Mal 67.2 26 0.00057 27.6 6.9 57 406-471 7-68 (74)
202 cd04877 ACT_TyrR N-terminal AC 66.8 21 0.00045 28.6 6.2 55 406-469 8-63 (74)
203 cd04903 ACT_LSD C-terminal ACT 66.6 18 0.0004 27.6 5.8 51 486-536 7-61 (71)
204 COG3603 Uncharacterized conser 65.3 36 0.00077 30.5 7.6 57 387-444 55-111 (128)
205 cd04875 ACT_F4HF-DF N-terminal 64.9 18 0.0004 28.8 5.6 32 479-512 2-33 (74)
206 TIGR00119 acolac_sm acetolacta 64.7 19 0.00041 33.9 6.3 53 485-539 8-64 (157)
207 PRK03381 PII uridylyl-transfer 64.5 2.7E+02 0.0059 33.0 17.2 138 393-538 597-772 (774)
208 PF13740 ACT_6: ACT domain; PD 63.4 34 0.00073 27.7 6.9 33 396-431 3-35 (76)
209 cd04886 ACT_ThrD-II-like C-ter 63.3 38 0.00083 25.8 7.1 51 486-536 6-66 (73)
210 cd04881 ACT_HSDH-Hom ACT_HSDH_ 62.7 49 0.0011 25.7 7.7 56 406-470 8-69 (79)
211 cd02116 ACT ACT domains are co 62.5 25 0.00055 24.4 5.6 37 407-443 7-49 (60)
212 PRK00194 hypothetical protein; 62.0 38 0.00082 28.1 7.2 33 396-431 4-36 (90)
213 cd04872 ACT_1ZPV ACT domain pr 61.3 16 0.00036 30.3 4.8 34 478-513 3-36 (88)
214 cd04895 ACT_ACR_1 ACT domain-c 60.4 90 0.0019 25.4 8.7 54 486-539 9-69 (72)
215 PRK05092 PII uridylyl-transfer 60.0 3.6E+02 0.0078 32.7 17.6 124 394-524 731-891 (931)
216 PRK13010 purU formyltetrahydro 59.9 1.3E+02 0.0028 31.2 12.1 33 396-431 10-42 (289)
217 PRK03059 PII uridylyl-transfer 59.7 3.7E+02 0.0079 32.4 17.3 123 394-523 677-833 (856)
218 cd04874 ACT_Af1403 N-terminal 59.6 33 0.00072 26.2 6.1 25 406-430 8-32 (72)
219 COG4747 ACT domain-containing 59.0 26 0.00056 31.4 5.6 66 485-552 10-80 (142)
220 PRK08577 hypothetical protein; 58.5 33 0.00071 31.2 6.7 35 393-430 54-88 (136)
221 cd04872 ACT_1ZPV ACT domain pr 58.4 51 0.0011 27.3 7.3 32 397-431 3-34 (88)
222 cd04880 ACT_AAAH-PDT-like ACT 58.2 30 0.00066 27.6 5.8 26 407-432 8-33 (75)
223 cd04869 ACT_GcvR_2 ACT domains 58.2 67 0.0015 25.7 7.9 30 398-430 2-31 (81)
224 cd04879 ACT_3PGDH-like ACT_3PG 57.7 28 0.00061 26.4 5.4 25 406-430 7-31 (71)
225 cd04875 ACT_F4HF-DF N-terminal 57.4 59 0.0013 25.8 7.3 31 398-431 2-32 (74)
226 cd04874 ACT_Af1403 N-terminal 57.3 48 0.001 25.3 6.7 41 485-525 7-50 (72)
227 cd04925 ACT_ACR_2 ACT domain-c 56.0 95 0.0021 24.9 8.3 45 478-524 2-48 (74)
228 PF13710 ACT_5: ACT domain; PD 55.2 20 0.00043 28.2 4.0 39 487-525 1-43 (63)
229 cd04905 ACT_CM-PDT C-terminal 55.1 80 0.0017 25.5 7.9 53 485-537 8-69 (80)
230 cd04886 ACT_ThrD-II-like C-ter 53.9 42 0.00091 25.6 5.8 25 406-430 6-30 (73)
231 PRK11589 gcvR glycine cleavage 53.5 38 0.00082 32.9 6.5 60 475-538 7-68 (190)
232 TIGR00655 PurU formyltetrahydr 53.5 31 0.00067 35.6 6.2 34 478-513 2-35 (280)
233 cd04905 ACT_CM-PDT C-terminal 53.5 57 0.0012 26.4 6.7 37 406-442 9-50 (80)
234 PRK05788 cobalamin biosynthesi 53.1 2.7E+02 0.0058 29.3 13.2 141 260-429 78-228 (315)
235 cd04819 PA_2 PA_2: Protease-as 53.0 76 0.0016 28.4 8.0 76 276-364 44-127 (127)
236 PRK03670 competence damage-ind 52.1 45 0.00097 33.9 7.0 70 204-301 20-89 (252)
237 cd04881 ACT_HSDH-Hom ACT_HSDH_ 51.9 75 0.0016 24.6 7.1 51 486-536 8-65 (79)
238 cd04884 ACT_CBS C-terminal ACT 51.6 63 0.0014 25.4 6.6 29 485-513 6-34 (72)
239 cd04879 ACT_3PGDH-like ACT_3PG 50.7 52 0.0011 24.9 5.8 50 486-535 7-60 (71)
240 PRK01759 glnD PII uridylyl-tra 50.5 2.9E+02 0.0063 33.2 14.5 126 393-525 675-832 (854)
241 PRK13010 purU formyltetrahydro 49.9 34 0.00073 35.5 5.8 35 476-512 9-43 (289)
242 cd04882 ACT_Bt0572_2 C-termina 49.9 18 0.00038 27.6 2.9 26 405-430 6-31 (65)
243 cd04931 ACT_PAH ACT domain of 49.5 84 0.0018 26.7 7.2 59 480-538 16-82 (90)
244 cd04902 ACT_3PGDH-xct C-termin 49.1 36 0.00077 26.5 4.7 50 485-534 6-59 (73)
245 cd04878 ACT_AHAS N-terminal AC 49.0 70 0.0015 24.2 6.4 40 486-525 8-51 (72)
246 TIGR00655 PurU formyltetrahydr 48.8 2.5E+02 0.0055 28.9 12.0 33 397-432 2-34 (280)
247 cd04889 ACT_PDH-BS-like C-term 48.3 23 0.0005 26.4 3.3 26 405-430 5-30 (56)
248 PRK00275 glnD PII uridylyl-tra 47.5 5.9E+02 0.013 30.8 16.6 125 394-525 703-863 (895)
249 cd04901 ACT_3PGDH C-terminal A 47.2 18 0.00038 28.1 2.6 52 485-536 6-59 (69)
250 cd04887 ACT_MalLac-Enz ACT_Mal 47.1 94 0.002 24.3 6.9 50 486-535 7-59 (74)
251 COG3602 Uncharacterized protei 46.9 16 0.00036 32.3 2.5 48 388-435 63-110 (134)
252 PF09413 DUF2007: Domain of un 46.4 54 0.0012 25.6 5.3 44 493-536 13-64 (67)
253 cd04883 ACT_AcuB C-terminal AC 46.2 1.1E+02 0.0023 23.8 7.1 26 405-430 8-33 (72)
254 PRK13581 D-3-phosphoglycerate 46.1 1.2E+02 0.0026 34.2 9.9 85 347-431 385-485 (526)
255 PF13291 ACT_4: ACT domain; PD 46.1 74 0.0016 25.6 6.3 55 479-535 9-67 (80)
256 cd04877 ACT_TyrR N-terminal AC 45.6 1E+02 0.0022 24.5 6.9 44 486-530 8-51 (74)
257 cd04903 ACT_LSD C-terminal ACT 45.2 54 0.0012 24.9 5.1 25 406-430 7-31 (71)
258 cd04893 ACT_GcvR_1 ACT domains 45.0 39 0.00083 27.4 4.4 32 397-431 3-34 (77)
259 cd04880 ACT_AAAH-PDT-like ACT 44.8 62 0.0014 25.7 5.6 51 486-536 7-66 (75)
260 cd04900 ACT_UUR-like_1 ACT dom 44.0 1.5E+02 0.0033 23.4 7.7 28 479-508 4-31 (73)
261 cd04929 ACT_TPH ACT domain of 43.7 1E+02 0.0022 25.0 6.6 52 486-537 8-66 (74)
262 PRK13011 formyltetrahydrofolat 43.5 99 0.0021 32.0 8.1 34 477-512 8-41 (286)
263 COG1058 CinA Predicted nucleot 43.5 1.1E+02 0.0024 31.2 8.2 68 205-301 22-89 (255)
264 PF00994 MoCF_biosynth: Probab 42.7 88 0.0019 28.4 6.9 69 203-300 16-84 (144)
265 TIGR00177 molyb_syn molybdenum 42.1 1.1E+02 0.0023 28.0 7.4 65 205-298 28-92 (144)
266 PRK06027 purU formyltetrahydro 41.6 91 0.002 32.2 7.5 62 476-539 6-78 (286)
267 cd04904 ACT_AAAH ACT domain of 41.2 1.2E+02 0.0025 24.4 6.6 51 486-536 8-65 (74)
268 cd00885 cinA Competence-damage 40.9 1.1E+02 0.0024 28.9 7.5 69 204-301 19-87 (170)
269 cd04871 ACT_PSP_2 ACT domains 40.8 20 0.00044 29.8 2.1 58 478-539 1-70 (84)
270 COG2150 Predicted regulator of 40.3 1.2E+02 0.0025 28.8 7.1 37 406-442 103-145 (167)
271 PRK06027 purU formyltetrahydro 39.5 2.8E+02 0.0061 28.6 10.7 34 395-431 6-39 (286)
272 cd04895 ACT_ACR_1 ACT domain-c 39.4 56 0.0012 26.6 4.4 31 396-429 2-32 (72)
273 cd05014 SIS_Kpsf KpsF-like pro 38.5 1.3E+02 0.0027 26.3 7.1 79 277-364 1-81 (128)
274 TIGR00719 sda_beta L-serine de 38.2 2E+02 0.0043 28.2 9.0 25 406-430 156-180 (208)
275 PF13511 DUF4124: Domain of un 37.8 28 0.00061 26.7 2.4 29 291-319 3-33 (60)
276 COG0440 IlvH Acetolactate synt 37.5 47 0.001 31.5 4.1 38 406-443 12-55 (163)
277 COG1707 ACT domain-containing 37.2 2.8E+02 0.0061 26.5 9.1 112 407-534 11-136 (218)
278 cd04876 ACT_RelA-SpoT ACT dom 37.0 1E+02 0.0022 22.4 5.5 24 407-430 7-30 (71)
279 COG0462 PrsA Phosphoribosylpyr 36.5 3.1E+02 0.0066 28.9 10.3 144 195-367 99-277 (314)
280 cd04897 ACT_ACR_3 ACT domain-c 36.2 2.4E+02 0.0053 23.1 7.7 49 477-527 2-52 (75)
281 cd04896 ACT_ACR-like_3 ACT dom 35.3 2.4E+02 0.0051 23.2 7.5 30 397-429 2-31 (75)
282 TIGR02726 phenyl_P_delta pheny 35.1 23 0.00049 33.7 1.7 49 304-366 9-59 (169)
283 COG0440 IlvH Acetolactate synt 35.0 52 0.0011 31.2 4.0 63 486-548 12-80 (163)
284 cd04909 ACT_PDH-BS C-terminal 34.7 65 0.0014 24.9 4.1 26 405-430 8-33 (69)
285 PRK01215 competence damage-ind 34.7 1.2E+02 0.0026 31.0 7.0 70 203-301 22-91 (264)
286 cd04884 ACT_CBS C-terminal ACT 34.3 49 0.0011 26.1 3.3 26 405-430 6-31 (72)
287 PRK08198 threonine dehydratase 34.2 1.7E+02 0.0037 31.5 8.6 45 484-528 333-384 (404)
288 cd04873 ACT_UUR-ACR-like ACT d 32.6 1.7E+02 0.0036 22.2 6.2 41 486-526 8-50 (70)
289 PRK03673 hypothetical protein; 32.0 1.6E+02 0.0035 32.0 7.7 69 204-301 21-89 (396)
290 cd04902 ACT_3PGDH-xct C-termin 31.7 1E+02 0.0023 23.7 4.9 25 406-430 7-31 (73)
291 PRK04374 PII uridylyl-transfer 30.9 1E+03 0.022 28.7 16.4 126 393-525 688-845 (869)
292 smart00852 MoCF_biosynth Proba 30.2 1.8E+02 0.004 25.9 6.8 69 203-300 17-85 (135)
293 TIGR01327 PGDH D-3-phosphoglyc 30.1 1.3E+02 0.0029 33.8 7.0 84 347-430 384-483 (525)
294 cd04899 ACT_ACR-UUR-like_2 C-t 29.9 83 0.0018 24.2 4.0 31 397-430 2-32 (70)
295 cd04876 ACT_RelA-SpoT ACT dom 29.2 2.2E+02 0.0048 20.5 7.0 39 486-524 6-47 (71)
296 COG4492 PheB ACT domain-contai 29.2 3E+02 0.0066 25.3 7.7 61 477-537 71-134 (150)
297 cd04925 ACT_ACR_2 ACT domain-c 29.1 72 0.0016 25.6 3.5 30 397-429 2-31 (74)
298 TIGR02667 moaB_proteo molybden 29.0 1.6E+02 0.0034 27.7 6.4 69 203-299 21-90 (163)
299 cd04896 ACT_ACR-like_3 ACT dom 28.7 2.3E+02 0.0049 23.3 6.3 38 486-524 8-50 (75)
300 cd04926 ACT_ACR_4 C-terminal 27.8 1.7E+02 0.0037 23.2 5.5 40 485-524 8-49 (72)
301 PRK08577 hypothetical protein; 27.6 2.1E+02 0.0046 25.8 6.8 50 476-527 56-109 (136)
302 cd04931 ACT_PAH ACT domain of 27.1 2E+02 0.0043 24.4 6.0 35 407-441 23-62 (90)
303 cd04926 ACT_ACR_4 C-terminal 27.1 1.2E+02 0.0026 24.1 4.4 25 405-429 8-32 (72)
304 cd00886 MogA_MoaB MogA_MoaB fa 26.8 2.1E+02 0.0046 26.3 6.8 66 205-299 21-88 (152)
305 cd04906 ACT_ThrD-I_1 First of 26.4 3.1E+02 0.0068 22.5 7.0 51 484-536 7-64 (85)
306 cd04871 ACT_PSP_2 ACT domains 25.7 62 0.0013 26.9 2.6 31 398-430 2-32 (84)
307 PF11760 CbiG_N: Cobalamin syn 25.6 1.4E+02 0.003 25.2 4.6 28 276-303 47-78 (84)
308 PRK00549 competence damage-ind 25.6 2.2E+02 0.0048 31.0 7.6 69 204-301 20-88 (414)
309 cd04897 ACT_ACR_3 ACT domain-c 25.1 1.3E+02 0.0027 24.8 4.3 31 396-429 2-32 (75)
310 PHA01735 hypothetical protein 24.9 1.9E+02 0.0041 23.4 5.0 34 194-228 22-57 (76)
311 cd00758 MoCF_BD MoCF_BD: molyb 24.7 2.7E+02 0.0058 24.9 6.8 66 204-298 19-84 (133)
312 cd04873 ACT_UUR-ACR-like ACT d 24.3 1.4E+02 0.003 22.7 4.3 30 398-430 3-32 (70)
313 PRK08198 threonine dehydratase 24.3 2.1E+02 0.0046 30.8 7.1 41 388-431 320-360 (404)
314 cd04930 ACT_TH ACT domain of t 23.8 3.1E+02 0.0067 24.3 6.9 57 480-536 43-106 (115)
315 cd04885 ACT_ThrD-I Tandem C-te 22.4 3.7E+02 0.0081 20.8 6.7 42 485-527 5-49 (68)
316 cd04904 ACT_AAAH ACT domain of 22.3 1.2E+02 0.0026 24.3 3.6 25 407-431 9-33 (74)
317 cd02129 PA_hSPPL_like PA_hSPPL 22.2 3.5E+02 0.0076 24.3 6.9 63 276-338 44-109 (120)
318 cd04927 ACT_ACR-like_2 Second 22.0 3.8E+02 0.0083 21.5 6.6 26 486-511 8-35 (76)
319 TIGR00200 cinA_nterm competenc 21.0 3.4E+02 0.0074 29.6 7.9 68 205-301 21-88 (413)
320 cd04929 ACT_TPH ACT domain of 20.3 1.4E+02 0.0031 24.1 3.7 25 407-431 9-33 (74)
321 COG0303 MoeA Molybdopterin bio 20.2 2.7E+02 0.0059 30.4 6.8 72 205-307 204-275 (404)
No 1
>KOG0456 consensus Aspartate kinase [Amino acid transport and metabolism]
Probab=100.00 E-value=1.8e-111 Score=849.79 Aligned_cols=550 Identities=70% Similarity=0.998 Sum_probs=518.6
Q ss_pred Cccccccccccccccccc---ccccccccccccccccccceecccCCCcccceeEeeccccchhhhccccccccccCcCC
Q 008621 2 ANTMQFSSIIQKNSLHCQ---ALSWQRFAFAKCVSSSSRLCVSVRNSCGGRGGLRVSCEGARIDVIERKKSENLGVDESE 78 (559)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (559)
++++|++|+.+++..-.+ +..+++.+|+.-.+++.+.++ .++||++ ++|++|+..++...+++.+++....+ +
T Consensus 1 ~a~~~~~~~~~~~l~l~~~r~~~~~~~~~f~~~~~~~~~~~~--~~s~~~i-~~~~~~~~~r~~l~~~k~~e~~~s~g-~ 76 (559)
T KOG0456|consen 1 MASTQVYGVKTPRLALTSKRLEFSSKGVDFSTLKKSSLPIGR--GSSCRNI-SLRVSCEAVRVVLLERKNPETDPSNG-E 76 (559)
T ss_pred CCceeEEeecCCCcccccccccccccCccchhhccccccccC--Cccceec-eeeeeeeeeeEeeecccCcccCccCC-C
Confidence 468999999776555332 556778888887777765555 5667777 89999999999999999888865555 7
Q ss_pred CcceEEEEeCccccCCHHHHHHHHHHHHcCCCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHH
Q 008621 79 KQLTCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (559)
Q Consensus 79 ~~~~~V~KFGGsSl~~~~~~~~va~iI~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~ 158 (559)
+..|+|+|||||||++++++..++..+..+++++++||+|||+++|+.|+..++++..|+..+.+..++++.|++.|++.
T Consensus 77 k~~~~V~KFGGsSV~s~~~~i~v~~l~~~~~~e~~~vV~SA~sk~Tna~~ta~~~~~~c~va~~~sie~l~iIke~Hi~t 156 (559)
T KOG0456|consen 77 KGLTCVMKFGGSSVGSAERMIEVAVLILYFPDERPVVVLSAMSKTTNALLTAGEKAVCCGVANVESIEELSIIKELHIRT 156 (559)
T ss_pred cceEEEEecCCccccccchhhhhhHHHHhcCCCCeEEEEEccccchhhhhhhhhheecccccCcchHHHHHHHHHHHHhh
Confidence 88899999999999999999999999998888999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCC
Q 008621 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (559)
Q Consensus 159 ~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (559)
+++|+.++..+.++++.|+++|+|+++++|.++|++|+++||||++|+++|++||+..|++|.++|..++++++.++|.+
T Consensus 157 a~e~~~d~~v~~~~le~leq~Lk~i~mm~Elt~RTrD~lvs~GE~lS~rf~aA~lnd~G~kar~~D~~~I~~~~~d~~t~ 236 (559)
T KOG0456|consen 157 AHELIVDPAVIAKLLEGLEQLLKGIAMMKELTLRTRDYLVSFGECLSTRFFAAYLNDIGHKARQYDAFEIGFITTDDFTN 236 (559)
T ss_pred HHHhccCHHHHHHHHHHHHHHHHHHHHHHhcchhhhhHhhhhhhHHHHHHHHHHHHhcCccceeechhheeccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCC
Q 008621 239 ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPN 318 (559)
Q Consensus 239 a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~ 318 (559)
+++.+.+++.+.+.+...|...+.|||++||.|+.++.|..+++||||||++|+.||.+||++++++|+|||||+|+|||
T Consensus 237 ~d~~~a~~~av~k~~~~~~aken~VPVvTGf~Gk~~~tg~lt~lGRG~sDl~At~i~~al~~~EiQVWKdVDGv~T~DP~ 316 (559)
T KOG0456|consen 237 DDILEATYPAVSKLLSGDWAKENAVPVVTGFLGKGWPTGALTTLGRGGSDLTATTIGKALGLDEIQVWKDVDGVLTCDPR 316 (559)
T ss_pred hhHHHHHHHHHHHhcccccccCCccceEeeccccCccccceecccCCchhhHHHHHHHHcCchhhhhhhhcCceEecCCc
Confidence 99999999888888877887788999999999988889999999999999999999999999999999999999999999
Q ss_pred CCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCccceeeEEeeecCeEEE
Q 008621 319 IHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRNVTML 398 (559)
Q Consensus 319 ~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~It~Is~~~~ialI 398 (559)
++|.|+++|.+|++||.||+|||++|+||-+|+|+++.+|||||+|++||.++||.|.+++++++...|+|+.++|++++
T Consensus 317 ~~p~Ar~vp~lT~dEAaELaYfGaqVlHP~sM~~~~~~~IPvRvKN~~NP~~~GTvI~~d~~m~k~~~TsI~lK~nv~ml 396 (559)
T KOG0456|consen 317 IYPGARLVPYLTFDEAAELAYFGAQVLHPFSMRPAREGRIPVRVKNSYNPTAPGTVITPDRDMSKAGLTSIVLKRNVTML 396 (559)
T ss_pred cCCCccccCccCHHHHHHHHhhhhhhccccccchhhccCcceEeecCCCCCCCceEeccchhhhhccceEEEEeccEEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999998899999999999999
Q ss_pred EEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeE
Q 008621 399 DIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSI 478 (559)
Q Consensus 399 tV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~ai 478 (559)
.|.+++|+++.||++++|.+|+++||+||.+++||.+||+++++++.|++|++++ +++++.++|++++.+++.++.|+
T Consensus 397 dI~Str~l~q~GFLAkvFti~ek~~isVDvvaTSEV~iSltL~~~~~~sreliq~--~l~~a~eeL~ki~~vdll~~~sI 474 (559)
T KOG0456|consen 397 DIASTRMLGQHGFLAKVFTIFEKLGISVDVVATSEVSISLTLDPSKLDSRELIQG--ELDQAVEELEKIAVVDLLKGRSI 474 (559)
T ss_pred EecccchhhhhhHHHHHHHHHHHhCcEEEEEEeeeEEEEEecChhhhhhHHHHHh--hHHHHHHHHHHhhhhhhhccchH
Confidence 9999999999999999999999999999999999999999999999999999987 89999999999999999999999
Q ss_pred EEEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC-ccccccccccCCCCCC
Q 008621 479 ISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES-DLANLDCVCGSENNSS 557 (559)
Q Consensus 479 ISIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~-~~~~~~~~~~~~~~~~ 557 (559)
||+||+|+++.+++.|.|..|+++||||+||+||+|++|||++|+++++++++++||.+||+. +..|+..++...++.+
T Consensus 475 iSLiGnvq~ss~i~~rmF~~l~e~giNvqMISQGAskvNIS~ivne~ea~k~v~~lH~~~~e~~~~~e~~~q~~~~~~~~ 554 (559)
T KOG0456|consen 475 ISLIGNVQNSSGILERMFCVLAENGINVQMISQGASKVNISCIVNEKEAEKCVQALHKAFFETLDLHEVPSQASMGVEKP 554 (559)
T ss_pred HhhhhhhhhhhHHHHHHHHHHHhcCcceeeeccccccceEEEEEChHHHHHHHHHHHHHHcCCCCccccccccccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999998 8888888887776654
No 2
>PLN02551 aspartokinase
Probab=100.00 E-value=1.6e-103 Score=858.86 Aligned_cols=499 Identities=84% Similarity=1.207 Sum_probs=450.9
Q ss_pred cccCCCcccceeEeeccccchhhhccccccccccCcCCCcceEEEEeCccccCCHHHHHHHHHHHHcCCCCCcEEEEcCC
Q 008621 41 SVRNSCGGRGGLRVSCEGARIDVIERKKSENLGVDESEKQLTCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAM 120 (559)
Q Consensus 41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~KFGGsSl~~~~~~~~va~iI~~~~~~~~vVVVSA~ 120 (559)
+...++.+++.+++.|..+......+..++..........+++|+|||||||+|+++|++|+++|....+.++|||||||
T Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~KFGGtSv~~~e~i~~v~~iI~~~~~~~~vVVvSA~ 91 (521)
T PLN02551 12 RSVGSSCRNIVLRVNCSAGRVEALVEAPSETRQGGGTEKQLTVVMKFGGSSVASAERMREVADLILSFPDERPVVVLSAM 91 (521)
T ss_pred ccccccchhHHHHhhhhhhhhHhhhhcccccccccccccCceEEEEECCCccCCHHHHHHHHHHHHhcCCCCEEEEEcCC
Confidence 33444444457888887777666666666665666667778899999999999999999999999987666799999999
Q ss_pred CcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhh
Q 008621 121 GKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSF 200 (559)
Q Consensus 121 g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~ 200 (559)
+|+||.|+++++.+..++..+.++.+.++.++++|.+++++|+.+...+..++++|+++++++.++++++++.+|+|+|+
T Consensus 92 ~~~Td~L~~~~~~a~~~~~~~~~~~~~l~~i~~~h~~~~~~L~~~~~~~~~~~~~l~~ll~~i~~~~~~~~~~~d~ils~ 171 (521)
T PLN02551 92 GKTTNNLLLAGEKAVSCGVTNVSEIEELSAIRELHLRTADELGVDESVVEKLLDELEQLLKGIAMMKELTPRTRDYLVSF 171 (521)
T ss_pred CCchHHHHHHHHHHhhccccchhhHHHHHHHHHHHHHHHHHhhcchHHHHHHHHHHHHHHHhhhhhcccchHHHHHHHhH
Confidence 99999999998888766554455677899999999999999998888899999999999999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCcee
Q 008621 201 GECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAIT 280 (559)
Q Consensus 201 GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~ 280 (559)
||++|+.||+++|+++|++|.++|++++||+|+++|+++++.+.+++++.+.+...|.+.+.|||+|||+|.++++|++|
T Consensus 172 GE~lSa~lla~~L~~~Gi~a~~lda~~~gi~t~~~~~~a~i~~~~~~~l~~~l~~~~~~~~~v~Vv~GFig~~~~~G~~t 251 (521)
T PLN02551 172 GERMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWIDDPAVPVVTGFLGKGWKTGAIT 251 (521)
T ss_pred HHHHHHHHHHHHHHHCCCCcEEechHHcceEecCCCCccchhhhhHHHHHHHHHhhhccCCeEEEEcCccccCCCCCcEE
Confidence 99999999999999999999999999999999999999999877888888877665555678999999999982279999
Q ss_pred eecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCE
Q 008621 281 TLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPV 360 (559)
Q Consensus 281 tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv 360 (559)
|||||||||||+++|++|+|++|+||||||||||+|||++|+|+++++|||+||.||+|+||+||||+|++||++++|||
T Consensus 252 tLGRGGSD~sA~~la~~L~A~~v~I~tDV~Gi~taDPr~v~~A~~l~~lsy~Ea~elA~~GakVlhp~ai~pa~~~~Ipi 331 (521)
T PLN02551 252 TLGRGGSDLTATTIGKALGLREIQVWKDVDGVLTCDPRIYPNAVPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPV 331 (521)
T ss_pred ecCCChHHHHHHHHHHHcCCCEEEEEeCCCceeCCCCCCCCCceEecccCHHHHHHHHhCCCcccCHHHHHHHHHCCceE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEecCCCCCCCCeEEecCCCCccceeeEEeeecCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEe
Q 008621 361 RVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTL 440 (559)
Q Consensus 361 ~I~n~~~p~~~GT~I~~~~~~~~~~It~Is~~~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v 440 (559)
+|+|+|+|+.+||+|++..++++..||+|+.++|+++|+|.+.+|++.+||++++|+.|+++||+|+||++|+.+|+|++
T Consensus 332 ~vknt~~p~~~GT~I~~~~~~~~~~v~~It~~~~v~li~i~~~~m~~~~g~~arvf~~l~~~~I~Vd~IssSe~sIs~~v 411 (521)
T PLN02551 332 RVKNSYNPTAPGTLITKTRDMSKAVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSISLTL 411 (521)
T ss_pred EEEecCCCCCCCcEEecccccCCCcccceecCCCeEEEEEecCCCCCcccHHHHHHHHHHHcCCcEEEEeccCCEEEEEE
Confidence 99999999999999988765555679999999999999999999999999999999999999999999999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEE
Q 008621 441 DPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISL 520 (559)
Q Consensus 441 ~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~ 520 (559)
+.++.+..+.+++ .++.+..+|+++..+.+.+++++||+||+|+..+++++|+|++|+++||||+||+||+|+++|||
T Consensus 412 ~~~~~~~~~~i~~--~l~~l~~el~~~~~V~v~~~vAiISvVG~~~~~~gvaariF~aLa~~gInV~mIsqgaSeinIS~ 489 (521)
T PLN02551 412 DPSKLWSRELIQQ--ELDHLVEELEKIAVVNLLQGRSIISLIGNVQRSSLILEKVFRVLRTNGVNVQMISQGASKVNISL 489 (521)
T ss_pred ehhHhhhhhhHHH--HHHHHHHHhhcCCeEEEeCCEEEEEEEccCCCCccHHHHHHHHHHHCCCCeEEEEecCCCcEEEE
Confidence 9887654444443 45566777877778999999999999999878899999999999999999999999999999999
Q ss_pred EEecccHHHHHHHHHHHhccC
Q 008621 521 IVNDDEAEQCVRALHETFFES 541 (559)
Q Consensus 521 vV~~~d~~kAv~~LH~~f~~~ 541 (559)
+|+++|.++|+++||++||..
T Consensus 490 vV~~~d~~~Av~aLH~~Ff~~ 510 (521)
T PLN02551 490 IVNDDEAEQCVRALHSAFFEG 510 (521)
T ss_pred EEeHHHHHHHHHHHHHHHhcC
Confidence 999999999999999999986
No 3
>COG0527 LysC Aspartokinases [Amino acid transport and metabolism]
Probab=100.00 E-value=9.5e-93 Score=759.75 Aligned_cols=439 Identities=38% Similarity=0.624 Sum_probs=382.1
Q ss_pred cceEEEEeCccccCCHHHHHHHHHHHHcCCC--CCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHH
Q 008621 80 QLTCVMKFGGSSLASAERMREVAELILSFPN--ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~~~~~~va~iI~~~~~--~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~ 157 (559)
|.|+|+|||||||+|+++|++++++|.+..+ .++|||+||||++||.|+++++.+..... ... .++|.+
T Consensus 1 m~~iV~KFGGTSva~~e~i~~va~iv~~~~~~g~~vVVVvSA~~~vTd~Lv~~a~~~~~~~~-------~~~--~~~~~~ 71 (447)
T COG0527 1 MRLIVQKFGGTSVADAERILRVADIVKEDSEEGVKVVVVVSAMGGVTDLLVALAEGAESGRD-------AVA--EQRHRD 71 (447)
T ss_pred CceEEEEeCCcccCCHHHHHHHHHHHHhhhhcCCcEEEEECCCCCchHHHHHHHhhcccccc-------hhH--HHHHHH
Confidence 3489999999999999999999999998653 67899999999999999999886543221 111 667777
Q ss_pred HHHhcCCCHH---HHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEec
Q 008621 158 TVDELGIDRS---IIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (559)
Q Consensus 158 ~~~~L~~~~~---~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (559)
++.++..++. .+.....+++..+.++..+++.+++.+|+|+|+||++|+.||+++|+++|++|.+++++++++.+++
T Consensus 72 ~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~ilS~GE~~Sa~lla~~L~~~Gv~A~~~~~~~~~i~t~~ 151 (447)
T COG0527 72 IASELILDPFIAARLAEVIAEFKKVLLGIALLGEVSPRERDELLSLGERLSAALLAAALNALGVDARSLDGRQAGIATDS 151 (447)
T ss_pred HHHHHhhcchhhhhHhhhHhhhhHHhhhhhhccCCCHHHHHHHHhhchHHHHHHHHHHHHhCCCceEEEchHHceeeecC
Confidence 7777765542 2344444447778888899999999999999999999999999999999999999999999999999
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCccccc
Q 008621 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (559)
Q Consensus 235 ~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~t 314 (559)
.|+++.+....+.+. +. .+++.+.|||||||+|.+ ++|++||||||||||||++||++|+|++|+||||||||||
T Consensus 152 ~~~~a~i~~~~~~~~---l~-~~~~~~~v~Vv~GF~G~~-~~G~~tTLGRGGSD~SA~~laa~l~Ad~~~I~TDVdGI~T 226 (447)
T COG0527 152 NHGNARILDEDSERR---LL-RLLEEGKVPVVAGFQGIN-EDGETTTLGRGGSDYSAAALAAALGADEVEIWTDVDGVYT 226 (447)
T ss_pred cccccccchhhhhhh---HH-HHhcCCcEEEecCceeec-CCCCEEEeCCCcHHHHHHHHHHHcCCCEEEEEECCCCCcc
Confidence 999999877665541 22 235678999999999999 5899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCccceeeEEeeecC
Q 008621 315 CDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRN 394 (559)
Q Consensus 315 aDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~It~Is~~~~ 394 (559)
+|||+||+|++|++|||+||+||+++|||||||+|++|++++|||++|+|+|+|+.+||+|........+.+++|+..++
T Consensus 227 aDPRiVp~Ar~i~~isyeEa~ELA~~GAkVLHprav~pa~~~~Ip~~i~~t~~p~~~GTlI~~~~~~~~~~v~gIa~~~~ 306 (447)
T COG0527 227 ADPRIVPDARLLPEISYEEALELAYLGAKVLHPRAVEPAMRSGIPLRIKNTFNPDAPGTLITAETESDEPVVKGIALDDN 306 (447)
T ss_pred CCCCCCCcceEcCccCHHHHHHHHHCCchhcCHHHHHHHHhcCCcEEEEecCCCCCCceEEecCCcCCCCceEEEEeCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999986544468999999999
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEec--CceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeec
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS--EVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNL 472 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstS--e~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~ 472 (559)
+++|++.+..|.+.+||++++|..|+++||+|++|.++ +.+++|+++.++... +.+ .+.....+.. ..+.+
T Consensus 307 ~~~i~v~~~~~~~~~g~~a~vf~~l~~~~i~v~~I~q~~~~~~i~~~v~~~~~~~--a~~---~l~~~~~~~~--~~v~~ 379 (447)
T COG0527 307 VALITVSGPGMNGMVGFAARVFGILAEAGINVDLITQSISEVSISFTVPESDAPR--ALR---ALLEEKLELL--AEVEV 379 (447)
T ss_pred eEEEEEEccCccccccHHHHHHHHHHHcCCcEEEEEeccCCCeEEEEEchhhHHH--HHH---HHHHHHhhhc--ceEEe
Confidence 99999999999999999999999999999999999766 788999999876432 111 2222222221 16788
Q ss_pred ccceeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008621 473 LQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 541 (559)
Q Consensus 473 ~~~~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 541 (559)
.+++|+|++||. |...||+++++|++|++++|||.||+ +|++||||+|++++.++|+++||++|+.+
T Consensus 380 ~~~~a~vsiVG~gm~~~~gvaa~~f~aL~~~~ini~~is--sSe~~Is~vV~~~~~~~av~~LH~~~~~~ 447 (447)
T COG0527 380 EEGLALVSIVGAGMRSNPGVAARIFQALAEENINIIMIS--SSEISISFVVDEKDAEKAVRALHEAFFLG 447 (447)
T ss_pred eCCeeEEEEEccccccCcCHHHHHHHHHHhCCCcEEEEE--cCCceEEEEEccHHHHHHHHHHHHHHhcC
Confidence 899999999997 88899999999999999999999999 59999999999999999999999999863
No 4
>PRK09084 aspartate kinase III; Validated
Probab=100.00 E-value=1.2e-88 Score=734.87 Aligned_cols=440 Identities=36% Similarity=0.545 Sum_probs=392.5
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCCCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHHh
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (559)
|+|+|||||||+|++++++|+++|... +.+++||||||||+||.|+++++.+..+ .++.+.++.++++|..++++
T Consensus 1 m~V~KFGGtSv~~~e~i~~v~~ii~~~-~~~~vvVVSA~~~~Td~L~~~~~~~~~~----~~~~~~~~~i~~~h~~~~~~ 75 (448)
T PRK09084 1 LVVAKFGGTSVADFDAMNRSADIVLSN-PNTRLVVLSASAGVTNLLVALAEGAEPG----DERLALLDEIRQIQYAILDR 75 (448)
T ss_pred CEEEEECccCcCCHHHHHHHHHHHhcC-CCCEEEEEcCCCCchHHHHHHHHHHHcC----ccHHHHHHHHHHHHHHHHHH
Confidence 689999999999999999999999863 5678999999999999999998876542 35778899999999999999
Q ss_pred cCCCH---HHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCC
Q 008621 162 LGIDR---SIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (559)
Q Consensus 162 L~~~~---~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (559)
|..+. ..+.+.+++|+++++++.. +.+++.+|+|+|+||++|+.+++++|+++|++|.++|++++ ++|+++|++
T Consensus 76 l~~~~~~~~~i~~~~~~l~~l~~~~~~--~~~~~~~d~i~s~GE~lSa~l~~~~L~~~Gi~a~~l~~~~~-i~t~~~~~~ 152 (448)
T PRK09084 76 LGDPNVVREEIERLLENITVLAEAASL--ATSPALTDELVSHGELMSTLLFVELLRERGVQAEWFDVRKV-MRTDDRFGR 152 (448)
T ss_pred hccchHHHHHHHHHHHHHHHHHHhhhh--cCChhhhhhhhhHHHHHHHHHHHHHHHhCCCCcEEEchHHe-EEecCCCCc
Confidence 97654 3588899999999998866 77889999999999999999999999999999999999998 899999999
Q ss_pred ceeeecc-hHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCC
Q 008621 239 ADILEAT-YPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (559)
Q Consensus 239 a~i~~~~-~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP 317 (559)
+++.... ...+.+.+.+ +++.+ |||++||+|.+ .+|++||||||||||+|+++|++|+|+++++|||||||||+||
T Consensus 153 ~~~~~~~~~~~~~~~~~~-~~~~~-v~Vv~Gf~g~~-~~G~~ttLgRggSD~~a~~~a~~l~a~~~~i~tdv~Gi~t~dP 229 (448)
T PRK09084 153 AEPDVAALAELAQEQLLP-LLAEG-VVVTQGFIGSD-EKGRTTTLGRGGSDYSAALLAEALNASRVEIWTDVPGIYTTDP 229 (448)
T ss_pred ccccHHHHHHHHHHHHHH-hhcCC-cEEecCeeecC-CCCCEeecCCCchHHHHHHHHHHcCCCEEEEEECCCccccCCC
Confidence 8874433 2333344433 34566 99999999999 5899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCccceeeEEeeecCeEE
Q 008621 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRNVTM 397 (559)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~It~Is~~~~ial 397 (559)
|++|+|+++++|||+||.||+++|++++||+|++|++++|||++|+|+++|+.+||+|..... ....||+|+.++|+++
T Consensus 230 ~~~~~a~~i~~is~~ea~ela~~Ga~vlh~~~~~~~~~~~i~i~i~~~~~~~~~GT~I~~~~~-~~~~v~~it~~~~i~l 308 (448)
T PRK09084 230 RIVPAAKRIDEISFEEAAEMATFGAKVLHPATLLPAVRSNIPVFVGSSKDPEAGGTWICNDTE-NPPLFRAIALRRNQTL 308 (448)
T ss_pred CCCCCCeEcccCCHHHHHHHHhCCCcccCHHHHHHHHHcCCcEEEEeCCCCCCCceEEecCCC-CCCeeEEEEeeCCEEE
Confidence 999999999999999999999999999999999999999999999999999999999987643 3347999999999999
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhh--HHHHHHHHHHHHHHHHHhhhceeecccc
Q 008621 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWS--RELIQQASELDHVVEELEKIAIVNLLQH 475 (559)
Q Consensus 398 ItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~--~~~~~~~~~l~~~~~~L~~~~~v~~~~~ 475 (559)
|+|.+.+|.+.+|+++++|+.|++++|+|+|+++|+.+|+|++++++... ... ..+++..+++.+..+.+.++
T Consensus 309 Itv~~~~~~~~~g~~a~if~~l~~~~I~Vd~I~sse~sIs~~i~~~~~~~~~~~~-----~~~~l~~el~~~~~i~~~~~ 383 (448)
T PRK09084 309 LTLHSLNMLHARGFLAEVFGILARHKISVDLITTSEVSVSLTLDTTGSTSTGDTL-----LTQALLTELSQLCRVEVEEG 383 (448)
T ss_pred EEEecCCCCccccHHHHHHHHHHHcCCeEEEEeccCcEEEEEEechhhhhhhhHH-----HHHHHHHHHhcCCeEEEECC
Confidence 99999999999999999999999999999999999999999999876321 111 12345666766678888899
Q ss_pred eeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 476 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 476 ~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
+++|++||. |...||+++|+|++|++ +||.||+||+|+++|||+|+++|.++|+++||++||.
T Consensus 384 va~IsvvG~gm~~~~gv~arif~aL~~--~nI~~I~qgsSe~sIS~vV~~~d~~~al~~LH~~f~~ 447 (448)
T PRK09084 384 LALVALIGNNLSKACGVAKRVFGVLEP--FNIRMICYGASSHNLCFLVPESDAEQVVQALHQNLFE 447 (448)
T ss_pred eEEEEEECCCcccCcChHHHHHHHHHh--CCeEEEEEcCCCCcEEEEEcHHHHHHHHHHHHHHHhc
Confidence 999999997 78899999999999974 6999999999999999999999999999999999985
No 5
>PRK09034 aspartate kinase; Reviewed
Probab=100.00 E-value=2.9e-88 Score=733.32 Aligned_cols=440 Identities=32% Similarity=0.482 Sum_probs=390.9
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCCCCCcEEEEcCCCc-------ccHHHHHhhHhhhhcCcCcchhhhHHHHHHHH
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGK-------TTNKLLLAGEKAVSCGVTNISCIDELSFVKDL 154 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~~~~~vVVVSA~g~-------~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~ 154 (559)
|+|+|||||||+|++++++|+++|... .++++||||||+| +||.|+++++.+.+. .++.+.++.++++
T Consensus 1 m~V~KFGGtSv~~~~~i~~v~~ii~~~-~~~~vvVVSA~~~~~~~~~~~Td~L~~~~~~~~~~----~~~~~~~~~~~~~ 75 (454)
T PRK09034 1 MKVVKFGGSSLASAEQFKKVLNIVKSD-PERKIVVVSAPGKRFKEDTKVTDLLILYAEAVLAG----EDYEDIFEAIIAR 75 (454)
T ss_pred CEEEEeCccccCCHHHHHHHHHHHhcc-CCCEEEEEcCCcCCCCCccChHHHHHHHHHHHhcC----CcHHHHHHHHHHH
Confidence 689999999999999999999999864 4578999999986 999999988876542 3567789999999
Q ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEec
Q 008621 155 HHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (559)
Q Consensus 155 ~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (559)
|..++++|+.+.+.++.+.++|+++...+ .+.+++.+|+|+|+||++|+.+|+++|+++|+++.++|++++|++|++
T Consensus 76 ~~~~~~~L~~~~~~~~~~~~~l~~l~~~~---~~~~~~~~d~l~s~GE~~S~~l~a~~L~~~g~~a~~~~~~~~~~~t~~ 152 (454)
T PRK09034 76 YAEIAKELGLDADILEKIEEILEHLANLA---SRNPDRLLDAFKARGEDLNAKLIAAYLNYEGIPARYVDPKEAGIIVTD 152 (454)
T ss_pred HHHHHHHhccchHHHHHHHHHHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCcEEEchHHceEEecC
Confidence 99999999888777777777777776543 467889999999999999999999999999999999999999999999
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCccccc
Q 008621 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (559)
Q Consensus 235 ~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~t 314 (559)
+|+++.+...++.++.+. ...+.|||+|||+|.+ .+|+++|||||||||||+++|++|+|++++||||||||||
T Consensus 153 ~~~~a~i~~~~~~~~~~~-----~~~~~v~Vv~GFig~~-~~g~~ttlgRggSD~tA~~la~~l~A~~~~i~tdV~Gi~t 226 (454)
T PRK09034 153 EPGNAQVLPESYDNLKKL-----RDRDEKLVIPGFFGVT-KDGQIVTFSRGGSDITGAILARGVKADLYENFTDVDGIYA 226 (454)
T ss_pred CcCceeEcHhhHHHHHHH-----HhcCCEEEecCccccC-CCCCEEecCCCcHHHHHHHHHHHcCCCEEEEEecCCccCc
Confidence 999988866666544432 2356799999999999 5899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCc-cceeeEEeeec
Q 008621 315 CDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMS-KAVLTSIVLKR 393 (559)
Q Consensus 315 aDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~-~~~It~Is~~~ 393 (559)
+|||++|+|+++++|||+||.||+++|++||||+|++||+++|||++|+|+++|+++||+|....+.. +..||+|+.++
T Consensus 227 aDPr~v~~A~~l~~lsy~Ea~ela~~Gakvlhp~ai~~a~~~~Ipi~v~~~~~p~~~GT~I~~~~~~~~~~~Vk~It~~~ 306 (454)
T PRK09034 227 ANPRIVKNPKSIKEITYREMRELSYAGFSVFHDEALIPAYRGGIPINIKNTNNPEDPGTLIVPDRDNKNKNPITGIAGDK 306 (454)
T ss_pred CCCCCCCCCeECCccCHHHHHHHHhCCcccCCHHHHHHHHHcCCCEEEEcCCCCCCCccEEEeccccCccccceEEEecC
Confidence 99999999999999999999999999999999999999999999999999999999999998764322 24799999999
Q ss_pred CeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhh---hcee
Q 008621 394 NVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQASELDHVVEELEK---IAIV 470 (559)
Q Consensus 394 ~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~---~~~v 470 (559)
|+++|++.+.+|.+.+|+++++|+.|+++||+|+|+++++.+++|++++++.... .+..+..++++ ...+
T Consensus 307 ~i~~Itv~~~~~~~~~g~~a~if~~la~~~I~Vd~i~ss~~sis~~v~~~~~~~a-------~~~~l~~el~~~~~~~~I 379 (454)
T PRK09034 307 GFTSIYISKYLMNREVGFGRKVLQILEDHGISYEHMPSGIDDLSIIIRERQLTPK-------KEDEILAEIKQELNPDEL 379 (454)
T ss_pred CEEEEEEccCCCCCCccHHHHHHHHHHHcCCeEEEEcCCCcEEEEEEeHHHhhHH-------HHHHHHHHHHHhhCCceE
Confidence 9999999988899999999999999999999999999999999999987754310 01233444442 3568
Q ss_pred ecccceeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccCc
Q 008621 471 NLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFESD 542 (559)
Q Consensus 471 ~~~~~~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~~ 542 (559)
.+.+++++|++||. |...+++++++|++|+++||||.||+|+.|+.+|+|+|++++.+++++.||++||..+
T Consensus 380 ~~~~~va~VsivG~g~~~~~gv~arif~aL~~~~InV~mIsq~~Se~~Is~vV~~~d~~~av~~LH~~f~~~~ 452 (454)
T PRK09034 380 EIEHDLAIIMVVGEGMRQTVGVAAKITKALAEANINIQMINQGSSEISIMFGVKNEDAEKAVKAIYNAFFKEV 452 (454)
T ss_pred EEeCCEEEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCCcceEEEEEcHHHHHHHHHHHHHHHhccc
Confidence 88899999999997 7788999999999999999999999999999999999999999999999999999754
No 6
>PRK06291 aspartate kinase; Provisional
Probab=100.00 E-value=9.1e-87 Score=724.44 Aligned_cols=450 Identities=39% Similarity=0.667 Sum_probs=402.5
Q ss_pred ceEEEEeCccccCCHHHHHHHHHHHHcC--CCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHH
Q 008621 81 LTCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (559)
Q Consensus 81 ~~~V~KFGGsSl~~~~~~~~va~iI~~~--~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~ 158 (559)
|++|+|||||||+|++++++++++|... .+.+++||||||+|+||.|+++++.+... ...+++.+.++.++++|..+
T Consensus 1 ~~~V~KFGGtSv~~~~~~~~v~~ii~~~~~~~~~~vvVvSA~~~~Td~L~~~~~~~~~~-~~~~~~~~~~~~i~~~~~~~ 79 (465)
T PRK06291 1 MRLVMKFGGTSVGDGERIRHVAKLVKRYRSEGNEVVVVVSAMTGVTDALLEIAEQALDV-RDIAKVKDFIADLRERHYKA 79 (465)
T ss_pred CcEEEEeCcccCCCHHHHHHHHHHHHHHHhcCCCEEEEEcCCCCCHHHHHHHHHHHHhc-cchhhHHHHHHHHHHHHHHH
Confidence 4689999999999999999999999964 34678999999999999999988765331 11245778899999999999
Q ss_pred HHhcCCCH-------HHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEE
Q 008621 159 VDELGIDR-------SIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (559)
Q Consensus 159 ~~~L~~~~-------~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (559)
+++|..++ ..++..+++|+++++++..+++++++.+|+|+|+||++|+.|++++|+++|++|.++++++++++
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~~Sa~l~~~~L~~~Gi~a~~l~~~~~~i~ 159 (465)
T PRK06291 80 IEEAIKDPDIREEVSKTIDSRIEELEKALVGVSYLGELTPRSRDYILSFGERLSAPILSGALRDLGIKSVALTGGEAGII 159 (465)
T ss_pred HHHhhcChhhHHHHHHHHHHHHHHHHHHHHHHHHhccCChHHHHHHHhhhHHHHHHHHHHHHHhCCCCeEEEchHHCcEE
Confidence 99997543 24788899999999999999999999999999999999999999999999999999999999999
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcc
Q 008621 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (559)
Q Consensus 232 t~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~G 311 (559)
|+++|+++.+.+.++.++.+.+.. +++.+.|||++||+|.+ .+|+++|||||||||+|+++|.+|+|+++++||||||
T Consensus 160 t~~~~~~~~~~~~~~~~~~~~~~~-ll~~~~vpVv~Gfig~~-~~g~~~tlgrggsD~~A~~~A~~l~a~~~~i~tdV~G 237 (465)
T PRK06291 160 TDSNFGNARPLPKTYERVKERLEP-LLKEGVIPVVTGFIGET-EEGIITTLGRGGSDYSAAIIGAALDADEIWIWTDVDG 237 (465)
T ss_pred ecCCCCceeechhhHHHHHHHHHH-HhhcCcEEEEeCcEEcC-CCCCEEEecCCChHHHHHHHHHhcCCCEEEEEECCCC
Confidence 999999888766677777766654 46788999999999998 5899999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCccceeeEEee
Q 008621 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVL 391 (559)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~It~Is~ 391 (559)
|||+||+++|+|+++++|+|+||.+|+++|++++||+|++|++++|||++|+|+++|+++||+|.+...+....|++|+.
T Consensus 238 i~~~dP~~~~~a~~i~~l~~~ea~~l~~~G~~v~~~~a~~~~~~~~i~i~i~~~~~~~~~gt~i~~~~~~~~~~V~~It~ 317 (465)
T PRK06291 238 VMTTDPRIVPEARVIPKISYIEAMELSYFGAKVLHPRTIEPAMEKGIPVRVKNTFNPEFPGTLITSDSESSKRVVKAVTL 317 (465)
T ss_pred CCCCCCCCCCCCeEccccCHHHHHHHHhCCCcccCHHHHHHHHHcCCcEEEecCCCCCCCceEEEecccccCcccceEEe
Confidence 99999999999999999999999999999999999999999999999999999999999999998765444457999999
Q ss_pred ecCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEE--ecCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhh--h
Q 008621 392 KRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA--TSEVSLSLTLDPSKLWSRELIQQASELDHVVEELEK--I 467 (559)
Q Consensus 392 ~~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Is--tSe~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~--~ 467 (559)
++++++|++.+.+|.+.+|+++++|+.|+++||+|+|++ +++.+++|+++.++... + +..+.+++.. .
T Consensus 318 ~~~valIsI~g~~m~~~~g~~arvf~~L~~~gI~V~mIsq~sse~sIsf~V~~~d~~~--a------v~~L~~~~~~~~~ 389 (465)
T PRK06291 318 IKNVALINISGAGMVGVPGTAARIFSALAEEGVNVIMISQGSSESNISLVVDEADLEK--A------LKALRREFGEGLV 389 (465)
T ss_pred eCCEEEEEEeCCCCCCCccHHHHHHHHHHHCCCcEEEEEecCCCceEEEEEeHHHHHH--H------HHHHHHHHHHhcC
Confidence 999999999999999999999999999999999999998 57899999999865421 1 1222222332 4
Q ss_pred ceeecccceeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008621 468 AIVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 541 (559)
Q Consensus 468 ~~v~~~~~~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 541 (559)
..+++.+++++|++||. |...+|+++|+|++|+++||||.||+||+|+++|||+|+++|.++|+++||++|+..
T Consensus 390 ~~i~~~~~~a~IsvvG~gm~~~~gv~~rif~aL~~~~I~v~~isqgsSe~~Is~vV~~~d~~~av~~Lh~~f~~~ 464 (465)
T PRK06291 390 RDVTFDKDVCVVAVVGAGMAGTPGVAGRIFSALGESGINIKMISQGSSEVNISFVVDEEDGERAVKVLHDEFILG 464 (465)
T ss_pred cceEEeCCEEEEEEEcCCccCCcChHHHHHHHHHHCCCCEEEEEeccccCeEEEEEeHHHHHHHHHHHHHHhccC
Confidence 56888999999999997 788999999999999999999999999999999999999999999999999999753
No 7
>PRK09181 aspartate kinase; Validated
Probab=100.00 E-value=1.2e-85 Score=712.06 Aligned_cols=435 Identities=28% Similarity=0.377 Sum_probs=363.4
Q ss_pred CcceEEEEeCccccCCHHHHHHHHH-HHHcCC----CCCcEEEEcCCCcccHHHHHhhHhh-------hhcCcCcchhhh
Q 008621 79 KQLTCVMKFGGSSLASAERMREVAE-LILSFP----NERPVIVLSAMGKTTNKLLLAGEKA-------VSCGVTNISCID 146 (559)
Q Consensus 79 ~~~~~V~KFGGsSl~~~~~~~~va~-iI~~~~----~~~~vVVVSA~g~~Td~L~~~~~~~-------~~~~~~~~~~~~ 146 (559)
+|+.+|+||||||| +++++|.+ |+.... ..+.+||||||||+||.|+++.+.+ ...+ ..+++.+
T Consensus 1 ~~~~~V~KFGGtSv---~~~~~v~~~iv~~~~~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~-~~~~~~~ 76 (475)
T PRK09181 1 MMMHTVEKIGGTSM---SAFDAVLDNIILRPRKGEDLYNRIFVVSAYGGVTDALLEHKKTGEPGVYALFAKA-NDEAWRE 76 (475)
T ss_pred CCceEEEEECCCcH---HHHHHHHhheEeccccccCCCCeEEEEeCCCcchHHHHHhHhhcchhHHHHHHHh-cCccHHH
Confidence 46689999999999 45666766 444331 2578999999999999999866411 1110 1346778
Q ss_pred HHHHHHHHHHHHHHhcCCCH-------HH-------HHHHHHHHHHHHH-hhhhccCCCHHHHHHHHhhhHHHHHHHHHH
Q 008621 147 ELSFVKDLHHRTVDELGIDR-------SI-------IATHLEELEQLLK-GIAMLKELTPRSRDYLVSFGECMSTRIFAA 211 (559)
Q Consensus 147 ~l~~i~~~~~~~~~~L~~~~-------~~-------i~~~~~~l~~~l~-~i~~~~~~~~~~~d~ils~GE~lsa~ll~~ 211 (559)
.++.++++|..++++|..+. +. +..++.++++++. ++.++++++++.+|+|+|+||++|+.||+.
T Consensus 77 ~l~~i~~~~~~i~~~L~~~~~~~~~~~~~i~~~~~~~~~~l~~l~~~l~~~~~~l~e~~~~~~D~l~s~GE~lSa~lla~ 156 (475)
T PRK09181 77 ALEAVEQRMLAINAELFADGLDLARADKFIRERIEEARACLIDLQRLCAYGHFSLDEHLLTVREMLASIGEAHSAFNTAL 156 (475)
T ss_pred HHHHHHHHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHHHHHHHHHhcCcchhhccChhHhHHHhhHhHHHHHHHHHH
Confidence 89999999999999997432 12 3667777777777 888899999999999999999999999999
Q ss_pred HHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHH
Q 008621 212 YLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTA 291 (559)
Q Consensus 212 ~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tA 291 (559)
+|+++|++|.++|+..+ ..++ +.. ..+++.+.+.. |...+.|||+|||++ + ++|++||||||||||||
T Consensus 157 ~L~~~Gi~a~~ld~~~~--~~~~------~~~-~~~~i~~~l~~-~~~~~~v~Vv~GF~~-~-~~G~itTLGRGGSDyTA 224 (475)
T PRK09181 157 LLQNRGVNARFVDLTGW--DDDD------PLT-LDERIKKAFKD-IDVTKELPIVTGYAK-C-KEGLMRTFDRGYSEMTF 224 (475)
T ss_pred HHHhCCCCeEEeccccc--cCCc------ccc-hHHHHHHHHhh-hccCCcEEEecCCcC-C-CCCCEEecCCChHHHHH
Confidence 99999999999987543 1111 111 23445544432 223567999999975 5 47999999999999999
Q ss_pred HHHHHHcCcCcEEEeeCCcccccCCCCCC--CCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC
Q 008621 292 TTIGKALGLQEIQVWKDVDGVLTCDPNIH--PHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN 369 (559)
Q Consensus 292 a~lA~~L~A~~l~i~TDV~GV~taDP~~v--~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~ 369 (559)
++||++|+|++|+|||||+ |||+|||++ |+|++|++|||+||.||+++||+||||+|++||+++|||++|+|+|+|+
T Consensus 225 ailAa~L~A~~~~IwTDV~-I~taDPriV~~~~A~~i~~lsy~Ea~ELA~~GAkVLHp~ti~pa~~~~Ipi~V~nt~~p~ 303 (475)
T PRK09181 225 SRIAVLTGADEAIIHKEYH-LSSADPKLVGEDKVVPIGRTNYDVADQLANLGMEAIHPKAAKGLRQAGIPLRIKNTFEPE 303 (475)
T ss_pred HHHHHHcCCCEEEEeCCCc-cccCCCCcCCCCCCeEcCccCHHHHHHHHHcCchhcCHHHHHHHHHcCCeEEEecCCCCC
Confidence 9999999999999999997 999999999 6999999999999999999999999999999999999999999999999
Q ss_pred CCCeEEecCCCCccceeeEEeeecCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhhHH
Q 008621 370 APGTLIRRSRDMSKAVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRE 449 (559)
Q Consensus 370 ~~GT~I~~~~~~~~~~It~Is~~~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~~~ 449 (559)
.+||+|.+...+....+++|+.++++++|++.+.+|.+.+|+++++|+.|++++|+|+++++++.+++|+++.+ ..
T Consensus 304 ~~GT~I~~~~~~~~~~ik~It~~~~~~~i~i~~~~~~~~~g~~~~if~~l~~~~i~v~~i~ss~~sis~~v~~~-~~--- 379 (475)
T PRK09181 304 HPGTLITKDYVSEQPRVEIIAGSDKVFALEVFDQDMVGEDGYDLEILEILTRHKVSYISKATNANTITHYLWGS-LK--- 379 (475)
T ss_pred CCCeEEecCcccccccceeEeccCCEEEEEEcCCCCCCcchHHHHHHHHHHHcCCeEEEEEecCcEEEEEEcCC-hH---
Confidence 99999987543344568999999999999999999999999999999999999999999999999999999876 11
Q ss_pred HHHHHHHHHHHHHHHhh---hceeecccceeEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEeccc
Q 008621 450 LIQQASELDHVVEELEK---IAIVNLLQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDE 526 (559)
Q Consensus 450 ~~~~~~~l~~~~~~L~~---~~~v~~~~~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d 526 (559)
.+++++++|++ ...+.. +++|+|++||..+..+|+++|+|++|+++|||+.||+||+|+++||++|+++|
T Consensus 380 ------~~~~~~~~L~~~~~~~~i~~-~~~a~VsvVG~gm~~~gv~ak~f~aL~~~~Ini~~i~qg~se~~Is~vV~~~d 452 (475)
T PRK09181 380 ------TLKRVIAELEKRYPNAEVTV-RKVAIVSAIGSNIAVPGVLAKAVQALAEAGINVLALHQSMRQVNMQFVVDEDD 452 (475)
T ss_pred ------HHHHHHHHHHHhcCCceEEE-CCceEEEEeCCCCCcccHHHHHHHHHHHCCCCeEEEEecCCcceEEEEEeHHH
Confidence 12233334442 134664 89999999998335899999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhccC
Q 008621 527 AEQCVRALHETFFES 541 (559)
Q Consensus 527 ~~kAv~~LH~~f~~~ 541 (559)
.++|+++||++||..
T Consensus 453 ~~~Av~~lH~~f~~~ 467 (475)
T PRK09181 453 YEKAICALHEALVEN 467 (475)
T ss_pred HHHHHHHHHHHHhcC
Confidence 999999999999854
No 8
>PRK05925 aspartate kinase; Provisional
Probab=100.00 E-value=6.8e-84 Score=693.01 Aligned_cols=436 Identities=26% Similarity=0.387 Sum_probs=378.0
Q ss_pred cceEEEEeCccccCCHHHHHHHHHHHHcCCCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHH
Q 008621 80 QLTCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~~~~~~va~iI~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (559)
|.|+|+|||||||+|++++++++++|... .+++||||||+|+||.|+++++.+. ....+.++.++++|..++
T Consensus 1 ~~~~V~KFGGtSv~~~e~i~~v~~ii~~~--~~~vVVvSA~~~~Td~L~~~~~~a~------~~~~~~~~~i~~~~~~~~ 72 (440)
T PRK05925 1 MAPLVYKFGGTSLGTAESIRRVCDIICKE--KPSFVVVSAVAGVTDLLEEFCRLSK------GKREALTEKIREKHEEIA 72 (440)
T ss_pred CCcEEEEECccccCCHHHHHHHHHHHhcC--CCEEEEECCCCCCHHHHHHHHHHhh------hhHHHHHHHHHHHHHHHH
Confidence 57899999999999999999999999863 5689999999999999999877542 224567899999999999
Q ss_pred HhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCc
Q 008621 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNA 239 (559)
Q Consensus 160 ~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a 239 (559)
++|..+. .+.+++++|++++. .++++++.+|+++|+||++|+.|++++|+++|++|.++|++++ ++|+++|+++
T Consensus 73 ~~l~~~~-~~~~~~~~L~~~~~----~~~~~~~~~d~i~s~GE~~Sa~l~a~~L~~~Gi~a~~ld~~~~-i~t~~~~~~a 146 (440)
T PRK05925 73 KELGIEF-SLSPWWERLEHFED----VEEISSEDQARILAIGEDISASLICAYCCTYVLPLEFLEARQV-ILTDDQYLRA 146 (440)
T ss_pred HHhhcch-hhhHHHHHHHHHHH----hCcCCchhhhhheehhHHHHHHHHHHHHHhCCCCeEEEcHHHh-EeecCCcccc
Confidence 9997643 25566777777765 4677889999999999999999999999999999999999998 8999999988
Q ss_pred eeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCC
Q 008621 240 DILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (559)
Q Consensus 240 ~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~ 319 (559)
+++ .+.+.+.+....++++.|||+|||+|.+ ++|+++|||||||||+|+++|.+|+|++++||||||||||+||++
T Consensus 147 ~~~---~~~~~~~~~~~~~~~~~v~Vv~GF~g~~-~~G~~ttLgrGgsD~~AallA~~l~Ad~~~i~TdVdGvytaDP~~ 222 (440)
T PRK05925 147 VPD---LALMQTAWHELALQEDAIYIMQGFIGAN-SSGKTTVLGRGGSDFSASLIAELCKAREVRIYTDVNGIYTMDPKI 222 (440)
T ss_pred ccC---HHHHHHHHHHhhccCCcEEEecCcceeC-CCCCEEEeccCcHHHHHHHHHHHcCCCEEEEEEcCCccCCCCcCC
Confidence 873 2233344443334566899999999999 589999999999999999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCC--CccceeeEEeeecCeEE
Q 008621 320 HPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRD--MSKAVLTSIVLKRNVTM 397 (559)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~--~~~~~It~Is~~~~ial 397 (559)
+|+|++|++++|+||.||+++|++++||++++||+++|||++|+|+++|+++||+|.+..+ .+...||+|+.++|+++
T Consensus 223 ~~~A~~i~~is~~ea~ela~~Ga~vl~~~~~~~a~~~~Ipi~I~~~~~p~~~GT~i~~~~~~~~~~~~ik~It~~~~~~~ 302 (440)
T PRK05925 223 IKDAQLIPELSFEEMQNLASFGAKVLHPPMLKPCVRAGIPIFVTSTFDVTKGGTWIYASDKEVSYEPRIKALSLKQNQAL 302 (440)
T ss_pred CCCCeEeeEECHHHHHHHHhCCCCcCCHHHHHHHHHCCCcEEEecCCCCCCCccEEecCCccccCCCceEEEEEeCCEEE
Confidence 9999999999999999999999999999999999999999999999999999999987532 33446999999999999
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeeccccee
Q 008621 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRS 477 (559)
Q Consensus 398 ItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~a 477 (559)
+++.+. ....++++++|+.|+++||+++++++++.+++|+++.++... . .+..+..+++.+..+++.+++|
T Consensus 303 i~v~~~--~~~~~~~~~if~~l~~~~I~vd~i~s~~~sis~~i~~~~~~~-~------~~~~l~~~l~~~~~i~~~~~~a 373 (440)
T PRK05925 303 WSVDYN--SLGLVRLEDVLGILRSLGIVPGLVMAQNLGVYFTIDDDDISE-E------YPQHLTDALSAFGTVSCEGPLA 373 (440)
T ss_pred EEEecC--CcchhHHHHHHHHHHHcCCcEEEEeccCCEEEEEEechhccH-H------HHHHHHHHhcCCceEEEECCEE
Confidence 999753 235788999999999999999999877899999999765321 1 2333455566667788899999
Q ss_pred EEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccCccc
Q 008621 478 IISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFESDLA 544 (559)
Q Consensus 478 iISIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~~~~ 544 (559)
+||+||..+..+++++++|.+|++.|||+.+++| |+.+|||+|+++|.++|+++||++||.++|+
T Consensus 374 ~VsvVG~gm~~~~v~~~~~~aL~~~~Ini~~i~~--s~~~is~vV~~~d~~~av~~LH~~f~~~~~~ 438 (440)
T PRK05925 374 LITMIGAKLASWKVVRTFTEKLRGYQTPVFCWCQ--SDMALNLVVNEELAVAVTELLHNDYVKQKFS 438 (440)
T ss_pred EEEEeCCCcccccHHHHHHHHHhhCCCCEEEEEC--CCceEEEEEehHHHHHHHHHHHHHHhccccc
Confidence 9999998333488999999999999999999988 6679999999999999999999999999886
No 9
>PRK09466 metL bifunctional aspartate kinase II/homoserine dehydrogenase II; Provisional
Probab=100.00 E-value=7.4e-83 Score=726.94 Aligned_cols=439 Identities=24% Similarity=0.358 Sum_probs=370.1
Q ss_pred CCcceEEEEeCccccCCHHHHHHHHHHHHcCCCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHH
Q 008621 78 EKQLTCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (559)
Q Consensus 78 ~~~~~~V~KFGGsSl~~~~~~~~va~iI~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~ 157 (559)
..|.|+|+|||||||+|++++++|+++|....+.+++||||||+|+||.|+++++.+... ...+.+.++.++++|.+
T Consensus 8 ~~M~~~V~KFGGtSv~~~e~i~~v~~iI~~~~~~~~vVVVSA~~~~Td~L~~~~~~~~~~---~~~~~~~l~~i~~~h~~ 84 (810)
T PRK09466 8 GAMGRQLHKFGGSSLADAKCYRRVAGILAEYSQPDDLVVVSAAGKTTNQLISWLKLSQTD---RLSAHQVQQTLRRYQQD 84 (810)
T ss_pred ccceeEEEEECccccCCHHHHHHHHHHHhhhccCCEEEEEcCCCCCHHHHHHHHHHhhcC---chhHHHHHHHHHHHHHH
Confidence 567899999999999999999999999997655568999999999999999988765321 23456778999999999
Q ss_pred HHHhcCCCHH------HHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEE
Q 008621 158 TVDELGIDRS------IIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (559)
Q Consensus 158 ~~~~L~~~~~------~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (559)
++++|..+.. .+.+.+++|++++. ++++++.+|+|+|+||+||+.||+++|+++|+++.++|++++ +
T Consensus 85 ~~~~L~~~~~~~~~~~~i~~~~~~l~~~l~-----~~~~~~~~d~ils~GE~~Sa~lla~~L~~~G~~a~~ld~~~~--i 157 (810)
T PRK09466 85 LIEGLLPAEQARSLLSRLISDLERLAALLD-----GGINDAQYAEVVGHGEVWSARLMAALLNQQGLPAAWLDARSF--L 157 (810)
T ss_pred HHHHhhcchhhhHHHHHHHHHHHHHHHHhh-----ccCCchhhhheecHHHHHHHHHHHHHHHhCCCCcEEEcHHHh--e
Confidence 9999976432 25556666666665 478889999999999999999999999999999999999995 5
Q ss_pred EecCCCCceee-ecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCc
Q 008621 232 TTDDFTNADIL-EATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVD 310 (559)
Q Consensus 232 t~~~~~~a~i~-~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~ 310 (559)
+++++.++++. ..+.+++.+.+.. ..+.+||+|||+|.+ ++|++||||||||||||+++|++|+|++|+||||||
T Consensus 158 ~~~~~~~~~i~~~~~~~~l~~~~~~---~~~~v~Vv~GF~g~~-~~G~~ttLGRGGSD~tA~~la~~l~A~~v~i~tDV~ 233 (810)
T PRK09466 158 RAERAAQPQVDEGLSYPLLQQLLAQ---HPGKRLVVTGFISRN-EAGETVLLGRNGSDYSATLIGALAGVERVTIWSDVA 233 (810)
T ss_pred ecCCCCCcccchhhhHHHHHHHHhc---cCCeEEEeeCccccC-CCCCEEEcCCChHHHHHHHHHHHcCCCEEEEEeCCC
Confidence 55555556653 2344444443321 134799999999999 589999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCccceeeEEe
Q 008621 311 GVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIV 390 (559)
Q Consensus 311 GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~It~Is 390 (559)
||||+|||++|+|++|++|||+||.||+++||+||||+|++|++++||||+|+|+|+|+.+||+|..... ....+++|+
T Consensus 234 Gi~taDPr~v~~A~~i~~isy~Ea~ela~~GakVlHp~ti~pa~~~~Ipi~V~ntf~p~~~GT~I~~~~~-~~~~v~~It 312 (810)
T PRK09466 234 GVYSADPRKVKDACLLPLLRLDEASELARLAAPVLHARTLQPVSGSDIDLQLRCSYQPEQGSTRIERVLA-SGTGARIVT 312 (810)
T ss_pred ccccCCcccCCCceEcccCCHHHHHHHHHcCccccCHHHHHHHHHcCCeEEEecCCCCCCCceEEecCcc-cccceeeee
Confidence 9999999999999999999999999999999999999999999999999999999999999999986422 233589999
Q ss_pred eecCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe--cCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhc
Q 008621 391 LKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIA 468 (559)
Q Consensus 391 ~~~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist--Se~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~ 468 (559)
.++++++|++.+.++.+.+|+++++|+.|++++|+++|+++ ++.+++|+++.++.. .+...++++....
T Consensus 313 ~~~~v~~i~i~~~~~~g~~g~~~~if~~l~~~~I~v~~i~~~~s~~sis~~i~~~~~~---------~~~~~l~~~~~~~ 383 (810)
T PRK09466 313 SLDDVCLIELQVPASHDFKLAQKELDQLLKRAQLRPLAVGVHPDRQLLQLAYTSEVAD---------SALKLLDDAALPG 383 (810)
T ss_pred ccCCEEEEEEecCCcCCcchHHHHHHHHHHHCCCeEEEEEecCCCcEEEEEEeHHHHH---------HHHHHHHhhcCCC
Confidence 99999999999887788899999999999999999999964 456799999755321 1122222332346
Q ss_pred eeecccceeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccCc
Q 008621 469 IVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFESD 542 (559)
Q Consensus 469 ~v~~~~~~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~~ 542 (559)
.+.+.+++|+||+||. |.+.+|+++|+|++|.+.+|++ +++++|+.||||+|+++|.++|+++||++||...
T Consensus 384 ~i~v~~~~a~VsvVG~gm~~~~gv~~~~f~aL~~~~I~i--i~~~~s~~sis~vV~~~d~~~av~~LH~~f~~~~ 456 (810)
T PRK09466 384 ELKLREGLALVALVGAGVTRNPLHCHRFYQQLKDQPVEF--IWQSEDGLSLVAVLRQGPTESLIQGLHQSLFRAE 456 (810)
T ss_pred cEEEeCCeEEEEEeCCCcccCccHHHHHHHHHHhCCCcE--EEEeCCCcEEEEEEehHHHHHHHHHHHHHHhCcC
Confidence 7888899999999997 7889999999999999886665 5556699999999999999999999999999763
No 10
>PRK09436 thrA bifunctional aspartokinase I/homoserine dehydrogenase I; Provisional
Probab=100.00 E-value=6.1e-81 Score=715.97 Aligned_cols=445 Identities=32% Similarity=0.510 Sum_probs=388.3
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCC-CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHH
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVD 160 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~-~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~ 160 (559)
|+|+|||||||++++++++++++|.... ..++|||||||+|+||.|+++++.+.+. +.++...++.++++|. +++
T Consensus 1 m~V~KFGGtSv~~~~~i~~v~~iI~~~~~~~~~vVVVSA~~~vTd~L~~~~~~~~~~---~~~~~~~~~~~~~~h~-~~~ 76 (819)
T PRK09436 1 MRVLKFGGTSVANAERFLRVADIIESNARQEQVAVVLSAPAKVTNHLVAMIEKAAKG---DDAYPEILDAERIFHE-LLD 76 (819)
T ss_pred CEEEEeCccccCCHHHHHHHHHHHHhhcccCCEEEEEcCCcCcHHHHHHHHHHHhcC---CchHHHHHHHHHHHHH-HHH
Confidence 6899999999999999999999999753 3678999999999999999998876542 1345667888888884 333
Q ss_pred hc---CCC------HHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEE
Q 008621 161 EL---GID------RSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (559)
Q Consensus 161 ~L---~~~------~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (559)
.| ... .+.+.+.+++|++++++++++++++++.+|+|+|+||+||+.||+++|+++|++|.++|++++ ++
T Consensus 77 ~l~~~~~~~~~~~~~~~i~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-i~ 155 (819)
T PRK09436 77 GLAAALPGFDLAQLKAKVDQEFAQLKDILHGISLLGECPDSVNAAIISRGERLSIAIMAAVLEARGHDVTVIDPREL-LL 155 (819)
T ss_pred HHHhhccchhhHHHHHHHHHHHHHHHHHHHHHHhhccCChhhhhheeeHHHHHHHHHHHHHHHhCCCCeEEECHHHe-EE
Confidence 33 111 135888999999999999999999999999999999999999999999999999999999998 88
Q ss_pred EecCCCCceee-ecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCc
Q 008621 232 TTDDFTNADIL-EATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVD 310 (559)
Q Consensus 232 t~~~~~~a~i~-~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~ 310 (559)
|++.|+++.+. +...+.+++. +.+.+.|||+|||+|.+ .+|+++||||||||++|+++|.+|+|+++++|||||
T Consensus 156 t~~~~~~~~~~~~~~~~~i~~~----~~~~~~v~Vv~Gfig~~-~~G~~ttlGRgGSD~~A~~~A~~l~A~~~~i~tdVd 230 (819)
T PRK09436 156 ADGHYLESTVDIAESTRRIAAS----FIPADHVILMPGFTAGN-EKGELVTLGRNGSDYSAAILAACLDADCCEIWTDVD 230 (819)
T ss_pred ecCCCCCceechHhhHHHHHHH----HhcCCcEEEecCcccCC-CCCCEEEeCCCCchHHHHHHHHHcCCCEEEEEECCC
Confidence 88888888873 3344444433 23457899999999998 589999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCccceeeEEe
Q 008621 311 GVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIV 390 (559)
Q Consensus 311 GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~It~Is 390 (559)
||||+||+++|+|++|++|||+||.+|+++|++++||+|++||+++|||++|+|+++|+.+||+|+...++....|++|+
T Consensus 231 Gvyt~DP~~~~~A~~i~~isy~ea~el~~~G~kvlhp~a~~~a~~~~Ipi~i~n~~~p~~~GT~I~~~~~~~~~~Vk~It 310 (819)
T PRK09436 231 GVYTADPRVVPDARLLKSLSYQEAMELSYFGAKVLHPRTIAPIAQFQIPCLIKNTFNPQAPGTLIGAESDEDSLPVKGIS 310 (819)
T ss_pred ceECCCCCCCCCCeEeeEecHHHHHHHHhcCCccchHHHHHHHHHCCceEEEccCCCCCCCceEEEecCcccccccceEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999876544455799999
Q ss_pred eecCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEE--ecCceeEEEeCCCchhhHHHHHHHHHHHH-HHHHHh--
Q 008621 391 LKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA--TSEVSLSLTLDPSKLWSRELIQQASELDH-VVEELE-- 465 (559)
Q Consensus 391 ~~~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Is--tSe~sIs~~v~~~~~~~~~~~~~~~~l~~-~~~~L~-- 465 (559)
.++|+++|++.+.+|.+.+|+++++|+.|+++||+|+|++ +|+.+++|+++.++... +++ .+++ +..++.
T Consensus 311 ~~~dvalIsV~G~gm~~~~G~~arIf~~La~~gI~V~mIsqssSe~sIsf~V~~~d~~~--av~---~L~~~f~~el~~~ 385 (819)
T PRK09436 311 NLNNMAMFNVSGPGMKGMVGMASRVFAALSRAGISVVLITQSSSEYSISFCVPQSDAAK--AKR---ALEEEFALELKEG 385 (819)
T ss_pred EeCCEEEEEEEcCCCCCCcCHHHHHHHHHHHCCCcEEEEEcCCCCceEEEEEeHHHHHH--HHH---HHHHHHHHHhccC
Confidence 9999999999999999999999999999999999999998 56899999999876432 111 1222 112332
Q ss_pred hhceeecccceeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008621 466 KIAIVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 541 (559)
Q Consensus 466 ~~~~v~~~~~~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 541 (559)
.+..+++.+++++|++||. |...+++++|+|++|.++||||+||+||+|+++|||+|+++|.++|+++||++|+..
T Consensus 386 ~~~~i~~~~~valIsvvG~gm~~~~gv~arif~aL~~~~InI~~IsqgsSe~~Is~vV~~~d~~~al~~LH~~f~~~ 462 (819)
T PRK09436 386 LLEPLEVEENLAIISVVGDGMRTHPGIAAKFFSALGRANINIVAIAQGSSERSISVVIDNDDATKALRACHQSFFLS 462 (819)
T ss_pred CcceEEEeCCEEEEEEEccCcccCcCHHHHHHHHHHHCCCCEEEEEeccccceEEEEEcHHHHHHHHHHHHHHHhcc
Confidence 2456888899999999997 888999999999999999999999999999999999999999999999999999876
No 11
>PRK08961 bifunctional aspartate kinase/diaminopimelate decarboxylase protein; Provisional
Probab=100.00 E-value=1.7e-79 Score=710.48 Aligned_cols=449 Identities=27% Similarity=0.469 Sum_probs=389.5
Q ss_pred CCcceEEEEeCccccCCHHHHHHHHHHHHcC--CCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHH
Q 008621 78 EKQLTCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLH 155 (559)
Q Consensus 78 ~~~~~~V~KFGGsSl~~~~~~~~va~iI~~~--~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~ 155 (559)
..|.|+|+|||||||+|++++++++++|... .+++++||||||+|+||+|+++++.+.+ .++.+.++.++++|
T Consensus 5 ~~~~~~V~KFGGtSv~~~~~~~~v~~ii~~~~~~~~~~vvVvSA~~~~Td~L~~~~~~~~~-----~~~~~~~~~i~~~~ 79 (861)
T PRK08961 5 STDRWVVLKFGGTSVSRRHRWDTIAKIVRKRLAEGGRVLVVVSALSGVSNELEAIIAAAGA-----GDSASRVAAIRQRH 79 (861)
T ss_pred CCCCcEEEEECccccCCHHHHHHHHHHHHhhcccCCCEEEEEeCCCCchHHHHHHHHHHhc-----cCHHHHHHHHHHHH
Confidence 3478899999999999999999999999864 2467899999999999999998765432 34678899999999
Q ss_pred HHHHHhcCCCHH-HHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEec
Q 008621 156 HRTVDELGIDRS-IIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (559)
Q Consensus 156 ~~~~~~L~~~~~-~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (559)
..++++|+.+.+ .+.+.+++|+++++++..+++.+++.+|+++|+||++|+.||+++|+++|+++.++|++++ +++++
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-~~~~~ 158 (861)
T PRK08961 80 RELLAELGVDAEAVLAERLAALQRLLDGIRALTRASLRWQAEVLGQGELLSTTLGAAYLEASGLDMGWLDAREW-LTALP 158 (861)
T ss_pred HHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHhccCChhhhheEEEehHHHHHHHHHHHHHhCCCCcEEEcHHHh-EeecC
Confidence 999999976643 6889999999999999999999999999999999999999999999999999999999998 55655
Q ss_pred C-CC--Cceeeecch-HHHHHHHhhchhcCC-cEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCC
Q 008621 235 D-FT--NADILEATY-PAVAKRLHGDWITDL-AIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDV 309 (559)
Q Consensus 235 ~-~~--~a~i~~~~~-~~i~~~l~~~l~~~~-~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV 309 (559)
+ +. ......... ......+...+++.+ .|||+|||+|.+ .+|++|||||||||++|+++|.+|+|+++++||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~Vv~Gf~g~~-~~g~~ttLgrggsD~~A~~iA~~l~a~~~~i~tdv 237 (861)
T PRK08961 159 QPNQSEWSQYLSVSCQWQSDPALRERFAAQPAQVLITQGFIARN-ADGGTALLGRGGSDTSAAYFAAKLGASRVEIWTDV 237 (861)
T ss_pred ccccccccccccceecHhhHHHHHHHHhccCCeEEEeCCcceeC-CCCCEEEEeCCchHHHHHHHHHHcCCCEEEEEeCC
Confidence 2 21 122211110 112222332233444 599999999999 58999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCccceeeEE
Q 008621 310 DGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSI 389 (559)
Q Consensus 310 ~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~It~I 389 (559)
|||||+||+++|+|+++++|||+||.||+++|++|+||+|++||+++|||++|+|+++|+.+||+|..+. +....||+|
T Consensus 238 ~Gv~t~dP~~~~~a~~i~~ls~~e~~el~~~g~~v~~~~a~~~a~~~~i~i~v~~~~~~~~~gT~I~~~~-~~~~~v~~I 316 (861)
T PRK08961 238 PGMFSANPKEVPDARLLTRLDYDEAQEIATTGAKVLHPRSIKPCRDAGIPMAILDTERPDLSGTSIDGDA-EPVPGVKAI 316 (861)
T ss_pred CccccCCCCCCCCceEecccCHHHHHHHHHCCCeEECHHHHHHHHHCCCCEEEEeCCCCCCCccEEeCCC-CCCCcceeE
Confidence 9999999999999999999999999999999999999999999999999999999999999999998754 334579999
Q ss_pred eeecCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchh-hHHHHHHHHHHHHHHHHHhhhc
Q 008621 390 VLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLW-SRELIQQASELDHVVEELEKIA 468 (559)
Q Consensus 390 s~~~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~-~~~~~~~~~~l~~~~~~L~~~~ 468 (559)
+.++|+++|++.+.+|.+.+||++++|+.|++++|+|+||++|+.+++|++++.+.. ..+ .++.+..+++.+.
T Consensus 317 t~~~~v~lItv~~~~~~~~~g~~a~if~~la~~~I~Vd~I~sse~sis~~i~~~~~~~~~~------~~~~l~~~l~~~~ 390 (861)
T PRK08961 317 SRKNGIVLVSMETIGMWQQVGFLADVFTLFKKHGLSVDLISSSETNVTVSLDPSENLVNTD------VLAALSADLSQIC 390 (861)
T ss_pred EEECCEEEEEEecCCccccccHHHHHHHHHHHcCCeEEEEEcCCCEEEEEEccccccchHH------HHHHHHHHHhhcC
Confidence 999999999999999999999999999999999999999999999999999886532 111 2344555666667
Q ss_pred eeecccceeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccCc
Q 008621 469 IVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFESD 542 (559)
Q Consensus 469 ~v~~~~~~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~~ 542 (559)
.+.+.+++|+||+||. |...+|+++|+|++|++. +|.+++||+|+++|||+|+++|.++|++.||++||..+
T Consensus 391 ~i~~~~~va~ISvVG~gm~~~~gv~arif~aL~~~--~I~~i~~gsSe~~Is~vV~~~d~~~av~~LH~~f~~~~ 463 (861)
T PRK08961 391 RVKIIVPCAAVSLVGRGMRSLLHKLGPAWATFGAE--RVHLISQASNDLNLTFVIDESDADGLLPRLHAELIESG 463 (861)
T ss_pred cEEEeCCeEEEEEeCCCcccCcChHHHHHHHHhhc--CeEEEECCCccccEEEEEeHHHHHHHHHHHHHHHhcCC
Confidence 7888899999999997 888999999999999874 67889999999999999999999999999999999874
No 12
>TIGR00657 asp_kinases aspartate kinase. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. This may be a feature of a number of closely related forms, including a paralog from B. subtilis.
Probab=100.00 E-value=2e-76 Score=640.58 Aligned_cols=434 Identities=36% Similarity=0.583 Sum_probs=370.1
Q ss_pred ceEEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHH
Q 008621 81 LTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (559)
Q Consensus 81 ~~~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~ 158 (559)
+|+|+|||||||+|++++++++++|.... +.+++||||||+|+||.|+++++.+... ...+.++.++++|.++
T Consensus 1 ~~~V~KFGGssv~~~~~~~~v~~~i~~~~~~~~~~vvVvSA~~~~Td~L~~~~~~~~~~-----~~~~~~~~i~~~~~~~ 75 (441)
T TIGR00657 1 ALIVQKFGGTSVGNAERIRRVAKIVLKEKKKGNQVVVVVSAMAGVTDALVELAEQASPG-----PSKEFLEKIREKHIEI 75 (441)
T ss_pred CCEEEEeCcccCCCHHHHHHHHHHHHHHHhcCCCEEEEEcCCCCCHHHHHHHHHHHhcC-----CchHHHHHHHHHHHHH
Confidence 47899999999999999999999999743 4578999999999999999988766432 1256789999999999
Q ss_pred HHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCC
Q 008621 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (559)
Q Consensus 159 ~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (559)
+++|. +. ...++++++.+.+.. ...+++.+|+++|+||++|+.+++++|+++|++++++++.+.+++++++|++
T Consensus 76 ~~~l~-~~----~~~~~~~~~~~~~~~-~~~~~~~~d~ils~GE~~s~~l~~~~l~~~Gi~a~~l~~~~~~l~t~~~~~~ 149 (441)
T TIGR00657 76 LERLI-PQ----AIAEELKRLLDAELV-LEEKPREMDRILSFGERLSAALLSAALEELGVKAVSLLGGEAGILTDSNFGR 149 (441)
T ss_pred HHHhh-hH----HHHHHHHHHHHHHHh-hhcCcchHhheecHHHHHHHHHHHHHHHhCCCCCEEEEcCcceEEecCCCCc
Confidence 99997 32 233334444443321 1223678899999999999999999999999999999999999999998887
Q ss_pred ce-eeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCC
Q 008621 239 AD-ILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (559)
Q Consensus 239 a~-i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP 317 (559)
+. +...+...+. .+++.+.|||++||+|.+ .+|+++++||||||++|+++|.+|+|+++++||||||||++||
T Consensus 150 ~~~~~~~~~~~l~-----~~l~~~~vpVv~G~~g~~-~~g~~~~lgrggsD~~A~~lA~~l~a~~l~~~tDV~Gv~~~DP 223 (441)
T TIGR00657 150 ARVIIEILTERLE-----PLLEEGIIPVVAGFQGAT-EKGETTTLGRGGSDYTAALLAAALKADECEIYTDVDGIYTTDP 223 (441)
T ss_pred eeecHhhhHHHHH-----HHHhcCCEEEEeCcEeeC-CCCCEeecCCCchHHHHHHHHHHcCCCEEEEEECCCCCCcCCC
Confidence 65 3334443332 245678999999999998 4899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCC-CccceeeEEeeecCeE
Q 008621 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRD-MSKAVLTSIVLKRNVT 396 (559)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~-~~~~~It~Is~~~~ia 396 (559)
+++|+++++++|||+||.+|+++|++++||+|++|+++++||++|+|+++|+.+||+|.+..+ +.+..+++|+.+++++
T Consensus 224 ~~~~~a~~i~~is~~ea~el~~~G~~v~~~~a~~~~~~~~i~i~i~~~~~~~~~GT~I~~~~~~~~~~~i~~It~~~~v~ 303 (441)
T TIGR00657 224 RIVPDARRIDEISYEEMLELASFGAKVLHPRTLEPAMRAKIPIVVKSTFNPEAPGTLIVASTKEMEEPIVKGLSLDRNQA 303 (441)
T ss_pred CCCCCCeECCccCHHHHHHHHhcCCcccCHHHHHHHHHcCCeEEEecCCCCCCCceEEEeCCCccccCccceEEEeCCEE
Confidence 999999999999999999999999999999999999999999999999999999999987654 3445799999999999
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEEE--ecCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeeccc
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA--TSEVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQ 474 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Is--tSe~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~ 474 (559)
+|++.+.+|.+ +|+++++|+.|+++||++++++ +++.+|+|+++.++... +.+ .+.. ......+..+++.+
T Consensus 304 ~Isv~g~~~~~-~g~la~if~~L~~~~I~I~~i~q~~se~sIs~~I~~~~~~~--a~~---~L~~-~~~~~~~~~I~~~~ 376 (441)
T TIGR00657 304 RVTVSGLGMKG-PGFLARVFGALAEAGINVDLITQSSSETSISFTVDKEDADQ--AKT---LLKS-ELNLSALSSVEVEK 376 (441)
T ss_pred EEEEECCCCCC-ccHHHHHHHHHHHcCCeEEEEEecCCCceEEEEEEHHHHHH--HHH---HHHH-HHHhcCcceEEEcC
Confidence 99999988888 9999999999999999999997 45789999998765321 111 1111 11122345688899
Q ss_pred ceeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 475 HRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 475 ~~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
++++|+++|. |...|++++++|++|+++||||.||++ |+.+|+|+|+++|.++|+++||++|++
T Consensus 377 ~~a~VsvvG~~~~~~~g~~a~if~~La~~~Inv~~i~~--se~~Is~vV~~~d~~~a~~~Lh~~f~~ 441 (441)
T TIGR00657 377 GLAKVSLVGAGMKSAPGVASKIFEALAQNGINIEMISS--SEINISFVVDEKDAEKAVRLLHNALFE 441 (441)
T ss_pred CeEEEEEEcCCCCCCCchHHHHHHHHHHCCCCEEEEEe--cCCcEEEEEeHHHHHHHHHHHHHHhhC
Confidence 9999999997 778899999999999999999999996 789999999999999999999999974
No 13
>PRK08841 aspartate kinase; Validated
Probab=100.00 E-value=1.1e-73 Score=607.43 Aligned_cols=378 Identities=30% Similarity=0.452 Sum_probs=329.7
Q ss_pred cceEEEEeCccccCCHHHHHHHHHHHHcC--CCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHH
Q 008621 80 QLTCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~~~~~~va~iI~~~--~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~ 157 (559)
|.|+|+|||||||+|++++++++++|... .+.+++||||||+++||.|++++...
T Consensus 1 m~~~V~KfGGtsv~~~~~i~~va~~I~~~~~~g~~vvvVvSa~~~~td~ll~~~~~~----------------------- 57 (392)
T PRK08841 1 MPLIVQKFGGTSVGSIERIQTVAEHIIKAKNDGNQVVVVVSAMAGETNRLLGLAKQV----------------------- 57 (392)
T ss_pred CCeEEEeECcccCCCHHHHHHHHHHHHHHHHCCCCEEEEECCCchHHHHHHHhhhhh-----------------------
Confidence 46899999999999999999999999964 34678999999999999998753210
Q ss_pred HHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCC
Q 008621 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFT 237 (559)
Q Consensus 158 ~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~ 237 (559)
. +..+++.+|.++|+||++|+.|++++|+++|+++.+++++|.++++++.+.
T Consensus 58 -----~-----------------------~~~~~~~~d~l~s~GE~~s~~lla~~L~~~Gi~a~~l~~~~~~i~t~~~~~ 109 (392)
T PRK08841 58 -----D-----------------------SVPTARELDVLLSAGEQVSMALLAMTLNKLGYAARSLTGAQANIVTDNQHN 109 (392)
T ss_pred -----c-----------------------cCCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEEehhHcCEEecCCCC
Confidence 0 112466789999999999999999999999999999999998899988888
Q ss_pred CceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCC
Q 008621 238 NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (559)
Q Consensus 238 ~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP 317 (559)
++++...+...+.+ +++.+.|||++||+|.+ .+|+++|||||||||+|+++|.+|+|+++++|||||||||+||
T Consensus 110 ~~~i~~~~~~~i~~-----ll~~~~vpVv~Gf~g~~-~~g~~ttlgrggsD~tAa~lA~~L~Ad~l~i~TDVdGVyt~DP 183 (392)
T PRK08841 110 DATIKHIDTSTITE-----LLEQDQIVIVAGFQGRN-ENGDITTLGRGGSDTTAVALAGALNADECQIFTDVDGVYTCDP 183 (392)
T ss_pred CceechhhHHHHHH-----HHhCCCEEEEeCCcccC-CCCCEEEeCCCChHHHHHHHHHHcCCCEEEEEeCCCCCCcCCC
Confidence 78776555443332 34678899999999999 4899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCccceeeEEeeecCeEE
Q 008621 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRNVTM 397 (559)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~It~Is~~~~ial 397 (559)
+++|+|+++++|+|+||.||+++|++||||+|++|++++|||++|+|+++| .+||+|.... ....||+|+.++|+++
T Consensus 184 ~~v~~A~~i~~is~~ea~ela~~Ga~vlhp~ai~~a~~~~Ipi~i~n~~~~-~~GT~I~~~~--~~~~i~~i~~~~~~~~ 260 (392)
T PRK08841 184 RVVKNARKLDVIDFPSMEAMARKGAKVLHLPSVQHAWKHSVPLRVLSSFEV-GEGTLIKGEA--GTQAVCGIALQRDLAL 260 (392)
T ss_pred CCCCCceEcccccHHHHHHHHhcCccccCHHHHHHHHHCCCeEEEEecCCC-CCCeEEEecc--CCCcEEEEEEeCCeEE
Confidence 999999999999999999999999999999999999999999999999997 6899997642 3447999999999999
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeeccccee
Q 008621 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRS 477 (559)
Q Consensus 398 ItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~a 477 (559)
|++.+. .++++|+.|+++||+++++++++.+++|+++..++ +.+...+ ...+...++++
T Consensus 261 i~v~~~-------~~~~i~~~l~~~~i~v~~i~~~~~~~~~~v~~~~~------------~~~~~~~--~~~i~~~~~~a 319 (392)
T PRK08841 261 IEVESE-------SLPSLTKQCQMLGIEVWNVIEEADRAQIVIKQDAC------------AKLKLVF--DDKIRNSESVS 319 (392)
T ss_pred EEeccc-------hHHHHHHHHHHcCCCEEEEEecCCcEEEEECHHHH------------HHHHHhC--cccEEEeCCEE
Confidence 999752 46899999999999999999999999999986432 1111111 12467778999
Q ss_pred EEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccCc
Q 008621 478 IISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFESD 542 (559)
Q Consensus 478 iISIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~~ 542 (559)
+|++||.. .||+++|+|++|.+++||+.++++ |+++|||+|+++|.++|+++||++|+..+
T Consensus 320 ~vsvVG~~--~~gv~~~~~~aL~~~~I~i~~i~~--s~~~is~vv~~~~~~~av~~lH~~f~~~~ 380 (392)
T PRK08841 320 LLTLVGLE--ANGMVEHACNLLAQNGIDVRQCST--EPQSSMLVLDPANVDRAANILHKTYVTSE 380 (392)
T ss_pred EEEEECCC--ChHHHHHHHHHHHhCCCCEEEEEC--CCcEEEEEEeHHHHHHHHHHHHHHHcCCc
Confidence 99999973 389999999999999999999998 78999999999999999999999999874
No 14
>TIGR00656 asp_kin_monofn aspartate kinase, monofunctional class. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. The protein slr0657 from Synechocystis PCC6803 is extended by a duplication of the C-terminal region corresponding to the beta chain. Incorporation of a second copy of the C-terminal domain may be quite common in this subgroup of aspartokinases.
Probab=100.00 E-value=1.1e-71 Score=597.12 Aligned_cols=394 Identities=36% Similarity=0.586 Sum_probs=343.3
Q ss_pred ceEEEEeCccccCCHHHHHHHHHHHHcC--CCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHH
Q 008621 81 LTCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (559)
Q Consensus 81 ~~~V~KFGGsSl~~~~~~~~va~iI~~~--~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~ 158 (559)
+++|+|||||+|++++.+++++++|... .+.+++|||||++++||.|+++++...
T Consensus 1 ~~iViK~GGs~~~~~~~i~~~~~~i~~~~~~g~~~vvV~sg~~~~t~~l~~~~~~~~----------------------- 57 (401)
T TIGR00656 1 ELIVQKFGGTSVGSGERIKNAARIVLKEKKEGHKVVVVVSAMSGVTDALVEISEKAI----------------------- 57 (401)
T ss_pred CcEEEEECCcCcCCHHHHHHHHHHHHHHHHcCCCEEEEEeCCCCChHHHHHHHHHHh-----------------------
Confidence 4689999999999999999999999864 346889999999999999987643110
Q ss_pred HHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCC
Q 008621 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (559)
Q Consensus 159 ~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (559)
-...++..+|+++++||++|+.+++++|+++|+++.++++.+.+++|++++++
T Consensus 58 ---------------------------~~~~~~~~~~~i~~~Ge~~s~~~~~~~l~~~g~~a~~l~~~~~~~~t~~~~~~ 110 (401)
T TIGR00656 58 ---------------------------RDAITPRERDELVSHGERLSSALFSGALRDLGVKAIWLDGGEAGIITDDNFGN 110 (401)
T ss_pred ---------------------------ccCCChHHHHHHhhHHHHHHHHHHHHHHHhCCCceEEeccccceEEeCCCCCc
Confidence 01235677899999999999999999999999999999999999999998888
Q ss_pred ceeeecch-HHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCC
Q 008621 239 ADILEATY-PAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (559)
Q Consensus 239 a~i~~~~~-~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP 317 (559)
+++.+... ..+.+ +++.+.|||++||+|.+ .+|+++|+||||||++|+++|.+|+|+++++|||||||||+||
T Consensus 111 ~~~~~~~~~~~l~~-----~l~~~~vpVi~g~~~~~-~~g~~~~lgrg~sD~~A~~lA~~l~A~~l~i~tdV~Gv~~~DP 184 (401)
T TIGR00656 111 AKIDIIATEERLLP-----LLEEGIIVVVAGFQGAT-EKGYTTTLGRGGSDYTAALLAAALKADRVDIYTDVPGVYTTDP 184 (401)
T ss_pred eEeeecchHHHHHH-----HHhCCCEEEecCcceeC-CCCCEeecCCCcHHHHHHHHHHHcCCCEEEEEECCCCCCcCCC
Confidence 87766554 33332 35678999999999998 4899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCccceeeEEeeecCeEE
Q 008621 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRNVTM 397 (559)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~It~Is~~~~ial 397 (559)
+++|+|+++++|||+||.+|+++|++++||+|++||++++||++|+|+++|+ +||+|.+... ..+.+++|+.++|+++
T Consensus 185 ~~~~~a~~i~~ls~~ea~~l~~~G~~v~~~~a~~~a~~~~i~i~i~~~~~~~-~gT~I~~~~~-~~~~v~~I~~~~~va~ 262 (401)
T TIGR00656 185 RVVEAAKRIDKISYEEALELATFGAKVLHPRTVEPAMRSGVPIEVRSSFDPE-EGTLITNSME-NPPLVKGIALRKNVTR 262 (401)
T ss_pred CCCCCcEECCccCHHHHHHHHHcCCcccCHHHHHHHHHCCCeEEEEECCCCC-CCeEEEeCcc-cCCceEEEEEECCEEE
Confidence 9999999999999999999999999999999999999999999999999998 8999987532 2236999999999999
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe--cCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccc
Q 008621 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQH 475 (559)
Q Consensus 398 ItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist--Se~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~ 475 (559)
|++.+.+|.+.+|+++++|+.|++++|+++++++ |+.+++|+++.++... +.+ .+++..... ....+.+.++
T Consensus 263 vsv~g~~~~~~~g~~~~if~~L~~~~I~i~~i~~~~s~~~Is~~V~~~d~~~--a~~---~L~~~~~~~-~~~~i~~~~~ 336 (401)
T TIGR00656 263 VTVHGLGMLGKRGFLARIFGALAERNINVDLISQTPSETSISLTVDETDADE--AVR---ALKDQSGAA-GLDRVEVEEG 336 (401)
T ss_pred EEEecCCCCCCccHHHHHHHHHHHcCCcEEEEEcCCCCceEEEEEeHHHHHH--HHH---HHHHHHHhc-CCceEEEeCC
Confidence 9999999999999999999999999999999998 7899999998765321 111 122211111 1245778899
Q ss_pred eeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 476 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 476 ~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
+++|++||. |...||+++++|++|+++|||+.+++ +|+.+++|+|+++|.++|+++||++||.
T Consensus 337 ~a~IsvVG~~~~~~~g~~a~i~~~L~~~gIni~~i~--~s~~~is~vv~~~d~~~av~~Lh~~f~~ 400 (401)
T TIGR00656 337 LAKVSIVGAGMVGAPGVASEIFSALEEKNINILMIG--SSETNISFLVDEKDAEKAVRKLHEVFEE 400 (401)
T ss_pred eEEEEEECCCcccCccHHHHHHHHHHHCCCcEEEEE--cCCCEEEEEEeHHHHHHHHHHHHHHHcc
Confidence 999999997 78899999999999999999999987 5899999999999999999999999985
No 15
>PRK08210 aspartate kinase I; Reviewed
Probab=100.00 E-value=3.3e-68 Score=570.38 Aligned_cols=388 Identities=31% Similarity=0.519 Sum_probs=333.7
Q ss_pred cceEEEEeCccccCCHHHHHHHHHHHHcC--CCCCcEEEEcCCCc-----ccHHHHHhhHhhhhcCcCcchhhhHHHHHH
Q 008621 80 QLTCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGK-----TTNKLLLAGEKAVSCGVTNISCIDELSFVK 152 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~~~~~~va~iI~~~--~~~~~vVVVSA~g~-----~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~ 152 (559)
|.++|+|||||++.|++.++++++.|... .+.+++||+||||+ +|+.|+..+...
T Consensus 1 m~~iViK~GGs~l~~~~~~~~~~~~i~~~~~~g~~~vvV~sa~g~~G~~~~t~~l~~~~~~~------------------ 62 (403)
T PRK08210 1 MKIIVQKFGGTSVSTEERRKMAVNKIKKALKEGYKVVVVVSAMGRKGDPYATDTLLSLVGEE------------------ 62 (403)
T ss_pred CCeEEEeECCcccCCHHHHHHHHHHHHHHHHcCCCEEEEEeCCCCCCCCCccHHHHHHHHHh------------------
Confidence 56899999999999999999999998863 24578999999977 588876543210
Q ss_pred HHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEE
Q 008621 153 DLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFIT 232 (559)
Q Consensus 153 ~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit 232 (559)
....+++.+|.++++||.+|+.+++++|+++|+++.++++++.+++|
T Consensus 63 ---------------------------------~~~~~~~~~~~l~~~Ge~~s~~~~~~~l~~~Gi~a~~l~~~~~~~~t 109 (403)
T PRK08210 63 ---------------------------------FSEISKREQDLLMSCGEIISSVVFSNMLNENGIKAVALTGGQAGIIT 109 (403)
T ss_pred ---------------------------------ccCCChHHHHHHHhHhHHHHHHHHHHHHHhCCCCeEEechHHccEEc
Confidence 01235677888999999999999999999999999999999988999
Q ss_pred ecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCccc
Q 008621 233 TDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGV 312 (559)
Q Consensus 233 ~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV 312 (559)
+++++++++...+...+.+ +++.+.|||++||+|.+ .+|+++|+||||||++|+++|.+|+|++++||||||||
T Consensus 110 ~~~~~~~~v~~~~~~~l~~-----~l~~~~vpVi~G~~~~~-~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~i~tDV~GV 183 (403)
T PRK08210 110 DDNFTNAKIIEVNPDRILE-----ALEEGDVVVVAGFQGVT-ENGDITTLGRGGSDTTAAALGVALKAEYVDIYTDVDGI 183 (403)
T ss_pred cCCCCceeeehhhHHHHHH-----HHhcCCEEEeeCeeecC-CCCCEEEeCCCchHHHHHHHHHHcCCCEEEEEECCCCC
Confidence 9988877775555443332 34678999999999998 58999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCC------Ccccee
Q 008621 313 LTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRD------MSKAVL 386 (559)
Q Consensus 313 ~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~------~~~~~I 386 (559)
|++||+++|++++|++|||+||.+|+++|++|+||+|++||+++|||++|+|+++| .+||+|.+..+ +....|
T Consensus 184 ~~~dP~~~~~a~~i~~ls~~ea~~l~~~G~~v~~~~a~~~~~~~~i~i~i~~~~~~-~~gT~I~~~~~~~~~~~~~~~~v 262 (403)
T PRK08210 184 MTADPRIVEDARLLDVVSYNEVFQMAYQGAKVIHPRAVEIAMQANIPLRIRSTYSD-SPGTLITSLGDAKGGIDVEERLI 262 (403)
T ss_pred CcCCCCcCCCCeECCccCHHHHHHHHHCCccccCHHHHHHHHHCCCeEEEEecCCC-cCCcEEEecCccccccccccCce
Confidence 99999999999999999999999999999999999999999999999999999985 46999987632 234579
Q ss_pred eEEeeecCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhh
Q 008621 387 TSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQASELDHVVEELEK 466 (559)
Q Consensus 387 t~Is~~~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~ 466 (559)
|+|+.++|+++|++.+..+ .+|+++++|+.|+++||+|++++++..+++|+++.++.. .+..++.++.
T Consensus 263 ~~It~~~~i~~isv~~~~~--~~g~la~If~~L~~~~I~i~~i~~~~~~is~~v~~~~~~---------~a~~~l~~~~- 330 (403)
T PRK08210 263 TGIAHVSNVTQIKVKAKEN--AYDLQQEVFKALAEAGISVDFINIFPTEVVFTVSDEDSE---------KAKEILENLG- 330 (403)
T ss_pred EEEEEcCCcEEEEEecCCC--cchHHHHHHHHHHHcCCeEEEEEecCceEEEEEcHHHHH---------HHHHHHHHhC-
Confidence 9999999999999986543 499999999999999999999998888999999865431 1222333332
Q ss_pred hceeecccceeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 467 IAIVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 467 ~~~v~~~~~~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
..+.+.+++++|+++|. |...||+++|+|++|+++|||+.++++ |+++++|+|+++|.++|+++||++|+.
T Consensus 331 -~~v~~~~~~a~isvvG~~~~~~~g~~~~i~~aL~~~~I~i~~~~~--s~~~is~vv~~~~~~~a~~~Lh~~f~~ 402 (403)
T PRK08210 331 -LKPSVRENCAKVSIVGAGMAGVPGVMAKIVTALSEEGIEILQSAD--SHTTIWVLVKEEDMEKAVNALHDAFEL 402 (403)
T ss_pred -CcEEEeCCcEEEEEEcCCcCCCccHHHHHHHHHHhCCCCEEEEec--CCCEEEEEEcHHHHHHHHHHHHHHhcC
Confidence 14777889999999997 888999999999999999999988766 899999999999999999999999964
No 16
>PRK07431 aspartate kinase; Provisional
Probab=100.00 E-value=1.2e-67 Score=590.70 Aligned_cols=395 Identities=30% Similarity=0.478 Sum_probs=340.4
Q ss_pred cceEEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHH
Q 008621 80 QLTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~ 157 (559)
|+|+|+|||||||+|++.+++++++|.... +.+++||+||+|++||+|++++...
T Consensus 1 m~~iViKfGGss~~~~~~i~~~a~~I~~~~~~g~~vvvV~sa~g~~t~~l~~~~~~~----------------------- 57 (587)
T PRK07431 1 MALIVQKFGGTSVGSVERIQAVAQRIARTKEAGNDVVVVVSAMGKTTDELVKLAKEI----------------------- 57 (587)
T ss_pred CCeEEEEECchhcCCHHHHHHHHHHHHHHHHCCCCEEEEECCCCchhHHHHHHHHHh-----------------------
Confidence 568999999999999999999999999643 4578999999999999998653210
Q ss_pred HHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCC
Q 008621 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFT 237 (559)
Q Consensus 158 ~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~ 237 (559)
.++.+...+|+++++||++|+.+++.+|+++|+++++++++++++++++.++
T Consensus 58 ----------------------------t~~~~~~~~~~~ls~Ge~~s~~l~~~~l~~~gi~a~~l~~~~~~~~~~~~~~ 109 (587)
T PRK07431 58 ----------------------------SSNPPRREMDMLLSTGEQVSIALLSMALHELGQPAISLTGAQVGIVTESEHG 109 (587)
T ss_pred ----------------------------ccCCCHHHHHHHHHHhHHHHHHHHHHHHHHCCCCeEEechhHcCeEecCCCC
Confidence 1233567789999999999999999999999999999999999899988888
Q ss_pred CceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccC-CCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCC
Q 008621 238 NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAW-RTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCD 316 (559)
Q Consensus 238 ~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~-~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taD 316 (559)
.+++...+.+.+.+ +++.+.|||++||+|.+. .+|+++|+||||||++|+++|.+|+|+++++|||||||||+|
T Consensus 110 ~~~i~~~~~~~l~~-----~l~~g~vpVv~g~~g~~~~~~g~~~~lgrggsD~~A~~lA~~l~A~~l~i~TDVdGVyt~D 184 (587)
T PRK07431 110 RARILEIKTDRIQR-----HLDAGKVVVVAGFQGISLSSNLEITTLGRGGSDTSAVALAAALGADACEIYTDVPGVLTTD 184 (587)
T ss_pred ceeeeeccHHHHHH-----HHhCCCeEEecCCcCCCCCCCCCEeecCCCchHHHHHHHHHHcCCCEEEEEeCCCccCcCC
Confidence 78877666554443 346789999999999753 238899999999999999999999999999999999999999
Q ss_pred CCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCc--------cceeeE
Q 008621 317 PNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMS--------KAVLTS 388 (559)
Q Consensus 317 P~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~--------~~~It~ 388 (559)
|+++|+|++|++|+|+|+.+|+++|+++|||+|++|++++|||++|+|++ |+.+||+|.+..+.. ...+++
T Consensus 185 P~~~~~a~~i~~i~~~e~~el~~~G~~v~~~~a~~~~~~~~i~i~i~~~~-~~~~GT~i~~~~~~~~~~~~~~~~~~i~g 263 (587)
T PRK07431 185 PRLVPEAQLMDEISCDEMLELASLGASVLHPRAVEIARNYGVPLVVRSSW-SDAPGTLVTSPPPRPRSLGGLELGKPVDG 263 (587)
T ss_pred CCCCCCCeECCCcCHHHHHHHHhCCCceEhHHHHHHHHHcCCcEEEecCC-CCCCCeEEEeCCcccccccchhcccccce
Confidence 99999999999999999999999999999999999999999999999999 466899998764321 346899
Q ss_pred EeeecCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEec-----CceeEEEeCCCchhhHHHHHHHHHHHHHHHH
Q 008621 389 IVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS-----EVSLSLTLDPSKLWSRELIQQASELDHVVEE 463 (559)
Q Consensus 389 Is~~~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstS-----e~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~ 463 (559)
++..++++++++. ++.+.+||++++|+.|+++||+|+|++++ ..+++|+++.++... ..+ .++.+..+
T Consensus 264 i~~~~~~a~itl~--~~~~~~g~~a~if~~l~~~~I~v~~i~qs~~~~~~~~isf~i~~~d~~~--~~~---~l~~l~~~ 336 (587)
T PRK07431 264 VELDEDQAKVALL--RVPDRPGIAAQLFEELAAQGVNVDLIIQSIHEGNSNDIAFTVAENELKK--AEA---VAEAIAPA 336 (587)
T ss_pred EEEecCceEEEEe--cCCCcccHHHHHHHHHHHcCCcEEEEEeccCCCCCccEEEEEeHHHHHH--HHH---HHHHHHHH
Confidence 9999999999996 57889999999999999999999999863 278999998766432 111 23333333
Q ss_pred HhhhceeecccceeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008621 464 LEKIAIVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 541 (559)
Q Consensus 464 L~~~~~v~~~~~~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 541 (559)
+.. ..+++.+++++|+++|. |...+|+++|+|++|++++|||.+|+ +|+++|||+|+++|+++|++.||++|+..
T Consensus 337 ~~~-~~i~~~~~~a~IsvvG~gm~~~~gi~~ki~~aL~~~~I~i~~i~--sSe~~Is~vv~~~d~~~av~~Lh~~f~~~ 412 (587)
T PRK07431 337 LGG-AEVLVETNVAKLSISGAGMMGRPGIAAKMFDTLAEAGINIRMIS--TSEVKVSCVIDAEDGDKALRAVCEAFELE 412 (587)
T ss_pred cCC-CcEEEeCCeEEEEEECCCcccCccHHHHHHHHHHHCCCcEEEEE--cCCCEEEEEEcHHHHHHHHHHHHHHhccC
Confidence 332 56888899999999997 88899999999999999999999999 49999999999999999999999999765
No 17
>PRK06635 aspartate kinase; Reviewed
Probab=100.00 E-value=7.9e-67 Score=560.06 Aligned_cols=393 Identities=33% Similarity=0.543 Sum_probs=340.6
Q ss_pred cceEEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHH
Q 008621 80 QLTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~ 157 (559)
|+++|+|||||+|.|++.++++++.|.... +.+++|||||++++||+|++..+...
T Consensus 1 m~~iViK~GGs~l~~~~~~~~~~~~i~~~~~~g~~~vvV~sg~~~~~~~l~~~~~~~~---------------------- 58 (404)
T PRK06635 1 MALIVQKFGGTSVGDVERIKRVAERVKAEVEAGHQVVVVVSAMGGTTDELLDLAKEVS---------------------- 58 (404)
T ss_pred CCeEEEeECCcccCCHHHHHHHHHHHHHHHHcCCCEEEEEeCCCCcHHHHHHHHHHhc----------------------
Confidence 568999999999999999999999999743 45789999999999999987532100
Q ss_pred HHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCC
Q 008621 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFT 237 (559)
Q Consensus 158 ~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~ 237 (559)
...++..+|+++++||++|+.+++.+|+++|+++++++++|++++++++|+
T Consensus 59 -----------------------------~~~~~~~~~~~~~~Ge~~~~~~~~~~l~~~g~~a~~l~~~~~~~~~~~~~~ 109 (404)
T PRK06635 59 -----------------------------PLPDPRELDMLLSTGEQVSVALLAMALQSLGVKARSFTGWQAGIITDSAHG 109 (404)
T ss_pred -----------------------------cCCCHHHHHHHhhhhHHHHHHHHHHHHHhCCCCeEEeChhhCCEEecCCCC
Confidence 011456778999999999999999999999999999999999899988888
Q ss_pred CceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCC
Q 008621 238 NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (559)
Q Consensus 238 ~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP 317 (559)
++++...+...+.+ +++.+.|||++||+|.+ .+|.++|+||||||++|+++|.+|+|+++++||||||||++||
T Consensus 110 ~~~~~~~~~~~l~~-----~l~~~~ipVi~g~~~~~-~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~~~tDV~Gv~~~dP 183 (404)
T PRK06635 110 KARITDIDPSRIRE-----ALDEGDVVVVAGFQGVD-EDGEITTLGRGGSDTTAVALAAALKADECEIYTDVDGVYTTDP 183 (404)
T ss_pred ceEeeecCHHHHHH-----HHhCCCEEEecCccEeC-CCCCEEecCCCChHHHHHHHHHHhCCCEEEEEEcCCCCCcCCC
Confidence 88876666554443 34678999999999999 4899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCC--CccceeeEEeeecCe
Q 008621 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRD--MSKAVLTSIVLKRNV 395 (559)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~--~~~~~It~Is~~~~i 395 (559)
+++|+++++++++|+|+.+|+++|++++||+|++|++++|||++|+|+++| .+||+|..... +.+..+++|+..+++
T Consensus 184 ~~~~~a~~i~~i~~~e~~~l~~~g~~~~~~~a~~~~~~~~i~~~i~~~~~~-~~gT~i~~~~~~~~~~~~i~~I~~~~~v 262 (404)
T PRK06635 184 RIVPKARKLDKISYEEMLELASLGAKVLHPRSVEYAKKYNVPLRVRSSFSD-NPGTLITGEEEEIMEQPVVTGIAFDKDE 262 (404)
T ss_pred CCCCCceECCccCHHHHHHHHHcCCcccCHHHHHHHHHcCceEEEEcCCCC-CCCCEEeeCCccccccCceEEEEecCCe
Confidence 999999999999999999999999999999999999999999999999998 68999987643 345579999999999
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEec-----CceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhcee
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS-----EVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIV 470 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstS-----e~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v 470 (559)
++|++.+ |.+.+|+++++|+.|+++||++++++++ +.+++|+++.++... +.+ .+++...++ .+..+
T Consensus 263 ~~Isv~g--~~~~~g~l~~i~~~L~~~~I~i~~is~s~~~~~~~~is~~v~~~~~~~--a~~---~L~~~~~~~-~~~~i 334 (404)
T PRK06635 263 AKVTVVG--VPDKPGIAAQIFGALAEANINVDMIVQNVSEDGKTDITFTVPRDDLEK--ALE---LLEEVKDEI-GAESV 334 (404)
T ss_pred EEEEECC--CCCCccHHHHHHHHHHHcCCeEEEEEecCCCCCceeEEEEEcHHHHHH--HHH---HHHHHHHHc-CcceE
Confidence 9999987 8889999999999999999999999886 467999998765321 111 222211111 23458
Q ss_pred ecccceeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 471 NLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 471 ~~~~~~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
++.+++++|+++|. +...||+++++|++|+++||||.++++ |+.+++|+|+++|.++|++.||++|+.
T Consensus 335 ~~~~~ia~isvvG~~~~~~~g~~a~i~~~La~~~Ini~~i~s--s~~~is~vv~~~d~~~a~~~Lh~~f~~ 403 (404)
T PRK06635 335 TYDDDIAKVSVVGVGMRSHPGVAAKMFEALAEEGINIQMIST--SEIKISVLIDEKYLELAVRALHEAFGL 403 (404)
T ss_pred EEcCCeEEEEEECCCCCCCchHHHHHHHHHHHCCCCEEEEEe--cCCeEEEEEcHHHHHHHHHHHHHHHCC
Confidence 88899999999996 888899999999999999999999986 789999999999999999999999953
No 18
>cd04245 AAK_AKiii-YclM-BS AAK_AKiii-YclM-BS: Amino Acid Kinase Superfamily (AAK), AKiii-YclM-BS; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. In Bacillus subtilis (BS), YclM is reported to be a single polypeptide of 50 kD. The Bacillus subtilis 168 AKIII is induced by lysine and repressed by threonine, and it is synergistically inhibited by lysine and threonine.
Probab=100.00 E-value=2.5e-66 Score=528.38 Aligned_cols=281 Identities=35% Similarity=0.514 Sum_probs=250.4
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCCCCCcEEEEcCCC-------cccHHHHHhhHhhhhcCcCcchhhhHHHHHHHH
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMG-------KTTNKLLLAGEKAVSCGVTNISCIDELSFVKDL 154 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~~~~~vVVVSA~g-------~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~ 154 (559)
|.|+|||||||+|+++|++++++|... .++++||||||+ |+||.|+++++.+.+. .++.+.++.++++
T Consensus 1 m~V~KFGGtSv~~~~~i~~v~~ii~~~-~~~~vvVvSA~~~~~~~~~~vTd~L~~~~~~~~~~----~~~~~~~~~i~~~ 75 (288)
T cd04245 1 MKVVKFGGSSLASAEQFQKVKAIVKAD-PERKIVVVSAPGKRFKDDTKVTDLLILYAEAVLAG----EDTESIFEAIVDR 75 (288)
T ss_pred CEEEEECcCccCCHHHHHHHHHHHHhc-CCCEEEEEcCCCCCCCchhhHHHHHHHHHHHHhcC----cchHHHHHHHHHH
Confidence 589999999999999999999999965 467899999998 5999999988766442 2456789999999
Q ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEec
Q 008621 155 HHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (559)
Q Consensus 155 ~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (559)
|.+++++|..+.+.+.++.+.++++.+. ....+++.+|+|+|+||++|+.+|+.+|++.|+++.++|++++|++|++
T Consensus 76 h~~~~~~L~~~~~~~~~i~~~~~~l~~~---~~~~~~~~~d~i~s~GE~lSa~ll~~~L~~~Gi~a~~ld~~~~~i~t~~ 152 (288)
T cd04245 76 YAEIADELGLPMSILEEIAEILENLANL---DYANPDYLLDALKARGEYLNAQLMAAYLNYQGIDARYVIPKDAGLVVTD 152 (288)
T ss_pred HHHHHHHhhhhhhHHHHHHHHHHHHHHh---hccCCHHHHHHHHHHhHHHHHHHHHHHHHHCCCCeEEEcHHHCceeecC
Confidence 9999999987766555555555555542 2356789999999999999999999999999999999999999999999
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCccccc
Q 008621 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (559)
Q Consensus 235 ~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~t 314 (559)
+|+++.+...+..++.+.+ +.+.|||++||+|.+ .+|+++|||||||||+|+++|++|+|+++++|||||||||
T Consensus 153 ~~~~a~~~~~~~~~~~~~~-----~~~~v~Vv~Gf~g~~-~~G~~ttLgRggSD~tAal~A~~l~A~~v~i~tdVdGvyt 226 (288)
T cd04245 153 EPGNAQILPESYQKIKKLR-----DSDEKLVIPGFYGYS-KNGDIKTFSRGGSDITGAILARGFQADLYENFTDVDGIYA 226 (288)
T ss_pred CccccccchhhHHHHHHHH-----hCCCEEEEeCccccC-CCCCEEEcCCCchHHHHHHHHHHcCCCEEEEEeCCCceEC
Confidence 9999888666665554433 457899999999999 5899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEe
Q 008621 315 CDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (559)
Q Consensus 315 aDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (559)
+|||++|+|+++++|||+||.||+++|++||||+|+.|++++||||+|+|+++|+.+||+|.
T Consensus 227 aDPr~v~~A~~i~~lsy~EA~ela~~GakVlhp~ai~~a~~~~Ipi~v~n~~~p~~~GT~I~ 288 (288)
T cd04245 227 ANPRIVANPKPISEMTYREMRELSYAGFSVFHDEALIPAIEAGIPINIKNTNHPEAPGTLIV 288 (288)
T ss_pred CCCCCCCCCeEeCccCHHHHHHHHHCCCcccCHHHHHHHHHCCCcEEEeeCCCCCCCCceeC
Confidence 99999999999999999999999999999999999999999999999999999999999984
No 19
>cd04258 AAK_AKiii-LysC-EC AAK_AKiii-LysC-EC: Amino Acid Kinase Superfamily (AAK), AKiii-LysC-EC: this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine-sensitive aspartokinase isoenzyme AKIII. AKIII is a monofunctional class enzyme (LysC) found in some bacteria such as E. coli. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. In E. coli, LysC is reported to be a homodimer of 50 kD subunits.
Probab=100.00 E-value=3.2e-66 Score=528.60 Aligned_cols=288 Identities=39% Similarity=0.558 Sum_probs=260.2
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCCCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHHh
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (559)
|+|+|||||||+|++++++++++|... ++++|||||||+|+||.|+++++.+.++.. .++...++.++++|..++++
T Consensus 1 m~V~KFGGtSv~~~~~i~~v~~ii~~~-~~~~vVVVSA~~~vTd~L~~~~~~~~~~~~--~~~~~~l~~l~~~h~~~~~~ 77 (292)
T cd04258 1 MVVAKFGGTSVADYAAMLRCAAIVKSD-ASVRLVVVSASAGVTNLLVALADAAESGEE--IESIPQLHEIRAIHFAILNR 77 (292)
T ss_pred CEEEEECccccCCHHHHHHHHHHHhcc-CCCEEEEEeCCCCchHHHHHHHHHHhcCCc--chhhHHHHHHHHHHHHHHHH
Confidence 689999999999999999999999875 567899999999999999999887655321 23455799999999999999
Q ss_pred cCCCHH---HHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCC
Q 008621 162 LGIDRS---IIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (559)
Q Consensus 162 L~~~~~---~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (559)
|..+.+ .+...+++|+++++++.++++++++.+|+|+|+||++|+.+++++|+++|+++.++|++++ ++|+++|++
T Consensus 78 L~~~~~~~~~i~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-i~t~~~~~~ 156 (292)
T cd04258 78 LGAPEELRAKLEELLEELTQLAEGAALLGELSPASRDELLSFGERMSSLLFSEALREQGVPAEWFDVRTV-LRTDSRFGR 156 (292)
T ss_pred hhcchhHHHHHHHHHHHHHHHHhhhccccccChHhHhHhhhHHHHHHHHHHHHHHHhCCCCeEEEchHHe-EEecCCCcc
Confidence 987754 5888999999999999999999999999999999999999999999999999999999998 899999999
Q ss_pred ceeeecc-hHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCC
Q 008621 239 ADILEAT-YPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (559)
Q Consensus 239 a~i~~~~-~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP 317 (559)
++++... ..++.+.+.. + .++.|||+|||+|.+ .+|++|||||||||++|+++|.+|+|+++++|||||||||+||
T Consensus 157 a~~~~~~~~~~~~~~~~~-~-~~~~v~Vv~Gf~g~~-~~G~~ttLGrggsD~~a~~~a~~l~a~~~~i~tdv~Gv~~~dP 233 (292)
T cd04258 157 AAPDLNALAELAAKLLKP-L-LAGTVVVTQGFIGST-EKGRTTTLGRGGSDYSAALLAEALHAEELQIWTDVAGIYTTDP 233 (292)
T ss_pred ccccHHHHHHHHHHHHHH-h-hcCCEEEECCccccC-CCCCEEecCCCchHHHHHHHHHHcCCCEEEEEECCCccCCCCC
Confidence 8875433 3344443332 2 356899999999999 5899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEe
Q 008621 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (559)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (559)
+++|+|++++.|||+||.||+++|++|+||+|+.|+++++|||+|+|+++|+++||+|+
T Consensus 234 ~~~~~a~~i~~isy~Ea~ela~~Gakvlhp~a~~~~~~~~ipi~i~~~~~p~~~GT~I~ 292 (292)
T cd04258 234 RICPAARAIKEISFAEAAEMATFGAKVLHPATLLPAIRKNIPVFVGSSKDPEAGGTLIT 292 (292)
T ss_pred CCCCCCeEeceeCHHHHHHHHHCCCcccCHHHHHHHHHcCCcEEEEeCCCCCCCCceeC
Confidence 99999999999999999999999999999999999999999999999999999999985
No 20
>cd04244 AAK_AK-LysC-like AAK_AK-LysC-like: Amino Acid Kinase Superfamily (AAK), AK-LysC-like; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine-sensitive AK isoenzyme found in higher plants. The lysine-sensitive AK isoenzyme is a monofunctional protein. It is involved in the overall regulation of the aspartate pathway and can be synergistically inhibited by S-adenosylmethionine. Also included in this CD is an uncharacterized LysC-like AK found in Euryarchaeota and some bacteria. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP.
Probab=100.00 E-value=8.7e-66 Score=528.70 Aligned_cols=290 Identities=55% Similarity=0.830 Sum_probs=265.3
Q ss_pred EEEEeCccccCCHHHHHHHHHHHHcC-CCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHHh
Q 008621 83 CVMKFGGSSLASAERMREVAELILSF-PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (559)
Q Consensus 83 ~V~KFGGsSl~~~~~~~~va~iI~~~-~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (559)
+|+|||||||+|++++++++++|... .+++++||||||+|+||.|+++++.+.... ..++.+.++.++++|..++++
T Consensus 2 ~V~KFGGtSv~~~~~~~~v~~iI~~~~~~~~~vvVvSA~~~iTd~L~~~~~~~~~~~--~~~~~~~l~~i~~~h~~~~~~ 79 (298)
T cd04244 2 LVMKFGGTSVGSAERIRHVADLVGTYAEGHEVVVVVSAMGGVTDRLLLAAEAAVSGR--IAGVKDFIEILRLRHIKAAKE 79 (298)
T ss_pred EEEEECcccCCCHHHHHHHHHHHHHhhcCCCEEEEEeCCCCcHHHHHHHHHHHhcCC--chhHHHHHHHHHHHHHHHHHH
Confidence 69999999999999999999999974 346889999999999999999887664321 235677899999999999999
Q ss_pred cCCCH------HHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecC
Q 008621 162 LGIDR------SIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDD 235 (559)
Q Consensus 162 L~~~~------~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~ 235 (559)
|..+. +.++.++++|+++++++..+++++++.+|+++|+||++|+.|++++|+++|++|.++++++++++|+++
T Consensus 80 l~~~~~~~~~~~~i~~~~~~l~~~~~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~l~~~~~~i~t~~~ 159 (298)
T cd04244 80 AISDEEIAEVESIIDSLLEELEKLLYGIAYLGELTPRSRDYIVSFGERLSAPIFSAALRSLGIKARALDGGEAGIITDDN 159 (298)
T ss_pred hhcchhhHHHHHHHHHHHHHHHHHHHHHHhhhcCCchHhhHhccHhHHHHHHHHHHHHHhCCCCeEEEcHHHcceeecCc
Confidence 98753 458899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccC
Q 008621 236 FTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTC 315 (559)
Q Consensus 236 ~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~ta 315 (559)
++++.+...+..++.+.+.. +++.+.|||++||+|.+ .+|+++|||||||||+|+++|.+|+|++++||||||||||+
T Consensus 160 ~~~a~~~~~~~~~i~~~l~~-ll~~~~vpVv~Gfig~~-~~g~~ttlgRggsD~~A~~~A~~l~a~~l~i~tdV~Gv~~~ 237 (298)
T cd04244 160 FGNARPLPATYERVRKRLLP-MLEDGKIPVVTGFIGAT-EDGAITTLGRGGSDYSATIIGAALDADEIWIWKDVDGVMTA 237 (298)
T ss_pred ccccccchhHHHHHHHHHHH-HhhcCCEEEEeCccccC-CCCCEEEecCCChHHHHHHHHHHcCCCEEEEEECCCCCCCC
Confidence 88877665566677776654 46778999999999998 58999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEe
Q 008621 316 DPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (559)
Q Consensus 316 DP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (559)
||+.+|+|+++++|||+||.||+++|++|+||+|++||+++|||++|+|+++|+.+||+|+
T Consensus 238 dP~~~~~a~~i~~lsy~Ea~el~~~Ga~vlhp~ai~~a~~~~Ipi~i~n~~~p~~~GT~I~ 298 (298)
T cd04244 238 DPRIVPEARTIPRLSYAEAMELAYFGAKVLHPRTVEPAMEKGIPVRVKNTFNPEAPGTLIT 298 (298)
T ss_pred CCCCCCCCeEcCccCHHHHHHHHhCCCcccCHHHHHHHHHcCCcEEEeeCCCCCCCCCEeC
Confidence 9999999999999999999999999999999999999999999999999999999999995
No 21
>cd04257 AAK_AK-HSDH AAK_AK-HSDH: Amino Acid Kinase Superfamily (AAK), AK-HSDH; this CD includes the N-terminal catalytic domain of aspartokinase (AK) of the bifunctional enzyme AK - homoserine dehydrogenase (HSDH). These aspartokinases are found in bacteria (E. coli AKI-HSDHI, ThrA and E. coli AKII-HSDHII, MetL) and higher plants (Z. mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. ThrA and MetL are involved in threonine and methionine biosynthesis, respectively. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathway end products. Maize AK-HSDH is a Thr-sensitive 180-kD enzyme. Arabidopsis AK-HSDH is an alanine-act
Probab=100.00 E-value=4.5e-65 Score=521.83 Aligned_cols=286 Identities=39% Similarity=0.617 Sum_probs=258.5
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCC-CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHH
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVD 160 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~-~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~ 160 (559)
|.|+|||||||+|+++|++++++|.... +.+++||||||+|+||.|+++++.+.+.. ..+...++.++++|..+++
T Consensus 1 m~V~KFGGtSv~~~~~i~~v~~iI~~~~~~~~~vvVvSA~~gvTd~L~~~~~~~~~~~---~~~~~~l~~i~~~h~~~~~ 77 (294)
T cd04257 1 MKVLKFGGTSLANAERIRRVADIILNAAKQEQVAVVVSAPGKVTDLLLELAELASSGD---DAYEDILQELESKHLDLIT 77 (294)
T ss_pred CEEEEeCccccCCHHHHHHHHHHHHhhccCCCEEEEEcCCCCcHHHHHHHHHHHhcCC---hhHHHHHHHHHHHHHHHHH
Confidence 5899999999999999999999999753 46789999999999999999988765422 2356679999999999999
Q ss_pred hcCCCH------HHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEec
Q 008621 161 ELGIDR------SIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (559)
Q Consensus 161 ~L~~~~------~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (559)
+|..+. +.|.+.+++|+++++++..+++++++.+|+|+|+||+||+.||+++|+++|+++.++|++++ ++|++
T Consensus 78 ~l~~~~~~~~~~~~i~~~~~~l~~~l~~~~~~~~~~~~~~d~ils~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-i~t~~ 156 (294)
T cd04257 78 ELLSGDAAAELLSALGNDLEELKDLLEGIYLLGELPDSIRAKVLSFGERLSARLLSALLNQQGLDAAWIDAREL-IVTDG 156 (294)
T ss_pred HhhcchhhHHHHHHHHHHHHHHHHHHHHHHhhccCChhHhhhheeHHHHHHHHHHHHHHHhCCCCeEEEchHHe-eEecC
Confidence 997653 35888999999999999999999999999999999999999999999999999999999996 89998
Q ss_pred CCCCceeee-cchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccc
Q 008621 235 DFTNADILE-ATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVL 313 (559)
Q Consensus 235 ~~~~a~i~~-~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~ 313 (559)
+|+++.+.. .+.+++.+.+. ..+.|||++||+|.+ .+|++|||||||||++|+++|.+|+|++++|||||||||
T Consensus 157 ~~~~a~~~~~~~~~~l~~~~~----~~~~v~Vv~Gfig~~-~~G~~ttlGRGGSD~~A~~lA~~l~a~~l~i~tdVdGvy 231 (294)
T cd04257 157 GYLNAVVDIELSKERIKAWFS----SNGKVIVVTGFIASN-PQGETTTLGRNGSDYSAAILAALLDADQVEIWTDVDGVY 231 (294)
T ss_pred CCCceEechHhhHHHHHHHHh----cCCCEEEecCcccCC-CCCCEEECCCCchHHHHHHHHHHhCCCEEEEEeCCCccC
Confidence 999888854 34454544332 227899999999998 589999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEe
Q 008621 314 TCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (559)
Q Consensus 314 taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (559)
|+||+.+|+|+++++|||+||.+|+++|++++||+|+.|++++|||++|+|+++|+.+||+|+
T Consensus 232 t~DP~~~~~A~~i~~is~~ea~~l~~~Gakv~h~~~~~~a~~~~Ipi~i~~~~~p~~~GT~I~ 294 (294)
T cd04257 232 SADPRKVKDARLLPSLSYQEAMELSYFGAKVLHPKTIQPVAKKNIPILIKNTFNPEAPGTLIS 294 (294)
T ss_pred CCCCCCCCCCeEeceeCHHHHHHHHhCCCcccCHHHHHHHHHCCCCEEEeeCCCCCCCCCEeC
Confidence 999999999999999999999999999999999999999999999999999999999999985
No 22
>cd04243 AAK_AK-HSDH-like AAK_AK-HSDH-like: Amino Acid Kinase Superfamily (AAK), AK-HSDH-like; this family includes the N-terminal catalytic domain of aspartokinase (AK) of the bifunctional enzyme AK- homoserine dehydrogenase (HSDH). These aspartokinases are found in such bacteria as E. coli (AKI-HSDHI, ThrA and AKII-HSDHII, MetL) and in higher plants (Z. mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. ThrA and MetL are involved in threonine and methionine biosynthesis, respectively. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathway end products. Maize AK-HSDH is a Thr-sensitive 180-kD enzyme. Arabidopsis AK-
Probab=100.00 E-value=1.3e-64 Score=518.19 Aligned_cols=285 Identities=40% Similarity=0.644 Sum_probs=257.1
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCCCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHHh
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (559)
|+|+|||||||+|+++|++++++|....+.+++||||||+|+||.|+++++.+.+.. ..+...++.++++|..++++
T Consensus 1 m~V~KFGGtSv~~~~~i~~v~~iI~~~~~~~~vvVvSA~~gvTd~L~~~~~~a~~~~---~~~~~~l~~i~~~h~~~~~~ 77 (293)
T cd04243 1 MKVLKFGGTSVASAERIRRVADIIKSRASSPVLVVVSALGGVTNRLVALAELAASGD---DAQAIVLQEIRERHLDLIKE 77 (293)
T ss_pred CEEEEECccccCCHHHHHHHHHHHHHhcCCCEEEEEcCCCCcHHHHHHHHHHHhcCC---hhHHHHHHHHHHHHHHHHHH
Confidence 689999999999999999999999975456889999999999999999988765432 23444699999999999999
Q ss_pred cCCCHH------HHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecC
Q 008621 162 LGIDRS------IIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDD 235 (559)
Q Consensus 162 L~~~~~------~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~ 235 (559)
|..+.. .+...+++|+++++++.++++++++.+|+|+|+||+||+.|++++|+++|+++.++|++++ +++++.
T Consensus 78 L~~~~~~~~~~~~i~~~~~~l~~~l~~~~~~~~~s~~~~d~ils~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-i~t~~~ 156 (293)
T cd04243 78 LLSGESAAELLAALDSLLERLKDLLEGIRLLGELSDKTRAEVLSFGELLSSRLMSAYLQEQGLPAAWLDAREL-LLTDDG 156 (293)
T ss_pred hhcchhhHHHHHHHHHHHHHHHHHHHhhhhhccCCchhhhHheeHHHHHHHHHHHHHHHhCCCCcEEEcHHHe-EEecCC
Confidence 987643 4888999999999999999999999999999999999999999999999999999999997 888888
Q ss_pred CCCceeeecc-hHHHHHHHhhchhcC-CcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccc
Q 008621 236 FTNADILEAT-YPAVAKRLHGDWITD-LAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVL 313 (559)
Q Consensus 236 ~~~a~i~~~~-~~~i~~~l~~~l~~~-~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~ 313 (559)
++++.+.... ...+.+. ++. +.|||++||+|.+ .+|+++||||||||++|+++|.+|+|+++++||||||||
T Consensus 157 ~~~~~~~~~~s~~~~~~~-----~~~~~~v~Vv~Gfig~~-~~G~~ttLGRggsD~~A~~~a~~l~a~~~~i~tdvdGiy 230 (293)
T cd04243 157 FLNAVVDLKLSKERLAQL-----LAEHGKVVVTQGFIASN-EDGETTTLGRGGSDYSAALLAALLDAEEVEIWTDVDGVY 230 (293)
T ss_pred CCcchhhhHHHHHHHHHH-----HhcCCCEEEecCccccC-CCCCEEEeCCCCcHHHHHHHHHHcCCCEEEEEeCCCccC
Confidence 8887764432 3333332 233 7899999999999 589999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEe
Q 008621 314 TCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (559)
Q Consensus 314 taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (559)
|+||+++|+|++|++|+|+||.+|+++|++++||+|++|++++|||++|+|+++|+.+||+|+
T Consensus 231 t~dP~~~~~a~~i~~ls~~ea~~l~~~Gakvl~p~ai~~a~~~~i~i~i~~~~~p~~~GT~I~ 293 (293)
T cd04243 231 TADPRKVPDARLLKELSYDEAMELAYFGAKVLHPRTIQPAIRKNIPIFIKNTFNPEAPGTLIS 293 (293)
T ss_pred CCCCCCCCCCeEeceeCHHHHHHHHhCCCcccCHHHHHHHHHCCCcEEEecCCCCCCCCCEeC
Confidence 999999999999999999999999999999999999999999999999999999999999985
No 23
>cd04259 AAK_AK-DapDC AAK_AK-DapDC: Amino Acid Kinase Superfamily (AAK), AK-DapDC; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the bifunctional enzyme AK - DAP decarboxylase (DapDC) found in some bacteria. Aspartokinase is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. DapDC, which is the lysA gene product, catalyzes the decarboxylation of DAP to lysine.
Probab=100.00 E-value=1.6e-64 Score=517.68 Aligned_cols=284 Identities=34% Similarity=0.550 Sum_probs=253.2
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHH
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (559)
|+|+|||||||+|++++++++++|.... +++++||||||+|+||.|+++++.+.. ..+.+.++.+.++|.+++
T Consensus 1 ~~V~KFGGtSv~~~~~~~~v~~ii~~~~~~~~~~vVVVSA~~gvTd~L~~~~~~a~~-----~~~~~~l~~i~~~~~~~~ 75 (295)
T cd04259 1 WVVLKFGGTSVSSRARWDTIAKLAQKHLNTGGQPLIVCSALSGISNKLEALIDQALL-----DEHHSLFNAIQSRHLNLA 75 (295)
T ss_pred CEEEEeCccccCCHHHHHHHHHHHHHHhhcCCCEEEEEeCCCCCchHHHHHHHHHhc-----cChHHHHHHHHHHHHHHH
Confidence 6899999999999999999999998642 357899999999999999998876643 125667999999999999
Q ss_pred HhcCCCH-HHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCC
Q 008621 160 DELGIDR-SIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (559)
Q Consensus 160 ~~L~~~~-~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (559)
++|+.+. ..++..+++|+++++++.++++++++.+|+|+|+||+||+.||+++|+++|+++.++|++++ +++++++++
T Consensus 76 ~~L~~~~~~~i~~~~~~l~~~l~~~~~~~~~~~~~~d~i~s~GE~lSa~lla~~L~~~Gi~a~~ld~~~~-i~~~~~~~~ 154 (295)
T cd04259 76 EQLEVDADALLANDLAQLQRWLTGISLLKQASPRTRAEVLALGELMSTRLGAAYLEAQGLKVKWLDAREL-LTATPTLGG 154 (295)
T ss_pred HHhhhhhhhHHHHHHHHHHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEEcHHHh-eeecccccc
Confidence 9998654 36889999999999999999999999999999999999999999999999999999999998 777777754
Q ss_pred c-------eee-ecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCc
Q 008621 239 A-------DIL-EATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVD 310 (559)
Q Consensus 239 a-------~i~-~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~ 310 (559)
+ ++. +.+..++.+.+ .+.+.|||+|||+|.+ .+|++|||||||||++|+++|.+|+|+++++|||||
T Consensus 155 ~~~~~~~a~v~~~~~~~~l~~~l----~~~~~v~Vv~GFig~~-~~G~~ttLGrggsD~tA~~lA~~l~A~~l~i~TdV~ 229 (295)
T cd04259 155 ETMNYLSARCESEYADALLQKRL----ADGAQLIITQGFIARN-AHGETVLLGRGGSDTSAAYFAAKLQAARCEIWTDVP 229 (295)
T ss_pred cccccccceehhhhhHHHHHHHH----hcCCceeEeCCceeeC-CCCCEEEECCCChHHHHHHHHHHcCCCEEEEEECCC
Confidence 3 331 22334444333 2235799999999999 589999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEe
Q 008621 311 GVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (559)
Q Consensus 311 GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (559)
||||+||+.+|+|+++++|||+||.+|+++|++++||+|++|++++|||++|+|+++|+.+||+|+
T Consensus 230 Gvyt~DP~~~~~a~~i~~ls~~ea~~l~~~Ga~v~h~~a~~~a~~~~ipi~i~~~~~p~~~GT~I~ 295 (295)
T cd04259 230 GLFTANPHEVPHARLLKRLDYDEAQEIATMGAKVLHPRCIPPARRANIPMVVRSTERPELSGTLIT 295 (295)
T ss_pred ccccCCCCCCCCCeEeceeCHHHHHHHHHcCCcccCHHHHHHHHHCCCCEEEEeCCCCCCCCcEeC
Confidence 999999999999999999999999999999999999999999999999999999999999999985
No 24
>cd04247 AAK_AK-Hom3 AAK_AK-Hom3: Amino Acid Kinase Superfamily (AAK), AK-Hom3; this CD includes the N-terminal catalytic domain of the aspartokinase HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae and other related AK domains. Aspartokinase, the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single aspartokinase isoenzyme type, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies show that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydrodynamic size.
Probab=100.00 E-value=1.8e-64 Score=517.99 Aligned_cols=288 Identities=32% Similarity=0.500 Sum_probs=246.2
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcC--CCCCcEEEEcCCC------cccHHHHHhhHhhhhcCcCcchhhhHHHHHHH
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMG------KTTNKLLLAGEKAVSCGVTNISCIDELSFVKD 153 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~--~~~~~vVVVSA~g------~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~ 153 (559)
|+|+|||||||+|++ ++++++|... .+.+++||||||+ |+||.|+++++.+.... ..++.+.++.+++
T Consensus 2 ~~V~KFGGtSv~~~~--~~v~~~i~~~~~~~~~~vVVvSA~~~~~~~~gvTd~L~~~~~~a~~~~--~~~~~~~l~~i~~ 77 (306)
T cd04247 2 WVVQKFGGTSVGKFP--DNIADDIVKAYLKGNKVAVVCSARSTGTKAEGTTNRLLQAADEALDAQ--EKAFHDIVEDIRS 77 (306)
T ss_pred CEEEEeCchhhccHH--HHHHHHHHhhhccCCceEEEEeccccCCCccChHHHHHHHHHHHHhhc--cccHHHHHHHHHH
Confidence 789999999999984 7999866642 2457899999998 99999999988765321 2467788999999
Q ss_pred HHHHHHHhcCCCH-------HHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEeccc
Q 008621 154 LHHRTVDELGIDR-------SIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAF 226 (559)
Q Consensus 154 ~~~~~~~~L~~~~-------~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~ 226 (559)
+|.+++++|..+. +.+++.+++|++++.++.++++++++.+|+|+|+||+||+.||+++|+++|+++.++|++
T Consensus 78 ~h~~~~~~L~~~~~~~~~~~~~i~~~~~~l~~~l~~~~~l~~~~~~~~d~i~s~GE~lSa~l~a~~L~~~Gi~a~~ld~~ 157 (306)
T cd04247 78 DHLAAARKFIKNPELQAELEEEINKECELLRKYLEAAKILSEISPRTKDLVISTGEKLSCRFMAAVLRDRGVDAEYVDLS 157 (306)
T ss_pred HHHHHHHHhccChhhHHHHHHHHHHHHHHHHHHHHHHHhhhhcchHHHHHHhhHHHHHHHHHHHHHHHhCCCCeEEEcHH
Confidence 9999999997653 247788999999999999999999999999999999999999999999999999999999
Q ss_pred ceEEEEecCCCCceeeecchHHHHHHHhhchhc-CCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEE
Q 008621 227 DIGFITTDDFTNADILEATYPAVAKRLHGDWIT-DLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQV 305 (559)
Q Consensus 227 ~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~-~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i 305 (559)
++ +.++.. ...........+.+.+...+.+ ++.|||+|||+|.+ .+|++||||||||||+|+++|.+|+|++++|
T Consensus 158 ~~-i~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~v~Vv~GFig~~-~~G~~ttLGRgGsD~~A~~la~~l~a~~v~i 233 (306)
T cd04247 158 HI-VDLDFS--IEALDQTFYDELAQVLGEKITACENRVPVVTGFFGNV-PGGLLSQIGRGYTDLCAALCAVGLNADELQI 233 (306)
T ss_pred Hh-eecCCC--ccccccchhHHHHHHHHHHhhccCCceEEeeccEecC-CCCCeEEeCCCchHHHHHHHHHHcCCCEEEE
Confidence 96 444332 1111111112233333332222 46799999999998 5899999999999999999999999999999
Q ss_pred eeCCcccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEec
Q 008621 306 WKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRR 377 (559)
Q Consensus 306 ~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~ 377 (559)
|||||||||+||+++|+|++|++|||+||.||+++|++||||+|++||+++||||+|+|+|+|+++||+|.+
T Consensus 234 ~tdVdGvyt~DP~~~~~a~~i~~is~~ea~el~~~GakVlHp~ti~pa~~~~Ipi~i~nt~~P~~~GT~I~~ 305 (306)
T cd04247 234 WKEVDGIFTADPRKVPTARLLPSITPEEAAELTYYGSEVIHPFTMEQVIKARIPIRIKNVENPRGEGTVIYP 305 (306)
T ss_pred eecCCeeECCCCCCCCCCeEecccCHHHHHHHHhCcCcccCHHHHHHHHHcCCcEEEecCCCCCCCCcEEcC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999976
No 25
>PRK08373 aspartate kinase; Validated
Probab=100.00 E-value=5.8e-61 Score=498.30 Aligned_cols=323 Identities=29% Similarity=0.467 Sum_probs=268.4
Q ss_pred cceEEEEeCccccCCHHHHHHHHHHHHcCC-CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHH
Q 008621 80 QLTCVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~~~~~~va~iI~~~~-~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~ 158 (559)
.+|+|+|||||||++ ++++++++|.... +++++||||||+|+||.|+++++.+ ..+.++.++++|.++
T Consensus 3 ~~m~V~KFGGsSv~~--~~~~v~~ii~~~~~~~~vvVVVSA~~gvTd~L~~l~~~~---------~~~~l~~i~~~h~~~ 71 (341)
T PRK08373 3 EKMIVVKFGGSSVRY--DFEEALELVKYLSEENEVVVVVSALKGVTDKLLKLAETF---------DKEALEEIEEIHEEF 71 (341)
T ss_pred CCCEEEEECCcchHh--HHHHHHHHHHHHhcCCCEEEEecCCchHHHHHHHHHHHH---------hHHHHHHHHHHHHHH
Confidence 467999999999998 5999999998533 4578999999999999999987643 245789999999999
Q ss_pred HHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCC
Q 008621 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (559)
Q Consensus 159 ~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (559)
+++|+.+.. .+.++|++.++.+..+ .+++.+|+|+|+||++|+.+++.+|+++|+++.+++++++ +.|+++|++
T Consensus 72 ~~~L~~~~~---~~~~~l~~~~~~~~~~--~~~~~~D~ils~GE~lSa~lla~~L~~~Gi~a~~l~~~~~-i~t~~~~~~ 145 (341)
T PRK08373 72 AKRLGIDLE---ILSPYLKKLFNSRPDL--PSEALRDYILSFGERLSAVLFAEALENEGIKGKVVDPWEI-LEAKGSFGN 145 (341)
T ss_pred HHHhccchh---hHHHHHHHHHHHhhcc--CChHHHHHHHHHHHHHHHHHHHHHHHHCCCceEEEeHHHh-eeecCCccc
Confidence 999987653 3445566666543322 3578899999999999999999999999999999999998 888888988
Q ss_pred ceeeec-chHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCC
Q 008621 239 ADILEA-TYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (559)
Q Consensus 239 a~i~~~-~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP 317 (559)
+++... +..++ +.+. .+++.+.|||++||+| + .+|.++|||||||||+|+++|++|+|++++||||||||||+||
T Consensus 146 a~i~~~~s~~~~-~~l~-~~l~~g~VpVv~Gf~g-~-~~G~~ttLGRGGSD~tA~~lA~~L~A~~v~i~TDVdGVytaDP 221 (341)
T PRK08373 146 AFIDIKKSKRNV-KILY-ELLERGRVPVVPGFIG-N-LNGFRATLGRGGSDYSAVALGVLLNAKAVLIMSDVEGIYTADP 221 (341)
T ss_pred eeechhhhhhhH-HHHH-HHHhCCcEEEEeCCcc-C-CCCeEEEcCCCchHHHHHHHHHHcCCCEEEEEECCCccCCCCC
Confidence 887322 11222 2233 2457889999999999 7 4899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCccceeeEEeeecCeEE
Q 008621 318 NIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRNVTM 397 (559)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~It~Is~~~~ial 397 (559)
+++|+|+++++|||+||.||+++|++++||+|++|+++ |||++|+|+|+| .+||+|.+... ....++++ +.+|.+.
T Consensus 222 ~~v~~A~~i~~isy~Ea~ela~~Gakvlhp~ai~~a~~-~Ipi~v~~t~~~-~~GT~I~~~~~-~~~~~~~~-~~~~~~~ 297 (341)
T PRK08373 222 KLVPSARLIPYLSYDEALIAAKLGMKALHWKAIEPVKG-KIPIIFGRTRDW-RMGTLVSNESS-GMPILVHK-VGEEHAE 297 (341)
T ss_pred CCCCCCeEcccCCHHHHHHHHHCcChhhhHHHHHHHHc-CCcEEEecCCCC-CCCcEEecCCC-CCceEEEE-ecCCEEE
Confidence 99999999999999999999999999999999999999 999999999999 58999987643 23568898 8999999
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCc
Q 008621 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSK 444 (559)
Q Consensus 398 ItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~ 444 (559)
|++.+. ...+++ . .+.-++..+.+.+++++
T Consensus 298 i~~~~~--~~~~~~-------------~--~~~~~~~~~~~~~~~~~ 327 (341)
T PRK08373 298 ILVVGV--EEEIGY-------------P--VYEEGEFWFKIKVPKEE 327 (341)
T ss_pred EEEecc--CCCCCC-------------C--ceecCCceEEEecCHHH
Confidence 999852 222321 1 24456677888887653
No 26
>TIGR02078 AspKin_pair Pyrococcus aspartate kinase subunit, putative. This family consists of proteins restricted to and found as paralogous pairs (typically close together) in species of Pyrococcus, a hyperthermophilic archaeal genus. Members are always found close to other genes of threonine biosynthesis and appear to represent the Pyrococcal form of aspartate kinase. Alignment to aspartokinase III from E. coli shows that 300 N-terminal and 20 C-terminal amino acids are homologous, but the form in Pyrococcus lacks ~ 100 amino acids in between.
Probab=100.00 E-value=6.3e-58 Score=473.15 Aligned_cols=288 Identities=31% Similarity=0.467 Sum_probs=244.4
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCC-CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHH
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVD 160 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~-~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~ 160 (559)
|+|+|||||||+++ +++++++|.... +.+++||||||+|+||.|+++++.+ ..+.++.++++|.++++
T Consensus 1 m~V~KFGGsSv~~~--~~~v~~ii~~~~~~~~~vVVVSA~~gvTd~L~~~~~~~---------~~~~l~~i~~~h~~~~~ 69 (327)
T TIGR02078 1 MIVVKFGGSSVRYA--FEEALELVKSLSEEKRVIVVVSALKGITDCLIRYANTF---------DKSAALEIEEIYEEFAK 69 (327)
T ss_pred CEEEEECCcchHHH--HHHHHHHHHHHhcCCCEEEEeCCCcchHHHHHHHHHHH---------HHHHHHHHHHHHHHHHH
Confidence 58999999999986 999999998643 4578999999999999999976421 13568899999999999
Q ss_pred hcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCce
Q 008621 161 ELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNAD 240 (559)
Q Consensus 161 ~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~ 240 (559)
+|+.+.+.+.+.++++.+. .. -.++..+|+|+|+||++|+.|+++ |+++.+++++++ ++|++.|+++.
T Consensus 70 ~L~~~~~~~~~~l~~~~~~---~~---l~~~~~~d~I~s~GE~lSa~Lla~-----gi~a~~vd~~~~-i~t~~~~~~a~ 137 (327)
T TIGR02078 70 ELGVDLNILSPYLKELFNP---PD---LPKEALRDYILSLGERLSAVIFAE-----GINGKVVDPWDI-FFAKGDFGNAF 137 (327)
T ss_pred HhccchhhhHHHHHHHHhh---hc---cCChHHHHHHHHHHHHHHHHHHHc-----cCCcEEEcHHHH-hccCCcCCcee
Confidence 9998765555555555443 11 235678999999999999999986 899999999998 88888999988
Q ss_pred eee-cchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCC
Q 008621 241 ILE-ATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (559)
Q Consensus 241 i~~-~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~ 319 (559)
++. .+..++.. +. .+++.+.|||++||+| + .+|.++||||||||++|+++|.+|+|+++++|||||||||+||++
T Consensus 138 ~~~~~~~~~~~~-l~-~~l~~g~IpVv~Gf~~-~-~~G~~ttlGRGgSD~~Aa~lA~~L~A~~v~i~TDVdGVytaDP~~ 213 (327)
T TIGR02078 138 IDIKKSKRNAKI-LY-EVLESGKIPVIPGFYG-N-LNGYRVTLGRGGSDYSAVALGVLLNSKLVAIMSDVEGIFTADPKL 213 (327)
T ss_pred echhhhHhhHHH-HH-HHHhCCcEEEEeCCcc-C-CCCeEEEcCCCChHHHHHHHHHhcCCCEEEEEECCCccCCCCCCc
Confidence 753 33333332 33 2356789999999999 7 489999999999999999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCccceeeEEeeecC-eEEE
Q 008621 320 HPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSKAVLTSIVLKRN-VTML 398 (559)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~~~It~Is~~~~-ialI 398 (559)
+|+|++++++||+||.+++++|++++||+|++|++++|||++|+|+++|+ +||+|+...+. ...|++++. +++|
T Consensus 214 v~~A~~i~~lsy~Ea~ela~~Gakvlhp~a~~~a~~~~Ipi~I~~t~~~~-~GT~I~~~~~~----~~~i~~~~~~i~~v 288 (327)
T TIGR02078 214 VPSARLIPYLSYEEIKIAAKLGMKALQWKAADLAKEYKIPVLFGRTRDWR-MGTLISNRSSG----MPLMVYKDGELLVV 288 (327)
T ss_pred CCCceEccccCHHHHHHHHHCCchhhHHHHHHHHHHCCCeEEEEeCCCcC-CCcEEecCCCC----CcEEEEccCcEEEE
Confidence 99999999999999999999999999999999999999999999999996 89999875422 345888888 9999
Q ss_pred EEE
Q 008621 399 DIV 401 (559)
Q Consensus 399 tV~ 401 (559)
.+.
T Consensus 289 ~~~ 291 (327)
T TIGR02078 289 NVR 291 (327)
T ss_pred EEe
Confidence 984
No 27
>cd04248 AAK_AK-Ectoine AAK_AK-Ectoine: Amino Acid Kinase Superfamily (AAK), AK-Ectoine; this CD includes the N-terminal catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and other various halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinase and L-aspartate-semialdehyde dehydrogenase. The M. alcaliphilum and the V. cholerae aspartokinases are encoded on the ectABCask operon.
Probab=100.00 E-value=5.2e-58 Score=464.47 Aligned_cols=279 Identities=28% Similarity=0.392 Sum_probs=224.9
Q ss_pred EEEEeCccccCCHHHHHHHHHHHHcCCC--CCcEEEEcCCCcccHHHHHhhHhh---hhcCc--CcchhhhHHHHHHHHH
Q 008621 83 CVMKFGGSSLASAERMREVAELILSFPN--ERPVIVLSAMGKTTNKLLLAGEKA---VSCGV--TNISCIDELSFVKDLH 155 (559)
Q Consensus 83 ~V~KFGGsSl~~~~~~~~va~iI~~~~~--~~~vVVVSA~g~~Td~L~~~~~~~---~~~~~--~~~~~~~~l~~i~~~~ 155 (559)
.|+|||||||++.+.++. ++|..... .++|+||||++|+||.|++.-+.. +...+ .+..|.+.|+.+.++|
T Consensus 2 ~V~K~GGTSms~~~~~~d--~i~~~~~~~~~~rv~VVSA~~gvT~~Lle~k~t~~~gv~~~~~~~~~~~~~al~~~~~~~ 79 (304)
T cd04248 2 TVEKIGGTSMSAFGAVLD--NIILKPDSDLYGRVFVVSAYSGVTNALLEHKKTGAPGIYQHFVDADEAWREALSALKQAM 79 (304)
T ss_pred ceeeecCcccccHHHHhh--hHhcCCcccCccEEEEEECCccchHHHHHhhhcCCcchhHHHhcCchHHHHHHHHHHHHH
Confidence 699999999999998888 66663222 368999999999999999731110 00001 1244788899999999
Q ss_pred HHHHHhcCCCH-------HHHH-------HHHHHHHHHH-HhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCce
Q 008621 156 HRTVDELGIDR-------SIIA-------THLEELEQLL-KGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKA 220 (559)
Q Consensus 156 ~~~~~~L~~~~-------~~i~-------~~~~~l~~~l-~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a 220 (559)
..+..+|..++ +++. .++.++.+++ .|+..+++++++.+|+|+|+||++|+.+++.+|+++|++|
T Consensus 80 ~~~~~~l~~~~~~~~~a~~~i~~r~~~~~~~l~~~~~~~~~g~~~l~e~~~~~rd~l~S~GE~~Sa~l~a~~L~~~Gi~A 159 (304)
T cd04248 80 LKINEAFADIGLDVEQADAFIGARIQDARACLHDLARLCSSGYFSLAEHLLAARELLASLGEAHSAFNTALLLQNRGVNA 159 (304)
T ss_pred HHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHhhCCHHHHHHHhhhCHHHHHHHHHHHHHHCCCCe
Confidence 88887776441 2233 3444555555 5788889999999999999999999999999999999999
Q ss_pred EEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCc
Q 008621 221 RQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGL 300 (559)
Q Consensus 221 ~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A 300 (559)
.++|...+ ...+.+. ....+.+.+.. +...+.|||+|||.+ + .+|+++|||||||||||++||++|+|
T Consensus 160 ~~vD~~~~--~~~~~~t-------~~~~i~~~~~~-~~~~~~v~IvtGF~~-~-~~G~itTLGRGGSDyTAs~iAa~l~A 227 (304)
T cd04248 160 RFVDLSGW--RDSGDMT-------LDERISEAFRD-IDPRDELPIVTGYAK-C-AEGLMREFDRGYSEMTFSRIAVLTGA 227 (304)
T ss_pred EEECcccc--cccCCCC-------cHHHHHHHHHh-hccCCcEEEeCCccC-C-CCCCEEEcCCCcHHHHHHHHHHHcCC
Confidence 99887654 1111111 12344444443 223567999999954 6 48999999999999999999999999
Q ss_pred CcEEEeeCCcccccCCCCCC--CCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEe
Q 008621 301 QEIQVWKDVDGVLTCDPNIH--PHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (559)
Q Consensus 301 ~~l~i~TDV~GV~taDP~~v--~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (559)
++++|||||+ |||+|||+| ++|++|++|||+||.||+++|++||||+|++|++++||||+|+|+|+|+++||+|+
T Consensus 228 ~ev~I~TDV~-i~taDPriV~~~~A~~i~~lsY~EA~ELA~~GakvLHP~ai~pa~~~~IPi~Vkntf~P~~~GTlIt 304 (304)
T cd04248 228 SEAIIHKEFH-LSSADPKLVGEDKARPIGRTNYDVADQLANLGMEAIHPKAAKGLRQAGIPLRVKNTFEPDHPGTLIT 304 (304)
T ss_pred CEEEEECCCc-eecCCCCccCCCCceEeCccCHHHHHHHHHcChhhcCHHHHHHHHHcCCeEEEecCCCCCCCCceeC
Confidence 9999999996 999999999 68999999999999999999999999999999999999999999999999999995
No 28
>cd04261 AAK_AKii-LysC-BS AAK_AKii-LysC-BS: Amino Acid Kinase Superfamily (AAK), AKii; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive aspartokinase isoenzymes. The B. subtilis 168 AKII is induced by methionine, and repressed and inhibited by lysine. Although Corynebacterium glutamicum is known to contain a single aspartokinase isoenzyme type, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In this organism and other various Gram-positive bacteria, the DAP-lysine pathway is feedback regulated by the concerted action of lysine and
Probab=100.00 E-value=2.5e-47 Score=381.53 Aligned_cols=237 Identities=38% Similarity=0.607 Sum_probs=211.1
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHH
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (559)
++|+||||+++.|++.++++++.|.... +.+++||+||+++.|++|++......
T Consensus 1 ~iViK~GGs~l~~~~~~~~~~~~i~~l~~~g~~~vvV~sg~g~~~~~l~~~~~~~~------------------------ 56 (239)
T cd04261 1 LIVQKFGGTSVASIERIKRVAERIKKRKKKGNQVVVVVSAMGGTTDELIELAKEIS------------------------ 56 (239)
T ss_pred CEEEEECCcccCCHHHHHHHHHHHHHHHHcCCCEEEEECCCCchhHHHHHHHHHhc------------------------
Confidence 4799999999999999999999998753 45789999999999999987532110
Q ss_pred HhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCc
Q 008621 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNA 239 (559)
Q Consensus 160 ~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a 239 (559)
+..+.+.+|.++++||++|+.+++++|+++|++++++++.|+++++.++|+++
T Consensus 57 ---------------------------~~~~~~~~~~i~a~Ge~~~~~l~~~~l~~~g~~a~~l~~~~~~l~~~~~~~~~ 109 (239)
T cd04261 57 ---------------------------PRPPARELDVLLSTGEQVSIALLAMALNRLGIKAISLTGWQAGILTDGHHGKA 109 (239)
T ss_pred ---------------------------cCCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEechhhCCEEecCCCCcc
Confidence 12245677889999999999999999999999999999999988998888777
Q ss_pred eeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCC
Q 008621 240 DILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (559)
Q Consensus 240 ~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~ 319 (559)
++...+...+.+ +++.+.|||++||+|.+ .+|.++++|||+||++|+++|.+|+|+++++||||||||++||+.
T Consensus 110 ~i~~~~~~~l~~-----ll~~~~ipVi~G~~~~~-~~g~~~~l~rg~sD~~A~~lA~~l~A~~lii~tdV~GVy~~dP~~ 183 (239)
T cd04261 110 RIIDIDPDRIRE-----LLEEGDVVIVAGFQGIN-EDGDITTLGRGGSDTSAVALAAALGADRCEIYTDVDGVYTADPRI 183 (239)
T ss_pred eechhhHHHHHH-----HHHcCCeEEEcCccccC-CCCCEEecCCCChHHHHHHHHHHcCCCEEEEEeCCCCCCCCCCCC
Confidence 775555443332 35678999999999999 489999999999999999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEe
Q 008621 320 HPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (559)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (559)
+|+++++++|+|+|+.+|+++|++++||+|++|++++|||++|+|+++|+ +||+|+
T Consensus 184 ~~~a~~i~~i~~~ea~~l~~~G~~~~~~~a~~~~~~~~i~i~I~n~~~~~-~gt~i~ 239 (239)
T cd04261 184 VPKARKLDEISYDEMLEMASLGAKVLHPRSVELAKKYGVPLRVLSSFSEE-PGTLIT 239 (239)
T ss_pred CCCceEccccCHHHHHHHHhccccccCHHHHHHHHHcCCeEEEecCCCCC-CCcEeC
Confidence 99999999999999999999999999999999999999999999999999 999985
No 29
>cd04234 AAK_AK AAK_AK: Amino Acid Kinase Superfamily (AAK), Aspartokinase (AK); this CD includes the N-terminal catalytic domain of aspartokinase (4-L-aspartate-4-phosphotransferase;). AK is the first enzyme in the biosynthetic pathway of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. It also catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. One mechanism for the regulation of this pathway is by the production of several isoenzymes of aspartokinase with different repressors and allosteric inhibitors. Pairs of ACT domains are proposed to specifically bind amino acids leading to allosteric regulation of the enzyme. In Escherichia coli, three different aspartokinase isoenzymes are regulated specifically by lysine, methionine, and threonine. AK-HSDHI (ThrA) and AK-HSDHII (MetL) are bifunctional enzymes that consist of an N-terminal AK and a C-terminal homoserine dehyd
Probab=100.00 E-value=1.8e-47 Score=379.68 Aligned_cols=225 Identities=49% Similarity=0.860 Sum_probs=198.7
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcC-CCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHH
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSF-PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVD 160 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~-~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~ 160 (559)
|+|+||||||+++++.+++++++|... .+.++|||+||++++|+.|++++
T Consensus 1 ~iViK~GGs~l~~~~~~~~~~~~i~~l~~g~~vvvV~Sg~~~~t~~l~~~~----------------------------- 51 (227)
T cd04234 1 MVVQKFGGTSVASAERIKRVADIIKAYEKGNRVVVVVSAMGGVTDLLIELA----------------------------- 51 (227)
T ss_pred CEEEEECccccCCHHHHHHHHHHHHHhhcCCCEEEEEcCCCcccHHHHHHH-----------------------------
Confidence 689999999999999999999999975 24578999999999999986530
Q ss_pred hcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCce
Q 008621 161 ELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNAD 240 (559)
Q Consensus 161 ~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~ 240 (559)
.++++||.+|+.+++++|+++|+++.+++++++++.+++.+...+
T Consensus 52 -----------------------------------~~~s~Ge~~~~~l~~~~l~~~Gi~a~~l~~~~~~~~~~~~~~~~~ 96 (227)
T cd04234 52 -----------------------------------LLLSFGERLSARLLAAALRDRGIKARSLDARQAGITTDDNHGAAR 96 (227)
T ss_pred -----------------------------------HHHHHHHHHHHHHHHHHHHHCCCCeEEeCHHHCCEEcCCccchhh
Confidence 578999999999999999999999999999998555544323333
Q ss_pred eeecchHHHHHHHhhchhcC-CcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCC
Q 008621 241 ILEATYPAVAKRLHGDWITD-LAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (559)
Q Consensus 241 i~~~~~~~i~~~l~~~l~~~-~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~ 319 (559)
+...+...+. .+++. +.|||++||+|.+ ++|.++++||||||++|+++|.+|+|+++++|||||||||+||+.
T Consensus 97 ~~~~~~~~l~-----~~l~~~~~vpVv~g~i~~~-~~g~~~~l~rg~sD~~A~~lA~~l~A~~l~~~tdV~Gvy~~dP~~ 170 (227)
T cd04234 97 IIEISYERLK-----ELLAEIGKVPVVTGFIGRN-EDGEITTLGRGGSDYSAAALAAALGADEVEIWTDVDGIYTADPRI 170 (227)
T ss_pred HHHHHHHHHH-----HHHhhCCCEEEecCceecC-CCCCEEEeeCCCcHHHHHHHHHHhCCCEEEEEECCCccCCCCCCC
Confidence 3333333332 23566 8999999999999 489999999999999999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEe
Q 008621 320 HPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (559)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (559)
+|+++++++++|+|+.+|+++|+++|||+|+++++++|||++|+|+++|+.+||+|+
T Consensus 171 ~~~a~~i~~i~~~e~~~l~~~G~~~~~~~a~~~a~~~~i~i~i~~~~~~~~~gT~I~ 227 (227)
T cd04234 171 VPEARLIPEISYDEALELAYFGAKVLHPRAVEPARKANIPIRVKNTFNPEAPGTLIT 227 (227)
T ss_pred CCCceEcCcCCHHHHHHHHhCCccccCHHHHHHHHHcCCeEEEEeCCCCCCCCCEeC
Confidence 999999999999999999999999999999999999999999999999999999984
No 30
>cd04246 AAK_AK-DapG-like AAK_AK-DapG-like: Amino Acid Kinase Superfamily (AAK), AK-DapG-like; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the diaminopimelate-sensitive aspartokinase isoenzyme AKI (DapG), a monofunctional enzymes found in Bacilli (Bacillus subtilis 168), Clostridia, and Actinobacteria bacterial species, as well as, the catalytic AK domain of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis 168, the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related isoenzymes. In Bacillus subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. The role of the AKI isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulati
Probab=100.00 E-value=7.1e-47 Score=378.22 Aligned_cols=237 Identities=39% Similarity=0.629 Sum_probs=210.5
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHH
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (559)
|+|+|||||++.|++.++++++.|.... +.+++||+||+++.+++|++......
T Consensus 1 ~iViK~GGs~l~~~~~~~~~~~~i~~l~~~g~~~viV~sg~g~~~~~ll~~~~~~~------------------------ 56 (239)
T cd04246 1 IIVQKFGGTSVADIERIKRVAERIKKAVKKGYQVVVVVSAMGGTTDELIGLAKEVS------------------------ 56 (239)
T ss_pred CEEEEECccccCCHHHHHHHHHHHHHHHHcCCCEEEEECCCCchHHHHHHHHHHhc------------------------
Confidence 6899999999999999999999998753 46789999999999999987532100
Q ss_pred HhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCc
Q 008621 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNA 239 (559)
Q Consensus 160 ~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a 239 (559)
...+...+|.++++||++|+.+++++|+++|++++++++.+.++++.++|+++
T Consensus 57 ---------------------------~~~~~~~~~~i~~~Ge~~~~~~~~~~l~~~g~~a~~l~~~~~~l~~~~~~~~~ 109 (239)
T cd04246 57 ---------------------------PRPSPRELDMLLSTGEQISAALLAMALNRLGIKAISLTGWQAGILTDDHHGNA 109 (239)
T ss_pred ---------------------------cCCCHHHHHHHHHHhHHHHHHHHHHHHHhCCCCeEEeccccCCEEecCCCCce
Confidence 01245677889999999999999999999999999999999888988888877
Q ss_pred eeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCC
Q 008621 240 DILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (559)
Q Consensus 240 ~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~ 319 (559)
++...+...+. .+++++.|||++||+|.+ .+|.++++||||||++|+++|.+|+|+++++||||||||++||+.
T Consensus 110 ~~~~~~~~~l~-----~ll~~g~ipVi~g~~~~~-~~g~~~~l~~g~~D~~A~~lA~~l~A~~li~~tdV~GVy~~dP~~ 183 (239)
T cd04246 110 RIIDIDPKRIL-----EALEEGDVVVVAGFQGVN-EDGEITTLGRGGSDTTAVALAAALKADRCEIYTDVDGVYTADPRI 183 (239)
T ss_pred eechhhHHHHH-----HHHhcCCEEEEcCccccC-CCCCEEecCCCChHHHHHHHHHHcCCCEEEEEECCCCCCCCCCCC
Confidence 77555444333 235678999999999998 489999999999999999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEe
Q 008621 320 HPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (559)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (559)
+|+++++++|+|+|+.+|+++|++++||+|++|++++|||++|+|+++|+ +||+|+
T Consensus 184 ~~~a~~i~~l~~~e~~~l~~~G~~~~~~~a~~~a~~~gi~i~i~~~~~~~-~gt~i~ 239 (239)
T cd04246 184 VPKARKLDVISYDEMLEMASLGAKVLHPRSVELAKKYNVPLRVRSSFSEN-PGTLIT 239 (239)
T ss_pred CCCCeEcccCCHHHHHHHHhCCCcccCHHHHHHHHHCCCeEEEecCCCCC-CCcEeC
Confidence 99999999999999999999999999999999999999999999999999 999985
No 31
>cd04260 AAK_AKi-DapG-BS AAK_AKi-DapG-BS: Amino Acid Kinase Superfamily (AAK), AKi-DapG; this CD includes the N-terminal catalytic aspartokinase (AK) domain of the diaminopimelate-sensitive aspartokinase isoenzyme AKI (DapG), a monofunctional class enzyme found in Bacilli (Bacillus subtilis 168), Clostridia, and Actinobacteria bacterial species. In Bacillus subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The B. subtilis AKI is tetrameric consisting of two alpha and two bet
Probab=100.00 E-value=1.7e-46 Score=376.57 Aligned_cols=237 Identities=34% Similarity=0.604 Sum_probs=207.4
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcc-----cHHHHHhhHhhhhcCcCcchhhhHHHHHHHH
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKT-----TNKLLLAGEKAVSCGVTNISCIDELSFVKDL 154 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~-----Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~ 154 (559)
++|+|||||++.|++.++++++.|.... +.+++||+||+|+. |+.|.+...
T Consensus 1 ~~ViK~GGs~l~~~~~~~~~~~~I~~~~~~g~~~vvV~sa~g~~G~~~~~~~l~~~~~---------------------- 58 (244)
T cd04260 1 IIVQKFGGTSVSTKERREQVAKKVKQAVDEGYKPVVVVSAMGRKGDPYATDTLINLVY---------------------- 58 (244)
T ss_pred CEEEEECchhcCCHHHHHHHHHHHHHHHHCCCCeEEEEECCCCCCCchHHHHHHHHHH----------------------
Confidence 3799999999999999999999999753 34789999998773 555443210
Q ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEec
Q 008621 155 HHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (559)
Q Consensus 155 ~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (559)
..+ ...++..+|.++++||.+++.+++++|+++|+++.++++.+.++++.+
T Consensus 59 ------~~~-----------------------~~~t~~~~~~~~~~Ge~~~~~~~~~~l~~~Gi~a~~l~~~~~~lit~~ 109 (244)
T cd04260 59 ------AEN-----------------------SDISPRELDLLMSCGEIISAVVLTSTLRAQGLKAVALTGAQAGILTDD 109 (244)
T ss_pred ------hhc-----------------------CCCCHHHHHHHHHHhHHHHHHHHHHHHHhCCCCeEEechHHcCEEecC
Confidence 000 123567789999999999999999999999999999999999999999
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCccccc
Q 008621 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (559)
Q Consensus 235 ~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~t 314 (559)
+++++++...+...+.+ +++.+.|||++||+|.++ +|+++++||||||++|+++|.+|+|+++++||||||||+
T Consensus 110 ~~~~~~v~~~~~~~l~~-----ll~~g~VPVv~g~~~~~~-~g~~~~l~rg~sD~~A~~lA~~l~A~~l~~~tDV~GVy~ 183 (244)
T cd04260 110 NYSNAKIIKVNPKKILS-----ALKEGDVVVVAGFQGVTE-DGEVTTLGRGGSDTTAAALGAALNAEYVEIYTDVDGIMT 183 (244)
T ss_pred CCCceeeeccCHHHHHH-----HHhCCCEEEecCCcccCC-CCCEEEeCCCchHHHHHHHHHHcCCCEEEEEECCCcCCc
Confidence 88877766555554432 356789999999999994 899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEe
Q 008621 315 CDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIR 376 (559)
Q Consensus 315 aDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~ 376 (559)
+||+.+|++++|++|+|+|+.+|+++|++++||+|++++++++||++|+|+++|+ +||+|+
T Consensus 184 ~dP~~~~~a~~i~~i~~~e~~~l~~~g~~v~~~~a~~~~~~~~i~v~I~~~~~~~-~gt~i~ 244 (244)
T cd04260 184 ADPRVVPNARILDVVSYNEVFQMAHQGAKVIHPRAVEIAMQANIPIRIRSTMSEN-PGTLIT 244 (244)
T ss_pred CCCCCCCCCeEcccCCHHHHHHHHHcCchhcCHHHHHHHHHcCCeEEEecCCCCC-CCCEeC
Confidence 9999999999999999999999999999999999999999999999999999998 999985
No 32
>cd02115 AAK Amino Acid Kinases (AAK) superfamily, catalytic domain; present in such enzymes like N-acetylglutamate kinase (NAGK), carbamate kinase (CK), aspartokinase (AK), glutamate-5-kinase (G5K) and UMP kinase (UMPK). The AAK superfamily includes kinases that phosphorylate a variety of amino acid substrates. These kinases catalyze the formation of phosphoric anhydrides, generally with a carboxylate, and use ATP as the source of the phosphoryl group; are involved in amino acid biosynthesis. Some of these kinases control the process via allosteric feed-back inhibition.
Probab=100.00 E-value=1.4e-36 Score=304.46 Aligned_cols=237 Identities=40% Similarity=0.606 Sum_probs=199.1
Q ss_pred EEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHHh
Q 008621 84 VMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (559)
Q Consensus 84 V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (559)
|+|||||++.+.+.++++++.|.... +.++|+|+||+++.|+.+.+.....
T Consensus 1 ViKiGGs~l~~~~~~~~~~~~i~~l~~~~~~~viV~ggg~~~~~~~~~~~~~~--------------------------- 53 (248)
T cd02115 1 VIKFGGSSVSSEERLRNLARILVKLASEGGRVVVVHGAGPQITDELLAHGELL--------------------------- 53 (248)
T ss_pred CEeeCccccCCHHHHHHHHHHHHHHHhcCCCEEEEECCCCCcCHHHHHHHHhh---------------------------
Confidence 78999999999999999999999752 4578999999999999987653210
Q ss_pred cCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCC-ce
Q 008621 162 LGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN-AD 240 (559)
Q Consensus 162 L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~-a~ 240 (559)
.+..+ ...+....+.++++||.+++.++.++|+++|+++.++++.++.+.+. +++. ..
T Consensus 54 ----------------~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~gi~a~~~~~~~~~~~~~-~~~~~g~ 112 (248)
T cd02115 54 ----------------GYARG----LRITDRETDALAAMGEGMSNLLIAAALEQHGIKAVPLDLTQAGFASP-NQGHVGK 112 (248)
T ss_pred ----------------hhhhc----cCCCHHHHHHHHHHHHHHHHHHHHHHHHhCCCCeEEEchHHcCeEeC-CCCCccc
Confidence 00011 23467788999999999999999999999999999999999855544 4443 44
Q ss_pred eeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCC
Q 008621 241 ILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIH 320 (559)
Q Consensus 241 i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v 320 (559)
+...+...+.+ +++.+.|||++||.+.+. + +..+++|++||++|+.+|.+|+|+++++||||||||++||+++
T Consensus 113 ~~~~~~~~l~~-----~l~~~~ipVv~g~~~~~~-~-~~~~~~~~~sD~~A~~lA~~l~A~~li~~tdV~Gv~~~dP~~~ 185 (248)
T cd02115 113 ITKVSTDRLKS-----LLENGILPILSGFGGTDE-K-ETGTLGRGGSDSTAALLAAALKADRLVILTDVDGVYTADPRKV 185 (248)
T ss_pred ceeeCHHHHHH-----HHhCCcEEEecCeEeccC-C-ceeeecCCCHHHHHHHHHHHcCCCEEEEEecCCeeecCCCCcC
Confidence 45555554443 346789999999988763 4 6788999999999999999999999999999999999999999
Q ss_pred CCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCC--------CCCCCeEE
Q 008621 321 PHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYN--------PNAPGTLI 375 (559)
Q Consensus 321 ~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~--------p~~~GT~I 375 (559)
|++++|++|+|+|+.++++.|+.++||+++.++.++++|++|.|+++ +++.||+|
T Consensus 186 ~~a~~i~~i~~~e~~~l~~~g~~~~k~~a~~~~~~~~~~v~I~~~~~~~~l~~~~~~~~GT~I 248 (248)
T cd02115 186 PDAKLLSELTYEEAAELAYAGAMVLKPKAADPAARAGIPVRIANTENPGALALFTPDGGGTLI 248 (248)
T ss_pred CcCeECCcCCHHHHHHHHHcCCCccCHHHHHHHHHcCCcEEEEeCCCcccccccCCCCCCCCC
Confidence 99999999999999999999999999999999999999999999988 56677765
No 33
>PRK12314 gamma-glutamyl kinase; Provisional
Probab=100.00 E-value=2e-32 Score=277.68 Aligned_cols=227 Identities=22% Similarity=0.311 Sum_probs=181.2
Q ss_pred CcceEEEEeCccccC------CHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHH
Q 008621 79 KQLTCVMKFGGSSLA------SAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSF 150 (559)
Q Consensus 79 ~~~~~V~KFGGsSl~------~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~ 150 (559)
.|+++|+||||||+. +.++++++++.|.... +.++|+|+||+++.+..++....
T Consensus 8 ~~~~iViK~Ggs~l~~~~~~~~~~~i~~~~~~I~~~~~~g~~vvlV~Sga~~~g~~~l~~~~------------------ 69 (266)
T PRK12314 8 NAKRIVIKVGSSTLSYENGKINLERIEQLVFVISDLMNKGKEVILVSSGAIGAGLTKLKLDK------------------ 69 (266)
T ss_pred hCCEEEEEeCCCeeeCCCCCcCHHHHHHHHHHHHHHHHCCCeEEEEeeCcccccceeecccc------------------
Confidence 367899999999999 7899999999998643 34567788998888876654210
Q ss_pred HHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEE
Q 008621 151 VKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGF 230 (559)
Q Consensus 151 i~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~i 230 (559)
...+...++.+++.||.+++.++..+|+++|+++ +|+ +
T Consensus 70 ------------------------------------~~~~~~~~~a~aa~Gq~~l~~~~~~~~~~~g~~~-----~q~-l 107 (266)
T PRK12314 70 ------------------------------------RPTSLAEKQALAAVGQPELMSLYSKFFAEYGIVV-----AQI-L 107 (266)
T ss_pred ------------------------------------CCCCHHHHHHHHHHhHHHHHHHHHHHHHHcCCeE-----EEE-E
Confidence 0012234688999999999999999999999974 666 8
Q ss_pred EEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeec----CCcchhHHHHHHHHcCcCcEEEe
Q 008621 231 ITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG----RGGSDLTATTIGKALGLQEIQVW 306 (559)
Q Consensus 231 it~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlg----RgGSD~tAa~lA~~L~A~~l~i~ 306 (559)
+|.++|.+.+.. .+..+.+. .|++.|.|||+.+ ++.+++.+ ||++|++|++||.+|+|+.++||
T Consensus 108 lT~~~~~~~~~~----~~~~~~l~-~ll~~g~IPVv~~-------nd~v~~~~~~~~~~~~D~~Aa~lA~~l~Ad~liil 175 (266)
T PRK12314 108 LTRDDFDSPKSR----ANVKNTFE-SLLELGILPIVNE-------NDAVATDEIDTKFGDNDRLSAIVAKLVKADLLIIL 175 (266)
T ss_pred EecccccchHHH----HHHHHHHH-HHHHCCCEEEEcC-------CCCeeeccccceecchHHHHHHHHHHhCCCEEEEE
Confidence 888888766542 23333343 3567899999943 45566666 89999999999999999999999
Q ss_pred eCCcccccCCCCCCCCCccccccCH--HHHHHHHHc-------CCCcchHhHHHHHHhCCCCEEEecCCCCC--------
Q 008621 307 KDVDGVLTCDPNIHPHAKPVPYLTF--DEAAELAYF-------GAQVLHPQSMRPAREGDIPVRVKNSYNPN-------- 369 (559)
Q Consensus 307 TDV~GV~taDP~~v~~a~~i~~ls~--~Ea~eLa~~-------Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~-------- 369 (559)
|||||||++||+.+|+|++|+.++| .|..+++.. |..+.|++++..+.+.|+|++|.|+++|+
T Consensus 176 TDVdGVy~~dP~~~~~a~~i~~I~~~~~~~~~~~~~~~~~~~tGGM~~Kl~aa~~a~~~gv~v~I~~g~~~~~i~~~l~g 255 (266)
T PRK12314 176 SDIDGLYDKNPRINPDAKLRSEVTEITEEILALAGGAGSKFGTGGMVTKLKAAKFLMEAGIKMVLANGFNPSDILDFLEG 255 (266)
T ss_pred eCCCcccCCCCCCCCCCeEEEEecCCCHHHHHHhccCCCCcccCchHHHHHHHHHHHHCCCeEEEEcCCCchHHHHHHcC
Confidence 9999999999999999999999997 666666543 45677889999999999999999988773
Q ss_pred -CCCeEEec
Q 008621 370 -APGTLIRR 377 (559)
Q Consensus 370 -~~GT~I~~ 377 (559)
..||+|.+
T Consensus 256 ~~~GT~i~~ 264 (266)
T PRK12314 256 ESIGTLFAP 264 (266)
T ss_pred CCCceEEcc
Confidence 46999865
No 34
>PF00696 AA_kinase: Amino acid kinase family Match to Glutamate-5-kinases, C-terminal end of the alignment Match to Aspartate kinases; InterPro: IPR001048 This entry contains proteins with various specificities and includes the aspartate, glutamate and uridylate kinase families. In prokaryotes and plants the synthesis of the essential amino acids lysine and threonine is predominantly regulated by feed-back inhibition of aspartate kinase (AK) and dihydrodipicolinate synthase (DHPS). In Escherichia coli, thrA, metLM, and lysC encode aspartokinase isozymes that show feedback inhibition by threonine, methionine, and lysine, respectively []. The lysine-sensitive isoenzyme of aspartate kinase from spinach leaves has a subunit composition of 4 large and 4 small subunits []. In plants although the control of carbon fixation and nitrogen assimilation has been studied in detail, relatively little is known about the regulation of carbon and nitrogen flow into amino acids. The metabolic regulation of expression of an Arabidopsis thaliana aspartate kinase/homoserine dehydrogenase (AK/HSD) gene, which encodes two linked key enzymes in the biosynthetic pathway of aspartate family amino acids has been studied []. The conversion of aspartate into either the storage amino acid asparagine or aspartate family amino acids may be subject to a coordinated, reciprocal metabolic control, and this biochemical branch point is a part of a larger, coordinated regulatory mechanism of nitrogen and carbon storage and utilization.; GO: 0008652 cellular amino acid biosynthetic process; PDB: 2X2W_B 2WXB_B 1B7B_C 2J4L_F 2J4K_E 2J4J_F 2OGX_B 3QUO_A 3D40_A 3D41_A ....
Probab=99.98 E-value=9.6e-33 Score=275.71 Aligned_cols=233 Identities=35% Similarity=0.455 Sum_probs=179.6
Q ss_pred ceEEEEeCccccCCH--HHHHHHHHHHHcCC-CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHH
Q 008621 81 LTCVMKFGGSSLASA--ERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (559)
Q Consensus 81 ~~~V~KFGGsSl~~~--~~~~~va~iI~~~~-~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~ 157 (559)
+++|+|||||++.+. + ++++++.|.... ...++|||||+|+.+|.+++........ .. ..+|..
T Consensus 1 k~~ViK~GGs~l~~~~~~-~~~~~~~i~~l~~~g~~vvvV~g~g~~~~~~~~~~~~~~~~-------~~-----~~r~~~ 67 (242)
T PF00696_consen 1 KTIVIKLGGSSLTDKDEE-LRELADDIALLSQLGIKVVVVHGGGSFTDELLEKYGIEPKF-------VD-----GSRVTD 67 (242)
T ss_dssp SEEEEEE-HHGHSSHSHH-HHHHHHHHHHHHHTTSEEEEEESSHHHHHHHHHHCTHTTSE-------ET-----HHCHBH
T ss_pred CeEEEEECchhhCCchHH-HHHHHHHHHHHHhCCCeEEEEECChhhcCchHHhccCCccc-------ch-----hhhhhh
Confidence 579999999999998 7 999999998643 3466799999999999998763211100 00 001111
Q ss_pred HHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCC
Q 008621 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFT 237 (559)
Q Consensus 158 ~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~ 237 (559)
....+.. -.....+|.+ ....|.+++.|+.+++.++...+.+.|+.+...++.
T Consensus 68 ~~~~~~~----~~~~~~~l~~------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 120 (242)
T PF00696_consen 68 IETGLII----TMAAAAELNR------------DALLDEIVSAGERLGAHAVGLSLSDGGISAAKRDAR----------- 120 (242)
T ss_dssp HHHHHHH----HHHHHHHHHH------------HHHHHHHHHHHHHCTHHEEEHHHTGGTEEEEEEESS-----------
T ss_pred hhhhHHH----HHHHhhcccc------------chhHHHHHHhhhhhhHHHHhhhhhcccchhhhhhhh-----------
Confidence 1000000 0001111111 467788999999999999999999988877666543
Q ss_pred CceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCC
Q 008621 238 NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDP 317 (559)
Q Consensus 238 ~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP 317 (559)
..+...+.+ +++++.|||++||.+.+ .+|++++++++++|++|+.||.+|+|+++++||||||||++||
T Consensus 121 -----~~~~~~i~~-----~l~~~~ipVv~g~~~~~-~~g~~~~~~~~~sD~~A~~lA~~l~A~~li~~tdV~Gv~~~dP 189 (242)
T PF00696_consen 121 -----EVDKEAIRE-----LLEQGIIPVVSGFAGID-DDGEVTTLGNVSSDYIAALLAAALGADKLIFLTDVDGVYTADP 189 (242)
T ss_dssp -----EEHHHHHHH-----HHHTTSEEEEESEEEEE-TTSTEEEEEEETHHHHHHHHHHHTTCSEEEEEESSSSEBSSST
T ss_pred -----hhHHHHHHH-----HHHCCCEEEEeCCcccC-CCCCcccCCCCCHHHHHHHHHHHhCchhhhhhhhcCceeecCC
Confidence 112233332 34578999999999888 4899999999999999999999999999999999999999999
Q ss_pred CCCCCCccccccCHHHHHHHH------HcCCCcchHhHHHHHHhCCCCEEEec
Q 008621 318 NIHPHAKPVPYLTFDEAAELA------YFGAQVLHPQSMRPAREGDIPVRVKN 364 (559)
Q Consensus 318 ~~v~~a~~i~~ls~~Ea~eLa------~~Ga~vlhp~a~~~a~~~~Ipv~I~n 364 (559)
+.+|+++++++|+|+|+.+|+ +.|++++||.|+++++++++|++|.|
T Consensus 190 ~~~~~~~~i~~l~~~e~~~l~~~~~~~~~gm~~k~~~a~~~~~~~~~~v~I~n 242 (242)
T PF00696_consen 190 RIVPDARLIPELSYDEAEELASKSGDVTGGMKPKHPAALEAAEEGGIPVHIIN 242 (242)
T ss_dssp TTSTTSEBESEEEHHHHHHHHHHTTSSTTTHHHHHHHHHHHHHHTTSEEEEEE
T ss_pred CCCCCCeeeeEeeHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHcCCCcEEEeC
Confidence 999999999999999999999 89999999999999999999999986
No 35
>cd04242 AAK_G5K_ProB AAK_G5K_ProB: Glutamate-5-kinase (G5K) catalyzes glutamate-dependent ATP cleavage; G5K transfers the terminal phosphoryl group of ATP to the gamma-carboxyl group of glutamate, in the first and controlling step of proline (and, in mammals, ornithine) biosynthesis. G5K is subject to feedback allosteric inhibition by proline or ornithine. In microorganisms and plants, proline plays an important role as an osmoprotectant and, in mammals, ornithine biosynthesis is crucial for proper ammonia detoxification, since a G5K mutation has been shown to cause human hyperammonaemia. Microbial G5K generally consists of two domains: a catalytic G5K domain and one PUA (pseudo uridine synthases and archaeosine-specific transglycosylases) domain, and some lack the PUA domain. G5K requires free Mg for activity, it is tetrameric, and it aggregates to higher forms in a proline-dependent way. G5K lacking the PUA domain remains tetrameric, active, and proline-inhibitable, but the Mg requir
Probab=99.97 E-value=3.6e-31 Score=266.76 Aligned_cols=221 Identities=24% Similarity=0.395 Sum_probs=174.7
Q ss_pred EEEEeCccccCCHH------HHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHH
Q 008621 83 CVMKFGGSSLASAE------RMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDL 154 (559)
Q Consensus 83 ~V~KFGGsSl~~~~------~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~ 154 (559)
+|+|||||++.+.+ .++++++.|.+.. +.+.|+|+||+++.+...+..
T Consensus 2 iViK~GGs~i~~~~~~~~~~~i~~~~~~i~~~~~~~~~viiV~sg~~~~g~~~~~~------------------------ 57 (251)
T cd04242 2 IVVKVGSSLLTDEDGGLDLGRLASLVEQIAELRNQGKEVILVSSGAVAAGRQRLGL------------------------ 57 (251)
T ss_pred EEEEeCCCeeeCCCCCcCHHHHHHHHHHHHHHHHCCCeEEEEecCchhhChhhhcc------------------------
Confidence 79999999999876 9999999998643 345677888877766321110
Q ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEec
Q 008621 155 HHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (559)
Q Consensus 155 ~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (559)
.. +......++.++++||..++.+++.+|+++|+++ +++ ++|++
T Consensus 58 ----------~~--------------------~~~~~~~~~~~~~~Gq~~l~~~~~~~l~~~Gi~~-----~q~-l~t~~ 101 (251)
T cd04242 58 ----------EK--------------------RPKTLPEKQALAAVGQSLLMALYEQLFAQYGIKV-----AQI-LLTRD 101 (251)
T ss_pred ----------Cc--------------------CCCchhHHHHHHHHhHHHHHHHHHHHHHHcCCeE-----EEE-EEehh
Confidence 00 0001234578999999999999999999999996 344 67877
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceee--ecCCcchhHHHHHHHHcCcCcEEEeeCCccc
Q 008621 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITT--LGRGGSDLTATTIGKALGLQEIQVWKDVDGV 312 (559)
Q Consensus 235 ~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~t--lgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV 312 (559)
+|.++.. +.+..+.+ ..|++.+.|||+.+ +|.+++ ++||++|++|+.+|.+|+|++++||||||||
T Consensus 102 ~~~~~~~----~~~~~~~i-~~ll~~g~iPVv~~-------~d~v~~~~~~~~~~D~~A~~lA~~l~Ad~liilTDVdGv 169 (251)
T cd04242 102 DFEDRKR----YLNARNTL-ETLLELGVIPIINE-------NDTVATEEIRFGDNDRLSALVAGLVNADLLILLSDVDGL 169 (251)
T ss_pred HhcchHH----HHHHHHHH-HHHHHCCCEEEEcC-------CCCeeeeccccCChHHHHHHHHHHcCCCEEEEecCcCEE
Confidence 7765542 22222333 34567899999943 355655 8999999999999999999999999999999
Q ss_pred ccCCCCCCCCCccccccC--HHHHHHHH-----HcCCCcchH--hHHHHHHhCCCCEEEecCCCCC---------CCCeE
Q 008621 313 LTCDPNIHPHAKPVPYLT--FDEAAELA-----YFGAQVLHP--QSMRPAREGDIPVRVKNSYNPN---------APGTL 374 (559)
Q Consensus 313 ~taDP~~v~~a~~i~~ls--~~Ea~eLa-----~~Ga~vlhp--~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~ 374 (559)
|++||+.+|++++|++++ ++|+.+++ .+|..+||| +++..+.++|+|++|.|++.|+ ..||+
T Consensus 170 y~~dP~~~~~a~~i~~i~~~~~e~~~~~~~~~~~~~tggm~~Kl~a~~~a~~~gi~v~I~~g~~~~~i~~~l~g~~~GT~ 249 (251)
T cd04242 170 YDKNPRENPDAKLIPEVEEITDEIEAMAGGSGSSVGTGGMRTKLKAARIATEAGIPVVIANGRKPDVLLDILAGEAVGTL 249 (251)
T ss_pred EeCCCCCCCCCeEEEEecCChHHHHHHhcccCcCcccCCcHHHHHHHHHHHHCCCcEEEEcCCCCCHHHHHHcCCCCCeE
Confidence 999999999999999999 99999996 678999999 6899999999999999998774 46777
Q ss_pred E
Q 008621 375 I 375 (559)
Q Consensus 375 I 375 (559)
|
T Consensus 250 i 250 (251)
T cd04242 250 F 250 (251)
T ss_pred e
Confidence 6
No 36
>PRK00358 pyrH uridylate kinase; Provisional
Probab=99.97 E-value=1.2e-29 Score=252.51 Aligned_cols=212 Identities=25% Similarity=0.364 Sum_probs=161.2
Q ss_pred ceEEEEeCccccC-------CHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHH
Q 008621 81 LTCVMKFGGSSLA-------SAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFV 151 (559)
Q Consensus 81 ~~~V~KFGGsSl~-------~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i 151 (559)
+++|+|||||++. +.+.++++++.|.+.. +.++++|+|+ |.....+.
T Consensus 1 ~~iViK~GGs~l~~~~~~~~~~~~i~~~~~~i~~~~~~g~~vvlV~gG-G~~a~~~~----------------------- 56 (231)
T PRK00358 1 KRVLLKLSGEALAGEKGFGIDPEVLDRIAEEIKEVVELGVEVAIVVGG-GNIFRGYI----------------------- 56 (231)
T ss_pred CeEEEEeccceecCCCCCCCCHHHHHHHHHHHHHHHHCCCeEEEEECC-CHHHHHHH-----------------------
Confidence 3689999999997 6789999999999753 2355666663 32211110
Q ss_pred HHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEE
Q 008621 152 KDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (559)
Q Consensus 152 ~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (559)
.. .++ .+....|++.+.++++|+.+++.+|+.+|+++..+++.+.+.+
T Consensus 57 -----~~--~~~-------------------------~~~~~~~~~~~~~~~l~~~ll~~~l~~~Gi~a~~~~~~~~~~~ 104 (231)
T PRK00358 57 -----GA--AAG-------------------------MDRATADYMGMLATVMNALALQDALERAGVDTRVQSAIPMPQV 104 (231)
T ss_pred -----Hh--hcC-------------------------CChhhHHHHHHHHHHHHHHHHHHHHHHcCCCeEEechhhcccc
Confidence 00 011 1223457788889999999999999999999987776554333
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcc
Q 008621 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (559)
Q Consensus 232 t~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~G 311 (559)
+. .+ .. +.+. .+++++.|||++||.+.. + +.||++|+++|.+|+|+++++||||||
T Consensus 105 ~~-~~--------~~----~~~~-~~l~~g~vPVv~g~~~~~---~-------~ssD~~A~~lA~~l~A~~li~~tdVdG 160 (231)
T PRK00358 105 AE-PY--------IR----RRAI-RHLEKGRVVIFAAGTGNP---F-------FTTDTAAALRAEEIGADVLLKATNVDG 160 (231)
T ss_pred cC-cc--------cH----HHHH-HHHHCCCEEEEECCCCCC---C-------CCchHHHHHHHHHcCCCEEEEeeCcCc
Confidence 21 10 11 2233 345788999999875421 1 238999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC---------CCCeEE
Q 008621 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLI 375 (559)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I 375 (559)
||++||+.+|+|++|++++|+|+.++ |++++||+++++|.++|+|++|.|+++|+ ..||+|
T Consensus 161 Vy~~dP~~~~~a~~i~~i~~~e~~~~---g~~~~d~~a~~~a~~~~i~v~I~~g~~~~~l~~~l~g~~~GT~i 230 (231)
T PRK00358 161 VYDADPKKDPDAKKYDRLTYDEVLEK---GLKVMDATAISLARDNKIPIIVFNMNKPGNLKRVVKGEHIGTLV 230 (231)
T ss_pred eEcCCCCCCCCCEEeeEecHHHHHHc---CCcchhHHHHHHHHHcCCcEEEECCCCchHHHHHHCCCCCCEEe
Confidence 99999999999999999999998777 99999999999999999999999998874 357776
No 37
>PRK14557 pyrH uridylate kinase; Provisional
Probab=99.97 E-value=2.3e-29 Score=252.20 Aligned_cols=218 Identities=24% Similarity=0.312 Sum_probs=169.5
Q ss_pred cceEEEEeCccccCC-------HHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHH
Q 008621 80 QLTCVMKFGGSSLAS-------AERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSF 150 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~-------~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~ 150 (559)
.+.+|+||||+++.+ .++++++++.|.... +.+++||||| | |.+..-
T Consensus 4 ~~riViKlGG~al~~~~~~~~~~~~i~~~a~~i~~~~~~g~~vvVVvGg-G---n~~rg~-------------------- 59 (247)
T PRK14557 4 YKRVLIKLSGGALADQTGNSFNSKRLEHIANEILSIVDLGIEVSIVIGG-G---NIFRGH-------------------- 59 (247)
T ss_pred ccEEEEEeCceeECCCCCCCcCHHHHHHHHHHHHHHHHcCCeEEEEECC-c---HHHHHH--------------------
Confidence 457999999999987 789999999998642 3567888887 3 444310
Q ss_pred HHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEE
Q 008621 151 VKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGF 230 (559)
Q Consensus 151 i~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~i 230 (559)
.++.++. +....|++.++||++|+.+++.+|++. ++++.++
T Consensus 60 -------~a~~~~~-------------------------~~~~~D~ig~~g~~lna~ll~~~l~~~-------~~~~~~i 100 (247)
T PRK14557 60 -------LAEEWGI-------------------------DRVEADNIGTLGTIINSLMLRGVLTSK-------TNKEVRV 100 (247)
T ss_pred -------HHHhcCC-------------------------ChHHHHHHHHHHHHHHHHHHHHHHHhh-------hCCceeE
Confidence 0111221 234569999999999999999999984 4556678
Q ss_pred EEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEee-CC
Q 008621 231 ITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWK-DV 309 (559)
Q Consensus 231 it~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~T-DV 309 (559)
+|+..+.... ..... .++.+. +++|.|||++||+|.. ..+ +|++|+++|..++|+.+++|| ||
T Consensus 101 ~t~~~~~~~~-~~~~~----~~~~~~-l~~g~VvV~~G~~g~~----~~s------tD~lAallA~~l~Ad~li~~ttdV 164 (247)
T PRK14557 101 MTSIPFNAVA-EPYIR----LRAVHH-LDNGYIVIFGGGNGQP----FVT------TDYPSVQRAIEMNSDAILVAKQGV 164 (247)
T ss_pred Eecccccccc-chhhH----HHHHHH-HhCCCEEEEECCcCCC----ccC------hHHHHHHHHHHhCCCEEEEecCCc
Confidence 8877665321 11111 223332 4678899999998842 233 899999999999999999995 99
Q ss_pred cccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC---------CCCeEEecCC
Q 008621 310 DGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLIRRSR 379 (559)
Q Consensus 310 ~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I~~~~ 379 (559)
|||||+||+.+|+|++|++++|+|+. +.+.++|||+|+++|.++|||++|.|+.+|+ ..||+|.+..
T Consensus 165 dGvY~~DP~~~~~Ak~i~~i~~~e~~---~~~~~~~~~~A~~~a~~~gi~v~I~ng~~~~~l~~~l~g~~~GT~i~~~~ 240 (247)
T PRK14557 165 DGVFTSDPKHNKSAKMYRKLNYNDVV---RQNIQVMDQAALLLARDYNLPAHVFNFDEPGVMRRICLGEHVGTLINDDA 240 (247)
T ss_pred CEeECCCCCCCCCCEEeeEEChhhhc---ccCHHHHHHHHHHHHHHCCCcEEEEeCCCChHHHHHHcCCCCcEEEecCc
Confidence 99999999999999999999999884 5688999999999999999999999998874 4799998654
No 38
>cd04239 AAK_UMPK-like AAK_UMPK-like: UMP kinase (UMPK)-like, the microbial/chloroplast uridine monophosphate kinase (uridylate kinase) enzyme that catalyzes UMP phosphorylation and plays a key role in pyrimidine nucleotide biosynthesis. Regulation of this process is via feed-back control and via gene repression of carbamoyl phosphate synthetase (the first enzyme of the pyrimidine biosynthesis pathway). The UMP kinases of E. coli (Ec) and Pyrococcus furiosus (Pf) are known to function as homohexamers, with GTP and UTP being allosteric effectors. Like other related enzymes (carbamate kinase, aspartokinase, and N-acetylglutamate kinase) the E. coli and most bacterial UMPKs have a conserved, N-terminal, lysine residue proposed to function in the catalysis of the phosphoryl group transfer, whereas most archaeal UMPKs appear to lack this residue and the Pyrococcus furiosus structure has an additional Mg ion bound to the ATP molecule which is proposed to function as the catalysis instead. Als
Probab=99.97 E-value=1.2e-29 Score=252.31 Aligned_cols=210 Identities=25% Similarity=0.357 Sum_probs=163.9
Q ss_pred EEEEeCccccCC------HHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHH
Q 008621 83 CVMKFGGSSLAS------AERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDL 154 (559)
Q Consensus 83 ~V~KFGGsSl~~------~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~ 154 (559)
+|+|||||++.+ .+.++++++.|.+.. +.++++|+|| |...+.....
T Consensus 2 iViKiGGs~l~~~~~~~~~~~i~~~a~~i~~~~~~g~~vvvV~gg-G~~a~~~~~~------------------------ 56 (229)
T cd04239 2 IVLKLSGEALAGEGGGIDPEVLKEIAREIKEVVDLGVEVAIVVGG-GNIARGYIAA------------------------ 56 (229)
T ss_pred EEEEECcceecCCCCCCCHHHHHHHHHHHHHHHHCCCEEEEEECC-ChHHhhHHHh------------------------
Confidence 799999999988 799999999998642 2355666665 4433332110
Q ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEec
Q 008621 155 HHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (559)
Q Consensus 155 ~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (559)
.+ ..++...|++.+.||++|+.+|+.+|+++|+++..+++.+++.++.
T Consensus 57 ------~~-------------------------~~~~~~~~~~~~~~~~l~~~l~~~~l~~~Gi~a~~~~~~~~~~~~~- 104 (229)
T cd04239 57 ------AR-------------------------GMPRATADYIGMLATVMNALALQDALEKLGVKTRVMSAIPMQGVAE- 104 (229)
T ss_pred ------hc-------------------------CCChhhHHHHHHHHHHHHHHHHHHHHHHcCCCEEEeCHHHHhhhhc-
Confidence 00 0123346888899999999999999999999999999887532211
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCccccc
Q 008621 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (559)
Q Consensus 235 ~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~t 314 (559)
. .+.. .+. .+++.+.|||++||.|.. . +.||++|+++|.+|+|+++++||||||||+
T Consensus 105 ~--------~~~~----~l~-~~l~~g~ipVi~g~~g~~--~--------~~sD~~A~~lA~~l~a~~li~~tdVdGvy~ 161 (229)
T cd04239 105 P--------YIRR----RAI-RHLEKGRIVIFGGGTGNP--G--------FTTDTAAALRAEEIGADVLLKATNVDGVYD 161 (229)
T ss_pred c--------ccHH----HHH-HHHhCCCEEEEeCccCCC--C--------CCcHHHHHHHHHHcCCCEEEEEECCCcccC
Confidence 0 1222 222 245688999999997643 1 239999999999999999999999999999
Q ss_pred CCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC---------CCCeEE
Q 008621 315 CDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLI 375 (559)
Q Consensus 315 aDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I 375 (559)
+||+.+|+|++|++++|+|+.+++. +++||.+++++.+.|+|++|.|+++|+ ..||+|
T Consensus 162 ~dP~~~~~a~~i~~i~~~e~~~~~~---~~~~~~a~~~~~~~~i~v~I~~g~~~~~l~~~l~g~~~GT~i 228 (229)
T cd04239 162 ADPKKNPDAKKYDRISYDELLKKGL---KVMDATALTLCRRNKIPIIVFNGLKPGNLLRALKGEHVGTLI 228 (229)
T ss_pred CCCCCCCCCeEEeEEcHHHHHHHhc---CCccHHHHHHHHHCCCeEEEECCCChhHHHHHHcCCCCCeEe
Confidence 9999999999999999999998875 899999999999999999999998874 357776
No 39
>PRK14558 pyrH uridylate kinase; Provisional
Probab=99.96 E-value=5.1e-29 Score=248.12 Aligned_cols=212 Identities=23% Similarity=0.321 Sum_probs=160.8
Q ss_pred eEEEEeCccccCCH-------HHHHHHHHHHHcCCC-CCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHH
Q 008621 82 TCVMKFGGSSLASA-------ERMREVAELILSFPN-ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKD 153 (559)
Q Consensus 82 ~~V~KFGGsSl~~~-------~~~~~va~iI~~~~~-~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~ 153 (559)
.+|.|+|||.+.+. +.++++++.|++..+ ...+|+|++.|.+-. +..
T Consensus 2 riviKlGgs~lt~~~~~~~~~~~i~~la~~i~~~~~~g~~viiV~GgGs~~~-----g~~-------------------- 56 (231)
T PRK14558 2 RVLLKLSGEALSGEGEKGFDPERVNYLVNEIKSVVEYGFKIGIVIGAGNLFR-----GVE-------------------- 56 (231)
T ss_pred eEEEEeeHHHccCCCCCCcCHHHHHHHHHHHHHHHHCCCeEEEEECccHHHH-----HHh--------------------
Confidence 47999999999643 678999999887532 334544443343210 100
Q ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEe
Q 008621 154 LHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITT 233 (559)
Q Consensus 154 ~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~ 233 (559)
+ ...++...|.+.++||+||+.+++.+|.++|+++.++++ +.+.
T Consensus 57 --------~------------------------~~~~~~~~d~ig~~~~~ln~~~~~~~l~~~gi~a~~~~~----~~~~ 100 (231)
T PRK14558 57 --------L------------------------KELSPTRADQIGMLGTVINALYLKDIFEKSGLKAVIVSQ----IVNL 100 (231)
T ss_pred --------c------------------------cCCChHHHHHHHHHHHHHHHHHHHHHHHHcCCCeEEecc----cccc
Confidence 0 112445678899999999999999999999999999885 2222
Q ss_pred cCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccc
Q 008621 234 DDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVL 313 (559)
Q Consensus 234 ~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~ 313 (559)
.+ +...+.. .+.. +++.+.|||++||.+.. .+.+|++|+++|..|+|+++++||||||||
T Consensus 101 ~~-----~~~~~~~----~i~~-ll~~g~vpV~~G~~~~~----------~~~~D~~a~~lA~~l~a~~l~~~tdVdGvy 160 (231)
T PRK14558 101 PS-----VEPINYD----DIEL-YFRAGYIVIFAGGTSNP----------FFTTDTAAALRAVEMKADILIKATKVDGIY 160 (231)
T ss_pred ch-----hhhhhHH----HHHH-HHHCCCEEEEECCCCCC----------CCCcHHHHHHHHHHcCCCEEEEEecCCeeE
Confidence 11 1112222 2332 35678999999986521 123899999999999999999999999999
Q ss_pred cCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC---------CCCeEEec
Q 008621 314 TCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLIRR 377 (559)
Q Consensus 314 taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I~~ 377 (559)
++||+.+|+|+++++++|+|+.++ |++++||+++++|+++|||++|.|+++|. ..||+|.+
T Consensus 161 ~~dP~~~~~a~~i~~i~~~e~~~~---g~~~~d~~a~~~a~~~gi~v~I~ng~~~~~l~~~l~g~~~GT~i~~ 230 (231)
T PRK14558 161 DKDPKKFPDAKKIDHLTFSEAIKM---GLKVMDTEAFSICKKYGITILVINFFEPGNLLKALKGENVGTLVVP 230 (231)
T ss_pred ccCCCCCCCCeEcccccHHHHHHc---CcccccHHHHHHHHHCCCCEEEEeCCCCCHHHHHHCCCCCcEEeCC
Confidence 999999999999999999999887 88999999999999999999999998874 35777754
No 40
>cd04254 AAK_UMPK-PyrH-Ec UMP kinase (UMPK)-Ec, the microbial/chloroplast uridine monophosphate kinase (uridylate kinase) enzyme that catalyzes UMP phosphorylation and plays a key role in pyrimidine nucleotide biosynthesis; regulation of this process is via feed-back control and via gene repression of carbamoyl phosphate synthetase (the first enzyme of the pyrimidine biosynthesis pathway). The UMP kinase of E. coli (Ec) is known to function as a homohexamer, with GTP and UTP being allosteric effectors. Like other related enzymes (carbamate kinase, aspartokinase, and N-acetylglutamate kinase) the E. coli and most bacterial and chloroplast UMPKs (this CD) have a conserved, N-terminal, lysine residue proposed to function in the catalysis of the phosphoryl group transfer, whereas most archaeal UMPKs appear to lack this residue and the Pyrococcus furiosus structure has an additional Mg ion bound to the ATP molecule which is proposed to function as the catalysis instead. Members of this CD be
Probab=99.96 E-value=2.6e-29 Score=250.17 Aligned_cols=213 Identities=24% Similarity=0.327 Sum_probs=163.8
Q ss_pred ceEEEEeCccccC-------CHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHH
Q 008621 81 LTCVMKFGGSSLA-------SAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFV 151 (559)
Q Consensus 81 ~~~V~KFGGsSl~-------~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i 151 (559)
+++|+|||||++. +.+.++++++.|++.. +.++|||+|| |..... .. +
T Consensus 1 ~~iViKlGGs~itdk~~~~~~~~~i~~~a~~i~~~~~~~~~~viVhGg-G~~~~~-~~----~----------------- 57 (231)
T cd04254 1 KRVLLKLSGEALAGENGFGIDPEVLNRIAREIKEVVDLGVEVAIVVGG-GNIFRG-AS----A----------------- 57 (231)
T ss_pred CeEEEEeCceEECCCCCCCCCHHHHHHHHHHHHHHHHCCCcEEEEECC-Cccccc-ch----h-----------------
Confidence 4689999999996 7899999999999643 3467788887 422100 00 0
Q ss_pred HHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEE
Q 008621 152 KDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (559)
Q Consensus 152 ~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (559)
..++. .....|++.++||++|+.+++.+|+++|+++.++++.+...+
T Consensus 58 --------~~~~~-------------------------~~~~~d~~g~~~~~~n~~ll~~~L~~~Gv~a~~l~~~~~~~~ 104 (231)
T cd04254 58 --------AEAGM-------------------------DRATADYMGMLATVINALALQDALESLGVKTRVMSAIPMQGV 104 (231)
T ss_pred --------hhcCC-------------------------CchhhhHHHHHHHHHHHHHHHHHHHHcCCCeEEEcHHHhhhh
Confidence 00111 111246787889999999999999999999999999875222
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcc
Q 008621 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (559)
Q Consensus 232 t~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~G 311 (559)
+ ...+... +. .+++++.|||++||.|.. .. .+|++|+++|.+|+|+++++||||||
T Consensus 105 ~---------~~~~~~~----l~-~~l~~g~ipV~~g~~G~~----~~------~~D~~a~~lA~~l~a~~l~~~tdVdG 160 (231)
T cd04254 105 A---------EPYIRRR----AI-RHLEKGRVVIFAGGTGNP----FF------TTDTAAALRAIEINADVILKATKVDG 160 (231)
T ss_pred h---------cccCHHH----HH-HHHHCCCEEEEECCcCCC----CC------CcHHHHHHHHHHcCCCEEEEEeCCCE
Confidence 1 0112222 22 235678999999987632 11 28999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC---------CCCeEEe
Q 008621 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLIR 376 (559)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I~ 376 (559)
||++||+.+|+++++++++|+|+.+ .|++++||+++++|.++|||++|.|+++|+ ..||+|+
T Consensus 161 vy~~dp~~~~~a~~i~~i~~~~~~~---~~~~~~d~~a~~~a~~~gi~~~I~~g~~~~~l~~~l~g~~~GT~i~ 231 (231)
T cd04254 161 VYDADPKKNPNAKRYDHLTYDEVLS---KGLKVMDATAFTLCRDNNLPIVVFNINEPGNLLKAVKGEGVGTLIS 231 (231)
T ss_pred EEecCCCCCCCcEEeeEecHHHHHh---cchhhhHHHHHHHHHHCCCeEEEEeCCCccHHHHHHCCCCCCEEeC
Confidence 9999999999999999999999876 488999999999999999999999998874 4677763
No 41
>TIGR02075 pyrH_bact uridylate kinase. This protein, also called UMP kinase, converts UMP to UDP by adding a phosphate from ATP. It is the first step in pyrimidine biosynthesis. GTP is an allosteric activator. In a large fraction of all bacterial genomes, the gene tends to be located immediately downstream of elongation factor Ts and upstream of ribosome recycling factor. A related protein family, believed to be equivalent in function and found in the archaea and in spirochetes, is described by a separate model, TIGR02076.
Probab=99.96 E-value=9.3e-28 Score=239.36 Aligned_cols=213 Identities=24% Similarity=0.347 Sum_probs=162.6
Q ss_pred ceEEEEeCccccC-------CHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHH
Q 008621 81 LTCVMKFGGSSLA-------SAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFV 151 (559)
Q Consensus 81 ~~~V~KFGGsSl~-------~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i 151 (559)
+++|+|||||++. +.+.++++++.|.+.. +.+.|+|+|| | +.+....
T Consensus 2 ~~iViKlGGs~i~~~~~~~~~~~~i~~~a~~i~~~~~~~~~vviV~G~-G---s~~~~~~-------------------- 57 (233)
T TIGR02075 2 KRVLLKLSGEALAGESGFGIDPDRLNRIANEIKELVKMGIEVGIVIGG-G---NIFRGVS-------------------- 57 (233)
T ss_pred CEEEEEeChhhcCCCCCCCCCHHHHHHHHHHHHHHHhCCCeEEEEECC-C---HHHHHHH--------------------
Confidence 4689999999998 5788999999998643 2355666666 3 2221110
Q ss_pred HHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEE
Q 008621 152 KDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (559)
Q Consensus 152 ~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (559)
+++++. +....|++.++++++++.+|+.+|+++|+++..+++.+.+ .
T Consensus 58 -------a~~~~~-------------------------~~~~~d~~g~~~~~l~~~l~~~~L~~~Gi~a~~l~~~~~~-~ 104 (233)
T TIGR02075 58 -------AKELGI-------------------------DRVTADYMGMLATVINGLALRDALEKLGVKTRVLSAISMP-Q 104 (233)
T ss_pred -------HHhcCC-------------------------CCccHHHHHHHHHHHHHHHHHHHHHhCCCCcEEeccccCC-C
Confidence 111211 1112478889999999999999999999999999987753 1
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeC-Cc
Q 008621 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKD-VD 310 (559)
Q Consensus 232 t~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TD-V~ 310 (559)
+...+ +. +.+.+ +++.|.|||++||.|.. ...+|++|+++|..|+|+.+++||| ||
T Consensus 105 ~~~~~--------~~----~~i~~-ll~~g~VpV~~g~~g~~----------~~s~D~~a~~lA~~l~a~~li~~td~Vd 161 (233)
T TIGR02075 105 ICESY--------IR----RKAIK-HLEKGKVVIFSGGTGNP----------FFTTDTAAALRAIEINADVILKGTNGVD 161 (233)
T ss_pred Ccccc--------CH----HHHHH-HHHCCCEEEEECCCCCC----------CCCchHHHHHHHHHcCCCEEEEeecccC
Confidence 11111 11 22333 45788899999986632 1128999999999999999999999 99
Q ss_pred ccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC---------CCCeEEe
Q 008621 311 GVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLIR 376 (559)
Q Consensus 311 GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I~ 376 (559)
|||++||+.+|+++++++++|+|+.++ |++++||+++++|.++|||++|.|+++|+ ..||+|+
T Consensus 162 Gvy~~dp~~~~~a~~i~~i~~~e~~~~---~~~~~d~~~~~~a~~~~i~v~i~~g~~~~~l~~~l~g~~~GT~i~ 233 (233)
T TIGR02075 162 GVYTADPKKNKDAKKYETITYNEALKK---NLKVMDLTAFALARDNNLPIVVFNIDEPGALKKVILGKGIGTLVS 233 (233)
T ss_pred eEEcCCCCCCCCCeECcEecHHHHHhc---CHHHHHHHHHHHHHHCCCeEEEEeCCCcchHHHHHCCCCCCEEeC
Confidence 999999999999999999999998765 88899999999999999999999988774 4677763
No 42
>PRK13402 gamma-glutamyl kinase; Provisional
Probab=99.96 E-value=9.7e-28 Score=252.65 Aligned_cols=226 Identities=19% Similarity=0.309 Sum_probs=174.2
Q ss_pred CcceEEEEeCccccCC------HHHHHHHHHHHHcCC--CCCcEEEEcCC--CcccHHHHHhhHhhhhcCcCcchhhhHH
Q 008621 79 KQLTCVMKFGGSSLAS------AERMREVAELILSFP--NERPVIVLSAM--GKTTNKLLLAGEKAVSCGVTNISCIDEL 148 (559)
Q Consensus 79 ~~~~~V~KFGGsSl~~------~~~~~~va~iI~~~~--~~~~vVVVSA~--g~~Td~L~~~~~~~~~~~~~~~~~~~~l 148 (559)
.++++|+||||++|.+ .+.+.++++.|.... +.++|+|+|++ .|. +.|
T Consensus 4 ~~kriVIKiGgs~L~~~~~~l~~~~i~~la~~I~~l~~~G~~vvlVsSGava~G~-~~l--------------------- 61 (368)
T PRK13402 4 NWKRIVVKVGSSLLTPHHQGCSSHYLLGLVQQIVYLKDQGHQVVLVSSGAVAAGY-HKL--------------------- 61 (368)
T ss_pred CCcEEEEEEchhhccCCCCCcCHHHHHHHHHHHHHHHHCCCEEEEEeCChhhcCc-ccc---------------------
Confidence 4578999999999985 589999999998643 34567777764 222 111
Q ss_pred HHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccce
Q 008621 149 SFVKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDI 228 (559)
Q Consensus 149 ~~i~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~ 228 (559)
+.. .......++.+.+.||.++..++..+|+++|+++. |+
T Consensus 62 --------------~~~---------------------~~~~~~~~qalaavGq~~l~~~~~~~f~~~g~~~a-----qv 101 (368)
T PRK13402 62 --------------GFI---------------------DRPSVPEKQAMAAAGQGLLMATWSKLFLSHGFPAA-----QL 101 (368)
T ss_pred --------------CCC---------------------CCCCccHHHHHHHhhHHHHHHHHHHHHHHCCCeEE-----EE
Confidence 000 00012345788999999999999999999999983 44
Q ss_pred EEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceee--ecCCcchhHHHHHHHHcCcCcEEEe
Q 008621 229 GFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITT--LGRGGSDLTATTIGKALGLQEIQVW 306 (559)
Q Consensus 229 ~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~t--lgRgGSD~tAa~lA~~L~A~~l~i~ 306 (559)
++|.+++.+.+ .+.++++.+.. |++.+.|||+.. ++.+++ ++||+||++|+++|.+++|+.++||
T Consensus 102 -LlT~~d~~~~~----~y~n~~~~l~~-LL~~g~IPIine-------nD~v~~~el~~GdnD~lAa~vA~~l~Ad~Liil 168 (368)
T PRK13402 102 -LLTHGDLRDRE----RYINIRNTINV-LLERGILPIINE-------NDAVTTDRLKVGDNDNLSAMVAALADADTLIIL 168 (368)
T ss_pred -EEecchhhhHH----HHHHHHHHHHH-HHHCCcEEEEeC-------CCcEeecccccCChHHHHHHHHHHhCCCEEEEE
Confidence 66766654322 24445555543 568899999942 233444 8899999999999999999999999
Q ss_pred eCCcccccCCCCCCCCCccccccCH--HHHHHHH-----HcCCCcchH--hHHHHHHhCCCCEEEecCCCCC--------
Q 008621 307 KDVDGVLTCDPNIHPHAKPVPYLTF--DEAAELA-----YFGAQVLHP--QSMRPAREGDIPVRVKNSYNPN-------- 369 (559)
Q Consensus 307 TDV~GV~taDP~~v~~a~~i~~ls~--~Ea~eLa-----~~Ga~vlhp--~a~~~a~~~~Ipv~I~n~~~p~-------- 369 (559)
|||||||++||+.+|+|++|+++++ +|+.+++ .+|..+|+| +++..|.++|+|++|.|+.+|+
T Consensus 169 TDVdGvy~~dP~~~p~a~~I~~I~~i~~e~~~l~~~~~s~~gtGGM~~Kl~Aa~~a~~~gi~v~I~~g~~~~~l~~~l~g 248 (368)
T PRK13402 169 SDIDGLYDQNPRTNPDAKLIKQVTEINAEIYAMAGGAGSNVGTGGMRTKIQAAKIAMSHGIETFIGNGFTADIFNQLLKG 248 (368)
T ss_pred ecCCeEEeCCCCCCCCCEEEEEeccCcHHHHHHhcccccCcCcCCchHHHHHHHHHHHcCCcEEEEcCCCchHHHHHhcC
Confidence 9999999999999999999999997 7787776 468899999 5899999999999999998873
Q ss_pred -CCCeEEecCC
Q 008621 370 -APGTLIRRSR 379 (559)
Q Consensus 370 -~~GT~I~~~~ 379 (559)
..||+|.+..
T Consensus 249 ~~~GT~i~~~~ 259 (368)
T PRK13402 249 QNPGTYFTPEE 259 (368)
T ss_pred CCCceEEecCC
Confidence 4699997643
No 43
>cd04253 AAK_UMPK-PyrH-Pf AAK_UMPK-PyrH-Pf: UMP kinase (UMPK)-Pf, the mostly archaeal uridine monophosphate kinase (uridylate kinase) enzymes that catalyze UMP phosphorylation and play a key role in pyrimidine nucleotide biosynthesis; regulation of this process is via feed-back control and via gene repression of carbamoyl phosphate synthetase (the first enzyme of the pyrimidine biosynthesis pathway). The UMP kinase of Pyrococcus furiosus (Pf) is known to function as a homohexamer, with GTP and UTP being allosteric effectors. Like other related enzymes (carbamate kinase, aspartokinase, and N-acetylglutamate kinase) the E. coli and most bacterial UMPKs have a conserved, N-terminal, lysine residue proposed to function in the catalysis of the phosphoryl group transfer, whereas most archaeal UMPKs (this CD) appear to lack this residue and the Pyrococcus furiosus structure has an additional Mg ion bound to the ATP molecule which is proposed to function as the catalysis instead. Members of thi
Probab=99.95 E-value=5.4e-27 Score=232.05 Aligned_cols=202 Identities=22% Similarity=0.301 Sum_probs=159.7
Q ss_pred EEEEeCccccCC---HHHHHHHHHHHHcCCCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHH
Q 008621 83 CVMKFGGSSLAS---AERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (559)
Q Consensus 83 ~V~KFGGsSl~~---~~~~~~va~iI~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (559)
+|+|||||++.+ .+.++++++.|++..+.+++|+|+++|..++.+.+.++
T Consensus 2 iViKlGGs~l~~~~~~~~i~~~~~~i~~~~~~~~iiiV~GgG~~a~~~~~~~~--------------------------- 54 (221)
T cd04253 2 IVISLGGSVLAPEKDADFIKEYANVLRKISDGHKVAVVVGGGRLAREYISVAR--------------------------- 54 (221)
T ss_pred EEEEeccceeCCCCChHHHHHHHHHHHHHhCCCEEEEEECCCHHHHHHHHHHH---------------------------
Confidence 699999999988 69999999999975434456677788887777654321
Q ss_pred HhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCc
Q 008621 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNA 239 (559)
Q Consensus 160 ~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a 239 (559)
+++. +....|++...++++|+.+++.+|+ .|++++.++
T Consensus 55 -~~~~-------------------------~~~~~d~~g~~~~~ln~~~~~~~l~-~~~~~~~~~--------------- 92 (221)
T cd04253 55 -KLGA-------------------------SEAFLDEIGIMATRLNARLLIAALG-DAYPPVPTS--------------- 92 (221)
T ss_pred -HcCC-------------------------CHHHHHHhcCHHHHHHHHHHHHHHh-cCCCcCCCC---------------
Confidence 1211 2234577888899999999998887 777664431
Q ss_pred eeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCC
Q 008621 240 DILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (559)
Q Consensus 240 ~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~ 319 (559)
...+. + +++.+.|||++||++ +.+ +|++|+++|..|+|+.+++||||||||++||+.
T Consensus 93 ------~~~~~----~-~l~~g~vpv~~G~~~-----~~s-------~D~~a~~lA~~l~a~~li~~tdVdGVy~~dP~~ 149 (221)
T cd04253 93 ------YEEAL----E-AMFTGKIVVMGGTEP-----GQS-------TDAVAALLAERLGADLLINATNVDGVYSKDPRK 149 (221)
T ss_pred ------HHHHH----H-HHHcCCeEEEECCCC-----CCc-------cHHHHHHHHHHcCCCEEEEEeCCCeeECCCCCC
Confidence 11122 2 245788999999864 222 799999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHHc-----CC-CcchHhHHHHHHhCCCCEEEecCCCCC---------CCCeEEe
Q 008621 320 HPHAKPVPYLTFDEAAELAYF-----GA-QVLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLIR 376 (559)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~~-----Ga-~vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I~ 376 (559)
+|+|++|++++++|+.+++.. |+ .++|+.+++++.++++|++|.|+.+|+ ..||+|.
T Consensus 150 ~~~a~~i~~i~~~e~~~~~~~~~~~~g~~~~~d~~a~~~~~~~gi~~~I~~g~~p~~l~~~l~g~~~GT~I~ 221 (221)
T cd04253 150 DPDAKKFDRLSADELIDIVGKSSWKAGSNEPFDPLAAKIIERSGIKTIVVDGRDPENLERALKGEFVGTIIE 221 (221)
T ss_pred CCCCeEeeEeCHHHHHHHccCCCcCCCCCcchHHHHHHHHHHCCCeEEEECCCCccHHHHHHCCCCCCeEeC
Confidence 999999999999999999876 55 689999999999999999999988774 3577763
No 44
>cd04249 AAK_NAGK-NC AAK_NAGK-NC: N-Acetyl-L-glutamate kinase - noncyclic (NAGK-NC) catalyzes the phosphorylation of the gamma-COOH group of N-acetyl-L-glutamate (NAG) by ATP in the second step of microbial arginine biosynthesis using the acetylated, noncyclic route of ornithine biosynthesis. There are two variants of this pathway. In one, typified by the pathway in Escherichia coli, glutamate is acetylated by acetyl-CoA and acetylornithine is deacylated hydrolytically. In this pathway, feedback inhibition by arginine occurs at the initial acetylation of glutamate and not at the phosphorylation of NAG by NAGK. Homodimeric NAGK-NC are members of the Amino Acid Kinase Superfamily (AAK).
Probab=99.94 E-value=1.5e-26 Score=233.35 Aligned_cols=224 Identities=18% Similarity=0.286 Sum_probs=172.3
Q ss_pred EEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHH
Q 008621 83 CVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVD 160 (559)
Q Consensus 83 ~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~ 160 (559)
.|+|||||++.+++.++++++.|.... ...++|+|||+|+.+|.|++....
T Consensus 1 ~ViK~GGs~l~~~~~~~~~~~~i~~~~~~~~~~iVlVhGgg~~~~~~~~~~g~--------------------------- 53 (252)
T cd04249 1 LVIKLGGALLETEAALEQLFSALSEYQQQHNRQLVIVHGGGCVVDELLKKLNF--------------------------- 53 (252)
T ss_pred CEEEEChHHhcChhhHHHHHHHHHHHHHhCCCCEEEECCCCHHHHHHHHHcCC---------------------------
Confidence 489999999999989999999998642 346789999999999998864221
Q ss_pred hcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHh-hhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCC-
Q 008621 161 ELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVS-FGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN- 238 (559)
Q Consensus 161 ~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils-~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~- 238 (559)
++ ++.++++. .++...+.+.. .++++|..++++++ ++|++++++++.+.++++.++++.
T Consensus 54 ----~~-----------~~~~g~rv---t~~~~l~~~~~~~~~~~n~~lv~~l~-~~Gv~a~~l~~~~~~~~~~~~~~~~ 114 (252)
T cd04249 54 ----PS-----------EKKNGLRV---TPKEQIPYITGALAGTANKQLMAQAI-KAGLKPVGLSLADGGMTAVTQLDPE 114 (252)
T ss_pred ----CC-----------EEECCEec---CCHHHHHHHHHHHcCcccHHHHHHHH-hCCCCceeeeccCCCEEEEEEcCCC
Confidence 00 01122222 24455566544 47899999888765 899999999999998998875542
Q ss_pred ----ceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCccccc
Q 008621 239 ----ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (559)
Q Consensus 239 ----a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~t 314 (559)
+++...+.+.++. +++.|.|||++| +|.+ .+|++++++ +|++|+.+|.+|+|+ +++||||||||+
T Consensus 115 ~~~~G~v~~i~~~~l~~-----ll~~g~ipVi~~-~g~~-~~g~~~~~~---~D~~A~~lA~~l~A~-~i~ltdv~Gv~~ 183 (252)
T cd04249 115 LGAVGKATANDPSLLND-----LLKAGFLPIISS-IGAD-DQGQLMNVN---ADQAATAIAQLLNAD-LVLLSDVSGVLD 183 (252)
T ss_pred CCcccceEEEcHHHHHH-----HHHCCCEEEECC-CEEC-CCCCEeeec---HHHHHHHHHHHcCCC-EEEEeCCcccCC
Confidence 4555555543333 356889999997 6888 489999998 999999999999999 789999999999
Q ss_pred CCCCCCCCCccccccCHHHHHHHHHcCC-----CcchHhHHHHHHhCCCCEEEecCCCCC
Q 008621 315 CDPNIHPHAKPVPYLTFDEAAELAYFGA-----QVLHPQSMRPAREGDIPVRVKNSYNPN 369 (559)
Q Consensus 315 aDP~~v~~a~~i~~ls~~Ea~eLa~~Ga-----~vlhp~a~~~a~~~~Ipv~I~n~~~p~ 369 (559)
.|| ++|++++++|+.++...|. ...++.|++.+.+.+++++|.|...|+
T Consensus 184 ~~~------~~i~~i~~~e~~~~~~~g~~~gGm~~kl~~a~~~~~~~~~~v~I~~g~~~~ 237 (252)
T cd04249 184 ADK------QLISELNAKQAAELIEQGVITDGMIVKVNAALDAAQSLRRGIDIASWQYPE 237 (252)
T ss_pred CCC------cCccccCHHHHHHHHhcCCCcCCcHHHHHHHHHHHHhCCCeEEEEeCCCcc
Confidence 876 5799999999999987653 344556888888888999999887663
No 45
>TIGR02076 pyrH_arch uridylate kinase, putative. This family consists of the archaeal and spirochete proteins most closely related to bacterial uridylate kinases (TIGR02075), an enzyme involved in pyrimidine biosynthesis. Members are likely, but not known, to be functionally equivalent to their bacterial counterparts. However, substantial sequence differences suggest that regulatory mechanisms may be different; the bacterial form is allosterically regulated by GTP.
Probab=99.94 E-value=2.5e-26 Score=227.26 Aligned_cols=202 Identities=24% Similarity=0.257 Sum_probs=156.6
Q ss_pred EEEEeCccccCC---HHHHHHHHHHHHcCCCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHH
Q 008621 83 CVMKFGGSSLAS---AERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (559)
Q Consensus 83 ~V~KFGGsSl~~---~~~~~~va~iI~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (559)
+|+|||||++.+ .+.++++++.|++..+.+++|+|+++|..++.+++.+
T Consensus 1 iViKlGGs~l~~~~~~~~i~~i~~~i~~~~~~~~viiV~ggG~~a~~~~~~~---------------------------- 52 (221)
T TIGR02076 1 IVISLGGSVLSPEIDAEFIKEFANILRKLSDEHKVGVVVGGGKTARRYIGVA---------------------------- 52 (221)
T ss_pred CEEEechhhcCCCCCHHHHHHHHHHHHHHHhCCeEEEEECCcHHHHHHHHHH----------------------------
Confidence 489999999988 6999999999997543345666666666665554332
Q ss_pred HhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCc
Q 008621 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNA 239 (559)
Q Consensus 160 ~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a 239 (559)
++++. +....|++...++++|+.++...|+..+++++..+..+
T Consensus 53 ~~~~~-------------------------~~~~~~~~g~~~~~ln~~~l~~ll~~~~~~~~~~~~~~------------ 95 (221)
T TIGR02076 53 RELGA-------------------------SETFLDEIGIDATRLNAMLLIAALGDDAYPKVPENFEE------------ 95 (221)
T ss_pred HHcCC-------------------------CHHHHHHhhhHHHHHHHHHHHHHHHhcCCCCcCCCHHH------------
Confidence 11211 23455788888999999999999988888765433111
Q ss_pred eeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCC
Q 008621 240 DILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNI 319 (559)
Q Consensus 240 ~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~ 319 (559)
..+ .+..+.+||++||++ |. .+|++|+++|.+|+|+.+++||||||||++||+.
T Consensus 96 ---------~~~-----~l~~g~ipv~~G~~~-----~~-------s~D~~A~~lA~~l~A~~li~ltdVdGvy~~dP~~ 149 (221)
T TIGR02076 96 ---------ALE-----AMSLGKIVVMGGTHP-----GH-------TTDAVAALLAEFSKADLLINATNVDGVYDKDPKK 149 (221)
T ss_pred ---------HHH-----HHHcCCEEEEcCCCC-----CC-------CcHHHHHHHHHHcCCCEEEEEeCCCcccCCCCCC
Confidence 111 135678999999862 32 2799999999999999999999999999999999
Q ss_pred CCCCccccccCHHHHHHHHH---cCCC---cchHhHHHHHHhCCCCEEEecCCCCC---------CCCeEE
Q 008621 320 HPHAKPVPYLTFDEAAELAY---FGAQ---VLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLI 375 (559)
Q Consensus 320 v~~a~~i~~ls~~Ea~eLa~---~Ga~---vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I 375 (559)
+|+|++|++++++|+.+++. +|.. .+|+.+++++.+.++|++|.|+.+|+ ..||+|
T Consensus 150 ~~~a~~i~~i~~~e~~~~~~~~~~~~g~~~~~~~~a~~~~~~~~i~v~I~~g~~~~~l~~~l~g~~~GT~i 220 (221)
T TIGR02076 150 DPDAKKFDKLTPEELVEIVGSSSVKAGSNEVVDPLAAKIIERSKIRTIVVNGRDPENLEKVLKGEHVGTII 220 (221)
T ss_pred CCCCeEeeEECHHHHHHHhcCCCccCCCCceeHHHHHHHHHHCCCcEEEECCCCccHHHHHHCCCCCCeEe
Confidence 99999999999999999987 3333 67999999999999999999988774 357776
No 46
>cd04250 AAK_NAGK-C AAK_NAGK-C: N-Acetyl-L-glutamate kinase - cyclic (NAGK-C) catalyzes the phosphorylation of the gamma-COOH group of N-acetyl-L-glutamate (NAG) by ATP in the second step of arginine biosynthesis found in some bacteria and photosynthetic organisms using the non-acetylated, cyclic route of ornithine biosynthesis. In this pathway, glutamate is first N-acetylated and then phosphorylated by NAGK to give phosphoryl NAG, which is converted to NAG-ornithine. There are two variants of this pathway. In one, typified by the pathway in Thermotoga maritima and Pseudomonas aeruginosa, the acetyl group is recycled by reversible transacetylation from acetylornithine to glutamate. The phosphorylation of NAG by NAGK is feedback inhibited by arginine. In photosynthetic organisms, NAGK is the target of the nitrogen-signaling protein PII. Hexameric formation of NAGK domains appears to be essential to both arginine inhibition and NAGK-PII complex formation. NAGK-C are members of the Amino A
Probab=99.94 E-value=1.1e-26 Score=237.57 Aligned_cols=230 Identities=20% Similarity=0.282 Sum_probs=172.8
Q ss_pred ceEEEEeCccccCCHHHHHHHHHHHHcC--CCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHH
Q 008621 81 LTCVMKFGGSSLASAERMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (559)
Q Consensus 81 ~~~V~KFGGsSl~~~~~~~~va~iI~~~--~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~ 158 (559)
.++|+|||||++.+++.++.+++.|... .+.++|+|++|++.+++.+.+.+..
T Consensus 15 ~~~ViKlGGs~i~~~~~~~~~~~~i~~l~~~g~~~ViVhG~g~~~~~~l~~~g~~------------------------- 69 (279)
T cd04250 15 KTVVIKYGGNAMKDEELKESFARDIVLLKYVGINPVVVHGGGPEINEMLKKLGIE------------------------- 69 (279)
T ss_pred CEEEEEEChHHhcCccHHHHHHHHHHHHHHCCCCEEEEcCCcHHHHHHHHHCCCC-------------------------
Confidence 5799999999999998888888888743 2346788888877777776554221
Q ss_pred HHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCC
Q 008621 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (559)
Q Consensus 159 ~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (559)
. .+.++++.+.+.+.+..+++++ | ++|..+ ++.|++.|++++++++.+.++++++.++.
T Consensus 70 -------~-----------~~~~g~r~t~~~~~~~~~~~~~-g-~ln~~l-~~~L~~~Gv~a~~l~~~~~~~~~~~~~~~ 128 (279)
T cd04250 70 -------S-----------EFVNGLRVTDEETMEIVEMVLV-G-KVNKEI-VSLINRAGGKAVGLSGKDGNLIKAKKKDA 128 (279)
T ss_pred -------C-----------EeECCeecCCHHHHHHHHHHHc-C-chHHHH-HHHHHHcCCCcceeecCCCCEEEEEECcc
Confidence 0 0111222222212233344555 7 689886 78899999999999999998999876652
Q ss_pred ------------ceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEe
Q 008621 239 ------------ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVW 306 (559)
Q Consensus 239 ------------a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~ 306 (559)
+++...+...+. .+++.+.|||++| ++.+ ..|++++++ +|.+|+.+|.+|+|+++++|
T Consensus 129 ~~~~~~~~~~~~g~i~~i~~~~i~-----~ll~~g~IPVi~~-~~~~-~~g~~~~~~---~D~~A~~lA~~l~A~~li~l 198 (279)
T cd04250 129 TVIEEIIDLGFVGEVTEVNPELLE-----TLLEAGYIPVIAP-VGVG-EDGETYNIN---ADTAAGAIAAALKAEKLILL 198 (279)
T ss_pred cccCCCcccCcccceEEEcHHHHH-----HHHHCCCeEEEcC-CccC-CCCcEEEeC---HHHHHHHHHHHhCCCEEEEE
Confidence 344444544333 3457889999999 6877 478888887 99999999999999999999
Q ss_pred eCCcccccCCCCCCCCCccccccCHHHHHHHHHc--CCCcchHh--HHHHHHhCCCC-EEEecCCCCC
Q 008621 307 KDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYF--GAQVLHPQ--SMRPAREGDIP-VRVKNSYNPN 369 (559)
Q Consensus 307 TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~--Ga~vlhp~--a~~~a~~~~Ip-v~I~n~~~p~ 369 (559)
|||||||++||+ ++++|++++++|+.++++. +...|.++ ++..+.+.|++ ++|.|+.+|+
T Consensus 199 tdv~Gv~~~~p~---~~~~i~~i~~~e~~~l~~~~~~tGgm~~Kl~~a~~a~~~g~~~v~I~~g~~~~ 263 (279)
T cd04250 199 TDVAGVLDDPND---PGSLISEISLKEAEELIADGIISGGMIPKVEACIEALEGGVKAAHIIDGRVPH 263 (279)
T ss_pred ECCcccccCCCC---CccccccCCHHHHHHHHHcCCCCCchHHHHHHHHHHHHhCCCEEEEeCCCCCc
Confidence 999999999984 4899999999999999865 34678775 66666777886 9999987774
No 47
>PRK05429 gamma-glutamyl kinase; Provisional
Probab=99.94 E-value=2.8e-26 Score=243.11 Aligned_cols=228 Identities=23% Similarity=0.365 Sum_probs=169.6
Q ss_pred cceEEEEeCccccCC------HHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHH
Q 008621 80 QLTCVMKFGGSSLAS------AERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFV 151 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~------~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i 151 (559)
|+++|+|||||++.+ .+.++++++.|.... +.++|+|+|++-+....
T Consensus 8 ~~~iVIKiGGs~l~~~~~~l~~~~i~~la~~I~~l~~~g~~vViV~sGai~~g~~------------------------- 62 (372)
T PRK05429 8 ARRIVVKVGSSLLTGGGGGLDRARIAELARQIAALRAAGHEVVLVSSGAVAAGRE------------------------- 62 (372)
T ss_pred CCEEEEEeChhhccCCCCCcCHHHHHHHHHHHHHHHHCCCeEEEEcccHhhhhHh-------------------------
Confidence 567999999999986 889999999998754 23555666542111110
Q ss_pred HHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEE
Q 008621 152 KDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (559)
Q Consensus 152 ~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (559)
.++... +......++.+.+.||..+++++..+|+++|+++..+ ++
T Consensus 63 ---------~l~l~~--------------------~~~~~~~~qa~aavGq~~L~~~~~~~l~~~gi~~~qi------l~ 107 (372)
T PRK05429 63 ---------RLGLPE--------------------RPKTLAEKQAAAAVGQSRLMQAYEELFARYGITVAQI------LL 107 (372)
T ss_pred ---------hcCCCC--------------------CCCchHHHHHHHHHhHHHHHHHHHHHHHHCCCCEEEE------Ee
Confidence 011110 0012234578889999999999999999999997553 56
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCce--eeecCCcchhHHHHHHHHcCcCcEEEeeCC
Q 008621 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAI--TTLGRGGSDLTATTIGKALGLQEIQVWKDV 309 (559)
Q Consensus 232 t~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~--~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV 309 (559)
|.+++.+.. .+-+..+.+ ..|++.+.|||+.+ ++.+ ..+++|++|++|+++|.+|+|+.++|||||
T Consensus 108 t~~d~~~~~----~~ln~~~~i-~~Ll~~g~IPVi~~-------nd~v~~~~l~~gd~D~~Aa~lA~~l~Ad~LiilTDV 175 (372)
T PRK05429 108 TRDDLEDRE----RYLNARNTL-RTLLELGVVPIINE-------NDTVATDEIKFGDNDTLSALVANLVEADLLILLTDV 175 (372)
T ss_pred ehhHhhhhh----HhhhHHHHH-HHHHHCCCEEEEcC-------CCccceecccccChHHHHHHHHHHcCCCEEEEecCC
Confidence 665553211 111222333 34567899999953 2222 237899999999999999999999999999
Q ss_pred cccccCCCCCCCCCccccccCH--HHHHHHHH-----cCCCcchH--hHHHHHHhCCCCEEEecCCCCC---------CC
Q 008621 310 DGVLTCDPNIHPHAKPVPYLTF--DEAAELAY-----FGAQVLHP--QSMRPAREGDIPVRVKNSYNPN---------AP 371 (559)
Q Consensus 310 ~GV~taDP~~v~~a~~i~~ls~--~Ea~eLa~-----~Ga~vlhp--~a~~~a~~~~Ipv~I~n~~~p~---------~~ 371 (559)
||||++||+.+|++++|+++++ +|+.+++. +|..+|+| +++..+.++|++++|.|+.+|+ ..
T Consensus 176 dGVy~~dP~~~p~a~~I~~i~~~~~e~~~~~~~~~~~~gtGGM~~Kl~aa~~a~~~Gi~v~I~~g~~~~~l~~~l~g~~~ 255 (372)
T PRK05429 176 DGLYTADPRKNPDAKLIPEVEEITDELEAMAGGAGSGLGTGGMATKLEAARIATRAGIPVVIASGREPDVLLRLLAGEAV 255 (372)
T ss_pred CeeEcCCCCCCCCceEEEEeccCCHHHHHHhcCCCCCcCcCCcHHHHHHHHHHHHCCCeEEEEcCCCccHHHHHhcCCCC
Confidence 9999999999999999999998 67888863 68889999 6899999999999999988773 47
Q ss_pred CeEEecCC
Q 008621 372 GTLIRRSR 379 (559)
Q Consensus 372 GT~I~~~~ 379 (559)
||+|.+..
T Consensus 256 GT~i~~~~ 263 (372)
T PRK05429 256 GTLFLPQE 263 (372)
T ss_pred CEEEeeCC
Confidence 99998653
No 48
>PRK00942 acetylglutamate kinase; Provisional
Probab=99.94 E-value=4e-26 Score=233.98 Aligned_cols=237 Identities=23% Similarity=0.322 Sum_probs=175.3
Q ss_pred cceEEEEeCccccCCHHHHHHHHHHHHcCCC-CCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHH
Q 008621 80 QLTCVMKFGGSSLASAERMREVAELILSFPN-ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~~~~~~va~iI~~~~~-~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~ 158 (559)
++++|+||||+++.+.+.+..+++.|....+ ..++||||++|+.++.+++...
T Consensus 23 ~~~iViK~GGs~l~~~~~~~~l~~~i~~l~~~g~~vVlVhGgg~~~~~~~~~~g-------------------------- 76 (283)
T PRK00942 23 GKTIVIKYGGNAMTDEELKEAFARDIVLLKQVGINPVVVHGGGPQIDELLKKLG-------------------------- 76 (283)
T ss_pred CCeEEEEEChHHhcCcchHHHHHHHHHHHHHCCCCEEEEeCChHHHHHHHHHCC--------------------------
Confidence 4679999999999999999999988885322 2346888999999999876311
Q ss_pred HHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCC--
Q 008621 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDF-- 236 (559)
Q Consensus 159 ~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~-- 236 (559)
... ++.++++.+.+.+....+++++ | +++..++ ++|+++|+++.++++.+.++++++++
T Consensus 77 -----~~~-----------~~~~g~~~t~~~~l~~~~~a~~-G-~l~~~i~-~~L~~~Gv~a~~l~~~~~~~~ta~~~~~ 137 (283)
T PRK00942 77 -----IES-----------EFVNGLRVTDAETMEVVEMVLA-G-KVNKELV-SLINKHGGKAVGLSGKDGGLITAKKLEE 137 (283)
T ss_pred -----CCc-----------EeeCCEecCCHHHHHHHHHHHc-C-chHHHHH-HHHHhCCCCccceeeccCCEEEEEECCC
Confidence 000 0112222211111122345555 7 7787766 78999999999999999999998765
Q ss_pred ----C-CceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcc
Q 008621 237 ----T-NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (559)
Q Consensus 237 ----~-~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~G 311 (559)
+ .+++...+...+.+ +++.|.|||++| +|.+. +|++++++ +|++|+.||.+|+|+++++||||||
T Consensus 138 ~~~~~~~g~i~~i~~~~l~~-----ll~~g~vpVv~~-~~~~~-~g~~~~l~---~D~~A~~lA~~l~A~~li~~tdv~G 207 (283)
T PRK00942 138 DEDLGFVGEVTPVNPALLEA-----LLEAGYIPVISP-IGVGE-DGETYNIN---ADTAAGAIAAALGAEKLILLTDVPG 207 (283)
T ss_pred CCCCccccceEEECHHHHHH-----HHHCCCEEEEcC-cEECC-CCcEEEEC---HHHHHHHHHHHcCCCEEEEEECCcc
Confidence 2 14454555443332 357889999997 68884 79999997 9999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCC--CcchHh--HHHHHHhCCC-CEEEecCCCCC----------CCCeEEe
Q 008621 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGA--QVLHPQ--SMRPAREGDI-PVRVKNSYNPN----------APGTLIR 376 (559)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga--~vlhp~--a~~~a~~~~I-pv~I~n~~~p~----------~~GT~I~ 376 (559)
||++ +++++++++++|+.+++..|. ..|.|+ ++..+.+.|+ +++|.|+.+|+ +.||+|.
T Consensus 208 v~~~------~~~~i~~i~~~e~~~~~~~~~~tggm~~Kl~~a~~~~~~gv~~v~I~~g~~~~~ll~~~~~~~~~GT~i~ 281 (283)
T PRK00942 208 VLDD------KGQLISELTASEAEELIEDGVITGGMIPKVEAALDAARGGVRSVHIIDGRVPHALLLELFTDEGIGTMIV 281 (283)
T ss_pred cccC------CCcccccCCHHHHHHHHHcCCCCCchHHHHHHHHHHHHhCCCEEEEeCCCCCchHHHHHhcCCCcceEEe
Confidence 9986 478999999999999988642 566665 5556667787 59999876654 3688887
Q ss_pred c
Q 008621 377 R 377 (559)
Q Consensus 377 ~ 377 (559)
+
T Consensus 282 ~ 282 (283)
T PRK00942 282 P 282 (283)
T ss_pred c
Confidence 5
No 49
>TIGR00761 argB acetylglutamate kinase. This model describes N-acetylglutamate kinases (ArgB) of many prokaryotes and the N-acetylglutamate kinase domains of multifunctional proteins from yeasts. This enzyme is the second step in the "acetylated" ornithine biosynthesis pathway. A related group of enzymes representing the first step of the pathway contain a homologous domain and are excluded from this model.
Probab=99.94 E-value=4.5e-26 Score=226.90 Aligned_cols=215 Identities=19% Similarity=0.275 Sum_probs=160.6
Q ss_pred eEEEEeCccccCCHHHHHHHHHHHHcCC-CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHH
Q 008621 82 TCVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVD 160 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~~~~~va~iI~~~~-~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~ 160 (559)
++|+|||||++.++ ++++++.|.... ...++|+||++|+.+|.+++.....
T Consensus 1 ~~ViK~GGs~l~~~--~~~~~~~i~~l~~~g~~~VlVhggg~~~~~~~~~~~~~-------------------------- 52 (231)
T TIGR00761 1 TIVIKIGGAAISDL--LEAFASDIAFLRAVGIKPVIVHGGGPEINELLEALGIP-------------------------- 52 (231)
T ss_pred CEEEEEChHHHhcc--HHHHHHHHHHHHHcCCCEEEEcCCcHHHHHHHHHcCCC--------------------------
Confidence 47999999999986 889999888643 2334678899999999987643210
Q ss_pred hcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHH-HhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCC--
Q 008621 161 ELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYL-VSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFT-- 237 (559)
Q Consensus 161 ~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~i-ls~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~-- 237 (559)
. ++.++++. .++...+.+ .+++++++..+++ +|+++|++++++++.+.++++..++.
T Consensus 53 -----~-----------~~~~g~r~---t~~~~~~~~~~~~~g~~~~~i~~-~L~~~G~~a~~l~~~~~~~it~~~~~~~ 112 (231)
T TIGR00761 53 -----P-----------EFKNGLRV---TDKETLEVVEMVLIGQVNKELVA-LLNKHGINAIGLTGGDGQLFTARSLDKE 112 (231)
T ss_pred -----C-----------EecCCCcc---CCHHHHHHHHHHHhcchHHHHHH-HHHhCCCCcccccCCCCCEEEEEECCCc
Confidence 0 00111111 122332222 2235588888775 89999999999999998888876543
Q ss_pred ----CceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccc
Q 008621 238 ----NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVL 313 (559)
Q Consensus 238 ----~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~ 313 (559)
.+++...+.+.+++ +++.+.|||++| +|.+ .+|++++++ +|++|+.||.+|+|++++|||||||||
T Consensus 113 ~~~~~g~i~~i~~~~i~~-----~l~~g~IPVi~~-~~~~-~~g~~~~l~---sD~~A~~lA~~l~A~~li~ltdv~Gv~ 182 (231)
T TIGR00761 113 DLGYVGEIKKVNKALLEA-----LLKAGYIPVISS-LALT-AEGQALNVN---ADTAAGALAAALGAEKLVLLTDVPGIL 182 (231)
T ss_pred cCCcccceEEEcHHHHHH-----HHHCCCeEEECC-CccC-CCCcEEEeC---HHHHHHHHHHHcCCCEEEEEECCCCee
Confidence 23454555444433 356789999999 5877 479999998 999999999999999999999999999
Q ss_pred cCCCCCCCCCccccccCHHHHHHHHHcC--CCcchHh--HHHHHHhCCCC
Q 008621 314 TCDPNIHPHAKPVPYLTFDEAAELAYFG--AQVLHPQ--SMRPAREGDIP 359 (559)
Q Consensus 314 taDP~~v~~a~~i~~ls~~Ea~eLa~~G--a~vlhp~--a~~~a~~~~Ip 359 (559)
++||+ ++|++|+++|+.++++.| ...|.|| ++..+.+.|++
T Consensus 183 ~~d~~-----~~i~~i~~~e~~~l~~~~~~tggm~~Kl~~a~~a~~~gv~ 227 (231)
T TIGR00761 183 NGDGQ-----SLISEIPLEEIEQLIEQGIITGGMIPKVNAALEALRGGVK 227 (231)
T ss_pred cCCCC-----eeccccCHHHHHHHHHcCCCCCchHHHHHHHHHHHHcCCC
Confidence 99984 689999999999999877 4788886 66677788886
No 50
>TIGR01027 proB glutamate 5-kinase. Bacterial ProB proteins hit the full length of this model, but the ProB-like domain of delta 1-pyrroline-5-carboxylate synthetase does not hit the C-terminal 100 residues of this model. The noise cutoff is set low enough to hit delta 1-pyrroline-5-carboxylate synthetase and other partial matches to this family.
Probab=99.93 E-value=2e-25 Score=235.74 Aligned_cols=225 Identities=22% Similarity=0.382 Sum_probs=166.2
Q ss_pred eEEEEeCccccCCHH------HHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHH
Q 008621 82 TCVMKFGGSSLASAE------RMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKD 153 (559)
Q Consensus 82 ~~V~KFGGsSl~~~~------~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~ 153 (559)
++|+|||||++.+.+ .++++++.|.... +.++|+|+|++ +.-.+
T Consensus 2 riVIKiGgs~l~~~~~~~~~~~i~~la~~I~~l~~~g~~vvlV~sG~--~~~g~-------------------------- 53 (363)
T TIGR01027 2 RIVVKVGSSSLTGSSGSLDRSHIAELVEQVAALHAAGHEVVIVSSGA--IAAGF-------------------------- 53 (363)
T ss_pred eEEEEeccceEeCCCCCcCHHHHHHHHHHHHHHHHCCCeEEEEeCcH--HhcCc--------------------------
Confidence 589999999999754 4899999988653 23455666543 21000
Q ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEe
Q 008621 154 LHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITT 233 (559)
Q Consensus 154 ~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~ 233 (559)
..++... +..+...++.+.+.|+..+..++...|.++|+++ .++ ++|.
T Consensus 54 ------~~lg~~~--------------------~~~~l~~~qa~aa~Gq~~l~~~~~~~l~~~Gi~~-----aqi-llt~ 101 (363)
T TIGR01027 54 ------EALGLPE--------------------RPKTLAEKQALAAVGQVRLMQLYEQLFSQYGIKV-----AQI-LLTR 101 (363)
T ss_pred ------cccCCCC--------------------CccchHHHHHHHHhChHHHHHHHHHHHHHcCCeE-----EEE-EEec
Confidence 0011110 0112234577899999999999999999999996 333 6777
Q ss_pred cCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCce--eeecCCcchhHHHHHHHHcCcCcEEEeeCCcc
Q 008621 234 DDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAI--TTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (559)
Q Consensus 234 ~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~--~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~G 311 (559)
++|.+.. .+.+....+. .|++.+.|||+.- ++.+ +.+++|++|++|+++|.+++|+.++|||||||
T Consensus 102 ~d~~~~~----~~lna~~~i~-~Ll~~g~iPVi~e-------nd~v~~~~l~~gd~D~lAa~lA~~l~Ad~liilTDVdG 169 (363)
T TIGR01027 102 ADFSDRE----RYLNARNTLE-ALLELGVVPIINE-------NDTVATEEIKFGDNDTLSALVAILVGADLLVLLTDVDG 169 (363)
T ss_pred cchhhHH----HHHHHHHHHH-HHHhCCCEEEEeC-------CCceeeeecCcCChHHHHHHHHHHcCCCEEEEEeCCCc
Confidence 7665432 2223333333 4567889999941 2222 45889999999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHH--HHHHHH-----HcCCCcchHh--HHHHHHhCCCCEEEecCCCCC---------CCCe
Q 008621 312 VLTCDPNIHPHAKPVPYLTFD--EAAELA-----YFGAQVLHPQ--SMRPAREGDIPVRVKNSYNPN---------APGT 373 (559)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~--Ea~eLa-----~~Ga~vlhp~--a~~~a~~~~Ipv~I~n~~~p~---------~~GT 373 (559)
||++||+.+|+|++|+++++. +..+++ .+|..+|+|| ++..+.++|+|++|.|+++|+ ..||
T Consensus 170 Vy~~dP~~~p~A~~I~~i~~~~~~~~~i~~~~~~~~gtGGM~~Kl~Aa~~a~~~gi~v~I~~g~~~~~l~~~l~g~~~GT 249 (363)
T TIGR01027 170 LYDADPRTNPDAKLIPVVEEITDLLLGVAGDSGSSVGTGGMRTKLQAADLATRAGVPVIIASGSKPEKIADALEGAPVGT 249 (363)
T ss_pred ccCCCCCCCCCCeEEEEeccCcHHHHHhhcCCCcCcCcCCchHHHHHHHHHHHCCCeEEEEeCCCccHHHHHhcCCCCcE
Confidence 999999999999999999974 455665 4788899998 899999999999999998774 4699
Q ss_pred EEecC
Q 008621 374 LIRRS 378 (559)
Q Consensus 374 ~I~~~ 378 (559)
+|.+.
T Consensus 250 ~i~~~ 254 (363)
T TIGR01027 250 LFHAQ 254 (363)
T ss_pred EEeeC
Confidence 99764
No 51
>PLN02418 delta-1-pyrroline-5-carboxylate synthase
Probab=99.93 E-value=3.3e-25 Score=252.16 Aligned_cols=239 Identities=18% Similarity=0.247 Sum_probs=178.3
Q ss_pred CcceEEEEeCccccCCHH------HHHHHHHHHHcC--CCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHH
Q 008621 79 KQLTCVMKFGGSSLASAE------RMREVAELILSF--PNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSF 150 (559)
Q Consensus 79 ~~~~~V~KFGGsSl~~~~------~~~~va~iI~~~--~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~ 150 (559)
.|+++|+|||||||.+.+ ++++++++|... .+.++|+|+||+.+.|+.++.+.+..
T Consensus 14 ~~~~iViK~G~ssl~~~~~~~~~~~i~~l~~~i~~l~~~g~~vvlVsSga~~~g~~~l~~~~~~---------------- 77 (718)
T PLN02418 14 DVKRVVIKVGTAVVTRDDGRLALGRLGALCEQIKELNSDGYEVILVSSGAVGVGRQRLRYRRLV---------------- 77 (718)
T ss_pred hCCEEEEEeCCCeecCCCCCccHHHHHHHHHHHHHHHHCCCEEEEEecchHHHHHHHHhhhhhh----------------
Confidence 367899999999999988 999999999864 24568999999999999988754311
Q ss_pred HHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEE
Q 008621 151 VKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGF 230 (559)
Q Consensus 151 i~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~i 230 (559)
+++..+ + .+......+..++|+||++++.+++.+|+++|++ ++|+ +
T Consensus 78 ---------~~~~~~-----------------~--~~~~~~~~~qa~aa~Gq~~l~~~~~~~f~~~g~~-----~~qi-l 123 (718)
T PLN02418 78 ---------NSSFAD-----------------L--QKPQMELDGKACAAVGQSELMALYDTLFSQLDVT-----ASQL-L 123 (718)
T ss_pred ---------hccccc-----------------C--CCCcchHHHHHHHHhhHHHHHHHHHHHHHHcCCe-----EEEE-E
Confidence 111000 0 0000111223789999999999999999999994 4666 8
Q ss_pred EEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecC---------CcchhHHHHHHHHcCcC
Q 008621 231 ITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGR---------GGSDLTATTIGKALGLQ 301 (559)
Q Consensus 231 it~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgR---------gGSD~tAa~lA~~L~A~ 301 (559)
+|+++|.+.+. +.+..+.+. .|++.|.|||+.| ++.+++..+ |++|++|+++|.+++|+
T Consensus 124 lT~~~~~~~~~----~~~~~~~l~-~ll~~g~iPVv~~-------nd~v~~~~~~~~~~~~~~~d~D~~A~~lA~~l~Ad 191 (718)
T PLN02418 124 VTDSDFRDPDF----RKQLSETVE-SLLDLRVIPIFNE-------NDAVSTRRAPYEDSSGIFWDNDSLAALLALELKAD 191 (718)
T ss_pred ecHhHhcchhH----hHhHHHHHH-HHHHCCCEEEEcC-------CCCccccccccccccCeecCcHHHHHHHHHHcCCC
Confidence 88888876543 233344444 3567889999955 344444422 26999999999999999
Q ss_pred cEEEeeCCcccccCCCCCCCCCccccccCHHHHHHHHH------cCCCcchH--hHHHHHHhCCCCEEEecCCCCC----
Q 008621 302 EIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAY------FGAQVLHP--QSMRPAREGDIPVRVKNSYNPN---- 369 (559)
Q Consensus 302 ~l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~------~Ga~vlhp--~a~~~a~~~~Ipv~I~n~~~p~---- 369 (559)
.++|||||||||++||+ .|++++|++++..+...... .|...|.| +++..+.++|++++|.|+..|+
T Consensus 192 ~li~~TdVdGvy~~~p~-~~~a~~i~~i~~~~~~~~i~~~~~s~~~tGGM~~Kl~Aa~~a~~~Gi~v~I~~g~~~~~l~~ 270 (718)
T PLN02418 192 LLILLSDVEGLYTGPPS-DPSSKLIHTYIKEKHQDEITFGEKSRVGRGGMTAKVKAAVNAASAGIPVVITSGYALDNIRK 270 (718)
T ss_pred EEEEeecCCeeecCCCC-CCCceEcceecccchhhhhhcccccccCCCCcHHHHHHHHHHHHCCCcEEEeCCCCcchHHH
Confidence 99999999999999998 59999999998765433222 24678998 4888999999999999987764
Q ss_pred -----CCCeEEecCCC
Q 008621 370 -----APGTLIRRSRD 380 (559)
Q Consensus 370 -----~~GT~I~~~~~ 380 (559)
..||+|.+...
T Consensus 271 ~l~g~~~GT~i~~~~~ 286 (718)
T PLN02418 271 VLRGERVGTLFHQDAH 286 (718)
T ss_pred HhcCCCCceEeccccc
Confidence 47999987543
No 52
>cd04238 AAK_NAGK-like AAK_NAGK-like: N-Acetyl-L-glutamate kinase (NAGK)-like . Included in this CD are the Escherichia coli and Pseudomonas aeruginosa type NAGKs which catalyze the phosphorylation of N-acetyl-L-glutamate (NAG) by ATP in the second step of arginine biosynthesis found in bacteria and photosynthetic organisms using either the acetylated, noncyclic (NC), or non-acetylated, cyclic (C) route of ornithine biosynthesis. Also included in this CD is a distinct group of uncharacterized (UC) bacterial and archeal NAGKs. Members of this CD belong to the Amino Acid Kinase Superfamily (AAK).
Probab=99.93 E-value=3.7e-25 Score=223.65 Aligned_cols=222 Identities=22% Similarity=0.287 Sum_probs=165.1
Q ss_pred EEEEeCccccCCHHHHHHHHHHHHcCC-CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHHh
Q 008621 83 CVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (559)
Q Consensus 83 ~V~KFGGsSl~~~~~~~~va~iI~~~~-~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (559)
+|+||||+++.+++.++++++.|.... ...++|||+++|+.+|.+++......+
T Consensus 1 ~ViKlGGs~l~~~~~~~~~~~~i~~l~~~g~~~VlVhG~g~~~~~~~~~~~~~~~------------------------- 55 (256)
T cd04238 1 VVIKYGGSAMKDEELKEAFADDIVLLKQVGINPVIVHGGGPEINELLKRLGIESE------------------------- 55 (256)
T ss_pred CEEEEChHHhcCccHHHHHHHHHHHHHHCCCCEEEECCCcHHHHHHHHHCCCCCE-------------------------
Confidence 489999999999999999999888532 233566669999999998865321100
Q ss_pred cCCCHHHHHHHHHHHHHHHHhhhhccCCCHH---HHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCC--
Q 008621 162 LGIDRSIIATHLEELEQLLKGIAMLKELTPR---SRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDF-- 236 (559)
Q Consensus 162 L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~---~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~-- 236 (559)
+.++++ ..+++ ..++.++ | ++|..+ +++|+++|++++++++.+.++++++.+
T Consensus 56 -----------------~~~~~r---~t~~~~l~~~~~a~~-g-~ln~~i-~~~L~~~Gv~a~~l~~~~~~~~~~~~~~~ 112 (256)
T cd04238 56 -----------------FVNGLR---VTDKETMEIVEMVLA-G-KVNKEL-VSLLNRAGGKAVGLSGKDGGLIKAEKKEE 112 (256)
T ss_pred -----------------eECCee---cCCHHHHHHHHHHHc-C-chHHHH-HHHHHhCCCCCCCcccccCCEEEEEECCC
Confidence 001111 11222 2234444 7 888886 788999999999999999889988653
Q ss_pred -----C-CceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCc
Q 008621 237 -----T-NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVD 310 (559)
Q Consensus 237 -----~-~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~ 310 (559)
+ .+++...+...+.. +++.+.|||++| ++.+ ..|++++++ +|++|+.+|.+|+|+++++|||||
T Consensus 113 ~~~~~~~~g~i~~i~~~~l~~-----ll~~g~ipVv~~-~~~~-~~g~~~~~~---~D~~A~~lA~~l~a~~li~ltdv~ 182 (256)
T cd04238 113 KDIDLGFVGEVTEVNPELLET-----LLEAGYIPVIAP-IAVD-EDGETYNVN---ADTAAGAIAAALKAEKLILLTDVP 182 (256)
T ss_pred CCCCcccccceEEECHHHHHH-----HHHCCCEEEECC-cEEC-CCCcEEEEC---HHHHHHHHHHHcCCCEEEEEeCCc
Confidence 2 14454555544432 357889999998 6877 479999998 999999999999999999999999
Q ss_pred ccccCCCCCCCCCccccccCHHHHHHHHHcC--CCcchHh--HHHHHHhCCC-CEEEecCCCC
Q 008621 311 GVLTCDPNIHPHAKPVPYLTFDEAAELAYFG--AQVLHPQ--SMRPAREGDI-PVRVKNSYNP 368 (559)
Q Consensus 311 GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~G--a~vlhp~--a~~~a~~~~I-pv~I~n~~~p 368 (559)
|||++ +++++++++++|+.+++..+ ...|.|+ ++..+.+.++ +++|.|+..|
T Consensus 183 Gv~~~------~~~~i~~i~~~e~~~~~~~~~~~ggm~~Kl~~a~~~~~~g~~~v~I~~g~~~ 239 (256)
T cd04238 183 GVLDD------PGSLISELTPKEAEELIEDGVISGGMIPKVEAALEALEGGVRKVHIIDGRVP 239 (256)
T ss_pred cccCC------CCCccccCCHHHHHHHHHcCCCCCChHHHHHHHHHHHHhCCCEEEEeCCCCC
Confidence 99987 27899999999999998643 3567775 5555666666 5999998766
No 53
>PRK14058 acetylglutamate/acetylaminoadipate kinase; Provisional
Probab=99.92 E-value=2.6e-24 Score=218.84 Aligned_cols=173 Identities=18% Similarity=0.251 Sum_probs=139.6
Q ss_pred CHHHHHHH-HhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEec----------------CCCC-ceeeecchHHHHH
Q 008621 190 TPRSRDYL-VSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD----------------DFTN-ADILEATYPAVAK 251 (559)
Q Consensus 190 ~~~~~d~i-ls~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~----------------~~~~-a~i~~~~~~~i~~ 251 (559)
+++..+.+ .++| ++|..+++ +|+++|++|+++++.+.++++.+ +++. +++...+.+.+..
T Consensus 67 ~~~~l~~~~~a~~-~ln~~lv~-~L~~~Gv~a~~l~~~~~~l~~~~~~~~~~~~~~g~~~~~d~g~~g~v~~v~~~~i~~ 144 (268)
T PRK14058 67 DRETLEVFIMAMA-LINKQLVE-RLQSLGVNAVGLSGLDGGLLEGKRKKAVRVVEEGKKKIIRGDYTGKIEEVNTDLLKL 144 (268)
T ss_pred CHHHHHHHHHHHH-HHHHHHHH-HHHhCCCCccccCcccCCEEEEEEecccccccCCcceeccCCceeEEEEECHHHHHH
Confidence 56666664 5889 99999885 89999999999999998777643 1221 4455555544433
Q ss_pred HHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccccCH
Q 008621 252 RLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTF 331 (559)
Q Consensus 252 ~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~ 331 (559)
+++.+.|||++|+ +.+ .+|+.++++ +|++|+.+|.+|+|++++|||||||||++||+ ++++|+++++
T Consensus 145 -----ll~~g~iPVi~~~-~~~-~~g~~~~i~---~D~~A~~lA~~l~A~~li~ltdv~Gv~~~~p~---~~~~i~~i~~ 211 (268)
T PRK14058 145 -----LLKAGYLPVVAPP-ALS-EEGEPLNVD---GDRAAAAIAGALKAEALVLLSDVPGLLRDPPD---EGSLIERITP 211 (268)
T ss_pred -----HHHCCCEEEEeCc-eEC-CCCcEEecC---HHHHHHHHHHHcCCCEEEEEeCChhhccCCCC---CCcCccCcCH
Confidence 4578899999996 555 478888887 99999999999999999999999999999994 5789999999
Q ss_pred HHHHHHHHcCCCcchHh--HHHHHHhCCC-CEEEecCCCCC-------CCCeEEec
Q 008621 332 DEAAELAYFGAQVLHPQ--SMRPAREGDI-PVRVKNSYNPN-------APGTLIRR 377 (559)
Q Consensus 332 ~Ea~eLa~~Ga~vlhp~--a~~~a~~~~I-pv~I~n~~~p~-------~~GT~I~~ 377 (559)
+|+.++..+....|.|| ++..+.+.|+ +++|.|..+|+ +.||+|.+
T Consensus 212 ~e~~~l~~~~tGgM~~Kl~aa~~a~~~Gv~~v~I~~g~~~~~l~~~l~G~GT~I~~ 267 (268)
T PRK14058 212 EEAEELSKAAGGGMKKKVLMAAEAVEGGVGRVIIADANVDDPISAALAGEGTVIVN 267 (268)
T ss_pred HHHHHHhhccCCccHHHHHHHHHHHHcCCCEEEEEcCCCcchHHHHhCCCceEEec
Confidence 99999988777889986 6677778899 79999987774 36999875
No 54
>PRK14556 pyrH uridylate kinase; Provisional
Probab=99.91 E-value=3.9e-23 Score=205.72 Aligned_cols=214 Identities=21% Similarity=0.293 Sum_probs=163.3
Q ss_pred ceEEEEeCccccCC-------HHHHHHHHHHHHcCCC--CCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHH
Q 008621 81 LTCVMKFGGSSLAS-------AERMREVAELILSFPN--ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFV 151 (559)
Q Consensus 81 ~~~V~KFGGsSl~~-------~~~~~~va~iI~~~~~--~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i 151 (559)
+.+|.|.+|..+.. ++.++++++.|+...+ .+..||| ++|.+-.-.
T Consensus 16 ~rvllKlsGe~l~~~~~~~~d~~~~~~~a~~i~~~~~~g~~i~iVv-GGGni~Rg~------------------------ 70 (249)
T PRK14556 16 KRILLKLSGESLSADQGFGINVESAQPIINQIKTLTNFGVELALVV-GGGNILRGG------------------------ 70 (249)
T ss_pred CEEEEEEehhhCcCCCCCCcCHHHHHHHHHHHHHHHhCCcEEEEEE-CCCHHHhCc------------------------
Confidence 46899999999974 4789999999988543 4555666 455443220
Q ss_pred HHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEE
Q 008621 152 KDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (559)
Q Consensus 152 ~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (559)
...++ ...+....|++...+.++|+.++..+|++.|++++.+++-..
T Consensus 71 -------~~~~~-----------------------~~~~r~~~D~~GmlaT~iNal~l~~~l~~~~~~~~v~sa~~~--- 117 (249)
T PRK14556 71 -------RANFG-----------------------NKIRRATADSMGMIATMINALALRDMLISEGVDAEVFSAKGV--- 117 (249)
T ss_pred -------hhhcc-----------------------CCCchhhhhHHHHHHHHHHHHHHHHHHHHcCCCeEEeecccc---
Confidence 00000 012345679999999999999999999999999988887432
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcc
Q 008621 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (559)
Q Consensus 232 t~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~G 311 (559)
..+ +++. ++.+ ..+. +++|.|+|++|+.|.. ..+ +|++|+++|..++|+.+++||||||
T Consensus 118 --~~~--~e~~--~~~~----~~~~-l~~g~vvi~~gg~G~p----~~S------tD~lAallA~~l~Ad~Lii~TdVDG 176 (249)
T PRK14556 118 --DGL--LKVA--SAHE----FNQE-LAKGRVLIFAGGTGNP----FVT------TDTTASLRAVEIGADALLKATTVNG 176 (249)
T ss_pred --CcC--CCCC--CHHH----HHHH-HhCCCEEEEECCCCCC----cCC------cHHHHHHHHHHcCCCEEEEEeCCCc
Confidence 111 2221 3322 3332 4678899989987732 233 8999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC---------CCCeEEe
Q 008621 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLIR 376 (559)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I~ 376 (559)
|||+||+.+|+|+++++++|+|+.+ .+.+++++.++++++++|||++|.|..+|+ ..||+|.
T Consensus 177 VYd~DP~~~p~A~~i~~I~~~e~~~---~~l~vmd~~A~~~a~~~gIpi~I~ng~~~~~L~~~l~Ge~~GT~i~ 247 (249)
T PRK14556 177 VYDKDPNKYSDAKRFDKVTFSEVVS---KELNVMDLGAFTQCRDFGIPIYVFDLTQPNALVDAVLDSKYGTWVT 247 (249)
T ss_pred cCCCCCCCCCCceEeeEEchhhhcc---cchHhHHHHHHHHHHHCCCcEEEECCCCchHHHHHHcCCCCceEEE
Confidence 9999999999999999999998876 366899999999999999999999988773 4688875
No 55
>cd04241 AAK_FomA-like AAK_FomA-like: This CD includes a fosfomycin biosynthetic gene product, FomA, and similar proteins found in a wide range of organisms. Together, the fomA and fomB genes in the fosfomycin biosynthetic gene cluster of Streptomyces wedmorensis confer high-level fosfomycin resistance. FomA and FomB proteins converted fosfomycin to fosfomycin monophosphate and fosfomycin diphosphate in the presence of ATP and a magnesium ion, indicating that FomA and FomB catalyzed phosphorylations of fosfomycin and fosfomycin monophosphate, respectively. FomA and related sequences in this CD are members of the Amino Acid Kinase Superfamily (AAK).
Probab=99.90 E-value=1.9e-22 Score=203.46 Aligned_cols=148 Identities=21% Similarity=0.253 Sum_probs=118.9
Q ss_pred HHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeee
Q 008621 203 CMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTL 282 (559)
Q Consensus 203 ~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tl 282 (559)
+++.. +.++|.++|+++.++++.++ +.+. ..++...+...+. .+++.|.|||++|+.+.+. +|.+.++
T Consensus 80 ~ln~~-~~~~l~~~g~~a~~l~~~~~-~~~~----~g~~~~~~~~~l~-----~ll~~g~iPVi~~~~~~~~-~~~~~~~ 147 (252)
T cd04241 80 ELNSI-VVDALLEAGVPAVSVPPSSF-FVTE----NGRIVSFDLEVIK-----ELLDRGFVPVLHGDVVLDE-GGGITIL 147 (252)
T ss_pred HHHHH-HHHHHHHCCCCeEEEChHHe-EEec----CCeeeeecHHHHH-----HHHhCCCEEEEcCCeEecC-CCCeEEe
Confidence 66664 66789999999999999996 3332 2344444443333 2457899999999887773 6777778
Q ss_pred cCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccccCHHHHHHHHHc-------CCCcchHh--HHHHH
Q 008621 283 GRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYF-------GAQVLHPQ--SMRPA 353 (559)
Q Consensus 283 gRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~-------Ga~vlhp~--a~~~a 353 (559)
+ +|++|+.+|.+|+|+++++||||||||++|| |++++|++++++|+.++... +...|.|| ++..+
T Consensus 148 ~---~D~~A~~lA~~l~A~~li~ltdv~Gv~~~~P---~~~~~i~~i~~~~~~~~~~~~~~~~~~~tGGm~~Kl~aa~~a 221 (252)
T cd04241 148 S---GDDIVVELAKALKPERVIFLTDVDGVYDKPP---PDAKLIPEIDVGSLEDILAALGSAGTDVTGGMAGKIEELLEL 221 (252)
T ss_pred C---hHHHHHHHHHHcCCCEEEEEeCCCeeECCCC---CCCeEcceeCccchHHHHHhcCcCCccccCCHHHHHHHHHHH
Confidence 7 9999999999999999999999999999999 89999999999998888652 34578886 67777
Q ss_pred HhCCCCEEEecCCCC
Q 008621 354 REGDIPVRVKNSYNP 368 (559)
Q Consensus 354 ~~~~Ipv~I~n~~~p 368 (559)
.++|++++|.|..+|
T Consensus 222 ~~~Gv~v~I~~g~~~ 236 (252)
T cd04241 222 ARRGIEVYIFNGDKP 236 (252)
T ss_pred HhcCCeEEEEeCCCH
Confidence 789999999998776
No 56
>PLN02512 acetylglutamate kinase
Probab=99.90 E-value=1.7e-22 Score=209.29 Aligned_cols=235 Identities=21% Similarity=0.307 Sum_probs=165.4
Q ss_pred ceEEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHH
Q 008621 81 LTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (559)
Q Consensus 81 ~~~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~ 158 (559)
+++|.||||+++.+++..+.+.+.|.... +.++|+| +++|...+.+++.
T Consensus 48 ~tiVIKlGGs~i~d~~~~~~~~~di~~l~~~g~~iVlV-HGgG~~i~~~~~~---------------------------- 98 (309)
T PLN02512 48 KTVVVKYGGAAMKDPELKAGVIRDLVLLSCVGLRPVLV-HGGGPEINSWLKK---------------------------- 98 (309)
T ss_pred CeEEEEECCeeccChhHHHHHHHHHHHHHHCCCCEEEE-ECCcHHHHHHHHH----------------------------
Confidence 67999999999998776666666665422 2344555 4555555554432
Q ss_pred HHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHH-h-hhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCC
Q 008621 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLV-S-FGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDF 236 (559)
Q Consensus 159 ~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~il-s-~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~ 236 (559)
++.++ ++.+|++.+ ++...+.+. . .| .++..+. ++|+++|++++++++.+.++++.+.+
T Consensus 99 ---~gi~~-----------~~~~G~rvT---~~~~lei~~~~l~g-~ln~~lv-~~L~~~Gv~av~l~g~d~~~i~a~~~ 159 (309)
T PLN02512 99 ---VGIEP-----------QFKNGLRVT---DAETMEVVEMVLVG-KVNKSLV-SLINKAGGTAVGLSGKDGRLLRARPS 159 (309)
T ss_pred ---cCCCC-----------cCCCCCcCC---CHHHHHHHHHHHhh-HHHHHHH-HHHHHcCCCeEEeehhhCCEEEEEEc
Confidence 11111 122333332 333333331 1 24 5676654 67999999999999999889988765
Q ss_pred CC-------ceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCC
Q 008621 237 TN-------ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDV 309 (559)
Q Consensus 237 ~~-------a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV 309 (559)
.+ +++...+...++ .+++.+.|||++|+ +.+ ..|+.++++ +|++|+.||.+|+|+++++||||
T Consensus 160 ~~~~~~~~~G~i~~v~~~~i~-----~lL~~g~IPVi~~~-~~d-~~g~~~~i~---~D~~A~~lA~~L~Ad~li~lTdV 229 (309)
T PLN02512 160 PNSADLGFVGEVTRVDPTVLR-----PLVDDGHIPVIATV-AAD-EDGQAYNIN---ADTAAGEIAAALGAEKLILLTDV 229 (309)
T ss_pred CcCccccccceeeecCHHHHH-----HHHhCCCEEEEeCc-eEC-CCCCEeccC---HHHHHHHHHHHcCCCEEEEEeCC
Confidence 32 344444444333 34578899999995 777 478888886 99999999999999999999999
Q ss_pred cccccCCCCCCCCCccccccCHHHHHHHHHcC--CCcchHh--HHHHHHhCCCC-EEEecCCCCC----------CCCeE
Q 008621 310 DGVLTCDPNIHPHAKPVPYLTFDEAAELAYFG--AQVLHPQ--SMRPAREGDIP-VRVKNSYNPN----------APGTL 374 (559)
Q Consensus 310 ~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~G--a~vlhp~--a~~~a~~~~Ip-v~I~n~~~p~----------~~GT~ 374 (559)
||||++|| +++++|++++++|+.++...| ...|.|| ++..+.+.|++ ++|.|...|+ ..||+
T Consensus 230 ~GV~~~~~---~~~~lI~~i~~~e~~~l~~~~~vtGGM~~Kl~aa~~a~~~Gv~~v~I~~g~~~~~ll~~l~~~~~~GT~ 306 (309)
T PLN02512 230 AGVLEDKD---DPGSLVKELDIKGVRKLIADGKIAGGMIPKVECCVRSLAQGVKTAHIIDGRVPHSLLLEILTDEGAGTM 306 (309)
T ss_pred cceeCCCC---CCcCCCcccCHHHHHHHHhCCCCCCcHHHHHHHHHHHHHcCCCEEEEecCCCCChHHHHHhcCCCCeeE
Confidence 99999875 358899999999999998544 4688886 55566778996 8998876652 35777
Q ss_pred Ee
Q 008621 375 IR 376 (559)
Q Consensus 375 I~ 376 (559)
|.
T Consensus 307 I~ 308 (309)
T PLN02512 307 IT 308 (309)
T ss_pred Ee
Confidence 75
No 57
>COG0528 PyrH Uridylate kinase [Nucleotide transport and metabolism]
Probab=99.90 E-value=2.1e-22 Score=195.57 Aligned_cols=214 Identities=23% Similarity=0.360 Sum_probs=165.6
Q ss_pred ceEEEEeCccccCC-------HHHHHHHHHHHHcCCC-CCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHH
Q 008621 81 LTCVMKFGGSSLAS-------AERMREVAELILSFPN-ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVK 152 (559)
Q Consensus 81 ~~~V~KFGGsSl~~-------~~~~~~va~iI~~~~~-~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~ 152 (559)
+.+|.|+||+.+.. ++.++++|+.|++..+ +..|.||-++|++-.......
T Consensus 6 ~rillkLsGe~l~g~~~~gid~~~i~~~a~~i~~~~~~g~eV~iVvGGGni~Rg~~~~~--------------------- 64 (238)
T COG0528 6 MRILLKLSGEALAGEQGFGIDPEVLDRIANEIKELVDLGVEVAVVVGGGNIARGYIGAA--------------------- 64 (238)
T ss_pred EEEEEEeecceecCCCCCCCCHHHHHHHHHHHHHHHhcCcEEEEEECCCHHHHhHHHHH---------------------
Confidence 56999999999974 6899999999998653 345545556676654443211
Q ss_pred HHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEE
Q 008621 153 DLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFIT 232 (559)
Q Consensus 153 ~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit 232 (559)
.|. +....|++..++.++|+.+|...|++.|++++.+++...+.+.
T Consensus 65 ---------~g~-------------------------~r~~~D~mGmlaTvmNal~L~~aL~~~~~~~~v~sai~~~~~~ 110 (238)
T COG0528 65 ---------AGM-------------------------DRVTADYMGMLATVMNALALQDALERLGVDTRVQSAIAMPQVA 110 (238)
T ss_pred ---------cCC-------------------------chhhhhHHHHHHHHHHHHHHHHHHHhcCCcceecccccCcccc
Confidence 011 3456689999999999999999999999999988875542111
Q ss_pred ecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeC-Ccc
Q 008621 233 TDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKD-VDG 311 (559)
Q Consensus 233 ~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TD-V~G 311 (559)
.. .++. +..++ ++++.|+|.+|-.|. + |.+ +|++|++.|..++||-+..-|+ |||
T Consensus 111 -e~--------~~~~----~A~~~-l~~grVvIf~gGtg~--P-~fT-------TDt~AALrA~ei~ad~ll~atn~VDG 166 (238)
T COG0528 111 -EP--------YSRR----EAIRH-LEKGRVVIFGGGTGN--P-GFT-------TDTAAALRAEEIEADVLLKATNKVDG 166 (238)
T ss_pred -Cc--------cCHH----HHHHH-HHcCCEEEEeCCCCC--C-CCc-------hHHHHHHHHHHhCCcEEEEeccCCCc
Confidence 11 1222 22222 467899999884442 1 555 6999999999999999999995 999
Q ss_pred cccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC---------CCCeEEe
Q 008621 312 VLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN---------APGTLIR 376 (559)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~---------~~GT~I~ 376 (559)
||++||+++|+|+++++|||+|+.+. +.+||+|.|+..+++++||++|.|.++|. +.||+|.
T Consensus 167 VY~~DPkk~pdA~~~~~Lty~e~l~~---~l~vmD~tA~~l~~~~~i~i~Vfn~~~~~~l~~~~~ge~~gT~V~ 237 (238)
T COG0528 167 VYDADPKKDPDAKKYDTLTYDEVLKI---GLKVMDPTAFSLARDNGIPIIVFNINKPGNLKRALKGEEVGTIVE 237 (238)
T ss_pred eeCCCCCCCCCceecccCCHHHHHHh---cCeeecHHHHHHHHHcCCcEEEEeCCCCccHHHHHcCCCCceEec
Confidence 99999999999999999999998887 47999999999999999999999977764 4667664
No 58
>COG0548 ArgB Acetylglutamate kinase [Amino acid transport and metabolism]
Probab=99.89 E-value=1.4e-22 Score=202.19 Aligned_cols=230 Identities=22% Similarity=0.304 Sum_probs=176.1
Q ss_pred cceEEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHH
Q 008621 80 QLTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~ 157 (559)
+++.|.|+||+.+.+.+.+..+++.|..+. +.++|||+.+..-+++.|-+.
T Consensus 2 ~k~~VIK~GG~~~~~~~l~~~~~~di~lL~~~G~~~VvVHGggp~I~~~l~~~--------------------------- 54 (265)
T COG0548 2 GKTIVIKLGGSAMEDENLLEAFASDIALLKSVGIRPVVVHGGGPQIDEMLAKL--------------------------- 54 (265)
T ss_pred CceEEEEECceeecCchHHHHHHHHHHHHHHCCCcEEEEeCCchHHHHHHHHc---------------------------
Confidence 578999999999999999999999877643 457765554444444444332
Q ss_pred HHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCC-
Q 008621 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDF- 236 (559)
Q Consensus 158 ~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~- 236 (559)
+.++ ++.+|++++.+.+.....+++ +-.++..|. +.|+..|.+++++++.|.++++....
T Consensus 55 -----gie~-----------~f~~glRvTd~~tlevv~mvl--~G~vNk~iv-a~l~~~g~~avGlsg~Dg~li~A~~~~ 115 (265)
T COG0548 55 -----GIEP-----------EFVKGLRVTDAETLEVVEMVL--GGTVNKEIV-ARLSKHGGQAVGLSGVDGNLVTAKKLD 115 (265)
T ss_pred -----CCCC-----------eeeCCEEcCCHHHHHHHHHHH--HHHHHHHHH-HHHHHhCCcceeeeecCCCEEEEEEcc
Confidence 2332 356666666544444444444 446787755 56999999999999999889987633
Q ss_pred -------CC-ceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeC
Q 008621 237 -------TN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKD 308 (559)
Q Consensus 237 -------~~-a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TD 308 (559)
+. +++..+++..+ ..+++++.|||+++ +|.+ .+|++.|++ +|++|+.+|.+|+|++++++||
T Consensus 116 ~~~~id~g~vG~i~~Vn~~~i-----~~ll~~~~IpViap-ia~~-~~G~~~Nvn---aD~~A~~iA~aLkAekLi~ltd 185 (265)
T COG0548 116 VDDGVDLGYVGEIRKVNPELI-----ERLLDNGAIPVIAP-IAVD-EDGETLNVN---ADTAAGALAAALKAEKLILLTD 185 (265)
T ss_pred cccccccceeeeEEEECHHHH-----HHHHhCCCceEEec-ceEC-CCCcEEeeC---HHHHHHHHHHHcCCCeEEEEeC
Confidence 32 35555665433 34567899999999 7888 489999999 9999999999999999999999
Q ss_pred CcccccCCCCCCCCCccccccCHHHHHHHHHcC--CCcchHh--HHHHHHhCCCC-EEEecCCCCC
Q 008621 309 VDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFG--AQVLHPQ--SMRPAREGDIP-VRVKNSYNPN 369 (559)
Q Consensus 309 V~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~G--a~vlhp~--a~~~a~~~~Ip-v~I~n~~~p~ 369 (559)
|+|||+.+|+. ..+++++.+|+.+|...| ...|.|+ ++..|.+.|++ ++|.|+..|.
T Consensus 186 v~Gvl~~~~~~----s~i~~~~~~~~~~li~~~~i~~GMi~Kv~~a~~A~~~Gv~~v~ii~g~~~~ 247 (265)
T COG0548 186 VPGVLDDKGDP----SLISELDAEEAEELIEQGIITGGMIPKVEAALEALESGVRRVHIISGRVPH 247 (265)
T ss_pred CcccccCCCCc----eeeccCCHHHHHHHHhcCCccCccHHHHHHHHHHHHhCCCeEEEecCCCcc
Confidence 99999988752 689999999999999988 5788886 77888899995 9999887663
No 59
>CHL00202 argB acetylglutamate kinase; Provisional
Probab=99.88 E-value=8.7e-22 Score=201.87 Aligned_cols=234 Identities=18% Similarity=0.252 Sum_probs=166.8
Q ss_pred ceEEEEeCccccCCHHHHHHHHHHHHcCC-CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHH
Q 008621 81 LTCVMKFGGSSLASAERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (559)
Q Consensus 81 ~~~V~KFGGsSl~~~~~~~~va~iI~~~~-~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (559)
++.|.|+||+.+.++...+.+++.|.... ...++|+|++.|..-+.+++.
T Consensus 24 ~~~VIk~gG~~~~~~~l~~~~~~di~~l~~~g~~~VlVHGgg~~i~~~~~~----------------------------- 74 (284)
T CHL00202 24 RIMVIKYGGAAMKNLILKADIIKDILFLSCIGLKIVVVHGGGPEINFWLKQ----------------------------- 74 (284)
T ss_pred CeEEEEEChHHhcCcchHHHHHHHHHHHHHCCCcEEEEeCCcHHHHHHHHH-----------------------------
Confidence 57999999999988766667777776542 233455556666544444321
Q ss_pred HhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHh--hhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCC-
Q 008621 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVS--FGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDF- 236 (559)
Q Consensus 160 ~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils--~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~- 236 (559)
++.++ ++++|++.+ ++...+.+.. .| .++..+. ++|++.|++++++++.+.++++...+
T Consensus 75 --~g~~~-----------~~~~G~rvT---~~~~l~~~~~~l~g-~ln~~lv-~~L~~~Gv~av~l~~~d~~~i~a~~~~ 136 (284)
T CHL00202 75 --LNISP-----------KFWNGIRVT---DKVTMEIVEMVLAG-KVNKDLV-GSINANGGKAVGLCGKDANLIVARASD 136 (284)
T ss_pred --CCCCC-----------EeECCcccC---CHHHHHHHHHHHhh-HHHHHHH-HHHHhCCCCeeeeeeccCCEEEEEeCC
Confidence 12221 123455443 3444443321 24 5677755 56899999999999999888886543
Q ss_pred ----CC-ceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcc
Q 008621 237 ----TN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (559)
Q Consensus 237 ----~~-a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~G 311 (559)
+. +++...+...+. .+++.|.|||++|+ |.+ ..|++++++ +|++|+.+|.+|+|++++|||||||
T Consensus 137 ~~d~~~~G~i~~v~~~~i~-----~ll~~g~iPVi~~~-~~~-~~g~~~ni~---~D~~A~~lA~~l~Ad~li~lTdv~G 206 (284)
T CHL00202 137 KKDLGLVGEIQQVDPQLID-----MLLEKNYIPVIASV-AAD-HDGQTYNIN---ADVVAGEIAAKLNAEKLILLTDTPG 206 (284)
T ss_pred CcccccceeEEecCHHHHH-----HHHHCCCEEEECCC-ccC-CCCcEEecC---HHHHHHHHHHHhCCCEEEEEeCChh
Confidence 22 455555554443 34578899999995 777 479999998 9999999999999999999999999
Q ss_pred cccC--CCCCCCCCccccccCHHHHHHHHHcC--CCcchHh--HHHHHHhCCCC-EEEecCCCCC----------CCCeE
Q 008621 312 VLTC--DPNIHPHAKPVPYLTFDEAAELAYFG--AQVLHPQ--SMRPAREGDIP-VRVKNSYNPN----------APGTL 374 (559)
Q Consensus 312 V~ta--DP~~v~~a~~i~~ls~~Ea~eLa~~G--a~vlhp~--a~~~a~~~~Ip-v~I~n~~~p~----------~~GT~ 374 (559)
||++ || .+++++++++|+.++...| ...|.|| ++..+.++|++ ++|.|..+|+ +.||+
T Consensus 207 v~~~~~d~-----~~~i~~i~~~e~~~l~~~g~~tGGM~~Kl~aa~~a~~~Gv~~v~I~~g~~~~~ll~el~~~~g~GT~ 281 (284)
T CHL00202 207 ILADINDP-----NSLISTLNIKEARNLASTGIISGGMIPKVNCCIRALAQGVEAAHIIDGKEKHALLLEILTEKGIGSM 281 (284)
T ss_pred hcCCCCCC-----CCccccccHHHHHHHHhcCCCCCCHHHHHHHHHHHHHcCCCEEEEeCCCCCChHHHHHhcCCCCceE
Confidence 9984 34 3799999999999998775 3688886 66667788987 7998887664 35888
Q ss_pred Ee
Q 008621 375 IR 376 (559)
Q Consensus 375 I~ 376 (559)
|.
T Consensus 282 i~ 283 (284)
T CHL00202 282 LV 283 (284)
T ss_pred Ee
Confidence 74
No 60
>cd04251 AAK_NAGK-UC AAK_NAGK-UC: N-Acetyl-L-glutamate kinase - uncharacterized (NAGK-UC). This domain is similar to Escherichia coli and Pseudomonas aeruginosa NAGKs which catalyze the phosphorylation of the gamma-COOH group of N-acetyl-L-glutamate (NAG) by ATP in the second step of microbial arginine biosynthesis. These uncharacterized domain sequences are found in some bacteria (Deinococci and Chloroflexi) and archea and belong to the Amino Acid Kinase Superfamily (AAK).
Probab=99.87 E-value=7.6e-21 Score=192.30 Aligned_cols=221 Identities=20% Similarity=0.293 Sum_probs=159.8
Q ss_pred EEEEeCccccCCHHHHHHHHHHHHcCCCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHHhc
Q 008621 83 CVMKFGGSSLASAERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDEL 162 (559)
Q Consensus 83 ~V~KFGGsSl~~~~~~~~va~iI~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~L 162 (559)
+|.||||+.+.+. +++++.|... +. ++|+|+++|...+.+++. +
T Consensus 1 ~VIKlGGs~l~~~---~~~~~~i~~l-g~-~~VlVHGgg~~i~~~~~~-------------------------------~ 44 (257)
T cd04251 1 IVVKIGGSVVSDL---DKVIDDIANF-GE-RLIVVHGGGNYVNEYLKR-------------------------------L 44 (257)
T ss_pred CEEEEChHHhhCh---HHHHHHHHHc-CC-CEEEECCCHHHHHHHHHH-------------------------------c
Confidence 4899999999864 5677777765 33 477778888766665542 1
Q ss_pred CCCHHHHHHHHHHHHHHHH---hhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCC---
Q 008621 163 GIDRSIIATHLEELEQLLK---GIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDF--- 236 (559)
Q Consensus 163 ~~~~~~i~~~~~~l~~~l~---~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~--- 236 (559)
++++. +++ |+. .+-.+++..+.+....+.+|..+++ +|+++|+++.++++++.++++.+.+
T Consensus 45 gi~~~-----------~~~~~~G~~-~Rvt~~~~l~~~~~a~~~ln~~iv~-~L~~~Gi~a~~l~~~~~~~~~~~~~~~~ 111 (257)
T cd04251 45 GVEPK-----------FVTSPSGIR-SRYTDKETLEVFVMVMGLINKKIVA-RLHSLGVKAVGLTGLDGRLLEAKRKEIV 111 (257)
T ss_pred CCCcE-----------EEeCCCCCc-cccCCHHHHHHHHHHHHHHHHHHHH-HHHhCCCCceecccccCCEEEEEEeecc
Confidence 11110 110 110 0123456666665444899999765 8999999999999999877765532
Q ss_pred -------------C-CceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCc
Q 008621 237 -------------T-NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQE 302 (559)
Q Consensus 237 -------------~-~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~ 302 (559)
+ .+++...+.+.++ .+++.+.|||++|| +.+ .+|++++++ +|++|+.+|.+|+|++
T Consensus 112 ~~~~~~~~~~~d~~~~G~v~~v~~~~i~-----~ll~~g~vpVi~~~-~~~-~~G~~~~i~---~D~~A~~lA~~L~A~~ 181 (257)
T cd04251 112 RVNERGRKMIIRGGYTGKVEKVNSDLIE-----ALLDAGYLPVVSPV-AYS-EEGEPLNVD---GDRAAAAIAAALKAER 181 (257)
T ss_pred cccccCcccccCCcceEEEEEEcHHHHH-----HHHhCCCeEEEeCc-EEC-CCCcEEecC---HHHHHHHHHHHcCCCE
Confidence 1 0244444544333 34578899999986 445 379999997 9999999999999999
Q ss_pred EEEeeCCcccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHh--HHHHHHhCCC-CEEEecCCCCC
Q 008621 303 IQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQ--SMRPAREGDI-PVRVKNSYNPN 369 (559)
Q Consensus 303 l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~--a~~~a~~~~I-pv~I~n~~~p~ 369 (559)
++|||||||||++ ++++++++++|+.++...-...|.|| ++..+.+.|+ .++|.+...|+
T Consensus 182 li~~tdv~Gv~~~-------~~~i~~i~~~e~~~l~~~~~ggm~~Kl~aa~~a~~~gv~~v~i~~g~~~~ 244 (257)
T cd04251 182 LILLTDVEGLYLD-------GRVIERITVSDAESLLEKAGGGMKRKLLAAAEAVEGGVREVVIGDARADS 244 (257)
T ss_pred EEEEeCChhheeC-------CcccCccCHHHHHHHHhhCCCchHHHHHHHHHHHHcCCCEEEEecCCCcc
Confidence 9999999999963 78999999999999986656678775 7777778888 48898887764
No 61
>cd04255 AAK_UMPK-MosAB AAK_UMPK-MosAB: This CD includes the alpha and beta subunits of the Mo storage protein (MosA and MosB) which are related to uridine monophosphate kinase (UMPK) enzymes that catalyze the phosphorylation of UMP by ATP, yielding UDP, and playing a key role in pyrimidine nucleotide biosynthesis. The Mo storage protein from the nitrogen-fixing bacterium, Azotobacter vinelandii, is characterized as an alpha4-beta4 octamer containing a polynuclear molybdenum-oxide cluster which is ATP-dependent to bind Mo and pH-dependent to release Mo. These and related bacterial sequences in this CD are members of the Amino Acid Kinase Superfamily (AAK).
Probab=99.86 E-value=2.7e-20 Score=188.34 Aligned_cols=212 Identities=21% Similarity=0.282 Sum_probs=146.2
Q ss_pred ceEEEEeCccccCC--HHHHHHHHHHHHcCCCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHH
Q 008621 81 LTCVMKFGGSSLAS--AERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRT 158 (559)
Q Consensus 81 ~~~V~KFGGsSl~~--~~~~~~va~iI~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~ 158 (559)
.++|.|+|||.+.+ .+.++++++.|++..+...+++|++.|.......+ .
T Consensus 31 ~~~ViKiGGSvitdk~~~~i~~la~~i~~~~~~~~vilV~GGG~~~r~~~~----------------------------~ 82 (262)
T cd04255 31 DLNVVKIGGQSIIDRGAEAVLPLVEEIVALRPEHKLLILTGGGTRARHVYS----------------------------I 82 (262)
T ss_pred CcEEEEeccceecCCcHHHHHHHHHHHHHHhCCCcEEEEECCHHHHHHHHH----------------------------H
Confidence 35999999999954 67899999999876544456555554432211111 1
Q ss_pred HHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCC
Q 008621 159 VDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTN 238 (559)
Q Consensus 159 ~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~ 238 (559)
...++. +....|++...-.++++.++...|...|+++. +..
T Consensus 83 ~~~~g~-------------------------~~~~~~~~~~aa~~ln~lv~~~~l~~~g~~~i----------~~~---- 123 (262)
T cd04255 83 GLDLGM-------------------------PTGVLAKLGASVSEQNAEMLATLLAKHGGSKV----------GHG---- 123 (262)
T ss_pred HHHcCC-------------------------CchHHHHHHHHHHHHHHHHHHHHHHHcCCCcc----------ccc----
Confidence 112222 12233444433456777777777888888652 111
Q ss_pred ceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCc------chhHHHHHHHHcCcCcEEEeeCCccc
Q 008621 239 ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGG------SDLTATTIGKALGLQEIQVWKDVDGV 312 (559)
Q Consensus 239 a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgG------SD~tAa~lA~~L~A~~l~i~TDV~GV 312 (559)
+... +. .+++.+.|||+.|+.+.+ ..++++|+| +|++|+++|.+|+|+.+++|||||||
T Consensus 124 ------~~~~----l~-~lL~~g~vPVi~g~~~~~----~~~i~~~~g~~~~~~~D~~Aa~lA~~l~ad~li~~TdVdGV 188 (262)
T cd04255 124 ------DLLQ----LP-TFLKAGRAPVISGMPPYG----LWEHPAEEGRIPPHRTDVGAFLLAEVIGARNLIFVKDEDGL 188 (262)
T ss_pred ------cHHH----HH-HHHHCCCeEEEeCCcCCC----eeeecCCCccCCCCCcHHHHHHHHHHhCCCEEEEEeccCee
Confidence 1111 22 235789999999987543 345667666 99999999999999999999999999
Q ss_pred ccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCC--CCEEEecCCCCC---------CCCeEE
Q 008621 313 LTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGD--IPVRVKNSYNPN---------APGTLI 375 (559)
Q Consensus 313 ~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~--Ipv~I~n~~~p~---------~~GT~I 375 (559)
|++||+.+|+|++|++++++|+.++.. +..+|...+...++..+ +|++|.|+.+|+ ..||+|
T Consensus 189 y~~dP~~~~~a~~i~~i~~~~~~~~~~-~~~~~~~~~~~~l~aa~~~~~v~I~~g~~~~~L~~~l~g~~~GT~i 261 (262)
T cd04255 189 YTADPKKNKKAEFIPEISAAELLKKDL-DDLVLERPVLDLLQNARHVKEVQIVNGLVPGNLTRALRGEHVGTII 261 (262)
T ss_pred ECCCCCCCCCCeEccEeCHHHHHHHhc-CCCCCcHHHHHHHHHhCCCCcEEEEeCCCCCHHHHHHcCCCCceEe
Confidence 999999999999999999999888752 22346666665555333 699999988774 357776
No 62
>cd04256 AAK_P5CS_ProBA AAK_P5CS_ProBA: Glutamate-5-kinase (G5K) domain of the bifunctional delta 1-pyrroline-5-carboxylate synthetase (P5CS), composed of an N-terminal G5K (ProB) and a C-terminal glutamyl 5- phosphate reductase (G5PR, ProA), the first and second enzyme catalyzing proline (and, in mammals, ornithine) biosynthesis. G5K transfers the terminal phosphoryl group of ATP to the gamma-carboxyl group of glutamate, and is subject to feedback allosteric inhibition by proline or ornithine. In plants, proline plays an important role as an osmoprotectant and, in mammals, ornithine biosynthesis is crucial for proper ammonia detoxification, since a G5K mutation has been shown to cause human hyperammonaemia.
Probab=99.85 E-value=3.8e-20 Score=189.44 Aligned_cols=245 Identities=16% Similarity=0.205 Sum_probs=165.3
Q ss_pred cceEEEEeCccccCCH-------HHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHH
Q 008621 80 QLTCVMKFGGSSLASA-------ERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSF 150 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~-------~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~ 150 (559)
.+.+|.|+|||++.+. +.+.++++.|.... +.+.|+|.|+....--..+.....
T Consensus 8 ~~~iVvKiGss~lt~~~~~~~~~~~l~~l~~~i~~l~~~g~~vilVssGAv~~G~~~l~~~~~----------------- 70 (284)
T cd04256 8 AKRIVVKLGSAVVTREDECGLALGRLASIVEQVSELQSQGREVILVTSGAVAFGKQRLRHEIL----------------- 70 (284)
T ss_pred CCEEEEEeCchhccCCCCCccCHHHHHHHHHHHHHHHHCCCEEEEEeeCcHHhChHHhhhccc-----------------
Confidence 4679999999999653 56788888888642 234444766554433222211000
Q ss_pred HHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhcc-CCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceE
Q 008621 151 VKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLK-ELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIG 229 (559)
Q Consensus 151 i~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~-~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ 229 (559)
+... .++..+|..... ..+...+..+.+.|+..-..++...|..+|+++ .|+
T Consensus 71 -----------~~~~----------~~~~~~g~~~~~~~~~~~~~qa~aa~gq~~L~~~y~~~f~~~~~~~-----~q~- 123 (284)
T cd04256 71 -----------LSSS----------MRQTLKSGQLKDMPQMELDGRACAAVGQSGLMALYEAMFTQYGITV-----AQV- 123 (284)
T ss_pred -----------cccc----------hhhhcccccccCCcchhHHHHHHHHcccHHHHHHHHHHHHHcCCcH-----HHe-
Confidence 0000 000111111111 112233466788999999999999999999875 676
Q ss_pred EEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccC-----CCCceeeecCCcchhHHHHHHHHcCcCcEE
Q 008621 230 FITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAW-----RTCAITTLGRGGSDLTATTIGKALGLQEIQ 304 (559)
Q Consensus 230 iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~-----~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~ 304 (559)
++|.++|.+.+. +.+..+.+. .|++.|.|||+.|+=+... .+|+.. ...+++|+.|+++|.+++|+.++
T Consensus 124 llt~~d~~~~~~----~~~~~~~l~-~lL~~g~iPVi~~nD~v~~~~~~~~~~~~~-~~i~d~D~lAa~lA~~l~Ad~Li 197 (284)
T cd04256 124 LVTKPDFYDEQT----RRNLNGTLE-ELLRLNIIPIINTNDAVSPPPEPDEDLQGV-ISIKDNDSLAARLAVELKADLLI 197 (284)
T ss_pred eeeccccccHHH----HHHHHHHHH-HHHHCCCEEEEeCCCccccccccccccccc-ccccChHHHHHHHHHHcCCCEEE
Confidence 888888887652 334444444 4578899999976311110 011111 12357999999999999999999
Q ss_pred EeeCCcccccCCCCCCCCCccccccCHHHHHHHHH-----cCCCcchHh--HHHHHHhCCCCEEEecCCCCC--------
Q 008621 305 VWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAY-----FGAQVLHPQ--SMRPAREGDIPVRVKNSYNPN-------- 369 (559)
Q Consensus 305 i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~-----~Ga~vlhp~--a~~~a~~~~Ipv~I~n~~~p~-------- 369 (559)
++|||||||++||+ .|++++|++++..|..++++ .|...|.|| ++..+.++|++++|.|+.+|+
T Consensus 198 ~lTDVdGVy~~dP~-~~~a~~I~~i~~~~~~~~~~~~~s~~gtGGM~~Kl~Aa~~a~~~Gi~v~I~~G~~~~~i~~~l~G 276 (284)
T cd04256 198 LLSDVDGLYDGPPG-SDDAKLIHTFYPGDQQSITFGTKSRVGTGGMEAKVKAALWALQGGTSVVITNGMAGDVITKILEG 276 (284)
T ss_pred EEeCCCeeecCCCC-CCCCeEcccccHhHHHHhhcccccCcccCCcHHHHHHHHHHHHCCCeEEEEcCCCccHHHHHHcC
Confidence 99999999999997 69999999999988766643 356789985 888899999999999987763
Q ss_pred -CCCeEE
Q 008621 370 -APGTLI 375 (559)
Q Consensus 370 -~~GT~I 375 (559)
..||+|
T Consensus 277 ~~~GT~~ 283 (284)
T cd04256 277 KKVGTFF 283 (284)
T ss_pred CCCCEEe
Confidence 467876
No 63
>TIGR01092 P5CS delta l-pyrroline-5-carboxylate synthetase. This protein contains a glutamate 5-kinase (ProB, EC 2.7.2.11) region followed by a gamma-glutamyl phosphate reductase (ProA, EC 1.2.1.41) region.
Probab=99.84 E-value=4.1e-20 Score=210.90 Aligned_cols=236 Identities=17% Similarity=0.282 Sum_probs=167.3
Q ss_pred cceEEEEeCccccCCHH------HHHHHHHHHHcC--CCCCcEEEEc---CCCcccHHHHHhhHhhhhcCcCcchhhhHH
Q 008621 80 QLTCVMKFGGSSLASAE------RMREVAELILSF--PNERPVIVLS---AMGKTTNKLLLAGEKAVSCGVTNISCIDEL 148 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~~------~~~~va~iI~~~--~~~~~vVVVS---A~g~~Td~L~~~~~~~~~~~~~~~~~~~~l 148 (559)
.+.+|.|||||++.+.+ .+.++++.|... .+.+.|+|+| |+|..+..+.+....
T Consensus 7 ~~~iViKiGss~lt~~~~~~~~~~l~~l~~~i~~l~~~g~~vilVsSGA~a~G~~~~~~~~~~~~--------------- 71 (715)
T TIGR01092 7 VKRIVVKVGTAVVTRGDGRLALGRLGSICEQLSELNSDGREVILVTSGAVAFGRQRLRHRILVNS--------------- 71 (715)
T ss_pred CCEEEEEeCcceeECCCCCCCHHHHHHHHHHHHHHHHCCCEEEEEccchHHhchHHhccchhccc---------------
Confidence 46799999999998754 899999998864 2346677788 666666544322100
Q ss_pred HHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccce
Q 008621 149 SFVKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDI 228 (559)
Q Consensus 149 ~~i~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~ 228 (559)
+.. ...+..+...+..+.+.|+..-..++...|..+++.+ .|+
T Consensus 72 --------------~~~------------------~~~~~~~~~~~qa~aa~gq~~L~~~y~~~f~~~~i~~-----aQ~ 114 (715)
T TIGR01092 72 --------------SFA------------------DLQKPQPELDGKACAAVGQSGLMALYETMFTQLDITA-----AQI 114 (715)
T ss_pred --------------ccc------------------ccCCCCchHHHHHHHHHHHHHHHHHHHHHHHHcCCee-----EEE
Confidence 000 0001112233444567777766677777777777764 666
Q ss_pred EEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCc---------chhHHHHHHHHcC
Q 008621 229 GFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGG---------SDLTATTIGKALG 299 (559)
Q Consensus 229 ~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgG---------SD~tAa~lA~~L~ 299 (559)
++|.++|.+.+. +.+..+.+. .|++.|.|||+.| +|.+++.+++| +|++|+++|.+|+
T Consensus 115 -Llt~~d~~~~~~----~~~~~~~l~-~lL~~g~iPVin~-------nD~V~~~~~~~~~~~g~~~d~D~lAa~lA~~l~ 181 (715)
T TIGR01092 115 -LVTDLDFRDEQF----RRQLNETVH-ELLRMNVVPVVNE-------NDAVSTRAAPYSDSQGIFWDNDSLAALLALELK 181 (715)
T ss_pred -EechhhcccHHH----HHHHHHHHH-HHHHCCCEEEEcC-------CCcccccccccccccceecchHHHHHHHHHHcC
Confidence 888888776543 233344444 4568899999954 45666666654 7999999999999
Q ss_pred cCcEEEeeCCcccccCCCCCCCCCccccccCHHHHH-HHHH-----cCCCcchH--hHHHHHHhCCCCEEEecCCCCC--
Q 008621 300 LQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAA-ELAY-----FGAQVLHP--QSMRPAREGDIPVRVKNSYNPN-- 369 (559)
Q Consensus 300 A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~-eLa~-----~Ga~vlhp--~a~~~a~~~~Ipv~I~n~~~p~-- 369 (559)
|+.+++||||||||++||+ .|++++|++++..+.. ++.+ .+...|.| +++..+.++|++++|.|+.+|+
T Consensus 182 Ad~LiilTDVdGVy~~dP~-~~~a~~I~~i~~~~~~~~i~~~~~~~~~tGGM~~Kl~aa~~a~~~gi~v~I~~g~~~~~l 260 (715)
T TIGR01092 182 ADLLILLSDVEGLYDGPPS-DDDSKLIDTFYKEKHQGEITFGTKSRLGRGGMTAKVKAAVWAAYGGTPVIIASGTAPKNI 260 (715)
T ss_pred CCEEEEEeCCCeeeCCCCC-CCCCeEeeeecccchhhhhccCcccccCCCCchHHHHHHHHHHHCCCeEEEeCCCCcchH
Confidence 9999999999999999996 6999999999876554 3322 34567888 5888999999999999987763
Q ss_pred -------CCCeEEecCCCC
Q 008621 370 -------APGTLIRRSRDM 381 (559)
Q Consensus 370 -------~~GT~I~~~~~~ 381 (559)
..||+|.+...|
T Consensus 261 ~~~l~g~~~GT~~~~~~~~ 279 (715)
T TIGR01092 261 TKVVEGKKVGTLFHEDAHL 279 (715)
T ss_pred HHHhcCCCCceEecccchh
Confidence 469999876544
No 64
>COG0263 ProB Glutamate 5-kinase [Amino acid transport and metabolism]
Probab=99.83 E-value=2.1e-19 Score=183.33 Aligned_cols=230 Identities=21% Similarity=0.391 Sum_probs=176.5
Q ss_pred CcceEEEEeCccccCC------HHHHHHHHHHHHcCC-CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHH
Q 008621 79 KQLTCVMKFGGSSLAS------AERMREVAELILSFP-NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFV 151 (559)
Q Consensus 79 ~~~~~V~KFGGsSl~~------~~~~~~va~iI~~~~-~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i 151 (559)
+.+.+|.|+|-|++.+ .+.+..+++.|.... ..+.||+||.+. +. ++.
T Consensus 5 ~~~riVvKiGSs~Lt~~~g~l~~~~l~~l~~~ia~L~~~G~eVilVSSGA-ia-----aG~------------------- 59 (369)
T COG0263 5 SARRIVVKIGSSSLTDGTGGLDRSKLEELVRQVAALHKAGHEVVLVSSGA-IA-----AGR------------------- 59 (369)
T ss_pred cceEEEEEECcceeeCCCCCcCHHHHHHHHHHHHHHHhCCCEEEEEccch-hh-----hCh-------------------
Confidence 4567999999999975 467777777777653 345666666422 21 100
Q ss_pred HHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEE
Q 008621 152 KDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFI 231 (559)
Q Consensus 152 ~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~ii 231 (559)
..|+.+. +......+..+.+.|+..-+..+...|..+|++. .|+ ++
T Consensus 60 --------~~Lg~~~--------------------rp~~l~~kQA~AAVGQ~~Lm~~y~~~f~~~g~~v-----~Qi-LL 105 (369)
T COG0263 60 --------TRLGLPK--------------------RPKTLAEKQAAAAVGQVRLMQLYEELFARYGIKV-----GQI-LL 105 (369)
T ss_pred --------hhcCCCC--------------------CCcchHHHHHHHHhCHHHHHHHHHHHHHhcCCee-----eEE-Ee
Confidence 1233221 1223355677889999999999999999999986 455 78
Q ss_pred EecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceee--ecCCcchhHHHHHHHHcCcCcEEEeeCC
Q 008621 232 TTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITT--LGRGGSDLTATTIGKALGLQEIQVWKDV 309 (559)
Q Consensus 232 t~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~t--lgRgGSD~tAa~lA~~L~A~~l~i~TDV 309 (559)
|.+++.+.+ .|.+.+..+.. |++.|.|||| || |+.+.+ +-.|+||..++++|...+||.++++||+
T Consensus 106 Tr~D~~~r~----ry~Nar~Tl~~-Ll~~gvVPII------NE-NDtva~~EikfGDND~LsA~VA~lv~ADlLvlLsDi 173 (369)
T COG0263 106 TRDDFSDRR----RYLNARNTLSA-LLELGVVPII------NE-NDTVATEEIKFGDNDTLSALVAILVGADLLVLLSDI 173 (369)
T ss_pred ehhhhhhHH----HHHHHHHHHHH-HHHCCceeee------cC-CCceeeeeeeecCCchHHHHHHHHhCCCEEEEEEcc
Confidence 887776543 56667777765 5789999999 74 776644 7799999999999999999999999999
Q ss_pred cccccCCCCCCCCCccccccCH--HHHHHHHH-----cCCCcchHh--HHHHHHhCCCCEEEecCCCCC---------CC
Q 008621 310 DGVLTCDPNIHPHAKPVPYLTF--DEAAELAY-----FGAQVLHPQ--SMRPAREGDIPVRVKNSYNPN---------AP 371 (559)
Q Consensus 310 ~GV~taDP~~v~~a~~i~~ls~--~Ea~eLa~-----~Ga~vlhp~--a~~~a~~~~Ipv~I~n~~~p~---------~~ 371 (559)
||+||+|||.+|+|++|++++- .|...++. +|...|.-| |.+.|.++|+|+.|.|+.+|+ ..
T Consensus 174 DGLyd~nPr~~pdAk~i~~V~~it~ei~~~aggsgs~~GTGGM~TKl~AA~iA~~aG~~~iI~~g~~~~~i~~~~~~~~~ 253 (369)
T COG0263 174 DGLYDANPRTNPDAKLIPEVEEITPEIEAMAGGSGSELGTGGMRTKLEAAKIATRAGVPVIIASGSKPDVILDALEGEAV 253 (369)
T ss_pred CcccCCCCCCCCCCeeehhhcccCHHHHHHhcCCCCCCCcccHHHHHHHHHHHHHcCCcEEEecCCCcchHHHHHhCCCC
Confidence 9999999999999999999874 46666765 466788865 999999999999999999875 57
Q ss_pred CeEEecCC
Q 008621 372 GTLIRRSR 379 (559)
Q Consensus 372 GT~I~~~~ 379 (559)
||++.+..
T Consensus 254 GT~F~~~~ 261 (369)
T COG0263 254 GTLFEPQA 261 (369)
T ss_pred ccEEecCC
Confidence 99998654
No 65
>PTZ00489 glutamate 5-kinase; Provisional
Probab=99.83 E-value=5.4e-19 Score=178.83 Aligned_cols=228 Identities=18% Similarity=0.233 Sum_probs=156.6
Q ss_pred cceEEEEeCccccCCH-----HHHHHHHHHHHcCCCCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHH
Q 008621 80 QLTCVMKFGGSSLASA-----ERMREVAELILSFPNERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDL 154 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~-----~~~~~va~iI~~~~~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~ 154 (559)
.+.+|.|+|||.+.+. +.+..+++++....+.+.||+||.++ +.--...
T Consensus 8 ~~riVIKlG~Svit~~~~~~~~~~~~l~~~i~~l~~~~~vilVssGa-va~g~~~------------------------- 61 (264)
T PTZ00489 8 VKRIVVKVGSSILVDNQEIAAHRIEALCRFIADLQTKYEVILVTSGA-VAAGYTK------------------------- 61 (264)
T ss_pred CCEEEEEeccceeeCCCCcCHHHHHHHHHHHHHHhcCCeEEEEecCh-HhcChhh-------------------------
Confidence 4568999999999653 55888888887754445566666322 3211100
Q ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEec
Q 008621 155 HHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD 234 (559)
Q Consensus 155 ~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~ 234 (559)
++.. +. ....+..+.+.|+..-..++...|.++|+++. |+ ++|..
T Consensus 62 -------~~~~---------------------~~-~~~~~qa~aaiGq~~L~~~y~~~f~~~~~~~a-----qi-Llt~~ 106 (264)
T PTZ00489 62 -------KEMD---------------------KS-YVPNKQALASMGQPLLMHMYYTELQKHGILCA-----QM-LLAAY 106 (264)
T ss_pred -------cCCC---------------------cc-ccHHHHHHHHhCHHHHHHHHHHHHHhCCCeEE-----Ee-eeecc
Confidence 0100 00 11234556678987788889999999999873 33 46665
Q ss_pred CCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCccccc
Q 008621 235 DFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (559)
Q Consensus 235 ~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~t 314 (559)
++.+.. .+.+..+.+. .|++.|.|||+.|.-. . ..++ +-.|++|..|+++|..++|+.++|+|||||||+
T Consensus 107 d~~~~~----~~~n~~~~l~-~lL~~g~VPIinend~-~-~~~e---~~~gdnD~lAa~lA~~l~Ad~LiilTDVdGVy~ 176 (264)
T PTZ00489 107 DLDSRK----RTINAHNTIE-VLISHKVIPIINENDA-T-ALHE---LVFGDNDRLSALVAHHFKADLLVILSDIDGYYT 176 (264)
T ss_pred ccccch----hhHHHHHHHH-HHHHCCCEEEECCCCC-c-ccce---eEeCChHHHHHHHHHHhCCCEEEEeeccCeeEc
Confidence 554321 2233344444 3568899999977211 1 1122 235679999999999999999999999999999
Q ss_pred CCCCCCCCCcc---ccccCHHHHHHHH----HcCCCcchHh--HHHHHHhCCCCEEEecCCCCC-----------CCCeE
Q 008621 315 CDPNIHPHAKP---VPYLTFDEAAELA----YFGAQVLHPQ--SMRPAREGDIPVRVKNSYNPN-----------APGTL 374 (559)
Q Consensus 315 aDP~~v~~a~~---i~~ls~~Ea~eLa----~~Ga~vlhp~--a~~~a~~~~Ipv~I~n~~~p~-----------~~GT~ 374 (559)
+||+..|+|++ ++++++++..... ..|...|.+| ++..+.++|++++|.|+.+|+ ..||+
T Consensus 177 ~dP~~~~~A~~~~~i~~i~~~~~~~~~~~~~~~~tGGM~~Kl~aa~~a~~~Gi~v~I~~g~~~~~i~~~l~g~~~~~GT~ 256 (264)
T PTZ00489 177 ENPRTSTDAKIRSVVHELSPDDLVAEATPNNRFATGGIVTKLQAAQFLLERGGKMYLSSGFHLEKARDFLIGGSHEIGTL 256 (264)
T ss_pred CCCCCCCccceeeeeccCCHHHHHHhcCcCCCcccCChHHHHHHHHHHHHCCCCEEEEeCCCchHHHHHHcCCCCCCceE
Confidence 99999999998 7888987764432 2355678775 888999999999999987763 25898
Q ss_pred EecC
Q 008621 375 IRRS 378 (559)
Q Consensus 375 I~~~ 378 (559)
|.+.
T Consensus 257 ~~~~ 260 (264)
T PTZ00489 257 FYPR 260 (264)
T ss_pred Eeec
Confidence 8654
No 66
>TIGR01890 N-Ac-Glu-synth amino-acid N-acetyltransferase. This model represents a clade of amino-acid N-acetyltransferases acting mainly on glutamate in the first step of the "acetylated" ornithine biosynthesis pathway. For this reason it is also called N-acetylglutamate synthase. The enzyme may also act on aspartate.
Probab=99.75 E-value=2.9e-17 Score=178.01 Aligned_cols=235 Identities=14% Similarity=0.164 Sum_probs=160.5
Q ss_pred ceEEEEeCccccCCHHHHHHHHHHHHcCCC-CCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHH
Q 008621 81 LTCVMKFGGSSLASAERMREVAELILSFPN-ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (559)
Q Consensus 81 ~~~V~KFGGsSl~~~~~~~~va~iI~~~~~-~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (559)
++.|.|+||+.+.++ .+..+++.|..... ..++|+|++.|..-+++++
T Consensus 18 ~~~ViK~GG~~~~~~-~~~~~~~~i~~l~~~g~~~vlVHGgg~~i~~~~~------------------------------ 66 (429)
T TIGR01890 18 KTFVVGLGGELVEGG-NLGNIVADIALLHSLGVRLVLVHGARPQIERILA------------------------------ 66 (429)
T ss_pred CEEEEEEChhhccCc-cHHHHHHHHHHHHHCCCcEEEEcCCCHHHHHHHH------------------------------
Confidence 679999999999875 34677777765432 3345566666655444432
Q ss_pred HhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceE-----EecccceEEEEec
Q 008621 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKAR-----QYDAFDIGFITTD 234 (559)
Q Consensus 160 ~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~-----~l~~~~~~iit~~ 234 (559)
.+++++ ++++|++++.+.+.....++ .| .+|..|.+ .|++. +++. .+.+.|.++++..
T Consensus 67 -~~g~~~-----------~~~~G~RvT~~~~l~~~~~~--~g-~vn~~l~~-~l~~~-~~~~~~~~~~l~~~dg~~~~a~ 129 (429)
T TIGR01890 67 -ARGRTP-----------HYHRGLRVTDEASLEQAQQA--AG-TLRLAIEA-RLSMS-LSNTPMAGSRLPVVSGNFVTAR 129 (429)
T ss_pred -HcCCCc-----------eeeCCcccCCHHHHHHHHHH--hC-hHHHHHHH-HHHhc-CCcccccccCceEccceEEEEE
Confidence 123332 34567666543333333332 45 66766554 56665 4443 3666676677643
Q ss_pred C--------CCC-ceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEE
Q 008621 235 D--------FTN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQV 305 (559)
Q Consensus 235 ~--------~~~-a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i 305 (559)
. ++. +++..++.+.++ .+++.|.+||+++ +|.+ .+|+.++++ +|..|+.||.+|+|+++++
T Consensus 130 ~~~~~~~~~~g~~G~v~~v~~~~l~-----~ll~~g~ipvi~p-i~~~-~~g~~~nvn---aD~~A~~lA~al~a~kli~ 199 (429)
T TIGR01890 130 PIGVIEGVDYEHTGVIRKIDTEGIR-----RQLDAGSIVLLSP-LGHS-PTGETFNLD---MEDVATSVAISLKADKLIY 199 (429)
T ss_pred ECCCCcCccccccceEEEEcHHHHH-----HHHHCCCeEEECC-cccC-CCCCEEEeC---HHHHHHHHHHHcCCCEEEE
Confidence 2 332 456666665444 3457889999998 7888 489999999 9999999999999999999
Q ss_pred eeCCcccccCCCCCCCCCccccccCHHHHHHHHHcCCCc-chHh--HHHHHHhCCC-CEEEecCCCC----------CCC
Q 008621 306 WKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQV-LHPQ--SMRPAREGDI-PVRVKNSYNP----------NAP 371 (559)
Q Consensus 306 ~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~v-lhp~--a~~~a~~~~I-pv~I~n~~~p----------~~~ 371 (559)
+|||||||+. +.++|++|+.+|+.++....... +.|+ ++.-+.+.|+ +++|.|+..| ++.
T Consensus 200 ltdv~Gv~~~------~g~~i~~i~~~~~~~l~~~~~~~~~~~kl~~a~~a~~~gv~~v~i~~g~~~~~l~~el~~~~g~ 273 (429)
T TIGR01890 200 FTLSPGISDP------DGTLAAELSPQEVESLAERLGSETTRRLLSAAVKACRGGVHRSHIVSYAEDGSLLQELFTRDGI 273 (429)
T ss_pred EeCCCcccCC------CCCCcccCCHHHHHHHHHhccCCCcHHHHHHHHHHHHcCCCeEEEECCCCCcHHHHHHhcCCCC
Confidence 9999999963 36799999999999987643333 4676 6666778886 5999987655 347
Q ss_pred CeEEecCC
Q 008621 372 GTLIRRSR 379 (559)
Q Consensus 372 GT~I~~~~ 379 (559)
||+|..+.
T Consensus 274 GT~i~~d~ 281 (429)
T TIGR01890 274 GTSISKEA 281 (429)
T ss_pred cceEeccc
Confidence 99998653
No 67
>cd04236 AAK_NAGS-Urea AAK_NAGS-Urea: N-acetylglutamate (NAG) kinase-like domain of the NAG Synthase (NAGS) of the urea cycle found in animals. Ureogenic NAGS is a mitochondrial enzyme catalyzing the formation of NAG from acetylcoenzyme A and L-glutamate; NAG is an essential allosteric activator of carbamylphosphate synthase I, the first and rate limiting enzyme of the urea cycle. Ureogenic NAGS activity is dependent on the concentration of glutamate (substrate) and arginine (activator). Domain architecture of ureogenic NAGS consists of an N-terminal NAG kinase-like (ArgB) domain (this CD) and a C-terminal DUF619 domain. Members of this CD belong to the protein superfamily, the Amino Acid Kinase Family (AAKF).
Probab=99.73 E-value=1.8e-16 Score=160.62 Aligned_cols=207 Identities=11% Similarity=0.087 Sum_probs=153.3
Q ss_pred CCcceEEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHH
Q 008621 78 EKQLTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLH 155 (559)
Q Consensus 78 ~~~~~~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~ 155 (559)
..++..|.|+||+.+.+++.+..++..+.-.. +-++|+|+.++..++..|. . .
T Consensus 33 ~~~~f~VIK~GG~~~~~~~~~~~l~~dla~L~~lGl~~VlVHGggp~i~~~l~---~----~------------------ 87 (271)
T cd04236 33 DWPAFAVLEVDHSVFRSLEMVQSLSFGLAFLQRMDMKLLVVMGLSAPDGTNMS---D----L------------------ 87 (271)
T ss_pred CCCCEEEEEEChhhhcCchhHHHHHHHHHHHHHCCCeEEEEeCCChHHhhhhc---C----C------------------
Confidence 56788999999999999999999999888653 4577777755544433332 0 0
Q ss_pred HHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEec-
Q 008621 156 HRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTD- 234 (559)
Q Consensus 156 ~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~- 234 (559)
......+++. ..+.. +...|++.|++++++.+.. .+++..
T Consensus 88 ----------------------------------~~~~~~~v~~---~~n~~-Lv~~L~~~G~~A~gl~g~~-~~i~a~~ 128 (271)
T cd04236 88 ----------------------------------ELQAARSRLV---KDCKT-LVEALQANSAAAHPLFSGE-SVLQAEE 128 (271)
T ss_pred ----------------------------------cchheehhHH---HHHHH-HHHHHHhCCCCeeeecCcc-ceEEEEE
Confidence 0000112222 34555 4467899999999999874 466543
Q ss_pred --CCCC-ceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcc
Q 008621 235 --DFTN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDG 311 (559)
Q Consensus 235 --~~~~-a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~G 311 (559)
+++. +++..++...++. +++.|.|||++| +|.+ .+|++.+++ +|..|+.+|.+|+|++++++||++|
T Consensus 129 ~~d~g~vG~V~~Vd~~~I~~-----lL~~g~IPVisp-lg~~-~~G~~~NiN---aD~~A~~lA~aL~A~KLIfltd~~G 198 (271)
T cd04236 129 PEPGASKGPSVSVDTELLQW-----CLGSGHIPLVCP-IGET-SSGRSVSLD---SSEVTTAIAKALQPIKVIFLNRSGG 198 (271)
T ss_pred cccCCccceEEEECHHHHHH-----HHhCCCeEEECC-ceEC-CCCCEEEEC---HHHHHHHHHHHcCCCEEEEEeCCcc
Confidence 2222 4566666654443 457899999999 8888 489999999 9999999999999999999999999
Q ss_pred cccCCCCCCCCCccccccCH-HHHHHHHHcCC--Ccc---hHh--HHHHHHhCCCCEEEec
Q 008621 312 VLTCDPNIHPHAKPVPYLTF-DEAAELAYFGA--QVL---HPQ--SMRPAREGDIPVRVKN 364 (559)
Q Consensus 312 V~taDP~~v~~a~~i~~ls~-~Ea~eLa~~Ga--~vl---hp~--a~~~a~~~~Ipv~I~n 364 (559)
||+. +.++|++|+. +|..+|...|. ..| -|+ ++.-+...+..++|.+
T Consensus 199 V~~~------~g~lI~~l~~~~e~~~li~~g~i~gGm~~ki~ki~~~l~~l~~g~sv~I~~ 253 (271)
T cd04236 199 LRDQ------KHKVLPQVHLPADLPSLSDAEWLSETEQNRIQDIATLLNALPSMSSAVITS 253 (271)
T ss_pred eECC------CCCCccccCcHHHHHHHHhCCEEcCCeeechHHHHHHHHhcccCCeEEEeC
Confidence 9963 2578999995 99999998865 566 453 6777788999999987
No 68
>cd04237 AAK_NAGS-ABP AAK_NAGS-ABP: N-acetylglutamate (NAG) kinase-like domain of the NAG Synthase (NAGS) of the arginine-biosynthesis pathway (ABP) found in gamma- and beta-proteobacteria and higher plant chloroplasts. Domain architecture of these NAGS consisted of an N-terminal NAG kinase-like (ArgB) domain (this CD) and a C-terminal NAG synthase, acetyltransferase (ArgA) domain. Both bacterial and plant sequences in this CD have a conserved N-terminal extension; a similar sequence in the NAG kinases of the cyclic arginine-biosynthesis pathway has been implicated in feedback inhibition sensing. Plant sequences also have an N-terminal chloroplast transit peptide and an insert (approx. 70 residues) in the C-terminal region of ArgB. Members of this CD belong to the Amino Acid Kinase Superfamily (AAK).
Probab=99.73 E-value=1.6e-16 Score=162.76 Aligned_cols=223 Identities=19% Similarity=0.240 Sum_probs=147.8
Q ss_pred cceEEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHH
Q 008621 80 QLTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~ 157 (559)
++++|.|+||+.+.++ .++.+++.|.... +.++|+| ++.|..-+++++.
T Consensus 18 ~~~~VIKlGG~ai~~~-~l~~~~~~ia~l~~~g~~~ViV-HGggp~i~~~~~~--------------------------- 68 (280)
T cd04237 18 GKTFVIAFGGEAVAHP-NFDNIVHDIALLHSLGIRLVLV-HGARPQIDQRLAE--------------------------- 68 (280)
T ss_pred CCEEEEEEChHHhcCc-hHHHHHHHHHHHHHCCCcEEEE-eCCCHHHHHHHHH---------------------------
Confidence 3579999999999774 4566777666543 2344555 5555544433321
Q ss_pred HHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHH-HhhhHHHHHHHHHHHHHHcCCceEEecc-----cceEEE
Q 008621 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYL-VSFGECMSTRIFAAYLNKIGVKARQYDA-----FDIGFI 231 (559)
Q Consensus 158 ~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~i-ls~GE~lsa~ll~~~L~~~Gi~a~~l~~-----~~~~ii 231 (559)
++.++ ++++|++.+ ++...+.+ .++|+. +.. +.+.|+. |++++.+.+ .+..++
T Consensus 69 ----~gi~~-----------~~~~G~RvT---~~~~l~~~~~~~g~v-~~~-l~~~l~~-~~~a~~~~~~~~~~~~~~~v 127 (280)
T cd04237 69 ----RGLEP-----------RYHRGLRIT---DAAALECVKEAAGAV-RLE-IEALLSM-GLPNSPMAGARIRVVSGNFV 127 (280)
T ss_pred ----cCCCc-----------cccCCcCcC---CHHHHHHHHHHHHHH-HHH-HHHHHHh-hccccCcCCCceEEecCeEE
Confidence 12221 234454443 33444333 235644 666 4555655 888875543 232233
Q ss_pred EecCC--------C-CceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCc
Q 008621 232 TTDDF--------T-NADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQE 302 (559)
Q Consensus 232 t~~~~--------~-~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~ 302 (559)
..... + .+++...+...+. .+++.|.+||+++ +|.+ .+|+.++++ +|..|+.||.+|+|++
T Consensus 128 ~~~~~~~~~~~~~g~~G~v~~v~~~~i~-----~lL~~g~ipv~~~-~g~~-~~g~~lnvn---aD~~A~~LA~~L~a~k 197 (280)
T cd04237 128 TARPLGVVDGVDFGHTGEVRRIDADAIR-----RQLDQGSIVLLSP-LGYS-PTGEVFNLS---MEDVATAVAIALKADK 197 (280)
T ss_pred EEEECCcccCceEeeeccEEEEcHHHHH-----HHHHCCCEEEECC-ceEC-CCCCEEeeC---HHHHHHHHHHHcCCCE
Confidence 33221 1 1334444444333 3467889999988 6777 479999998 8999999999999999
Q ss_pred EEEeeCCcccccCCCCCCCCCccccccCHHHHHHHHHcCC---CcchHh--HHHHHHhCCC-CEEEecCCCC
Q 008621 303 IQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGA---QVLHPQ--SMRPAREGDI-PVRVKNSYNP 368 (559)
Q Consensus 303 l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga---~vlhp~--a~~~a~~~~I-pv~I~n~~~p 368 (559)
++|.|||||||++ +++++++++.+|+.++...|. ..|.|| ++..+.+.|+ +++|.+...|
T Consensus 198 lv~ltdv~GV~~~------~~~~i~~i~~~e~~~l~~~~~~~~ggM~~Kv~~a~~a~~~Gv~~v~I~~~~~~ 263 (280)
T cd04237 198 LIFLTDGPGLLDD------DGELIRELTAQEAEALLETGALLTNDTARLLQAAIEACRGGVPRVHLISYAED 263 (280)
T ss_pred EEEEeCCCcccCC------CCCccccCCHHHHHHHHHcCCCCCCCHHHHHHHHHHHHHcCCCEEEEeCCCCC
Confidence 9999999999973 368999999999999998764 679997 6666678899 6999988666
No 69
>PRK12353 putative amino acid kinase; Reviewed
Probab=99.70 E-value=3.1e-16 Score=162.73 Aligned_cols=123 Identities=13% Similarity=0.135 Sum_probs=89.7
Q ss_pred HhhchhcCCcEEEEcCC--CcccCCCCceeeec-CCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCcccccc
Q 008621 253 LHGDWITDLAIPIVTGF--LGKAWRTCAITTLG-RGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYL 329 (559)
Q Consensus 253 l~~~l~~~~~ipVv~Gf--ig~~~~~G~~~tlg-RgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~l 329 (559)
..+.|++.|.|||++|. ++....++.+.+.. .+.+|..|+++|.+|+|+.++++|||||||++||+ |++++|+++
T Consensus 177 ~i~~lL~~g~IpV~~g~gg~Pi~~~~~~~~~~~~~~d~D~lAa~lA~~l~Ad~Li~lTdvdGVy~~~~~--~~a~~i~~i 254 (314)
T PRK12353 177 AIKTLVDAGQVVIAAGGGGIPVIREGGGLKGVEAVIDKDFASAKLAELVDADLLIILTAVDKVYINFGK--PNQKKLDEV 254 (314)
T ss_pred HHHHHHHCCCEEEEcCCCCCCEEEeCCceeeeeEecCHHHHHHHHHHHhCCCEEEEEeCCccccCCCCC--CCCeECcCc
Confidence 33345688999999976 22211234332211 45689999999999999999999999999997663 899999999
Q ss_pred CHHHHHHHHH---cCCCcchHh--HH-HHH-HhCCCCEEEecCCCC-----CCCCeEEec
Q 008621 330 TFDEAAELAY---FGAQVLHPQ--SM-RPA-REGDIPVRVKNSYNP-----NAPGTLIRR 377 (559)
Q Consensus 330 s~~Ea~eLa~---~Ga~vlhp~--a~-~~a-~~~~Ipv~I~n~~~p-----~~~GT~I~~ 377 (559)
+++|+.++.. .+...|.|| ++ +.+ .+.+++++|.|..+. ...||+|.+
T Consensus 255 ~~~e~~~~~~~~~~~tGGM~~Kl~aA~~a~~~~~g~~v~I~~~~~i~~~l~g~~GT~i~~ 314 (314)
T PRK12353 255 TVSEAEKYIEEGQFAPGSMLPKVEAAISFVESRPGRKAIITSLEKAKEALEGKAGTVIVK 314 (314)
T ss_pred CHHHHHHHHhcCCcCCCCcHHHHHHHHHHHHHcCCCEEEECCchHHHHHhCCCCCeEecC
Confidence 9999999875 345678886 44 445 478999999873211 126888853
No 70
>PRK05279 N-acetylglutamate synthase; Validated
Probab=99.70 E-value=5.5e-16 Score=168.61 Aligned_cols=233 Identities=19% Similarity=0.247 Sum_probs=154.3
Q ss_pred ceEEEEeCccccCCHHHHHHHHHHHHcCCC-CCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHH
Q 008621 81 LTCVMKFGGSSLASAERMREVAELILSFPN-ERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTV 159 (559)
Q Consensus 81 ~~~V~KFGGsSl~~~~~~~~va~iI~~~~~-~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~ 159 (559)
+++|.|+||+.+.+++ ++++++.|..... ..++|+|++.|..-+++++.
T Consensus 26 ~~~VIk~GG~~l~~~~-~~~~~~~i~~l~~~g~~~VlVHGgg~~i~~~~~~----------------------------- 75 (441)
T PRK05279 26 KTFVIMLGGEAIAHGN-FSNIVHDIALLHSLGIRLVLVHGARPQIEEQLAA----------------------------- 75 (441)
T ss_pred CEEEEEECchhccChh-HHHHHHHHHHHHHCCCeEEEECCCCHHHHHHHHH-----------------------------
Confidence 5799999999998753 5677777766432 23444555555544443321
Q ss_pred HhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHH-HhhhHHHHHHHHHHHHHHcCCceEEecccce-----EEEEe
Q 008621 160 DELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYL-VSFGECMSTRIFAAYLNKIGVKARQYDAFDI-----GFITT 233 (559)
Q Consensus 160 ~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~i-ls~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~-----~iit~ 233 (559)
++.++ ++++|++++. +...+.+ ...| .++..+ .+.|+ .|++++++.+..+ .+++.
T Consensus 76 --~g~~~-----------~~~~G~RvT~---~~~l~~~~~~~g-~v~~~l-~~~l~-~g~~a~~~~~~~~~~~~~~~~~~ 136 (441)
T PRK05279 76 --RGIEP-----------RYHKGLRVTD---AAALECVKQAAG-ELRLDI-EARLS-MGLPNTPMAGAHIRVVSGNFVTA 136 (441)
T ss_pred --cCCCc-----------eecCCcccCC---HHHHHHHHHHHH-HHHHHH-HHHHh-ccCCCCcccCCcceEeeccEEEE
Confidence 22222 2345555543 3333333 2346 778775 55565 4999877654332 22222
Q ss_pred cC--------CCC-ceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEE
Q 008621 234 DD--------FTN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQ 304 (559)
Q Consensus 234 ~~--------~~~-a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~ 304 (559)
.. ++. +++...+...+. .+++.|.|||+++ +|.+ .+|++.+++ +|..|+.||.+|+|++++
T Consensus 137 ~~~~~~~~~~~g~~G~v~~v~~~~i~-----~ll~~g~ipV~~~-i~~~-~~g~~~ni~---~D~~a~~lA~~l~a~~lv 206 (441)
T PRK05279 137 RPLGVDDGVDYQHTGEVRRIDAEAIR-----RQLDSGAIVLLSP-LGYS-PTGESFNLT---MEEVATQVAIALKADKLI 206 (441)
T ss_pred EECCCCCCccccceeeEEEEeHHHHH-----HHHHCCCeEEECC-ceEC-CCCCEEEEC---HHHHHHHHHHHcCCCEEE
Confidence 21 221 334444444333 3467889999976 7777 479999998 999999999999999999
Q ss_pred EeeCCcccccCCCCCCCCCccccccCHHHHHHHHH---cC--CCcchHh--HHHHHHhCCC-CEEEecCCCCC-------
Q 008621 305 VWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAY---FG--AQVLHPQ--SMRPAREGDI-PVRVKNSYNPN------- 369 (559)
Q Consensus 305 i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~---~G--a~vlhp~--a~~~a~~~~I-pv~I~n~~~p~------- 369 (559)
++|||||||++ ++++|++++.+|+.++.. .| ...|-|| ++..+.+.|+ +++|.+...|+
T Consensus 207 ~ltdv~GV~~~------~~~~i~~i~~~~~~~~~~~~~~~~~~ggM~~Kv~~a~~~~~~gv~~v~i~~~~~~~~l~~~l~ 280 (441)
T PRK05279 207 FFTESQGVLDE------DGELIRELSPNEAQALLEALEDGDYNSGTARFLRAAVKACRGGVRRSHLISYAEDGALLQELF 280 (441)
T ss_pred EEECCCCccCC------CCchhhhCCHHHHHHHHhhhhcCCCCccHHHHHHHHHHHHHcCCCEEEEecCCCCcHHHHHHh
Confidence 99999999953 478999999999998876 44 3678886 5556667799 69998876552
Q ss_pred ---CCCeEEecC
Q 008621 370 ---APGTLIRRS 378 (559)
Q Consensus 370 ---~~GT~I~~~ 378 (559)
+.||.|...
T Consensus 281 ~~~g~GT~i~~~ 292 (441)
T PRK05279 281 TRDGIGTMIVME 292 (441)
T ss_pred cCCCCceEEecC
Confidence 479999875
No 71
>cd04252 AAK_NAGK-fArgBP AAK_NAGK-fArgBP: N-Acetyl-L-glutamate kinase (NAGK) of the fungal arginine-biosynthetic pathway (fArgBP). The nuclear-encoded, mitochondrial polyprotein precursor with an N-terminal NAGK (ArgB) domain (this CD), a central DUF619 domain, and a C-terminal reductase domain (ArgC, N-Acetylglutamate Phosphate Reductase, NAGPR). The precursor is cleaved in the mitochondria into two distinct enzymes (NAGK-DUF619 and NAGPR). Native molecular weights of these proteins indicate that the kinase is an octamer whereas the reductase is a dimer. This CD also includes some gamma-proteobacteria (Xanthomonas and Xylella) NAG kinases with an N-terminal NAGK (ArgB) domain (this CD) and a C-terminal DUF619 domain. The DUF619 domain is described as a putative distant homolog of the acetyltransferase, ArgA, predicted to function in NAG synthase association in fungi. Eukaryotic sequences have an N-terminal mitochondrial transit peptide. Members of this NAG kinase domain CD belong to th
Probab=99.69 E-value=8.5e-16 Score=154.75 Aligned_cols=212 Identities=17% Similarity=0.274 Sum_probs=144.0
Q ss_pred EEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHHHHHh
Q 008621 84 VMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHRTVDE 161 (559)
Q Consensus 84 V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~~~~~ 161 (559)
|.|+||+.+.+. +.++++.|.... +.++ |+|++.|..-+.+++ +
T Consensus 2 ViKiGG~~~~~~--l~~~~~di~~l~~~g~~~-VlVHGgg~~i~~~~~-------------------------------~ 47 (248)
T cd04252 2 VIKVGGAIIEDD--LDELAASLSFLQHVGLYP-IVVHGAGPQLNEELE-------------------------------A 47 (248)
T ss_pred EEEEChhhhhcc--HHHHHHHHHHHHHCCCcE-EEEeCCCHHHHHHHH-------------------------------H
Confidence 899999999874 677877777643 3355 555555554444432 1
Q ss_pred cCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHH-HhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEe-----cC
Q 008621 162 LGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYL-VSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITT-----DD 235 (559)
Q Consensus 162 L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~i-ls~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~-----~~ 235 (559)
++.++ ++.+|++++ ++...+.+ .+++ .++..+++ .|+++|++++++.+. +++. .+
T Consensus 48 ~gi~~-----------~~~~g~RvT---~~~~l~~v~~al~-~vn~~iv~-~l~~~g~~a~~l~~~---~~~a~~~~~~d 108 (248)
T cd04252 48 AGVEP-----------EYVDGLRVT---DPETLAVARKVFL-EENLKLVE-ALERNGARARPITSG---VFEAEYLDKDK 108 (248)
T ss_pred cCCCc-----------EeeCCcccC---CHHHHHHHHHHHH-HHHHHHHH-HHHhCCCCcccccCc---eEEEEECcCcc
Confidence 22222 233444333 34444443 3456 77887665 599999999999875 3333 23
Q ss_pred CCC-ceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCccccc
Q 008621 236 FTN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLT 314 (559)
Q Consensus 236 ~~~-a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~t 314 (559)
|+. +++...+.+.++. +++.|.|||++| +|.+ .+|++.+++ +|..|+.+|.+|+|+++++.|||||||+
T Consensus 109 ~g~~G~v~~i~~~~i~~-----~L~~g~IPVi~p-~~~~-~~g~~~nvn---aD~~A~~lA~aL~a~kli~ltdv~GV~~ 178 (248)
T cd04252 109 YGLVGKITGVNKAPIEA-----AIRAGYLPILTS-LAET-PSGQLLNVN---ADVAAGELARVLEPLKIVFLNETGGLLD 178 (248)
T ss_pred CCccCceeeECHHHHHH-----HHHCCCeEEECC-ceEC-CCCCEEEEC---HHHHHHHHHHHcCCCeEEEEECCcccCC
Confidence 432 4555556554443 457899999998 6777 479999999 9999999999999999999999999996
Q ss_pred CCCCCCCCCccccccCH-HHHHHHHHcCC--CcchHh--HHHHHHhC---CCCEEEec
Q 008621 315 CDPNIHPHAKPVPYLTF-DEAAELAYFGA--QVLHPQ--SMRPAREG---DIPVRVKN 364 (559)
Q Consensus 315 aDP~~v~~a~~i~~ls~-~Ea~eLa~~Ga--~vlhp~--a~~~a~~~---~Ipv~I~n 364 (559)
. +.+++++++. ++..++...|. ..|.|| ++..+.+. ...++|.+
T Consensus 179 ~------~g~~i~~i~~~~~~~~l~~~~~vtgGM~~Kl~~~~~~~~~~~~~~~v~i~~ 230 (248)
T cd04252 179 G------TGKKISAINLDEEYDDLMKQPWVKYGTKLKIKEIKELLDTLPRSSSVSITS 230 (248)
T ss_pred C------CCCcccccCHHHHHHHHHHcCCcCCchHHHHHHHHHHHHhCCCceEEEEEC
Confidence 4 3678999997 47778877653 567776 44455554 34577765
No 72
>PRK07431 aspartate kinase; Provisional
Probab=99.68 E-value=6.2e-16 Score=173.90 Aligned_cols=146 Identities=25% Similarity=0.400 Sum_probs=124.4
Q ss_pred ccceeeEEeeecCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEec-------CceeEEEeCCCchhhHHHHHHH
Q 008621 382 SKAVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS-------EVSLSLTLDPSKLWSRELIQQA 454 (559)
Q Consensus 382 ~~~~It~Is~~~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstS-------e~sIs~~v~~~~~~~~~~~~~~ 454 (559)
++..+++|+.++|+++|++. .+.+.+|+++++|+.|+++||+++|++++ ..+++|+++.+++..
T Consensus 426 ~~~~v~gIa~~~~~~~i~l~--~~~~~~g~~a~if~~l~~~~i~id~i~~~~~~~~~~~~~isf~v~~~~~~~------- 496 (587)
T PRK07431 426 DEPEVRGVALDRNQAQLAIR--NVPDRPGMAASIFGALAEANISVDMIVQSQRCRSDGTRDISFTVPKEDREA------- 496 (587)
T ss_pred CCCcEEEEEccCCEEEEEEC--CCCCCccHHHHHHHHHHHcCCeEEEEEecCCCCCCCceeEEEEEcHHHHHH-------
Confidence 34579999999999999996 57889999999999999999999999874 367999998875431
Q ss_pred HHHHHHHHHHhh---hceeecccceeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHH
Q 008621 455 SELDHVVEELEK---IAIVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQC 530 (559)
Q Consensus 455 ~~l~~~~~~L~~---~~~v~~~~~~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kA 530 (559)
...+++++++ ...+.+.+++|+||+||. |...||+++|+|++|+++||++.++++ |+++|+|+|++++.++|
T Consensus 497 --~~~~l~~l~~~~~~~~i~~~~~va~VSvVG~gm~~~~gv~~ri~~aL~~~~I~v~~i~~--S~~~Is~vV~~~~~~~a 572 (587)
T PRK07431 497 --AQKVLRELAKQLPGAEVEDGPAIAKVSIVGAGMPGTPGVAARMFRALADAGINIEMIAT--SEIRTSCVVAEDDGVKA 572 (587)
T ss_pred --HHHHHHHHHHhcCCceEEEeCCeEEEEEECCCccCCcCHHHHHHHHHHHCCCcEEEeec--cceEEEEEEeHHHHHHH
Confidence 2223333432 244677899999999997 778999999999999999999999986 99999999999999999
Q ss_pred HHHHHHHhcc
Q 008621 531 VRALHETFFE 540 (559)
Q Consensus 531 v~~LH~~f~~ 540 (559)
+++||++|..
T Consensus 573 v~~Lh~~f~~ 582 (587)
T PRK07431 573 LQAVHQAFGL 582 (587)
T ss_pred HHHHHHHhcc
Confidence 9999999943
No 73
>PLN02825 amino-acid N-acetyltransferase
Probab=99.66 E-value=4.3e-15 Score=162.51 Aligned_cols=197 Identities=14% Similarity=0.167 Sum_probs=138.4
Q ss_pred cceEEEEeCccccCCHHHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhHHHHHHHHHHH
Q 008621 80 QLTCVMKFGGSSLASAERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDELSFVKDLHHR 157 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~l~~i~~~~~~ 157 (559)
.++.|.||||+.+.++ .+..++..|.... +.++|+|+.+...++..|-+.
T Consensus 17 gktfVIk~gG~~l~~~-~~~~l~~DialL~~lGi~~VlVHGggpqI~~~l~~~--------------------------- 68 (515)
T PLN02825 17 GSTFVVVISGEVVAGP-HLDNILQDISLLHGLGIKFVLVPGTHVQIDKLLAER--------------------------- 68 (515)
T ss_pred CCEEEEEECchhhcCc-hHHHHHHHHHHHHHCCCCEEEEcCCCHHHHHHHHHc---------------------------
Confidence 4679999999999887 6888888877643 445565554444444444322
Q ss_pred HHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHH--------HHHHcCCce----EEecc
Q 008621 158 TVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAA--------YLNKIGVKA----RQYDA 225 (559)
Q Consensus 158 ~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~--------~L~~~Gi~a----~~l~~ 225 (559)
++++ ++.+|++++++ ...+.+.-..-.++..|.+. .|++.|+++ ..+.+
T Consensus 69 -----gi~~-----------~f~~G~RVTd~---~~L~~~~~~~G~v~~~i~a~Ls~~~~v~~l~~~G~~a~~~~~gl~~ 129 (515)
T PLN02825 69 -----GREP-----------KYVGAYRITDS---AALQASMEAAGKIRVMIEAKLSPGPSIPNLRRHGDNSRWHEVGVSV 129 (515)
T ss_pred -----CCCc-----------eeeCCcccCCH---HHHHHHHHHHHHHHHHHHHhhccccchhHHHhcCCCCccccCceEe
Confidence 2222 24455555543 33332222222556666654 589999999 78888
Q ss_pred cceEEEEecC--------CCC-ceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHH
Q 008621 226 FDIGFITTDD--------FTN-ADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGK 296 (559)
Q Consensus 226 ~~~~iit~~~--------~~~-a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~ 296 (559)
.+..+++..+ |+. +++..++...++. +++.|.|||+++ +|.+ .+|++.|++ +|..|+.+|.
T Consensus 130 ~~Gn~v~a~~~gv~dgvD~g~vG~V~~Vd~~~i~~-----~L~~g~Ipvisp-lg~s-~~Ge~~Nin---aD~vA~avA~ 199 (515)
T PLN02825 130 ASGNFLAAKRRGVVNGVDFGATGEVKKIDVSRIKE-----RLDSNCIVLLSN-LGYS-SSGEVLNCN---TYEVATACAL 199 (515)
T ss_pred ccCcEEEEEECCCCcCccccceeeEEEEcHHHHHH-----HHhCCCeEEECC-ceEC-CCCCEEeeC---HHHHHHHHHH
Confidence 8877888753 333 4566666654443 457899999999 7988 589999999 9999999999
Q ss_pred HcCcCcEEEeeCCcccccCCCCCCCCCccccccCHHHHHHHHHc
Q 008621 297 ALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYF 340 (559)
Q Consensus 297 ~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~ 340 (559)
+|+|++++++||++ +++. +.+++++|+.+|+.+|...
T Consensus 200 aL~A~KLI~ltd~~-~~~~------~g~li~~l~~~e~~~li~~ 236 (515)
T PLN02825 200 AIGADKLICIVDGP-ILDE------NGRLIRFMTLEEADMLIRK 236 (515)
T ss_pred HcCCCeEEEEeCcc-eecC------CCCCcCcCCHHHHHHHHHh
Confidence 99999999999977 5542 3578999999999998754
No 74
>PRK12352 putative carbamate kinase; Reviewed
Probab=99.64 E-value=4.1e-15 Score=153.75 Aligned_cols=239 Identities=15% Similarity=0.144 Sum_probs=147.4
Q ss_pred cceEEEEeCccccCCH----------HHHHHHHHHHHcCC--CCCcEEEEcCCCcccHHHHHhhHhhhhcCcCcchhhhH
Q 008621 80 QLTCVMKFGGSSLASA----------ERMREVAELILSFP--NERPVIVLSAMGKTTNKLLLAGEKAVSCGVTNISCIDE 147 (559)
Q Consensus 80 ~~~~V~KFGGsSl~~~----------~~~~~va~iI~~~~--~~~~vVVVSA~g~~Td~L~~~~~~~~~~~~~~~~~~~~ 147 (559)
++++|.||||..+.+. +.++++++.|.... +.++|+|+.+...+.+.|.+.....
T Consensus 2 ~k~iVI~lGGnAl~~~~~~~~~~~~~~~~~~~a~dia~l~~~G~~lVivHG~GPqI~~~l~~~~~~~------------- 68 (316)
T PRK12352 2 KELVVVAIGGNSIIKDNASQSIEHQAEAVKAVADTVLEMLASDYDIVLTHGNGPQVGLDLRRAEIAH------------- 68 (316)
T ss_pred CcEEEEEEChHHhcCCCCCcchhhHHHHHHHHHHHHHHHHHCCCeEEEEeCCCHHHHHHHHHcCccc-------------
Confidence 3589999999999761 46677777776643 4566666655555666655432110
Q ss_pred HHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHHHhhhhccCCCHHHHHHHHhhhHHHHHHHHHHHHHHcCCce-------
Q 008621 148 LSFVKDLHHRTVDELGIDRSIIATHLEELEQLLKGIAMLKELTPRSRDYLVSFGECMSTRIFAAYLNKIGVKA------- 220 (559)
Q Consensus 148 l~~i~~~~~~~~~~L~~~~~~i~~~~~~l~~~l~~i~~~~~~~~~~~d~ils~GE~lsa~ll~~~L~~~Gi~a------- 220 (559)
++ ++++.+... ..........|-.+++.|. ..|.+.|.++
T Consensus 69 ------------------------------~~-~g~rvt~~~-~~v~~~~g~i~~~i~~~L~-~~l~~~g~~~~~~vvt~ 115 (316)
T PRK12352 69 ------------------------------ER-EGLPLTPLA-NCVADTQGGIGYLIQQALN-NRLARHGEKKAVTVVTQ 115 (316)
T ss_pred ------------------------------cc-CCCCCCCHH-HHHHHHHHHHHHHHHHHHH-HHHHhcCCCCeeEEEEE
Confidence 01 122211110 1111223344667777754 5688878664
Q ss_pred EEecccceEEEEecC--------------------CCC----ce-----------eeecchHHHHHHHhhchhcCCcEEE
Q 008621 221 RQYDAFDIGFITTDD--------------------FTN----AD-----------ILEATYPAVAKRLHGDWITDLAIPI 265 (559)
Q Consensus 221 ~~l~~~~~~iit~~~--------------------~~~----a~-----------i~~~~~~~i~~~l~~~l~~~~~ipV 265 (559)
+.+++.|..|+...+ ++. .+ +..++. .+.+.|++++.|+|
T Consensus 116 v~vs~~D~~f~~~~kpiG~~y~~~~a~~~~~~~~~~~~~~d~g~G~rrvv~sp~pv~~V~~-----~~I~~ll~~g~iVi 190 (316)
T PRK12352 116 VEVDKNDPGFAHPTKPIGAFFSESQRDELQKANPDWRFVEDAGRGYRRVVASPEPKRIVEA-----PAIKALIQQGFVVI 190 (316)
T ss_pred EEECCCCccccCCcccccCcccHHHHHHHhhhcCCceEeecCCCCeEEecCCCCCceEEcH-----HHHHHHHHCCCEEE
Confidence 667777665542211 100 00 222333 34444567888944
Q ss_pred Ec-----CCCcccCCCCc----eeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccccCHHHHHH
Q 008621 266 VT-----GFLGKAWRTCA----ITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAE 336 (559)
Q Consensus 266 v~-----Gfig~~~~~G~----~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~e 336 (559)
.+ + ++.+ ..|+ ..+.+ .|+.|+.+|.+|+|++++|+|||+|||.++|+ |++++|++++.+|+.+
T Consensus 191 ~~ggggiP-v~~~-~~g~~~n~~~nIn---aD~aAa~iA~aL~AdkLI~LTDV~GV~~d~~~--~~~~li~~lt~~e~~~ 263 (316)
T PRK12352 191 GAGGGGIP-VVRT-DAGDYQSVDAVID---KDLSTALLAREIHADILVITTGVEKVCIHFGK--PQQQALDRVDIATMTR 263 (316)
T ss_pred ecCCCCCC-EEeC-CCCCccCceeeec---HHHHHHHHHHHhCCCEEEEEeCchhhccCCCC--CCcccccccCHHHHHH
Confidence 43 2 2222 1233 34466 89999999999999999999999999987764 6788999999999999
Q ss_pred HHHcC---CCcchHh---HHHHHHhCCCCEEEecCCC------CCCCCeEEec
Q 008621 337 LAYFG---AQVLHPQ---SMRPAREGDIPVRVKNSYN------PNAPGTLIRR 377 (559)
Q Consensus 337 La~~G---a~vlhp~---a~~~a~~~~Ipv~I~n~~~------p~~~GT~I~~ 377 (559)
+...| ...|-|| |++.+.+...+++|.+... .+ .||+|.+
T Consensus 264 li~~g~i~~GgM~pKl~aA~~al~~Gv~~v~I~~~~~i~~al~g~-~GT~I~~ 315 (316)
T PRK12352 264 YMQEGHFPPGSMLPKIIASLTFLEQGGKEVIITTPECLPAALRGE-TGTHIIK 315 (316)
T ss_pred HHhcCCcCCCCCHHHHHHHHHHHHhCCCeEEEcchHHHHHHHcCC-CCeEEEe
Confidence 98754 3578885 4444554555799986321 22 6888864
No 75
>cd04240 AAK_UC AAK_UC: Uncharacterized (UC) amino acid kinase-like proteins found mainly in archaea and a few bacteria. Sequences in this CD are members of the Amino Acid Kinase (AAK) superfamily.
Probab=99.62 E-value=1.3e-14 Score=141.86 Aligned_cols=97 Identities=23% Similarity=0.204 Sum_probs=77.5
Q ss_pred hcCCcEEEEcCCCc---ccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccccCHHHH
Q 008621 258 ITDLAIPIVTGFLG---KAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEA 334 (559)
Q Consensus 258 ~~~~~ipVv~Gfig---~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea 334 (559)
+..+.+||+.++-- .+ ..++..++. +|..|+.+|..|+|+.+++.|||||||++| ++++++++++|+
T Consensus 88 ~~~g~ipV~~P~~~~~~~~-~~~~~~~~t---tD~lAa~lA~~l~A~~Li~ltdVdGVy~~d------a~~i~~i~~~e~ 157 (203)
T cd04240 88 LERGKIAILLPYRLLLDTD-PLPHSWEVT---SDSIAAWLAKKLGAKRLVIVTDVDGIYEKD------GKLVNEIAAAEL 157 (203)
T ss_pred HHCCCcEEEeCchhhcccC-CCCcccccC---HHHHHHHHHHHcCCCEEEEEeCCccccCCC------CcCccccCHHHh
Confidence 35788999988521 12 133444455 999999999999999999999999999865 889999999876
Q ss_pred HHHHHcCCCcchHhHHHHHHhCCCCEEEecCCCCC
Q 008621 335 AELAYFGAQVLHPQSMRPAREGDIPVRVKNSYNPN 369 (559)
Q Consensus 335 ~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~~p~ 369 (559)
.+ ..++++-+.+.+.+.++|++|.|..+|+
T Consensus 158 ~~-----~~~id~~~~~~~~~~gi~v~I~~g~~~~ 187 (203)
T cd04240 158 LG-----ETSVDPAFPRLLTKYGIRCYVVNGDDPE 187 (203)
T ss_pred CC-----CCeehhhHHHHHHhCCCeEEEECCCCcc
Confidence 53 5677776777789999999999988773
No 76
>TIGR00746 arcC carbamate kinase. The seed alignment for this model includes experimentally confirmed examples from a set of phylogenetically distinct species. In a neighbor-joining tree constructed from an alignment of candidate carbamate kinases and several acetylglutamate kinases, the latter group forms a clear outgroup which roots the tree of carbamate kinase-like proteins. This analysis suggests that in E. coli, the ArcC paralog YqeA may be a second isozyme, while the paralog YahI branches as an outlier and is less likely to be an authentic carbamate kinase. The homolog from Mycoplasma pneumoniae likewise branches outside the set containing known carbamate kinases and also scores below the trusted cutoff.
Probab=99.61 E-value=2.1e-14 Score=148.29 Aligned_cols=179 Identities=18% Similarity=0.225 Sum_probs=115.1
Q ss_pred HHHHHhhhHHHHHHHHHHHHH----HcCCceEEecc-cceEEEEecC--CCCce-ee-----ec----------------
Q 008621 194 RDYLVSFGECMSTRIFAAYLN----KIGVKARQYDA-FDIGFITTDD--FTNAD-IL-----EA---------------- 244 (559)
Q Consensus 194 ~d~ils~GE~lsa~ll~~~L~----~~Gi~a~~l~~-~~~~iit~~~--~~~a~-i~-----~~---------------- 244 (559)
+|.+.+.|+-+-+.++..+|+ ++|++...... .|. +++.++ |.++. +. +.
T Consensus 74 ~~~~~A~~qg~lg~~~~~~l~~~l~~~g~~~~v~~~vtqv-~v~~~D~af~~p~k~ig~~y~~~~a~~~~~~~~~~~~~d 152 (310)
T TIGR00746 74 LDVLGAMSQGMIGYMLQQALNNELPKRGMEKPVATVLTQT-IVDPKDPAFQNPTKPIGPFYTEEEAKRLAAEKGWIVKED 152 (310)
T ss_pred chHHHHhhHHHHHHHHHHHHHHHHHhcCCCccceEEEEEE-EECCCcccccCCCCcCCCCcCHHHHHHHHHHcCCeEeec
Confidence 577777788777787877777 88866533221 232 455444 33221 10 00
Q ss_pred ------------ch-HHHHHHHhhchhcCCcEEEEcCCCc--c-cCCCCceeee-cCCcchhHHHHHHHHcCcCcEEEee
Q 008621 245 ------------TY-PAVAKRLHGDWITDLAIPIVTGFLG--K-AWRTCAITTL-GRGGSDLTATTIGKALGLQEIQVWK 307 (559)
Q Consensus 245 ------------~~-~~i~~~l~~~l~~~~~ipVv~Gfig--~-~~~~G~~~tl-gRgGSD~tAa~lA~~L~A~~l~i~T 307 (559)
.+ ..+.....+.|++.|.++|.+|.-| . + .+|.+.+. -.+.+|.+|+++|..|+||.++++|
T Consensus 153 ~~~~~rrvv~sp~p~~iv~~~~I~~LL~~G~iVI~~ggggiPvi~-e~~~~~g~e~~id~D~lAa~lA~~l~AD~LIiLT 231 (310)
T TIGR00746 153 AGRGWRRVVPSPRPKDIVEAETIKTLVENGVIVISSGGGGVPVVL-EGAELKGVEAVIDKDLASEKLAEEVNADILVILT 231 (310)
T ss_pred CCCcceEeecCCCchhhccHHHHHHHHHCCCEEEeCCCCCcCEEe-cCCeEEeeEecCCHHHHHHHHHHHhCCCEEEEEe
Confidence 00 0011123334567887666665322 2 3 24443211 1256999999999999999999999
Q ss_pred CCcccccCCCCCCCCCccccccCHHHHHHHHH---cCCCcchHh---HHHHHHhCCCCEEEecCCC------CCCCCeEE
Q 008621 308 DVDGVLTCDPNIHPHAKPVPYLTFDEAAELAY---FGAQVLHPQ---SMRPAREGDIPVRVKNSYN------PNAPGTLI 375 (559)
Q Consensus 308 DV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~---~Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~------p~~~GT~I 375 (559)
||||||+++ ..|++++|++++++|+.++.. ++...|.|| |++.+.+.+++++|.|..+ .+ .||+|
T Consensus 232 DVdGVy~~~--~~p~a~~i~~it~~e~~~~~~~g~~~tGgM~~Kl~AA~~~~~~g~~~v~I~~~~~i~~~l~G~-~GT~I 308 (310)
T TIGR00746 232 DVDAVYINY--GKPDEKALREVTVEELEDYYKAGHFAAGSMGPKVEAAIEFVESGGKRAIITSLENAVEALEGK-AGTRV 308 (310)
T ss_pred CCCceeCCC--CCCCCcCCcCcCHHHHHHHHhcCCcCCCCcHHHHHHHHHHHHhCCCeEEEechHHHHHHHCCC-CCcEE
Confidence 999999964 348899999999999999974 456788885 4466677788999986321 23 68888
Q ss_pred ec
Q 008621 376 RR 377 (559)
Q Consensus 376 ~~ 377 (559)
.+
T Consensus 309 ~~ 310 (310)
T TIGR00746 309 TK 310 (310)
T ss_pred eC
Confidence 53
No 77
>cd04235 AAK_CK AAK_CK: Carbamate kinase (CK) catalyzes both the ATP-phosphorylation of carbamate and carbamoyl phosphate (CP) utilization with the production of ATP from ADP and CP. Both CK (this CD) and nonhomologous CP synthetase synthesize carbamoyl phosphate, an essential precursor of arginine and pyrimidine bases, in the presence of ATP, bicarbonate, and ammonia. CK is a homodimer of 33 kDa subunits and is a member of the Amino Acid Kinase Superfamily (AAK).
Probab=99.55 E-value=1.5e-13 Score=141.37 Aligned_cols=120 Identities=18% Similarity=0.238 Sum_probs=89.1
Q ss_pred hhchhcCCcEEEEcCCCcccC--CCCceeeec-CCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccccC
Q 008621 254 HGDWITDLAIPIVTGFLGKAW--RTCAITTLG-RGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLT 330 (559)
Q Consensus 254 ~~~l~~~~~ipVv~Gfig~~~--~~G~~~tlg-RgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls 330 (559)
.+.|+++|.|||+.|--|... .+|...+.. ...+|++|+++|..|+|+.++++|||||||+++| .|++++|++++
T Consensus 174 I~~Ll~~g~IpI~~GggGiPv~~~~~~~~gveaVid~D~~AallA~~l~Ad~LiilTdVdGVy~~~~--~pda~~i~~Is 251 (308)
T cd04235 174 IKTLVDNGVIVIAAGGGGIPVVREGGGLKGVEAVIDKDLASALLAEEINADLLVILTDVDNVYINFG--KPNQKALEQVT 251 (308)
T ss_pred HHHHHHCCCEEEEECCCccCEEEcCCceeeeeeccCccHHHHHHHHHcCCCEEEEEecCCeEECCCC--CCCCeEcCCcC
Confidence 334568899999987421110 123322211 2457999999999999999999999999999655 38999999999
Q ss_pred HHHHHHHHH---cCCCcchHh---HHHHHHhCCCCEEEecCCCC-----CCCCeEE
Q 008621 331 FDEAAELAY---FGAQVLHPQ---SMRPAREGDIPVRVKNSYNP-----NAPGTLI 375 (559)
Q Consensus 331 ~~Ea~eLa~---~Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~p-----~~~GT~I 375 (559)
++|+.++.. ++...|+|| |++.+.+.+.+++|.+..+. ...||+|
T Consensus 252 ~~e~~~l~~~g~~~tGGM~pKv~aA~~~a~~gg~~v~I~~~~~i~~aL~G~~GT~I 307 (308)
T cd04235 252 VEELEKYIEEGQFAPGSMGPKVEAAIRFVESGGKKAIITSLENAEAALEGKAGTVI 307 (308)
T ss_pred HHHHHHHHhcCccccCCcHHHHHHHHHHHHhCCCeEEECCHHHHHHHHCCCCCeEE
Confidence 999999985 567899998 77788877889999763210 1258876
No 78
>PRK12686 carbamate kinase; Reviewed
Probab=99.50 E-value=7.6e-13 Score=136.29 Aligned_cols=121 Identities=14% Similarity=0.139 Sum_probs=88.1
Q ss_pred HhhchhcCCcEEEEcCCCc---ccCCCCceeeec-CCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccc
Q 008621 253 LHGDWITDLAIPIVTGFLG---KAWRTCAITTLG-RGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPY 328 (559)
Q Consensus 253 l~~~l~~~~~ipVv~Gfig---~~~~~G~~~tlg-RgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ 328 (559)
..+.|++.|.|||.+|--| .+ .+|...... .+.+|..|++||.+|+|+.++|+|||||||+ ||. .|++++|++
T Consensus 175 ~I~~Ll~~G~IpI~~GgggIPVv~-~~~~~~gv~avid~D~~Aa~LA~~L~Ad~LIiLTDVdGVy~-~~~-~p~ak~I~~ 251 (312)
T PRK12686 175 TIRTLVDGGNIVIACGGGGIPVIR-DDNTLKGVEAVIDKDFASEKLAEQIDADLLIILTGVENVFI-NFN-KPNQQKLDD 251 (312)
T ss_pred HHHHHHHCCCEEEEeCCCCCCeEe-cCCcEEeeecccCccHHHHHHHHHcCCCEEEEEeCchhhcc-CCC-CCCCeECCc
Confidence 3344568899999876522 12 245444432 4568999999999999999999999999999 455 488999999
Q ss_pred cCHHHHHHHHHc---CCCcchHh--HHHHHHh--CCCCEEEecCCCC-----CCCCeEEe
Q 008621 329 LTFDEAAELAYF---GAQVLHPQ--SMRPARE--GDIPVRVKNSYNP-----NAPGTLIR 376 (559)
Q Consensus 329 ls~~Ea~eLa~~---Ga~vlhp~--a~~~a~~--~~Ipv~I~n~~~p-----~~~GT~I~ 376 (559)
++.+|+.++... +...|.|| ++..+.+ .+.+++|.+..+. ...||+|.
T Consensus 252 I~~~e~~~li~~g~~~tGGM~pKveAA~~av~~g~g~~viI~~~~~i~~aL~G~~GT~I~ 311 (312)
T PRK12686 252 ITVAEAKQYIAEGQFAPGSMLPKVEAAIDFVESGEGKKAIITSLEQAKEALAGNAGTHIT 311 (312)
T ss_pred cCHHHHHHHhhCCCccCCCcHHHHHHHHHHHHhCCCCEEEEeCchHHHHHhCCCCCeEEe
Confidence 999999999754 45779997 4444443 3678888873221 12688885
No 79
>PRK04531 acetylglutamate kinase; Provisional
Probab=99.44 E-value=1.3e-12 Score=139.48 Aligned_cols=110 Identities=21% Similarity=0.343 Sum_probs=81.3
Q ss_pred hcCCcEEEEcCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccccCH-HHHHH
Q 008621 258 ITDLAIPIVTGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTF-DEAAE 336 (559)
Q Consensus 258 ~~~~~ipVv~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~-~Ea~e 336 (559)
++.|.|||+++ +|.+ .+|++.+++ +|..|+.||.+|+|++++++|||+|||+.| .+++++|+. +|...
T Consensus 126 L~~g~IPVlsp-lg~~-~~G~~~Nvn---aD~vA~~LA~aL~a~KLIfltdv~GV~d~~------g~~i~~i~~~~e~~~ 194 (398)
T PRK04531 126 LRAGSIPVIAS-LGET-PSGQILNIN---ADVAANELVSALQPYKIIFLTGTGGLLDAD------GKLISSINLSTEYDH 194 (398)
T ss_pred HHCCCEEEEeC-cEEC-CCCcEEEEC---HHHHHHHHHHHcCCCEEEEEECCCCccCCC------CCCcccCCHHHHHHH
Confidence 46899999998 5777 479999999 999999999999999999999999999743 678999996 57777
Q ss_pred HHHcCC--CcchHh--HHHHHHhCCCC-EEEecCCCC----------CCCCeEEecCC
Q 008621 337 LAYFGA--QVLHPQ--SMRPAREGDIP-VRVKNSYNP----------NAPGTLIRRSR 379 (559)
Q Consensus 337 La~~Ga--~vlhp~--a~~~a~~~~Ip-v~I~n~~~p----------~~~GT~I~~~~ 379 (559)
|...|. ..|.|+ ++..+.+ ++| +++.....| ++.||+|....
T Consensus 195 l~~~~~vtgGM~~KL~~a~~al~-~~~~~~~V~i~~~~~Ll~eLft~~G~GT~I~~g~ 251 (398)
T PRK04531 195 LMQQPWINGGMKLKLEQIKELLD-RLPLESSVSITSPSDLAKELFTHKGSGTLVRRGE 251 (398)
T ss_pred HHhcCCCCccHHHHHHHHHHHHh-CCCcEEEEEecCCCHHHHHHccCCCCCeEEecCC
Confidence 765442 467775 4444443 333 333222223 35799998743
No 80
>cd04915 ACT_AK-Ectoine_2 ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and various other halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinas
Probab=99.42 E-value=5.9e-13 Score=106.76 Aligned_cols=64 Identities=23% Similarity=0.511 Sum_probs=61.2
Q ss_pred eeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 476 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 476 ~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
+++|++||. | ..+++++|+|++|.++||+++||+||+|+++||++|+++|.++|+++||++||+
T Consensus 2 ~a~VsvVG~gm-~~~gv~~ki~~~L~~~~I~v~~i~~~~s~~~is~~V~~~~~~~av~~Lh~~f~~ 66 (66)
T cd04915 2 VAIVSVIGRDL-STPGVLARGLAALAEAGIEPIAAHQSMRNVDVQFVVDRDDYDNAIKALHAALVE 66 (66)
T ss_pred EEEEEEECCCC-CcchHHHHHHHHHHHCCCCEEEEEecCCeeEEEEEEEHHHHHHHHHHHHHHHhC
Confidence 689999997 6 589999999999999999999999999999999999999999999999999984
No 81
>cd04918 ACT_AK1-AT_2 ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1). This CD includes the second of two ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1), which can be synergistically inhibited by S-adenosylmethionine (SAM). This isoenzyme is found in higher plants, Arabidopsis thaliana (AT) and Zea mays, and also in Chlorophyta. In its inactive state, Arabidopsis AK1 binds the effectors lysine and SAM (two molecules each) at the interface of two ACT1 domain subunits. The second ACT domain (ACT2), this CD, does not interact with an effector. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.42 E-value=4.8e-13 Score=106.89 Aligned_cols=64 Identities=84% Similarity=1.138 Sum_probs=61.2
Q ss_pred eEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 477 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 477 aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
++|++||.+++.+++++|+|++|+++||++.||+||+|+++++|+|+++|.++|++.||++||.
T Consensus 2 a~VsvVG~~~~~~~~~~~i~~aL~~~~I~v~~i~~g~s~~sis~~v~~~~~~~av~~Lh~~f~~ 65 (65)
T cd04918 2 SIISLIGNVQRSSLILERAFHVLYTKGVNVQMISQGASKVNISLIVNDSEAEGCVQALHKSFFE 65 (65)
T ss_pred cEEEEECCCCCCccHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHHHHHHHHHHHHHhC
Confidence 7899999977778999999999999999999999999999999999999999999999999974
No 82
>PRK12454 carbamate kinase-like carbamoyl phosphate synthetase; Reviewed
Probab=99.42 E-value=1.8e-11 Score=126.06 Aligned_cols=119 Identities=19% Similarity=0.207 Sum_probs=87.4
Q ss_pred hchhcCCcEEEEcCCCc---ccCCCCceeeec-CCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccccC
Q 008621 255 GDWITDLAIPIVTGFLG---KAWRTCAITTLG-RGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLT 330 (559)
Q Consensus 255 ~~l~~~~~ipVv~Gfig---~~~~~G~~~tlg-RgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls 330 (559)
+.|++.|.|||++|.-| .+ .+|++.++. -...|.+|+++|..|+||.++|+|||||||++ |+ .|++++|++++
T Consensus 179 ~~LLe~G~IvI~~GgGGiPV~~-~~g~~~gveaViD~D~aAa~LA~~L~AD~LIiLTdVdGVy~~-~~-~p~~~~i~~It 255 (313)
T PRK12454 179 KALVENGFIVIASGGGGIPVIE-EDGELKGVEAVIDKDLASELLAEELNADIFIILTDVEKVYLN-YG-KPDQKPLDKVT 255 (313)
T ss_pred HHHHHCCCEEEEeCCCccceEc-CCCcEEeeeeecCccHHHHHHHHHcCCCEEEEEeCCceeeCC-CC-CCCCeEccccC
Confidence 34568899999997521 23 256554432 24579999999999999999999999999986 43 47899999999
Q ss_pred HHHHHHHHHc---CCCcchHh---HHHHHHhCCCCEEEecCCCC-----CCCCeEEe
Q 008621 331 FDEAAELAYF---GAQVLHPQ---SMRPAREGDIPVRVKNSYNP-----NAPGTLIR 376 (559)
Q Consensus 331 ~~Ea~eLa~~---Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~p-----~~~GT~I~ 376 (559)
++|+.++... +...|-|| |++.+.+.+.+++|.+..+. ...||+|.
T Consensus 256 ~~e~~~~i~~g~~~~GgM~pKv~AA~~~v~~gg~~a~I~~~~~i~~aL~G~~GT~I~ 312 (313)
T PRK12454 256 VEEAKKYYEEGHFKAGSMGPKILAAIRFVENGGKRAIIASLEKAVEALEGKTGTRII 312 (313)
T ss_pred HHHHHHHHhcCCcCCCChHHHHHHHHHHHHcCCCeEEECchHHHHHHHCCCCCeEeC
Confidence 9999988753 45678885 44556666678998753220 12688885
No 83
>COG1608 Predicted archaeal kinase [General function prediction only]
Probab=99.42 E-value=2.1e-11 Score=119.12 Aligned_cols=156 Identities=21% Similarity=0.190 Sum_probs=107.3
Q ss_pred HHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeee
Q 008621 203 CMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTL 282 (559)
Q Consensus 203 ~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tl 282 (559)
.++.. ++..|.+.|++++..-|... .+. ++++.......+. .+++.+.|||+.|-+-.+..+| ...+
T Consensus 81 ~L~~~-V~~~l~~~Gv~av~~~P~s~--~~~----~gr~~~~~l~~i~-----~~l~~gfvPvl~GDVv~d~~~g-~~Ii 147 (252)
T COG1608 81 ELNSI-VVDALLDAGVRAVSVVPISF--STF----NGRILYTYLEAIK-----DALEKGFVPVLYGDVVPDDDNG-YEII 147 (252)
T ss_pred HHHHH-HHHHHHhcCCccccccCcce--eec----CCceeechHHHHH-----HHHHcCCEeeeecceEEcCCCc-eEEE
Confidence 34444 66789999999987666553 221 2233221122222 2357899999999877664223 3334
Q ss_pred cCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccccCHHHHHHHHHcC-C---Ccch--HhHHHHHHhC
Q 008621 283 GRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFG-A---QVLH--PQSMRPAREG 356 (559)
Q Consensus 283 gRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~G-a---~vlh--p~a~~~a~~~ 356 (559)
. .|-.+..||..|+++++.+.|||||||+.||..+|+++.++++...+ .+...+ . ..|- -+++..+.+.
T Consensus 148 S---GDdIv~~LA~~l~pd~v~f~tdVdGVy~~~p~~~p~~~~l~~i~~~~--~~~gs~~~DVTGGi~~Kl~~~~~~~~~ 222 (252)
T COG1608 148 S---GDDIVLHLAKELKPDRVIFLTDVDGVYDRDPGKVPDARLLSEIEGRV--ALGGSGGTDVTGGIAKKLEALLEIARY 222 (252)
T ss_pred e---ccHHHHHHHHHhCCCEEEEEecCCceecCCCCcCccccchhhhhhhh--hhcCcCcccchhhHHHHHHHHHHHHhc
Confidence 3 59999999999999999999999999999999999999988876542 221112 1 1233 3466667778
Q ss_pred CCCEEEecCCCCC---------CCCeEEe
Q 008621 357 DIPVRVKNSYNPN---------APGTLIR 376 (559)
Q Consensus 357 ~Ipv~I~n~~~p~---------~~GT~I~ 376 (559)
+-++++.|+..|+ ..||+|.
T Consensus 223 ~~~vyi~ng~~~~ni~~~l~G~~vGT~I~ 251 (252)
T COG1608 223 GKEVYIFNGNKPENIYRALRGENVGTRID 251 (252)
T ss_pred CceEEEECCCCHHHHHHHhcCCCCceEec
Confidence 8889999988764 5788885
No 84
>KOG1154 consensus Gamma-glutamyl kinase [Amino acid transport and metabolism]
Probab=99.40 E-value=3.3e-12 Score=123.54 Aligned_cols=156 Identities=15% Similarity=0.263 Sum_probs=116.9
Q ss_pred HHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCC
Q 008621 196 YLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWR 275 (559)
Q Consensus 196 ~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~ 275 (559)
.+.+.|+.=-..++-..|.++|+.. .|+ ++|..++.+. ..+.++...+.+ |+.-+.|||+ |+
T Consensus 91 A~AAvGQ~~Lmalye~lF~Qy~~~i-----AQv-LvT~~Di~d~----~~r~Nl~~Ti~e-LL~m~viPIv------Ne- 152 (285)
T KOG1154|consen 91 ACAAVGQSGLMALYETLFTQYGITI-----AQV-LVTRNDILDE----QQRKNLQNTISE-LLSMNVIPIV------NE- 152 (285)
T ss_pred HHHHhCcchHHHHHHHHHHHhccch-----hee-eecCcchhhH----HHHHHHHHHHHH-HHhCCceeee------cC-
Confidence 4566677666677888899999976 455 7776665433 356677777665 5678999999 53
Q ss_pred CCcee--eecCCc---chhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccccCHHHHH-H-----HHHcCCCc
Q 008621 276 TCAIT--TLGRGG---SDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAA-E-----LAYFGAQV 344 (559)
Q Consensus 276 ~G~~~--tlgRgG---SD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~-e-----La~~Ga~v 344 (559)
|+.+. -..+|. ||..|+++|+.++||.++++|||||+||..|. ...+++++..+..+.. + -+..|...
T Consensus 153 NDavs~~~~~~~D~~dNDsLsA~laaei~ADlLilLsDVdglYt~PPd-~~~~~li~~~~~~~~~v~~tfG~~SkvGtGG 231 (285)
T KOG1154|consen 153 NDAVSPREIPFGDSSDNDSLAAILAAEIKADLLILLSDVDGLYTGPPD-ADPSKLIHTFSPGDPQVSTTFGSKSKVGTGG 231 (285)
T ss_pred CCccCCcccccCCCCcccHHHHHHHHHhccCEEEEEecccccccCCCC-CCcceeeeeeccCCCCCccccCccCccCcCc
Confidence 44432 255677 99999999999999999999999999995554 3457788887766554 2 23345668
Q ss_pred chHh--HHHHHHhCCCCEEEecCCCCCC
Q 008621 345 LHPQ--SMRPAREGDIPVRVKNSYNPNA 370 (559)
Q Consensus 345 lhp~--a~~~a~~~~Ipv~I~n~~~p~~ 370 (559)
|..| |..-|...|+++.|.|+..|+.
T Consensus 232 M~tKv~AA~~A~~~Gv~viI~~g~~p~~ 259 (285)
T KOG1154|consen 232 METKVKAAVNALNAGVSVIITNGDAPEN 259 (285)
T ss_pred chhhHHHHHHHhcCCceEEEeCCCChHH
Confidence 8764 8889999999999999999975
No 85
>PRK12354 carbamate kinase; Reviewed
Probab=99.37 E-value=1e-11 Score=127.54 Aligned_cols=123 Identities=20% Similarity=0.135 Sum_probs=88.3
Q ss_pred HhhchhcCCcEEEEcCCCccc---CCCCceeeec-CCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccc
Q 008621 253 LHGDWITDLAIPIVTGFLGKA---WRTCAITTLG-RGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPY 328 (559)
Q Consensus 253 l~~~l~~~~~ipVv~Gfig~~---~~~G~~~tlg-RgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ 328 (559)
..+.|++.+.|||.+|.=|.. ...|...... ..++|.+|++||..|+|+.++|+|||||||++++ .|++++|++
T Consensus 167 ~I~~Ll~~g~ivIa~GGGGIPV~~~~~~~~~gv~aViD~D~~Aa~LA~~l~Ad~LiiLTdVdGVy~~~~--~p~~k~i~~ 244 (307)
T PRK12354 167 PIRWLLEKGHLVICAGGGGIPVVYDADGKLHGVEAVIDKDLAAALLAEQLDADLLLILTDVDAVYLDWG--KPTQRAIAQ 244 (307)
T ss_pred HHHHHHHCCCEEEEeCCCccCeEecCCCceeeeeecCCccHHHHHHHHHcCCCEEEEEeCCcceecCCC--CCCCeECCC
Confidence 333456788988876432221 0123332221 4579999999999999999999999999999754 478999999
Q ss_pred cCHHHHHHHHHcCCCcchHh---HHHHHHhCCCCEEEecCCCC-----CCCCeEEecC
Q 008621 329 LTFDEAAELAYFGAQVLHPQ---SMRPAREGDIPVRVKNSYNP-----NAPGTLIRRS 378 (559)
Q Consensus 329 ls~~Ea~eLa~~Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~p-----~~~GT~I~~~ 378 (559)
++++|+.++ .++...|-|| |++.+.+.+.+++|.+..+. ...||+|.+.
T Consensus 245 it~~e~~~~-~f~~GgM~pKV~AA~~~~~~gg~~viI~~~~~l~~al~G~~GT~I~~~ 301 (307)
T PRK12354 245 ATPDELREL-GFAAGSMGPKVEAACEFVRATGKIAGIGSLEDIQAILAGEAGTRISPE 301 (307)
T ss_pred CCHHHHHhh-CCCcCChHHHHHHHHHHHHhCCCEEEECCHHHHHHHHCCCCceEEecC
Confidence 999999998 6788899997 44555666768888642210 1269999764
No 86
>cd04937 ACT_AKi-DapG-BS_2 ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI. This CD includes the C-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) strain 168), Clostridia, and Actinobacteria bacterial species. In B. subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive AK isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The BS AKI is tetrameric consisting of two alpha and two beta subunits; th
Probab=99.24 E-value=2.4e-11 Score=96.65 Aligned_cols=62 Identities=26% Similarity=0.501 Sum_probs=58.8
Q ss_pred eeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhc
Q 008621 476 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFF 539 (559)
Q Consensus 476 ~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~ 539 (559)
+++|+++|. |...+|+++|+|++|.++||++.++++ |+++|+|+|++++.++|+++||++|+
T Consensus 1 ~~~isvvG~~~~~~~gi~~~if~aL~~~~I~v~~~~~--Se~~is~~v~~~~~~~av~~Lh~~f~ 63 (64)
T cd04937 1 CAKVTIIGSRIRGVPGVMAKIVGALSKEGIEILQTAD--SHTTISCLVSEDDVKEAVNALHEAFE 63 (64)
T ss_pred CeEEEEECCCccCCcCHHHHHHHHHHHCCCCEEEEEc--CccEEEEEEcHHHHHHHHHHHHHHhc
Confidence 478999997 888999999999999999999998887 89999999999999999999999996
No 87
>cd04920 ACT_AKiii-DAPDC_2 ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC). This CD includes the second of two ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. Aspartokinase (AK) is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The lysA gene encodes the enzyme DAPDC, a pyridoxal-5'-phosphate (PLP)-dependent enzyme which catalyzes the final step in the lysine biosynthetic pathway converting meso-diaminopimelic acid (DAP) to l-lysine. Tandem ACT domains are positioned centrally with the AK catalytic domain N-terminal and the DAPDC domains C-terminal. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.24 E-value=2e-11 Score=96.97 Aligned_cols=62 Identities=27% Similarity=0.501 Sum_probs=57.0
Q ss_pred eEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 477 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 477 aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
|+||+||. |...+++++|+|++|.+. +|.++++|+|+++|||+|+++|.++++++||++||+
T Consensus 1 a~VsvVG~g~~~~~gv~~~~~~~L~~~--~i~~i~~~~s~~~is~vv~~~d~~~av~~LH~~f~~ 63 (63)
T cd04920 1 AAVSLVGRGIRSLLHKLGPALEVFGKK--PVHLVSQAANDLNLTFVVDEDQADGLCARLHFQLIE 63 (63)
T ss_pred CEEEEECCCcccCccHHHHHHHHHhcC--CceEEEEeCCCCeEEEEEeHHHHHHHHHHHHHHHhC
Confidence 58999997 778999999999999764 677799999999999999999999999999999984
No 88
>cd04917 ACT_AKiii-LysC-EC_2 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The E. coli AKIII (LysC) binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. The second ACT domain (ACT2), this CD, is not involved in the binding of heterotrophic effectors. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.23 E-value=2.8e-11 Score=96.16 Aligned_cols=63 Identities=32% Similarity=0.657 Sum_probs=59.1
Q ss_pred eeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 476 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 476 ~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
+++|++||. +...+++++|+|++|+ ++++.+++||+|+++++|+|+++|.++++++||++||.
T Consensus 1 ~alIsvvG~~~~~~~~v~~~i~~~L~--~i~i~~i~~~~s~~~is~~V~~~~~~~a~~~Lh~~f~~ 64 (64)
T cd04917 1 LALVALIGNDISETAGVEKRIFDALE--DINVRMICYGASNHNLCFLVKEEDKDEVVQRLHSRLFE 64 (64)
T ss_pred CeEEEEECCCccCCcCHHHHHHHHHH--hCCeEEEEEecCccEEEEEEeHHHHHHHHHHHHHHHhC
Confidence 489999997 7788999999999996 58999999999999999999999999999999999984
No 89
>cd04919 ACT_AK-Hom3_2 ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. AK is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single AK, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies shown that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydrodynamic size. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.23 E-value=3.3e-11 Score=95.88 Aligned_cols=65 Identities=32% Similarity=0.589 Sum_probs=61.7
Q ss_pred eeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 476 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 476 ~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
+++|+++|. +...+++.+++|++|++.||++.||+|+.|+.+++|++++++.+++++.||++||+
T Consensus 1 ~~~isvvg~~~~~~~~~~~~if~~L~~~~I~v~~i~q~~s~~~isf~v~~~~~~~a~~~lh~~~~~ 66 (66)
T cd04919 1 LAILSLVGKHMKNMIGIAGRMFTTLADHRINIEMISQGASEINISCVIDEKDAVKALNIIHTNLLE 66 (66)
T ss_pred CeEEEEECCCCCCCcCHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHHHHHHHHHHHHHhC
Confidence 479999997 77889999999999999999999999999999999999999999999999999984
No 90
>cd04922 ACT_AKi-HSDH-ThrA_2 ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). This CD includes the second of two ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). The ACT domains are positioned between the N-terminal catalytic domain of AK and the C-terminal HSDH domain found in bacteria (Escherichia coli (EC) ThrA) and higher plants (Zea mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. HSDH is the first committed reaction in the branch of the pathway that leads to Thr and Met. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathwa
Probab=99.21 E-value=5.2e-11 Score=94.47 Aligned_cols=65 Identities=35% Similarity=0.651 Sum_probs=61.5
Q ss_pred eeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 476 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 476 ~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
+++|+++|. +...+++.+++|++|+++||++.|++|+.|+.+++|++++++.++++++||++||+
T Consensus 1 ~~~isvvg~~~~~~~~~~~~i~~~l~~~~I~v~~i~~~~s~~~is~~v~~~~~~~~~~~lh~~~~~ 66 (66)
T cd04922 1 LSILALVGDGMAGTPGVAATFFSALAKANVNIRAIAQGSSERNISAVIDEDDATKALRAVHERFFL 66 (66)
T ss_pred CeEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCcccEEEEEEeHHHHHHHHHHHHHHHhC
Confidence 479999997 77889999999999999999999999998999999999999999999999999984
No 91
>PRK09411 carbamate kinase; Reviewed
Probab=99.21 E-value=8e-10 Score=112.76 Aligned_cols=116 Identities=17% Similarity=0.193 Sum_probs=85.4
Q ss_pred hhchhcCCcEEEEcCC--Cc--ccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCcccccc
Q 008621 254 HGDWITDLAIPIVTGF--LG--KAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYL 329 (559)
Q Consensus 254 ~~~l~~~~~ipVv~Gf--ig--~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~l 329 (559)
.+.|++.|.|||.+|. ++ .+ .+|...+++ .|.+|+.||.+|+|+.++|+|||||||..++ .|++++|+++
T Consensus 169 I~~Ll~~G~IVI~~gGGGIPV~~~-~~G~e~vID---kD~~Aa~LA~~L~Ad~LIiLTDVdGV~~n~~--~p~~~~I~~i 242 (297)
T PRK09411 169 IELLLKEGHVVICSGGGGVPVTED-GAGSEAVID---KDLAAALLAEQINADGLVILTDADAVYENWG--TPQQRAIRHA 242 (297)
T ss_pred HHHHHHCCCEEEecCCCCCCeEEc-CCCeEEecC---HHHHHHHHHHHhCCCEEEEEeCchhhccCCC--CCCCcCCCCc
Confidence 3345678899888743 22 22 234444455 8999999999999999999999999998653 5788999999
Q ss_pred CHHHHHHHHHcCCCcchHh---HHHHHHhCCCCEEEecCCCC-----CCCCeEEe
Q 008621 330 TFDEAAELAYFGAQVLHPQ---SMRPAREGDIPVRVKNSYNP-----NAPGTLIR 376 (559)
Q Consensus 330 s~~Ea~eLa~~Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~p-----~~~GT~I~ 376 (559)
+.+|+.++.. ....|.|| |++.+...+.+++|.+..+. ...||+|.
T Consensus 243 t~~e~~~~~~-~~GgM~pKVeAA~~~v~~~g~~a~I~~l~~~~~~l~G~~GT~I~ 296 (297)
T PRK09411 243 TPDELAPFAK-ADGAMGPKVTAVSGYVRSRGKPAWIGALSRIEETLAGEAGTCIS 296 (297)
T ss_pred CHHHHHHhcc-CCCCcHHHHHHHHHHHHhCCCeEEECChhHHHHHHCCCCCeEEe
Confidence 9999977765 45669997 55667777889999653220 12588874
No 92
>cd04916 ACT_AKiii-YclM-BS_2 ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. B. subtilis YclM is reported to be a single polypeptide of 50 kD. AKIII from B. subtilis strain 168 is induced by lysine and repressed by threonine and it is synergistically inhibited by lysine and threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.11 E-value=2.7e-10 Score=90.36 Aligned_cols=65 Identities=29% Similarity=0.614 Sum_probs=61.3
Q ss_pred eeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 476 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 476 ~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
+++|+++|. +...+++.+++|++|++.||++.|++|+.++.+++|+|+++|.+++++.||++||+
T Consensus 1 ~~lisivg~~~~~~~~~~~~i~~~L~~~~i~v~~i~~~~s~~~isf~v~~~d~~~~~~~lh~~~~~ 66 (66)
T cd04916 1 LALIMVVGEGMKNTVGVSARATAALAKAGINIRMINQGSSEISIMIGVHNEDADKAVKAIYEEFFN 66 (66)
T ss_pred CeEEEEEcCCCCCCccHHHHHHHHHHHCCCCEEEEEecCcccEEEEEEeHHHHHHHHHHHHHHHhC
Confidence 478999997 77889999999999999999999999998999999999999999999999999984
No 93
>cd04924 ACT_AK-Arch_2 ACT domains of a monofunctional aspartokinase found mostly in Archaea species (ACT_AK-Arch_2). Included in this CD is the second of two ACT domains of a monofunctional aspartokinase found mostly in Archaea species (ACT_AK-Arch_2). The first or N-terminal ACT domain of these proteins cluster with the ThrA-like ACT 1 domains (ACT_AKi-HSDH-ThrA-like_1) which includes the threonine-sensitive archaeal Methanococcus jannaschii aspartokinase ACT 1 domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=99.01 E-value=1.2e-09 Score=86.55 Aligned_cols=64 Identities=33% Similarity=0.620 Sum_probs=60.3
Q ss_pred eeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhc
Q 008621 476 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFF 539 (559)
Q Consensus 476 ~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~ 539 (559)
+++|+++|. +...+++.+++|+.|++.+|++.|++|+.++.+++|+++++|.+++++.||++|.
T Consensus 1 ~~~isivg~~~~~~~~~~~~i~~~L~~~~I~v~~i~q~~s~~~isf~i~~~~~~~~~~~Lh~~~~ 65 (66)
T cd04924 1 VAVVAVVGSGMRGTPGVAGRVFGALGKAGINVIMISQGSSEYNISFVVAEDDGWAAVKAVHDEFG 65 (66)
T ss_pred CeEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHHHHHHHHHHHHhc
Confidence 479999997 7788999999999999999999999999899999999999999999999999984
No 94
>PF13840 ACT_7: ACT domain ; PDB: 3S1T_A 1ZHV_A 3AB4_K 3AB2_O 2DTJ_A 3AAW_A 2RE1_B 3MAH_A 1ZVP_D.
Probab=98.97 E-value=2.2e-09 Score=85.79 Aligned_cols=62 Identities=34% Similarity=0.580 Sum_probs=56.6
Q ss_pred cccceeEEEEEee-ccc-cchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHH
Q 008621 472 LLQHRSIISLIGN-VQR-SSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHE 536 (559)
Q Consensus 472 ~~~~~aiISIVG~-~~~-~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~ 536 (559)
..+++++|+++|. +.. .||+++++|++|+++||||++++ |+.+++++|++++.++|+++||+
T Consensus 2 ~~~~~~~i~v~g~g~~~~~~Gv~a~i~~~La~~~I~i~~is---S~~~~~ilV~~~~~~~A~~~L~~ 65 (65)
T PF13840_consen 2 IEEDWAKISVVGPGLRFDVPGVAAKIFSALAEAGINIFMIS---SEISISILVKEEDLEKAVEALHE 65 (65)
T ss_dssp EESEEEEEEEEEECGTTTSHHHHHHHHHHHHHTTS-ECEEE---ESSEEEEEEEGGGHHHHHHHHHH
T ss_pred ccCCEEEEEEEccccCCCcccHHHHHHHHHHHCCCCEEEEE---EeeeEEEEEeHHHHHHHHHHhcC
Confidence 3578999999998 655 89999999999999999999999 79999999999999999999996
No 95
>cd04933 ACT_AK1-AT_1 ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1). This CD includes the first of two ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1), which can be synergistically inhibited by S-adenosylmethionine. This isoenzyme is found in higher plants, Arabidopsis thaliana (AT) and Zea mays, and also in Chlorophyta. Like the Escherichia coli AKIII (LysC), Arabidopsis AK1 binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. A loop in common is involved in the binding of both Lys and S-adenosylmethionine providing an explanation for the synergistic inhibition by these effectors. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.83 E-value=2e-08 Score=83.14 Aligned_cols=75 Identities=92% Similarity=1.237 Sum_probs=64.0
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceee
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVN 471 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~ 471 (559)
+++|+|.+.++.+.+|+++++|+.|+++||++|||++++.+++|+++.++.+....+.. +++.+..+|++++.++
T Consensus 1 ~~~i~i~~~~~~~~~g~~a~IF~~La~~~InVDmI~qs~~sISftV~~sd~~~~~~~~~--~l~~~~~~~~~~~~~~ 75 (78)
T cd04933 1 VTMLDITSTRMLGQYGFLAKVFSIFETLGISVDVVATSEVSISLTLDPSKLWSRELIQQ--ELDHVVEELEKDAVVN 75 (78)
T ss_pred CEEEEEEcCCCCCccCHHHHHHHHHHHcCCcEEEEEecCCEEEEEEEhhhhhhhhhHHH--HHHHHHHHHHHcCeEE
Confidence 36899999999999999999999999999999999999999999999988764444443 6778888888876554
No 96
>COG2054 Uncharacterized archaeal kinase related to aspartokinases, uridylate kinases [General function prediction only]
Probab=98.77 E-value=2.8e-07 Score=86.54 Aligned_cols=83 Identities=28% Similarity=0.328 Sum_probs=72.4
Q ss_pred chhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCC
Q 008621 287 SDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSY 366 (559)
Q Consensus 287 SD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~ 366 (559)
||..+..+|+.++|.++++.|||||||+.+|. ++++++|+..|... |-..++|-+-..+.+.++.++|.|+.
T Consensus 118 SDsis~~Ia~~~~~~~vv~aTDVdGI~~~~~~----~kLv~eI~A~dl~~----~~t~vD~~~P~Ll~k~~m~~~Vvng~ 189 (212)
T COG2054 118 SDSISVWIAAKAGATEVVKATDVDGIYEEDPK----GKLVREIRASDLKT----GETSVDPYLPKLLVKYKMNCRVVNGK 189 (212)
T ss_pred ccHHHHHHHHHcCCcEEEEEecCCcccccCCc----chhhhhhhHhhccc----CcccccchhhHHHHHcCCceEEECCC
Confidence 99999999999999999999999999998874 58899888665543 77899999999999999999999999
Q ss_pred CCC----------CCCeEEec
Q 008621 367 NPN----------APGTLIRR 377 (559)
Q Consensus 367 ~p~----------~~GT~I~~ 377 (559)
+|+ .+||+|.+
T Consensus 190 ~pervi~~lrGk~~v~T~Ivg 210 (212)
T COG2054 190 EPERVILALRGKEVVGTLIVG 210 (212)
T ss_pred CHHHHHHHHhccccceEEEeC
Confidence 885 36777754
No 97
>cd04892 ACT_AK-like_2 ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes the second of two ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). The exception in this group, is the inclusion of the first ACT domain of the bifunctional aspartokinase - homoserine dehydrogenase-like enzyme group (ACT_AKi-HSDH-ThrA-like_1) which includes the monofunctional, threonine-sensitive, aspartokinase found in Methanococcus jannaschii and other related archaeal species. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. AK is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. One mechanism for the regulation of this pathway is by the production of several isoenzymes of AK with different repressors an
Probab=98.73 E-value=4.3e-08 Score=76.33 Aligned_cols=64 Identities=41% Similarity=0.776 Sum_probs=59.3
Q ss_pred eEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 477 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 477 aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
++|+++|. +...+++.+++|+.|++.+|++.+++|+.++.+++|++++++.+++++.||++|+.
T Consensus 1 ~~i~i~g~~~~~~~~~~~~i~~~l~~~~i~v~~i~~~~~~~~i~~~v~~~~~~~~~~~l~~~~~~ 65 (65)
T cd04892 1 ALVSVVGAGMRGTPGVAARIFSALAEAGINIIMISQGSSEVNISFVVDEDDADKAVKALHEEFFL 65 (65)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCcEEEEEcCCCceeEEEEEeHHHHHHHHHHHHHHHhC
Confidence 57999997 77889999999999999999999999987889999999999999999999999873
No 98
>cd04923 ACT_AK-LysC-DapG-like_2 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related domains. This CD includes the C-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, as well as, the second and fourth, of four, ACT domains present in cyanobacteria AK. Also included are the C-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase isoenzyme AKI found in Bacilli (B. subtilis strain 168), Clostridia, and Actinobacteria bacterial species. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.73 E-value=4.2e-08 Score=76.62 Aligned_cols=61 Identities=39% Similarity=0.707 Sum_probs=56.6
Q ss_pred eEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhc
Q 008621 477 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFF 539 (559)
Q Consensus 477 aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~ 539 (559)
++|+++|. +...+++.+++|++|.+++|++.++++ ++.+++|+|++++.+++++.||++|+
T Consensus 1 ~~v~v~g~~~~~~~~~~~~i~~~L~~~~i~v~~i~~--s~~~is~~v~~~~~~~~~~~l~~~l~ 62 (63)
T cd04923 1 AKVSIVGAGMRSHPGVAAKMFKALAEAGINIEMIST--SEIKISCLVDEDDAEKAVRALHEAFE 62 (63)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEc--cCCeEEEEEeHHHHHHHHHHHHHHhc
Confidence 47899996 777899999999999999999999987 68999999999999999999999996
No 99
>cd04921 ACT_AKi-HSDH-ThrA-like_1 ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). This CD includes the first of two ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). The ACT domains are positioned between the N-terminal catalytic domain of AK and the C-terminal HSDH domain found in bacteria (Escherichia coli (EC) ThrA) and higher plants (Zea mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. HSDH is the first committed reaction in the branch of the pathway that leads to Thr and Met. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pat
Probab=98.73 E-value=4e-08 Score=81.16 Aligned_cols=66 Identities=32% Similarity=0.526 Sum_probs=61.6
Q ss_pred eeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008621 476 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 541 (559)
Q Consensus 476 ~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 541 (559)
+++|+++|. +...+++.+++|++|++.+|++.|++|++++.+++|+++.++.+++++.||++|+..
T Consensus 1 ~~~I~vvg~~~~~~~~~~~~i~~~L~~~~I~v~~i~~~~~~~~isf~v~~~d~~~~~~~l~~~~~~~ 67 (80)
T cd04921 1 VALINIEGTGMVGVPGIAARIFSALARAGINVILISQASSEHSISFVVDESDADKALEALEEEFALE 67 (80)
T ss_pred CEEEEEEcCCCCCCccHHHHHHHHHHHCCCcEEEEEecCCcceEEEEEeHHHHHHHHHHHHHHHHhh
Confidence 478999996 778899999999999999999999999999999999999999999999999999654
No 100
>cd04936 ACT_AKii-LysC-BS-like_2 ACT domains of the lysine-sensitive, aspartokinase (AK) isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related domains. This CD includes the C-terminal of the two ACT domains of the lysine-sensitive, aspartokinase (AK) isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis strain 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive AK isoenzymes. The B. subtilis strain 168 AKII is induced by methionine and repressed and inhibited by lysine. Although C. glutamicum is known to contain a single AK, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In corynebacteria and other various Gram-positive bacteria, the DAP-lysine pathway is feedback regu
Probab=98.71 E-value=5e-08 Score=76.20 Aligned_cols=61 Identities=38% Similarity=0.693 Sum_probs=56.5
Q ss_pred eEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhc
Q 008621 477 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFF 539 (559)
Q Consensus 477 aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~ 539 (559)
++|+++|. +...+++.+++|+.|++.+|++.++++ ++.+++|+|+++|.+++++.||++|+
T Consensus 1 ~~i~v~g~~~~~~~~~~~~i~~~L~~~~i~v~~i~~--s~~~is~~v~~~d~~~~~~~l~~~~~ 62 (63)
T cd04936 1 AKVSIVGAGMRSHPGVAAKMFEALAEAGINIEMIST--SEIKISCLIDEDDAEKAVRALHEAFE 62 (63)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCcEEEEEc--cCceEEEEEeHHHHHHHHHHHHHHhc
Confidence 47899997 777899999999999999999999986 67999999999999999999999996
No 101
>cd04932 ACT_AKiii-LysC-EC_1 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The E. coli AKIII (LysC) binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.71 E-value=7.9e-08 Score=79.06 Aligned_cols=72 Identities=40% Similarity=0.551 Sum_probs=59.0
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhhHHHHHHHHHHH-HHHHHHhhhceeec
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQASELD-HVVEELEKIAIVNL 472 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~~~~~~~~~~l~-~~~~~L~~~~~v~~ 472 (559)
+++|+|.+.++.+.+|+++++|+.|+++||+||||++++.+++|+++.++....+ .+. .+..+|++++.+.+
T Consensus 1 ~~~ItI~~~~~~~~~g~~~~IF~~La~~~I~VDmI~~s~~~iSftv~~~d~~~~~------~~~~~l~~~l~~~~~v~~ 73 (75)
T cd04932 1 QTLVTLKSPNMLHAQGFLAKVFGILAKHNISVDLITTSEISVALTLDNTGSTSDQ------LLTQALLKELSQICDVKV 73 (75)
T ss_pred CEEEEEecCCCCCCcCHHHHHHHHHHHcCCcEEEEeecCCEEEEEEeccccchhH------HHHHHHHHHHHhccEEEe
Confidence 4688998888999999999999999999999999999999999999987643211 343 57778888776654
No 102
>cd04934 ACT_AK-Hom3_1 CT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. AK is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single AK, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies shown that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydro
Probab=98.67 E-value=1e-07 Score=77.94 Aligned_cols=71 Identities=31% Similarity=0.550 Sum_probs=59.6
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeec
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNL 472 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~ 472 (559)
+++|+|.+.+|.+.+|+++++|+.|+++||++||+++++.+++|+++.+++.. +.++.+.++|++++.+++
T Consensus 1 ~~~I~i~~~~m~~~~g~~~~If~~la~~~I~vd~I~~s~~~isftv~~~~~~~-------~~l~~l~~el~~~~~v~~ 71 (73)
T cd04934 1 ILVINIHSNKKSLSHGFLARIFAILDKYRLSVDLISTSEVHVSMALHMENAED-------TNLDAAVKDLQKLGTVDI 71 (73)
T ss_pred CEEEEEEcccCccccCHHHHHHHHHHHcCCcEEEEEeCCCEEEEEEehhhcCh-------HHHHHHHHHHHHheEEEe
Confidence 46889999999999999999999999999999999999999999999875421 145567778887666654
No 103
>cd04935 ACT_AKiii-DAPDC_1 ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. This CD includes the first of two ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. Aspartokinase (AK) is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The lysA gene encodes the enzyme DAPDC, a pyridoxal-5'-phosphate (PLP)-dependent enzyme which catalyzes the final step in the lysine biosynthetic pathway converting meso-diaminopimelic acid (DAP) to l-lysine. Tandem ACT domains are positioned centrally with the AK catalytic domain N-terminal and the DAPDC domains C-terminal. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.59 E-value=2.8e-07 Score=75.83 Aligned_cols=72 Identities=35% Similarity=0.625 Sum_probs=59.2
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchh-hHHHHHHHHHHHHHHHHHhhhceeec
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLW-SRELIQQASELDHVVEELEKIAIVNL 472 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~-~~~~~~~~~~l~~~~~~L~~~~~v~~ 472 (559)
+++|++.+.++.+.+|+++++|+.|+++||++||+++++.+++|++++++.+ ..+ .++.+.++|++++.+++
T Consensus 1 ~~~i~i~~~~~~~~~g~~~~IF~~La~~~I~vDmI~~s~~~isftv~~~~~~~~~~------~~~~l~~el~~~~~v~~ 73 (75)
T cd04935 1 IRLVSMETLGMWQQVGFLADVFAPFKKHGVSVDLVSTSETNVTVSLDPDPNGLDPD------VLDALLDDLNQICRVKI 73 (75)
T ss_pred CEEEEEEcCCCCCccCHHHHHHHHHHHcCCcEEEEEeCCCEEEEEEeCcccccchH------HHHHHHHHHHhceEEEE
Confidence 4689999999999999999999999999999999999999999999987621 111 35567778887665553
No 104
>COG0549 ArcC Carbamate kinase [Amino acid transport and metabolism]
Probab=98.45 E-value=1.6e-05 Score=79.98 Aligned_cols=116 Identities=17% Similarity=0.211 Sum_probs=86.5
Q ss_pred HHhhchhcCCcEEEEcCCCcccCCCCceeeecCCc----------chhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCC
Q 008621 252 RLHGDWITDLAIPIVTGFLGKAWRTCAITTLGRGG----------SDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHP 321 (559)
Q Consensus 252 ~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgRgG----------SD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~ 321 (559)
...+.|+++|.++|..|-= |-+ +...++ =|+++++||..++||.++|+||||+||-.--+ |
T Consensus 175 ~~Ik~L~~~g~vVI~~GGG------GIP-Vv~~~~~~~GVeAVIDKDlasalLA~~i~AD~liILTdVd~Vy~n~gk--p 245 (312)
T COG0549 175 EAIKALLESGHVVIAAGGG------GIP-VVEEGAGLQGVEAVIDKDLASALLAEQIDADLLIILTDVDAVYVNFGK--P 245 (312)
T ss_pred HHHHHHHhCCCEEEEeCCC------Ccc-eEecCCCcceeeEEEccHHHHHHHHHHhcCCEEEEEeccchheecCCC--c
Confidence 3445567888888887621 211 121111 49999999999999999999999999986533 6
Q ss_pred CCccccccCHHHHHHHHHc---CCCcchHh---HHHHHHhCCCCEEEecCCCC-----CCCCeEEe
Q 008621 322 HAKPVPYLTFDEAAELAYF---GAQVLHPQ---SMRPAREGDIPVRVKNSYNP-----NAPGTLIR 376 (559)
Q Consensus 322 ~a~~i~~ls~~Ea~eLa~~---Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~p-----~~~GT~I~ 376 (559)
+-+.|.+++.+|+.++... ...-|-|| |+..+...|-+..|.+--+- ...||.|.
T Consensus 246 ~q~~L~~v~~~e~~~yl~eg~Fa~GSM~PKVeAai~Fv~~~gk~A~ItsLe~~~~~l~g~~GT~I~ 311 (312)
T COG0549 246 NQQALDRVTVDEMEKYLAEGQFAAGSMGPKVEAAISFVENTGKPAIITSLENAEAALEGKAGTVIV 311 (312)
T ss_pred cchhhcccCHHHHHHHHhcCCCCCCCccHHHHHHHHHHHcCCCceEECcHHHHHHHhccCCCcEec
Confidence 7889999999999988764 45789997 77888888888998763331 24688875
No 105
>cd04868 ACT_AK-like ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes each of two ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). Typically, AK consists of two ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Aspartokinase is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. One mechanism for the regulation of this pathway is by the production of several isoenzymes of aspartokinase with different repressors and allosteric inhibitors. Pairs of ACT domains are proposed to specifically bind am
Probab=98.43 E-value=6.6e-07 Score=68.17 Aligned_cols=59 Identities=39% Similarity=0.646 Sum_probs=54.4
Q ss_pred eEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHH
Q 008621 477 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALH 535 (559)
Q Consensus 477 aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH 535 (559)
++|+++|. +...+++.+++|+.|++++|++.+++++.++.+++|+++.++.+++++.||
T Consensus 1 ~~i~v~g~~~~~~~~~~~~i~~~l~~~~i~i~~i~~~~~~~~~s~~v~~~~~~~~~~~lh 60 (60)
T cd04868 1 AKVSIVGVGMRGTPGVAAKIFSALAEAGINVDMISQSESEVNISFTVDESDLEKAVKALH 60 (60)
T ss_pred CEEEEECCCCCCCCCHHHHHHHHHHHCCCcEEEEEcCCCcEEEEEEEeHHHHHHHHHHhC
Confidence 47899997 667899999999999999999999999887899999999999999999987
No 106
>cd04912 ACT_AKiii-LysC-EC-like_1 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC) and plants, (Zea mays Ask1, Ask2, and Arabidopsis thaliana AK1). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Like the A. thaliana AK1 (AK1-AT), the E. coli AKIII (LysC) has two bound feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. The lysine-sensitive plant isoenzyme is synergistically inhibited by S-adenosylmethionine. A homolog of this group appears to be the Saccharomyces cerevisiae AK (Hom3) which clusters with this group as well. Members of this CD
Probab=98.43 E-value=1.2e-06 Score=71.95 Aligned_cols=72 Identities=56% Similarity=0.789 Sum_probs=58.4
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceee
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVN 471 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~ 471 (559)
+++|++.+.++.+.+|+.+++|+.|+++||+++++++|+.+++|+++.++.... + ..++.+.++|+++..++
T Consensus 1 ~~~Vsi~g~~l~~~~g~~~~if~~L~~~~I~v~~i~~s~~~is~~v~~~~~~~~---~--~~~~~~~~~l~~~~~~~ 72 (75)
T cd04912 1 ITLLNIKSNRMLGAHGFLAKVFEIFAKHGLSVDLISTSEVSVSLTLDPTKNLSD---Q--LLLDALVKDLSQIGDVE 72 (75)
T ss_pred CEEEEEEcCCCCCCccHHHHHHHHHHHcCCeEEEEEcCCcEEEEEEEchhhccc---h--HHHHHHHHHHHhCCEEE
Confidence 468999999999999999999999999999999999999999999998764210 0 14556777887755554
No 107
>TIGR00656 asp_kin_monofn aspartate kinase, monofunctional class. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. The protein slr0657 from Synechocystis PCC6803 is extended by a duplication of the C-terminal region corresponding to the beta chain. Incorporation of a second copy of the C-terminal domain may be quite common in this subgroup of aspartokinases.
Probab=98.39 E-value=1.6e-06 Score=93.58 Aligned_cols=113 Identities=21% Similarity=0.303 Sum_probs=89.2
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCce-eEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeEEEEEee-cccc
Q 008621 411 FLAKVFSTFEDLGISVDVVATSEVS-LSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRS 488 (559)
Q Consensus 411 ~larIf~~L~~~gI~Vd~IstSe~s-Is~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~aiISIVG~-~~~~ 488 (559)
+..+-+....+++|++....+.... -+...+.. ..-..+..++..+++++|+++|. |.+.
T Consensus 212 ~~~~a~~~a~~~~i~i~i~~~~~~~~gT~I~~~~------------------~~~~~v~~I~~~~~va~vsv~g~~~~~~ 273 (401)
T TIGR00656 212 LHPRTVEPAMRSGVPIEVRSSFDPEEGTLITNSM------------------ENPPLVKGIALRKNVTRVTVHGLGMLGK 273 (401)
T ss_pred cCHHHHHHHHHCCCeEEEEECCCCCCCeEEEeCc------------------ccCCceEEEEEECCEEEEEEecCCCCCC
Confidence 3466778889999999877654322 22222110 00012456888899999999996 8888
Q ss_pred chHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008621 489 SLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 541 (559)
Q Consensus 489 ~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 541 (559)
+|+++++|++|++++|++.+++|++|+.+++|+|+++|.+++++.||+.|...
T Consensus 274 ~g~~~~if~~L~~~~I~i~~i~~~~s~~~Is~~V~~~d~~~a~~~L~~~~~~~ 326 (401)
T TIGR00656 274 RGFLARIFGALAERNINVDLISQTPSETSISLTVDETDADEAVRALKDQSGAA 326 (401)
T ss_pred ccHHHHHHHHHHHcCCcEEEEEcCCCCceEEEEEeHHHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999999999999999998443
No 108
>cd04890 ACT_AK-like_1 ACT domains found C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes the first of two ACT domains found C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids, lysine, threonine, methionine, and isoleucine. This CD, includes the first ACT domain of the Escherichia coli (EC) isoenzyme, AKIII (LysC) and the Arabidopsis isoenzyme, asparate kinase 1, both enzymes monofunctional and involved in lysine synthesis, as well as the the first ACT domain of Bacillus subtilis (BS) isoenzyme, AKIII (YclM), and of the Saccharomyces cerevisiae AK (Hom3). Also included are the first ACT domains of the Methylomicrobium alcaliphilum AK, the first enzyme of the ectoine biosynthetic pathway. Members of this CD bel
Probab=98.33 E-value=1.7e-06 Score=67.95 Aligned_cols=49 Identities=47% Similarity=0.692 Sum_probs=45.5
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCch
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~ 445 (559)
.|++.+.+|.+.+|+.+++|+.|++++|+++++++++.+++|+++.++.
T Consensus 2 ~i~i~~~~m~~~~~~~~~if~~l~~~~i~v~~i~t~~~~is~~v~~~~~ 50 (62)
T cd04890 2 AIEIFDQLMNGEVGFLRKIFEILEKHGISVDLIPTSENSVTLYLDDSLL 50 (62)
T ss_pred EEEEeccccCcccCHHHHHHHHHHHcCCeEEEEecCCCEEEEEEehhhh
Confidence 5788999999999999999999999999999999999999999987653
No 109
>PRK06291 aspartate kinase; Provisional
Probab=98.33 E-value=1.3e-06 Score=95.93 Aligned_cols=113 Identities=29% Similarity=0.410 Sum_probs=89.3
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCc--eeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeEEEEEee-ccc
Q 008621 411 FLAKVFSTFEDLGISVDVVATSEV--SLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSIISLIGN-VQR 487 (559)
Q Consensus 411 ~larIf~~L~~~gI~Vd~IstSe~--sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~aiISIVG~-~~~ 487 (559)
+-.+-+....++||++....+.+. .-++..+.... . . ..+..|+..+++++|+++|. |..
T Consensus 271 ~~~~a~~~~~~~~i~i~i~~~~~~~~~gt~i~~~~~~------------~----~-~~V~~It~~~~valIsI~g~~m~~ 333 (465)
T PRK06291 271 LHPRTIEPAMEKGIPVRVKNTFNPEFPGTLITSDSES------------S----K-RVVKAVTLIKNVALINISGAGMVG 333 (465)
T ss_pred cCHHHHHHHHHcCCcEEEecCCCCCCCceEEEecccc------------c----C-cccceEEeeCCEEEEEEeCCCCCC
Confidence 345667778899999887765331 22333221110 0 0 12467888999999999997 778
Q ss_pred cchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 488 SSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 488 ~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
.+++++++|++|+++||+|.||+|++|+.+++|+|++++.+++++.||++|..
T Consensus 334 ~~g~~arvf~~L~~~gI~V~mIsq~sse~sIsf~V~~~d~~~av~~L~~~~~~ 386 (465)
T PRK06291 334 VPGTAARIFSALAEEGVNVIMISQGSSESNISLVVDEADLEKALKALRREFGE 386 (465)
T ss_pred CccHHHHHHHHHHHCCCcEEEEEecCCCceEEEEEeHHHHHHHHHHHHHHHHH
Confidence 89999999999999999999999999999999999999999999999999875
No 110
>PRK09436 thrA bifunctional aspartokinase I/homoserine dehydrogenase I; Provisional
Probab=98.20 E-value=3.4e-06 Score=98.59 Aligned_cols=112 Identities=21% Similarity=0.287 Sum_probs=88.4
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCc--eeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeEEEEEee-ccc
Q 008621 411 FLAKVFSTFEDLGISVDVVATSEV--SLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSIISLIGN-VQR 487 (559)
Q Consensus 411 ~larIf~~L~~~gI~Vd~IstSe~--sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~aiISIVG~-~~~ 487 (559)
+-.+-+....++||++....+.+. .-++.....+. +-..+..++..+++++|+++|. |..
T Consensus 265 lhp~a~~~a~~~~Ipi~i~n~~~p~~~GT~I~~~~~~-----------------~~~~Vk~It~~~dvalIsV~G~gm~~ 327 (819)
T PRK09436 265 LHPRTIAPIAQFQIPCLIKNTFNPQAPGTLIGAESDE-----------------DSLPVKGISNLNNMAMFNVSGPGMKG 327 (819)
T ss_pred chHHHHHHHHHCCceEEEccCCCCCCCceEEEecCcc-----------------cccccceEEEeCCEEEEEEEcCCCCC
Confidence 345667788899999888765432 12222221100 0012456888899999999997 888
Q ss_pred cchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhc
Q 008621 488 SSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFF 539 (559)
Q Consensus 488 ~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~ 539 (559)
.+++++|+|++|+++||++.||+|++|+.+|+|+|++++.+++++.||++|.
T Consensus 328 ~~G~~arIf~~La~~gI~V~mIsqssSe~sIsf~V~~~d~~~av~~L~~~f~ 379 (819)
T PRK09436 328 MVGMASRVFAALSRAGISVVLITQSSSEYSISFCVPQSDAAKAKRALEEEFA 379 (819)
T ss_pred CcCHHHHHHHHHHHCCCcEEEEEcCCCCceEEEEEeHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999999985
No 111
>cd04937 ACT_AKi-DapG-BS_2 ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI. This CD includes the C-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) strain 168), Clostridia, and Actinobacteria bacterial species. In B. subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive AK isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The BS AKI is tetrameric consisting of two alpha and two beta subunits; th
Probab=98.17 E-value=7.2e-06 Score=65.03 Aligned_cols=51 Identities=22% Similarity=0.380 Sum_probs=47.3
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCch
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~ 445 (559)
+++|++.|.+|...+|+++|+|+.|++.||++.++++|+.+++|++++++.
T Consensus 1 ~~~isvvG~~~~~~~gi~~~if~aL~~~~I~v~~~~~Se~~is~~v~~~~~ 51 (64)
T cd04937 1 CAKVTIIGSRIRGVPGVMAKIVGALSKEGIEILQTADSHTTISCLVSEDDV 51 (64)
T ss_pred CeEEEEECCCccCCcCHHHHHHHHHHHCCCCEEEEEcCccEEEEEEcHHHH
Confidence 468999999999999999999999999999999999999999999987653
No 112
>cd04912 ACT_AKiii-LysC-EC-like_1 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC) and plants, (Zea mays Ask1, Ask2, and Arabidopsis thaliana AK1). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Like the A. thaliana AK1 (AK1-AT), the E. coli AKIII (LysC) has two bound feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. The lysine-sensitive plant isoenzyme is synergistically inhibited by S-adenosylmethionine. A homolog of this group appears to be the Saccharomyces cerevisiae AK (Hom3) which clusters with this group as well. Members of this CD
Probab=98.17 E-value=9.5e-06 Score=66.53 Aligned_cols=63 Identities=22% Similarity=0.416 Sum_probs=54.0
Q ss_pred eeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccH---HHHHHHHHHHhcc
Q 008621 476 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEA---EQCVRALHETFFE 540 (559)
Q Consensus 476 ~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~---~kAv~~LH~~f~~ 540 (559)
+++|+++|. +...+++++++|++|++++|++.++++ |+.++||+|++++. +..++.|-++|-.
T Consensus 1 ~~~Vsi~g~~l~~~~g~~~~if~~L~~~~I~v~~i~~--s~~~is~~v~~~~~~~~~~~~~~~~~~l~~ 67 (75)
T cd04912 1 ITLLNIKSNRMLGAHGFLAKVFEIFAKHGLSVDLIST--SEVSVSLTLDPTKNLSDQLLLDALVKDLSQ 67 (75)
T ss_pred CEEEEEEcCCCCCCccHHHHHHHHHHHcCCeEEEEEc--CCcEEEEEEEchhhccchHHHHHHHHHHHh
Confidence 478999997 778899999999999999999999987 78999999999986 4566666666654
No 113
>cd04891 ACT_AK-LysC-DapG-like_1 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII and related proteins. This CD includes the N-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, as well as, the first and third, of four, ACT domains present in cyanobacteria AK. Also included are the N-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase isoenzyme AKI found in Bacilli (Bacillus subtilis strain 168), Clostridia, and Actinobacteria bacterial species. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.03 E-value=1.9e-05 Score=60.53 Aligned_cols=57 Identities=28% Similarity=0.461 Sum_probs=50.0
Q ss_pred eEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCc---eEEEEEEecccHHHHHHHH
Q 008621 477 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASK---VNISLIVNDDEAEQCVRAL 534 (559)
Q Consensus 477 aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe---~sIs~vV~~~d~~kAv~~L 534 (559)
++|+++|. .+.+++++++|+.|.+++|++.+++|+.+. .+++|.+++++.+++++.|
T Consensus 1 ~~v~v~~~-~~~~~~~~~i~~~L~~~~i~i~~i~~~~~~~~~~~is~~v~~~~~~~~~~~l 60 (61)
T cd04891 1 AQVTIKGV-PDKPGVAAKIFSALAEAGINVDMIVQSVSRGGTTDISFTVPKSDLEKALAIL 60 (61)
T ss_pred CEEEEecC-CCCCcHHHHHHHHHHHcCCcEEEEEEcCCCCCcEEEEEEEeHHHHHHHHHHh
Confidence 36788884 566899999999999999999999998766 8899999999999988765
No 114
>cd04933 ACT_AK1-AT_1 ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1). This CD includes the first of two ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1), which can be synergistically inhibited by S-adenosylmethionine. This isoenzyme is found in higher plants, Arabidopsis thaliana (AT) and Zea mays, and also in Chlorophyta. Like the Escherichia coli AKIII (LysC), Arabidopsis AK1 binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. A loop in common is involved in the binding of both Lys and S-adenosylmethionine providing an explanation for the synergistic inhibition by these effectors. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=98.01 E-value=2.7e-05 Score=64.48 Aligned_cols=63 Identities=19% Similarity=0.319 Sum_probs=53.9
Q ss_pred eeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHH------HHHHHHHHHhcc
Q 008621 476 RSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAE------QCVRALHETFFE 540 (559)
Q Consensus 476 ~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~------kAv~~LH~~f~~ 540 (559)
+++|+|.+. +...+|+++++|+.|+++||++.||+| ++.++||.+++++.. .+++.|-.+|-.
T Consensus 1 ~~~i~i~~~~~~~~~g~~a~IF~~La~~~InVDmI~q--s~~sISftV~~sd~~~~~~~~~~l~~~~~~~~~ 70 (78)
T cd04933 1 VTMLDITSTRMLGQYGFLAKVFSIFETLGISVDVVAT--SEVSISLTLDPSKLWSRELIQQELDHVVEELEK 70 (78)
T ss_pred CEEEEEEcCCCCCccCHHHHHHHHHHHcCCcEEEEEe--cCCEEEEEEEhhhhhhhhhHHHHHHHHHHHHHH
Confidence 368899997 778899999999999999999999998 679999999999984 577777766644
No 115
>PF13840 ACT_7: ACT domain ; PDB: 3S1T_A 1ZHV_A 3AB4_K 3AB2_O 2DTJ_A 3AAW_A 2RE1_B 3MAH_A 1ZVP_D.
Probab=98.01 E-value=2.5e-05 Score=62.38 Aligned_cols=53 Identities=25% Similarity=0.429 Sum_probs=47.8
Q ss_pred ecCeEEEEEEecCccc-hhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCch
Q 008621 392 KRNVTMLDIVSTRMLG-QYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (559)
Q Consensus 392 ~~~ialItV~~~~m~~-~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~ 445 (559)
.++++.|+|.+.+|.. .+|+++++|+.|+++||++.+++ |+.++++.|+.+++
T Consensus 3 ~~~~~~i~v~g~g~~~~~~Gv~a~i~~~La~~~I~i~~is-S~~~~~ilV~~~~~ 56 (65)
T PF13840_consen 3 EEDWAKISVVGPGLRFDVPGVAAKIFSALAEAGINIFMIS-SEISISILVKEEDL 56 (65)
T ss_dssp ESEEEEEEEEEECGTTTSHHHHHHHHHHHHHTTS-ECEEE-ESSEEEEEEEGGGH
T ss_pred cCCEEEEEEEccccCCCcccHHHHHHHHHHHCCCCEEEEE-EeeeEEEEEeHHHH
Confidence 5789999999998866 99999999999999999999999 99999999998764
No 116
>cd04913 ACT_AKii-LysC-BS-like_1 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related proteins. This CD includes the N-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive aspartokinase isoenzymes. The B. subtilis 168 AKII is induced by methionine and repressed and inhibited by lysine. Although Corynebacterium glutamicum is known to contain a single aspartokinase, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In corynebacteria and other various Gram-positive bacteria, the DAP-lysine pathway is fee
Probab=98.01 E-value=2e-05 Score=63.20 Aligned_cols=61 Identities=26% Similarity=0.363 Sum_probs=53.4
Q ss_pred eEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecCC---ceEEEEEEecccHHHHHHHHHHHh
Q 008621 477 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGAS---KVNISLIVNDDEAEQCVRALHETF 538 (559)
Q Consensus 477 aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaS---e~sIs~vV~~~d~~kAv~~LH~~f 538 (559)
++|+++|. ...+++++++|+.|.++||++.+++|+.+ +.+++|++++++.+++++.||+..
T Consensus 2 ~~v~v~~~-~~~~g~~~~i~~~L~~~~I~i~~i~~~~~~~~~~~is~~v~~~d~~~~~~~l~~~~ 65 (75)
T cd04913 2 AKITLRGV-PDKPGVAAKIFGALAEANINVDMIVQNVSRDGTTDISFTVPKSDLKKALAVLEKLK 65 (75)
T ss_pred eEEEECCC-CCCCcHHHHHHHHHHHcCCeEEEEEeCCCCCCcEEEEEEecHHHHHHHHHHHHHHH
Confidence 67888884 55689999999999999999999999766 357999999999999999999954
No 117
>cd04919 ACT_AK-Hom3_2 ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. AK is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single AK, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies shown that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydrodynamic size. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.98 E-value=2.8e-05 Score=61.49 Aligned_cols=50 Identities=24% Similarity=0.541 Sum_probs=45.4
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe--cCceeEEEeCCCc
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSK 444 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist--Se~sIs~~v~~~~ 444 (559)
+++|++.|.++.+.+++.+++|+.|+++||+++|+++ ++.+++|++++++
T Consensus 1 ~~~isvvg~~~~~~~~~~~~if~~L~~~~I~v~~i~q~~s~~~isf~v~~~~ 52 (66)
T cd04919 1 LAILSLVGKHMKNMIGIAGRMFTTLADHRINIEMISQGASEINISCVIDEKD 52 (66)
T ss_pred CeEEEEECCCCCCCcCHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHH
Confidence 4689999999999999999999999999999999975 6789999998765
No 118
>cd04922 ACT_AKi-HSDH-ThrA_2 ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). This CD includes the second of two ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). The ACT domains are positioned between the N-terminal catalytic domain of AK and the C-terminal HSDH domain found in bacteria (Escherichia coli (EC) ThrA) and higher plants (Zea mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. HSDH is the first committed reaction in the branch of the pathway that leads to Thr and Met. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pathwa
Probab=97.93 E-value=3.9e-05 Score=60.49 Aligned_cols=50 Identities=26% Similarity=0.469 Sum_probs=45.3
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe--cCceeEEEeCCCc
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSK 444 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist--Se~sIs~~v~~~~ 444 (559)
+++|++.|.++.+.+++.+++|+.|+++||+++|+++ ++.+++|++++++
T Consensus 1 ~~~isvvg~~~~~~~~~~~~i~~~l~~~~I~v~~i~~~~s~~~is~~v~~~~ 52 (66)
T cd04922 1 LSILALVGDGMAGTPGVAATFFSALAKANVNIRAIAQGSSERNISAVIDEDD 52 (66)
T ss_pred CeEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCcccEEEEEEeHHH
Confidence 4689999999999999999999999999999999975 6789999998765
No 119
>cd04890 ACT_AK-like_1 ACT domains found C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes the first of two ACT domains found C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids, lysine, threonine, methionine, and isoleucine. This CD, includes the first ACT domain of the Escherichia coli (EC) isoenzyme, AKIII (LysC) and the Arabidopsis isoenzyme, asparate kinase 1, both enzymes monofunctional and involved in lysine synthesis, as well as the the first ACT domain of Bacillus subtilis (BS) isoenzyme, AKIII (YclM), and of the Saccharomyces cerevisiae AK (Hom3). Also included are the first ACT domains of the Methylomicrobium alcaliphilum AK, the first enzyme of the ectoine biosynthetic pathway. Members of this CD bel
Probab=97.93 E-value=4.2e-05 Score=59.96 Aligned_cols=59 Identities=20% Similarity=0.412 Sum_probs=52.3
Q ss_pred EEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHh
Q 008621 478 IISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETF 538 (559)
Q Consensus 478 iISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f 538 (559)
.|++.|. |...+++.+++|+.|++++|++.+|++ ++.+++|+++.++.++.++.|-+++
T Consensus 2 ~i~i~~~~m~~~~~~~~~if~~l~~~~i~v~~i~t--~~~~is~~v~~~~~~~~~~~l~~~l 61 (62)
T cd04890 2 AIEIFDQLMNGEVGFLRKIFEILEKHGISVDLIPT--SENSVTLYLDDSLLPKKLKRLLAEL 61 (62)
T ss_pred EEEEeccccCcccCHHHHHHHHHHHcCCeEEEEec--CCCEEEEEEehhhhhHHHHHHHHhh
Confidence 5788886 778899999999999999999999988 6799999999999888888877654
No 120
>cd04934 ACT_AK-Hom3_1 CT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the aspartokinase (AK) HOM3, a monofunctional class enzyme found in Saccharomyces cerevisiae, and other related ACT domains. AK is the first enzyme in the aspartate metabolic pathway, catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP, and in fungi, is responsible for the production of threonine, isoleucine and methionine. S. cerevisiae has a single AK, which is regulated by feedback, allosteric inhibition by L-threonine. Recent studies shown that the allosteric transition triggered by binding of threonine to AK involves a large change in the conformation of the native hexameric enzyme that is converted to an inactive one of different shape and substantially smaller hydro
Probab=97.91 E-value=4.4e-05 Score=62.42 Aligned_cols=62 Identities=24% Similarity=0.362 Sum_probs=53.6
Q ss_pred eEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHH-HHHHHHHHhcc
Q 008621 477 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQ-CVRALHETFFE 540 (559)
Q Consensus 477 aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~k-Av~~LH~~f~~ 540 (559)
++|.+.+. |...+|+++++|+.|+++|||+.||+| ++.+++|.++.++.+. .++.|.++|-.
T Consensus 2 ~~I~i~~~~m~~~~g~~~~If~~la~~~I~vd~I~~--s~~~isftv~~~~~~~~~l~~l~~el~~ 65 (73)
T cd04934 2 LVINIHSNKKSLSHGFLARIFAILDKYRLSVDLIST--SEVHVSMALHMENAEDTNLDAAVKDLQK 65 (73)
T ss_pred EEEEEEcccCccccCHHHHHHHHHHHcCCcEEEEEe--CCCEEEEEEehhhcChHHHHHHHHHHHH
Confidence 67889997 788899999999999999999999998 6699999999987654 77777777654
No 121
>COG0527 LysC Aspartokinases [Amino acid transport and metabolism]
Probab=97.87 E-value=9e-05 Score=80.78 Aligned_cols=114 Identities=23% Similarity=0.303 Sum_probs=93.5
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCce--eEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeEEEEEee-ccc
Q 008621 411 FLAKVFSTFEDLGISVDVVATSEVS--LSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSIISLIGN-VQR 487 (559)
Q Consensus 411 ~larIf~~L~~~gI~Vd~IstSe~s--Is~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~aiISIVG~-~~~ 487 (559)
+..+-++...+++|++..-++.... =++........ . ..+..|+..+++++|++.|. |..
T Consensus 257 LHprav~pa~~~~Ip~~i~~t~~p~~~GTlI~~~~~~~----------------~-~~v~gIa~~~~~~~i~v~~~~~~~ 319 (447)
T COG0527 257 LHPRAVEPAMRSGIPLRIKNTFNPDAPGTLITAETESD----------------E-PVVKGIALDDNVALITVSGPGMNG 319 (447)
T ss_pred cCHHHHHHHHhcCCcEEEEecCCCCCCceEEecCCcCC----------------C-CceEEEEeCCCeEEEEEEccCccc
Confidence 4577788899999999888765543 45555432100 0 12346888899999999997 777
Q ss_pred cchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhccC
Q 008621 488 SSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFES 541 (559)
Q Consensus 488 ~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~~ 541 (559)
.+|+++++|..|+++||++.+|.|+.++.+++|.+++++.+++.+.||+++...
T Consensus 320 ~~g~~a~vf~~l~~~~i~v~~I~q~~~~~~i~~~v~~~~~~~a~~~l~~~~~~~ 373 (447)
T COG0527 320 MVGFAARVFGILAEAGINVDLITQSISEVSISFTVPESDAPRALRALLEEKLEL 373 (447)
T ss_pred cccHHHHHHHHHHHcCCcEEEEEeccCCCeEEEEEchhhHHHHHHHHHHHHhhh
Confidence 889999999999999999999999999999999999999999999999999854
No 122
>cd04932 ACT_AKiii-LysC-EC_1 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The E. coli AKIII (LysC) binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.85 E-value=7.3e-05 Score=61.49 Aligned_cols=61 Identities=20% Similarity=0.422 Sum_probs=49.7
Q ss_pred eEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHH--HHHH-HHHHHhc
Q 008621 477 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAE--QCVR-ALHETFF 539 (559)
Q Consensus 477 aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~--kAv~-~LH~~f~ 539 (559)
++|++.|. +...+|+++++|+.|+++||+|.||+| ++.++||.++.++.. ++++ +|-.+|-
T Consensus 2 ~~ItI~~~~~~~~~g~~~~IF~~La~~~I~VDmI~~--s~~~iSftv~~~d~~~~~~~~~~l~~~l~ 66 (75)
T cd04932 2 TLVTLKSPNMLHAQGFLAKVFGILAKHNISVDLITT--SEISVALTLDNTGSTSDQLLTQALLKELS 66 (75)
T ss_pred EEEEEecCCCCCCcCHHHHHHHHHHHcCCcEEEEee--cCCEEEEEEeccccchhHHHHHHHHHHHH
Confidence 67889776 677899999999999999999999998 669999999999843 3554 5555443
No 123
>PRK06635 aspartate kinase; Reviewed
Probab=97.82 E-value=4.6e-05 Score=82.33 Aligned_cols=111 Identities=17% Similarity=0.279 Sum_probs=85.7
Q ss_pred HHHHHHHHHHhCCCcEEEEEec-CceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeEEEEEeeccccc
Q 008621 411 FLAKVFSTFEDLGISVDVVATS-EVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSIISLIGNVQRSS 489 (559)
Q Consensus 411 ~larIf~~L~~~gI~Vd~IstS-e~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~aiISIVG~~~~~~ 489 (559)
+..+.++.+.+.++++....+. +...++....... ..+ -..+..+...+++++|+++| +.+.+
T Consensus 211 ~~~~a~~~~~~~~i~~~i~~~~~~~~gT~i~~~~~~----------~~~-----~~~i~~I~~~~~v~~Isv~g-~~~~~ 274 (404)
T PRK06635 211 LHPRSVEYAKKYNVPLRVRSSFSDNPGTLITGEEEE----------IME-----QPVVTGIAFDKDEAKVTVVG-VPDKP 274 (404)
T ss_pred cCHHHHHHHHHcCceEEEEcCCCCCCCCEEeeCCcc----------ccc-----cCceEEEEecCCeEEEEECC-CCCCc
Confidence 4466788899999998877542 3344444432210 000 00134577889999999999 88889
Q ss_pred hHHHHHHHHHHhCCCcEEEEEecCCc---eEEEEEEecccHHHHHHHHHHH
Q 008621 490 LILEKAFRVLRRSGVNVQMISQGASK---VNISLIVNDDEAEQCVRALHET 537 (559)
Q Consensus 490 gv~~ri~~~L~~~~InI~~IsqgaSe---~sIs~vV~~~d~~kAv~~LH~~ 537 (559)
|+++++|++|++.|||+.+++|+.++ .+++|++++++.++++++||+.
T Consensus 275 g~l~~i~~~L~~~~I~i~~is~s~~~~~~~~is~~v~~~~~~~a~~~L~~~ 325 (404)
T PRK06635 275 GIAAQIFGALAEANINVDMIVQNVSEDGKTDITFTVPRDDLEKALELLEEV 325 (404)
T ss_pred cHHHHHHHHHHHcCCeEEEEEecCCCCCceeEEEEEcHHHHHHHHHHHHHH
Confidence 99999999999999999999998766 8999999999999999999993
No 124
>cd04911 ACT_AKiii-YclM-BS_1 ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Bacillus subtilis YclM is reported to be a single polypeptide of 50 kD. AKIII from Bacillus subtilis strain 168 is induced by lysine and repressed by threonine and it is synergistically inhibited by lysine and threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.77 E-value=6.2e-05 Score=61.84 Aligned_cols=64 Identities=22% Similarity=0.314 Sum_probs=52.5
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhh
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQASELDHVVEELEK 466 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~ 466 (559)
+.|++....|....||..|++++|+++||+++++.++.+++|++++++++... .++.++.+++.
T Consensus 2 ~~I~i~K~~Mn~evGF~rk~L~I~E~~~is~Eh~PSGID~~Siii~~~~~~~~-------~~~~i~~~i~~ 65 (76)
T cd04911 2 CSIYISKYLMNREVGFGRKLLSILEDNGISYEHMPSGIDDISIIIRDNQLTDE-------KEQKILAEIKE 65 (76)
T ss_pred ceEehhHhhccchhcHHHHHHHHHHHcCCCEeeecCCCccEEEEEEccccchh-------hHHHHHHHHHH
Confidence 45677888899999999999999999999999999999999999998866421 23445556654
No 125
>cd04924 ACT_AK-Arch_2 ACT domains of a monofunctional aspartokinase found mostly in Archaea species (ACT_AK-Arch_2). Included in this CD is the second of two ACT domains of a monofunctional aspartokinase found mostly in Archaea species (ACT_AK-Arch_2). The first or N-terminal ACT domain of these proteins cluster with the ThrA-like ACT 1 domains (ACT_AKi-HSDH-ThrA-like_1) which includes the threonine-sensitive archaeal Methanococcus jannaschii aspartokinase ACT 1 domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.72 E-value=0.00013 Score=57.29 Aligned_cols=51 Identities=25% Similarity=0.444 Sum_probs=45.2
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe--cCceeEEEeCCCch
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKL 445 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist--Se~sIs~~v~~~~~ 445 (559)
+++|++.|.++...+++.+++|+.|+++||+++|+++ ++.+++|+++.++.
T Consensus 1 ~~~isivg~~~~~~~~~~~~i~~~L~~~~I~v~~i~q~~s~~~isf~i~~~~~ 53 (66)
T cd04924 1 VAVVAVVGSGMRGTPGVAGRVFGALGKAGINVIMISQGSSEYNISFVVAEDDG 53 (66)
T ss_pred CeEEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHH
Confidence 4689999999999999999999999999999999974 56889999987653
No 126
>cd04936 ACT_AKii-LysC-BS-like_2 ACT domains of the lysine-sensitive, aspartokinase (AK) isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related domains. This CD includes the C-terminal of the two ACT domains of the lysine-sensitive, aspartokinase (AK) isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis strain 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive AK isoenzymes. The B. subtilis strain 168 AKII is induced by methionine and repressed and inhibited by lysine. Although C. glutamicum is known to contain a single AK, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In corynebacteria and other various Gram-positive bacteria, the DAP-lysine pathway is feedback regu
Probab=97.70 E-value=0.00014 Score=56.45 Aligned_cols=49 Identities=29% Similarity=0.521 Sum_probs=44.5
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCch
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~ 445 (559)
+|++.+.++.+.+++.+++|+.|++++|+++++++++.+++|+++.++.
T Consensus 2 ~i~v~g~~~~~~~~~~~~i~~~L~~~~i~v~~i~~s~~~is~~v~~~d~ 50 (63)
T cd04936 2 KVSIVGAGMRSHPGVAAKMFEALAEAGINIEMISTSEIKISCLIDEDDA 50 (63)
T ss_pred EEEEECCCCCCCccHHHHHHHHHHHCCCcEEEEEccCceEEEEEeHHHH
Confidence 5788888888899999999999999999999999889999999987653
No 127
>cd04923 ACT_AK-LysC-DapG-like_2 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related domains. This CD includes the C-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, as well as, the second and fourth, of four, ACT domains present in cyanobacteria AK. Also included are the C-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase isoenzyme AKI found in Bacilli (B. subtilis strain 168), Clostridia, and Actinobacteria bacterial species. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.68 E-value=0.00016 Score=56.18 Aligned_cols=49 Identities=29% Similarity=0.514 Sum_probs=44.5
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCch
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~ 445 (559)
+|++.+.++.+.++++.++|+.|++++|+++++++++.+++|+++.++.
T Consensus 2 ~v~v~g~~~~~~~~~~~~i~~~L~~~~i~v~~i~~s~~~is~~v~~~~~ 50 (63)
T cd04923 2 KVSIVGAGMRSHPGVAAKMFKALAEAGINIEMISTSEIKISCLVDEDDA 50 (63)
T ss_pred EEEEECCCCCCCccHHHHHHHHHHHCCCCEEEEEccCCeEEEEEeHHHH
Confidence 6788888888889999999999999999999999999999999987653
No 128
>cd04935 ACT_AKiii-DAPDC_1 ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. This CD includes the first of two ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. Aspartokinase (AK) is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The lysA gene encodes the enzyme DAPDC, a pyridoxal-5'-phosphate (PLP)-dependent enzyme which catalyzes the final step in the lysine biosynthetic pathway converting meso-diaminopimelic acid (DAP) to l-lysine. Tandem ACT domains are positioned centrally with the AK catalytic domain N-terminal and the DAPDC domains C-terminal. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.66 E-value=0.00025 Score=58.28 Aligned_cols=61 Identities=20% Similarity=0.384 Sum_probs=50.7
Q ss_pred eEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccH--H-HHHHHHHHHhc
Q 008621 477 SIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEA--E-QCVRALHETFF 539 (559)
Q Consensus 477 aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~--~-kAv~~LH~~f~ 539 (559)
++|++.+. +...+++++++|++|++++|++.||+| ++.+++|.++.++. . +.++.|-+++-
T Consensus 2 ~~i~i~~~~~~~~~g~~~~IF~~La~~~I~vDmI~~--s~~~isftv~~~~~~~~~~~~~~l~~el~ 66 (75)
T cd04935 2 RLVSMETLGMWQQVGFLADVFAPFKKHGVSVDLVST--SETNVTVSLDPDPNGLDPDVLDALLDDLN 66 (75)
T ss_pred EEEEEEcCCCCCccCHHHHHHHHHHHcCCcEEEEEe--CCCEEEEEEeCcccccchHHHHHHHHHHH
Confidence 67889997 777899999999999999999999998 66999999999982 3 36666655554
No 129
>cd04918 ACT_AK1-AT_2 ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1). This CD includes the second of two ACT domains located C-terminal to the catalytic domain of a monofunctional, lysine-sensitive, plant aspartate kinase 1 (AK1), which can be synergistically inhibited by S-adenosylmethionine (SAM). This isoenzyme is found in higher plants, Arabidopsis thaliana (AT) and Zea mays, and also in Chlorophyta. In its inactive state, Arabidopsis AK1 binds the effectors lysine and SAM (two molecules each) at the interface of two ACT1 domain subunits. The second ACT domain (ACT2), this CD, does not interact with an effector. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.64 E-value=0.00019 Score=57.08 Aligned_cols=49 Identities=18% Similarity=0.421 Sum_probs=43.4
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEE--ecCceeEEEeCCCch
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA--TSEVSLSLTLDPSKL 445 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Is--tSe~sIs~~v~~~~~ 445 (559)
++|++.|. +...+|+++++|+.|++.||++.|++ +|+.+++|.+++++.
T Consensus 2 a~VsvVG~-~~~~~~~~~~i~~aL~~~~I~v~~i~~g~s~~sis~~v~~~~~ 52 (65)
T cd04918 2 SIISLIGN-VQRSSLILERAFHVLYTKGVNVQMISQGASKVNISLIVNDSEA 52 (65)
T ss_pred cEEEEECC-CCCCccHHHHHHHHHHHCCCCEEEEEecCccceEEEEEeHHHH
Confidence 47889998 77789999999999999999999998 778899999987653
No 130
>cd04916 ACT_AKiii-YclM-BS_2 ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. B. subtilis YclM is reported to be a single polypeptide of 50 kD. AKIII from B. subtilis strain 168 is induced by lysine and repressed by threonine and it is synergistically inhibited by lysine and threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.63 E-value=0.00024 Score=55.89 Aligned_cols=51 Identities=18% Similarity=0.371 Sum_probs=45.3
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe--cCceeEEEeCCCch
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKL 445 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist--Se~sIs~~v~~~~~ 445 (559)
+++|++.|.++...+++.+++|+.|++.||+++|+++ ++.+++|+++.++.
T Consensus 1 ~~lisivg~~~~~~~~~~~~i~~~L~~~~i~v~~i~~~~s~~~isf~v~~~d~ 53 (66)
T cd04916 1 LALIMVVGEGMKNTVGVSARATAALAKAGINIRMINQGSSEISIMIGVHNEDA 53 (66)
T ss_pred CeEEEEEcCCCCCCccHHHHHHHHHHHCCCCEEEEEecCcccEEEEEEeHHHH
Confidence 4688999999999999999999999999999999985 56889999987653
No 131
>TIGR00657 asp_kinases aspartate kinase. The Lys-sensitive enzyme of Bacillus subtilis resembles the E. coli form but is an alpha 2/beta 2 heterotetramer, where the beta subunit is translated from an in-phase alternative initiator at Met-246. This may be a feature of a number of closely related forms, including a paralog from B. subtilis.
Probab=97.60 E-value=0.00016 Score=79.18 Aligned_cols=109 Identities=22% Similarity=0.336 Sum_probs=82.0
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCc--eeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeEEEEEee-ccc
Q 008621 411 FLAKVFSTFEDLGISVDVVATSEV--SLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSIISLIGN-VQR 487 (559)
Q Consensus 411 ~larIf~~L~~~gI~Vd~IstSe~--sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~aiISIVG~-~~~ 487 (559)
+..+.+....+++|++....+... .-+...+... .. +-..+..++..+++++|++.|. +..
T Consensus 251 ~~~~a~~~~~~~~i~i~i~~~~~~~~~GT~I~~~~~-----------~~-----~~~~i~~It~~~~v~~Isv~g~~~~~ 314 (441)
T TIGR00657 251 LHPRTLEPAMRAKIPIVVKSTFNPEAPGTLIVASTK-----------EM-----EEPIVKGLSLDRNQARVTVSGLGMKG 314 (441)
T ss_pred cCHHHHHHHHHcCCeEEEecCCCCCCCceEEEeCCC-----------cc-----ccCccceEEEeCCEEEEEEECCCCCC
Confidence 345667788899999887764321 1222222110 00 0012456888899999999997 655
Q ss_pred cchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHH
Q 008621 488 SSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHE 536 (559)
Q Consensus 488 ~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~ 536 (559)
+|+++++|++|++++|+|.+|+|++|+.+++|+|++++.+++++.|..
T Consensus 315 -~g~la~if~~L~~~~I~I~~i~q~~se~sIs~~I~~~~~~~a~~~L~~ 362 (441)
T TIGR00657 315 -PGFLARVFGALAEAGINVDLITQSSSETSISFTVDKEDADQAKTLLKS 362 (441)
T ss_pred -ccHHHHHHHHHHHcCCeEEEEEecCCCceEEEEEEHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999888744
No 132
>cd04915 ACT_AK-Ectoine_2 ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and various other halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinas
Probab=97.59 E-value=0.00032 Score=56.10 Aligned_cols=50 Identities=16% Similarity=0.348 Sum_probs=44.2
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe--cCceeEEEeCCCch
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKL 445 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist--Se~sIs~~v~~~~~ 445 (559)
+++|++.|.+|. .+|+.+++|+.|.+.||++.|+++ |+.+++|.+++++.
T Consensus 2 ~a~VsvVG~gm~-~~gv~~ki~~~L~~~~I~v~~i~~~~s~~~is~~V~~~~~ 53 (66)
T cd04915 2 VAIVSVIGRDLS-TPGVLARGLAALAEAGIEPIAAHQSMRNVDVQFVVDRDDY 53 (66)
T ss_pred EEEEEEECCCCC-cchHHHHHHHHHHHCCCCEEEEEecCCeeEEEEEEEHHHH
Confidence 678999999994 899999999999999999999987 45899999987653
No 133
>cd04868 ACT_AK-like ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes each of two ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). Typically, AK consists of two ACT domains in a tandem repeat, but the second ACT domain is inserted within the first, resulting in, what is normally the terminal beta strand of ACT2, formed from a region N-terminal of ACT1. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Aspartokinase is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. One mechanism for the regulation of this pathway is by the production of several isoenzymes of aspartokinase with different repressors and allosteric inhibitors. Pairs of ACT domains are proposed to specifically bind am
Probab=97.53 E-value=0.0003 Score=53.21 Aligned_cols=48 Identities=42% Similarity=0.657 Sum_probs=42.6
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecC--ceeEEEeCCCc
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSE--VSLSLTLDPSK 444 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe--~sIs~~v~~~~ 444 (559)
+|++.+..|.+.+++++++|+.|++++|++++++++. .+++|+++.++
T Consensus 2 ~i~v~g~~~~~~~~~~~~i~~~l~~~~i~i~~i~~~~~~~~~s~~v~~~~ 51 (60)
T cd04868 2 KVSIVGVGMRGTPGVAAKIFSALAEAGINVDMISQSESEVNISFTVDESD 51 (60)
T ss_pred EEEEECCCCCCCCCHHHHHHHHHHHCCCcEEEEEcCCCcEEEEEEEeHHH
Confidence 6788888888889999999999999999999999876 78999998653
No 134
>cd04920 ACT_AKiii-DAPDC_2 ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC). This CD includes the second of two ACT domains of a bifunctional AKIII (LysC)-like aspartokinase/meso-diaminopimelate decarboxylase (DAPDC) bacterial protein. Aspartokinase (AK) is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The lysA gene encodes the enzyme DAPDC, a pyridoxal-5'-phosphate (PLP)-dependent enzyme which catalyzes the final step in the lysine biosynthetic pathway converting meso-diaminopimelic acid (DAP) to l-lysine. Tandem ACT domains are positioned centrally with the AK catalytic domain N-terminal and the DAPDC domains C-terminal. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.41 E-value=0.0005 Score=54.40 Aligned_cols=50 Identities=12% Similarity=0.229 Sum_probs=45.3
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCch
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~ 445 (559)
++|++.|.+|...+|+++++|+.|++.+|++.+..+|+.+++|.++.++.
T Consensus 1 a~VsvVG~g~~~~~gv~~~~~~~L~~~~i~~i~~~~s~~~is~vv~~~d~ 50 (63)
T cd04920 1 AAVSLVGRGIRSLLHKLGPALEVFGKKPVHLVSQAANDLNLTFVVDEDQA 50 (63)
T ss_pred CEEEEECCCcccCccHHHHHHHHHhcCCceEEEEeCCCCeEEEEEeHHHH
Confidence 47899999999999999999999999999988888999999999987653
No 135
>cd04892 ACT_AK-like_2 ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). This CD includes the second of two ACT domains C-terminal to the catalytic domain of aspartokinase (AK; 4-L-aspartate-4-phosphotransferase). The exception in this group, is the inclusion of the first ACT domain of the bifunctional aspartokinase - homoserine dehydrogenase-like enzyme group (ACT_AKi-HSDH-ThrA-like_1) which includes the monofunctional, threonine-sensitive, aspartokinase found in Methanococcus jannaschii and other related archaeal species. AK catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. AK is the first enzyme in the pathway of the biosynthesis of the aspartate family of amino acids (lysine, threonine, methionine, and isoleucine) and the bacterial cell wall component, meso-diaminopimelate. One mechanism for the regulation of this pathway is by the production of several isoenzymes of AK with different repressors an
Probab=97.35 E-value=0.00075 Score=52.07 Aligned_cols=49 Identities=27% Similarity=0.570 Sum_probs=43.1
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEec--CceeEEEeCCCc
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS--EVSLSLTLDPSK 444 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstS--e~sIs~~v~~~~ 444 (559)
++|++.|.++.+.+++.+++|+.|++++|++++++++ +.+++|+++.++
T Consensus 1 ~~i~i~g~~~~~~~~~~~~i~~~l~~~~i~v~~i~~~~~~~~i~~~v~~~~ 51 (65)
T cd04892 1 ALVSVVGAGMRGTPGVAARIFSALAEAGINIIMISQGSSEVNISFVVDEDD 51 (65)
T ss_pred CEEEEECCCCCCCccHHHHHHHHHHHCCCcEEEEEcCCCceeEEEEEeHHH
Confidence 3688888889899999999999999999999999874 488999998764
No 136
>cd04921 ACT_AKi-HSDH-ThrA-like_1 ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). This CD includes the first of two ACT domains of the bifunctional enzyme aspartokinase (AK) - homoserine dehydrogenase (HSDH). The ACT domains are positioned between the N-terminal catalytic domain of AK and the C-terminal HSDH domain found in bacteria (Escherichia coli (EC) ThrA) and higher plants (Zea mays AK-HSDH). AK and HSDH are the first and third enzymes in the biosynthetic pathway of the aspartate family of amino acids. AK catalyzes the phosphorylation of Asp to P-aspartyl phosphate. HSDH catalyzes the NADPH-dependent conversion of Asp 3-semialdehyde to homoserine. HSDH is the first committed reaction in the branch of the pathway that leads to Thr and Met. In E. coli, ThrA is subject to allosteric regulation by the end product L-threonine and the native enzyme is reported to be tetrameric. As with bacteria, plant AK and HSDH are feedback inhibited by pat
Probab=97.22 E-value=0.0013 Score=53.98 Aligned_cols=51 Identities=35% Similarity=0.565 Sum_probs=44.9
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe--cCceeEEEeCCCch
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT--SEVSLSLTLDPSKL 445 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist--Se~sIs~~v~~~~~ 445 (559)
+++|++.|.++.+.+++..++|+.|++++|+++|+++ ++.+++|+++.++.
T Consensus 1 ~~~I~vvg~~~~~~~~~~~~i~~~L~~~~I~v~~i~~~~~~~~isf~v~~~d~ 53 (80)
T cd04921 1 VALINIEGTGMVGVPGIAARIFSALARAGINVILISQASSEHSISFVVDESDA 53 (80)
T ss_pred CEEEEEEcCCCCCCccHHHHHHHHHHHCCCcEEEEEecCCcceEEEEEeHHHH
Confidence 4688999989999999999999999999999999985 45789999987654
No 137
>PLN02551 aspartokinase
Probab=97.22 E-value=0.0018 Score=72.15 Aligned_cols=100 Identities=15% Similarity=0.234 Sum_probs=72.8
Q ss_pred CcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCcc---------------ceeeEEeeecCeEEEEEEecCccc
Q 008621 343 QVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSK---------------AVLTSIVLKRNVTMLDIVSTRMLG 407 (559)
Q Consensus 343 ~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~---------------~~It~Is~~~~ialItV~~~~m~~ 407 (559)
..+..+-+..+.++||+|....+.. .. =+......+... ..+..|...+++++|++.|. |..
T Consensus 380 ~g~~arvf~~l~~~~I~Vd~IssSe-~s-Is~~v~~~~~~~~~~i~~~l~~l~~el~~~~~V~v~~~vAiISvVG~-~~~ 456 (521)
T PLN02551 380 YGFLAKVFSTFEDLGISVDVVATSE-VS-ISLTLDPSKLWSRELIQQELDHLVEELEKIAVVNLLQGRSIISLIGN-VQR 456 (521)
T ss_pred ccHHHHHHHHHHHcCCcEEEEeccC-CE-EEEEEehhHhhhhhhHHHHHHHHHHHhhcCCeEEEeCCEEEEEEEcc-CCC
Confidence 3455667888899999987765432 11 111111111000 01346888899999999998 788
Q ss_pred hhhHHHHHHHHHHhCCCcEEEEE--ecCceeEEEeCCCch
Q 008621 408 QYGFLAKVFSTFEDLGISVDVVA--TSEVSLSLTLDPSKL 445 (559)
Q Consensus 408 ~~g~larIf~~L~~~gI~Vd~Is--tSe~sIs~~v~~~~~ 445 (559)
.+|+++++|+.|+++||+|.||+ +|+.+|+|+|++++.
T Consensus 457 ~~gvaariF~aLa~~gInV~mIsqgaSeinIS~vV~~~d~ 496 (521)
T PLN02551 457 SSLILEKVFRVLRTNGVNVQMISQGASKVNISLIVNDDEA 496 (521)
T ss_pred CccHHHHHHHHHHHCCCCeEEEEecCCCcEEEEEEeHHHH
Confidence 99999999999999999999998 678999999988754
No 138
>PRK09034 aspartate kinase; Reviewed
Probab=97.20 E-value=0.0011 Score=72.95 Aligned_cols=98 Identities=14% Similarity=0.250 Sum_probs=72.3
Q ss_pred hHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCc-------------cceeeEEeeecCeEEEEEEecCccchhhHH
Q 008621 346 HPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMS-------------KAVLTSIVLKRNVTMLDIVSTRMLGQYGFL 412 (559)
Q Consensus 346 hp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~-------------~~~It~Is~~~~ialItV~~~~m~~~~g~l 412 (559)
-.+-+..+.++||++...++.. .. =+...+..+.. ...+.+|+..+++++|++.|.+|.+.+|++
T Consensus 325 ~a~if~~la~~~I~Vd~i~ss~-~s-is~~v~~~~~~~a~~~~l~~el~~~~~~~~I~~~~~va~VsivG~g~~~~~gv~ 402 (454)
T PRK09034 325 GRKVLQILEDHGISYEHMPSGI-DD-LSIIIRERQLTPKKEDEILAEIKQELNPDELEIEHDLAIIMVVGEGMRQTVGVA 402 (454)
T ss_pred HHHHHHHHHHcCCeEEEEcCCC-cE-EEEEEeHHHhhHHHHHHHHHHHHHhhCCceEEEeCCEEEEEEECCCCCCCccHH
Confidence 3456778889999877764211 11 11222211110 012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCcEEEEE--ecCceeEEEeCCCch
Q 008621 413 AKVFSTFEDLGISVDVVA--TSEVSLSLTLDPSKL 445 (559)
Q Consensus 413 arIf~~L~~~gI~Vd~Is--tSe~sIs~~v~~~~~ 445 (559)
+++|+.|+++||+|+|++ +|+.+++|++++++.
T Consensus 403 arif~aL~~~~InV~mIsq~~Se~~Is~vV~~~d~ 437 (454)
T PRK09034 403 AKITKALAEANINIQMINQGSSEISIMFGVKNEDA 437 (454)
T ss_pred HHHHHHHHHCCCCEEEEEecCCcceEEEEEcHHHH
Confidence 999999999999999998 578999999987653
No 139
>PRK09181 aspartate kinase; Validated
Probab=97.18 E-value=0.0028 Score=69.92 Aligned_cols=111 Identities=12% Similarity=0.103 Sum_probs=83.4
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCc--eeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeEEEEEee-ccc
Q 008621 411 FLAKVFSTFEDLGISVDVVATSEV--SLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSIISLIGN-VQR 487 (559)
Q Consensus 411 ~larIf~~L~~~gI~Vd~IstSe~--sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~aiISIVG~-~~~ 487 (559)
+..+-++...+++|++...++... .=++....... .-..+..|+..+++++|++.|. |..
T Consensus 279 LHp~ti~pa~~~~Ipi~V~nt~~p~~~GT~I~~~~~~-----------------~~~~ik~It~~~~~~~i~i~~~~~~~ 341 (475)
T PRK09181 279 IHPKAAKGLRQAGIPLRIKNTFEPEHPGTLITKDYVS-----------------EQPRVEIIAGSDKVFALEVFDQDMVG 341 (475)
T ss_pred cCHHHHHHHHHcCCeEEEecCCCCCCCCeEEecCccc-----------------ccccceeEeccCCEEEEEEcCCCCCC
Confidence 456778889999999987765432 22333221100 0011346777889999999996 778
Q ss_pred cchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecc-c-HHHHHHHHHHHhcc
Q 008621 488 SSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDD-E-AEQCVRALHETFFE 540 (559)
Q Consensus 488 ~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~-d-~~kAv~~LH~~f~~ 540 (559)
.+|+++++|+.|++.+|+|.++++ |+.++||+++.+ + .+++++.|+++|-.
T Consensus 342 ~~g~~~~if~~l~~~~i~v~~i~s--s~~sis~~v~~~~~~~~~~~~~L~~~~~~ 394 (475)
T PRK09181 342 EDGYDLEILEILTRHKVSYISKAT--NANTITHYLWGSLKTLKRVIAELEKRYPN 394 (475)
T ss_pred cchHHHHHHHHHHHcCCeEEEEEe--cCcEEEEEEcCChHHHHHHHHHHHHhcCC
Confidence 899999999999999999999987 688999999988 3 67889999988853
No 140
>cd04910 ACT_AK-Ectoine_1 ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and various other halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinase
Probab=97.14 E-value=0.0026 Score=51.68 Aligned_cols=61 Identities=18% Similarity=0.345 Sum_probs=51.2
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhh
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKLWSRELIQQASELDHVVEELEK 466 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~ 466 (559)
..|.+.+.+|.|.+|+..+||+.|+++++++.+..++.++|+.++..+.- .++++..+|++
T Consensus 2 ~alevfdqdMvG~~g~d~~i~~~l~~~~v~ii~K~~nANtit~yl~~~~k----------~~~r~~~~Le~ 62 (71)
T cd04910 2 FALEVFDQDMVGEVGYDLEILELLQRFKVSIIAKDTNANTITHYLAGSLK----------TIKRLTEDLEN 62 (71)
T ss_pred eEEEEeCCCccCChhHHHHHHHHHHHcCCeEEEEecCCCeEEEEEEcCHH----------HHHHHHHHHHH
Confidence 46789999999999999999999999999999999999999999976531 34556666654
No 141
>cd04917 ACT_AKiii-LysC-EC_2 ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII. This CD includes the second of two ACT domains located C-terminal to the catalytic domain of the lysine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in bacteria (Escherichia coli (EC) LysC). Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. The E. coli AKIII (LysC) binds two feedback allosteric inhibitor lysine molecules at the dimer interface located between the ACT1 domain of two subunits. The second ACT domain (ACT2), this CD, is not involved in the binding of heterotrophic effectors. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=97.00 E-value=0.0028 Score=49.96 Aligned_cols=48 Identities=17% Similarity=0.427 Sum_probs=40.8
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEE--ecCceeEEEeCCCc
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA--TSEVSLSLTLDPSK 444 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Is--tSe~sIs~~v~~~~ 444 (559)
+++|++.|.+|.+.++.++++|+.|++ +++.+++ +++.+++|.+++++
T Consensus 1 ~alIsvvG~~~~~~~~v~~~i~~~L~~--i~i~~i~~~~s~~~is~~V~~~~ 50 (64)
T cd04917 1 LALVALIGNDISETAGVEKRIFDALED--INVRMICYGASNHNLCFLVKEED 50 (64)
T ss_pred CeEEEEECCCccCCcCHHHHHHHHHHh--CCeEEEEEecCccEEEEEEeHHH
Confidence 468999999999999999999999976 6666665 67789999998765
No 142
>cd04914 ACT_AKi-DapG-BS_1 ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI. This CD includes the N-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) strain 168), Clostridia, and Actinobacteria, bacterial species. In B. subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The B. subtilis AKI is tetrameric consisting of two alpha and
Probab=96.98 E-value=0.002 Score=51.63 Aligned_cols=48 Identities=23% Similarity=0.372 Sum_probs=39.2
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCch
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSKL 445 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~~ 445 (559)
+.++|.+. ...+|+++++|+.|+++||++|||+.+..+++|+++.++.
T Consensus 2 ~~vtv~~~--~~~~~~~a~if~~La~~~InvDmI~~~~~~isFtv~~~d~ 49 (67)
T cd04914 2 TQIKVKAK--DNENDLQQRVFKALANAGISVDLINVSPEEVIFTVDGEVA 49 (67)
T ss_pred eEEEEecC--CCCccHHHHHHHHHHHcCCcEEEEEecCCCEEEEEchhhH
Confidence 46677753 4568999999999999999999997655579999998764
No 143
>cd04914 ACT_AKi-DapG-BS_1 ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI. This CD includes the N-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase (AK) isoenzyme AKI, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) strain 168), Clostridia, and Actinobacteria, bacterial species. In B. subtilis, the regulation of the diaminopimelate-lysine biosynthetic pathway involves dual control by diaminopimelate and lysine, effected through separate diaminopimelate- and lysine-sensitive aspartokinase isoenzymes. AKI activity is invariant during the exponential and stationary phases of growth and is not altered by addition of amino acids to the growth medium. The role of this isoenzyme is most likely to provide a constant level of aspartyl-beta-phosphate for the biosynthesis of diaminopimelate for peptidoglycan synthesis and dipicolinate during sporulation. The B. subtilis AKI is tetrameric consisting of two alpha and
Probab=96.95 E-value=0.004 Score=49.90 Aligned_cols=56 Identities=20% Similarity=0.402 Sum_probs=45.2
Q ss_pred eEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHH
Q 008621 477 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALH 535 (559)
Q Consensus 477 aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH 535 (559)
+.|++.|.- ..+++++++|+.|++++|++.||++. ++ +++|.++.++.+++.+.|-
T Consensus 2 ~~vtv~~~~-~~~~~~a~if~~La~~~InvDmI~~~-~~-~isFtv~~~d~~~~~~il~ 57 (67)
T cd04914 2 TQIKVKAKD-NENDLQQRVFKALANAGISVDLINVS-PE-EVIFTVDGEVAEKAVDILE 57 (67)
T ss_pred eEEEEecCC-CCccHHHHHHHHHHHcCCcEEEEEec-CC-CEEEEEchhhHHHHHHHHH
Confidence 567777742 34789999999999999999999876 33 7999999999998865543
No 144
>PRK09466 metL bifunctional aspartate kinase II/homoserine dehydrogenase II; Provisional
Probab=96.85 E-value=0.0068 Score=71.03 Aligned_cols=110 Identities=12% Similarity=0.120 Sum_probs=83.9
Q ss_pred HHHHHHHHHHhCCCcEEEEEecCce--eEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeEEEEEee-ccc
Q 008621 411 FLAKVFSTFEDLGISVDVVATSEVS--LSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSIISLIGN-VQR 487 (559)
Q Consensus 411 ~larIf~~L~~~gI~Vd~IstSe~s--Is~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~aiISIVG~-~~~ 487 (559)
+..+-++...+++|++..-++.... =++...... . -.....|+..+++++|++.|. +..
T Consensus 268 lHp~ti~pa~~~~Ipi~V~ntf~p~~~GT~I~~~~~-----------~-------~~~v~~It~~~~v~~i~i~~~~~~g 329 (810)
T PRK09466 268 LHARTLQPVSGSDIDLQLRCSYQPEQGSTRIERVLA-----------S-------GTGARIVTSLDDVCLIELQVPASHD 329 (810)
T ss_pred cCHHHHHHHHHcCCeEEEecCCCCCCCceEEecCcc-----------c-------ccceeeeeccCCEEEEEEecCCcCC
Confidence 4567788889999998877654321 223322110 0 001234677789999999986 667
Q ss_pred cchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHh
Q 008621 488 SSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETF 538 (559)
Q Consensus 488 ~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f 538 (559)
.+++++++|+.|++++|++.+|+|++++.+++|.++.++.+++.+.|++..
T Consensus 330 ~~g~~~~if~~l~~~~I~v~~i~~~~s~~sis~~i~~~~~~~~~~~l~~~~ 380 (810)
T PRK09466 330 FKLAQKELDQLLKRAQLRPLAVGVHPDRQLLQLAYTSEVADSALKLLDDAA 380 (810)
T ss_pred cchHHHHHHHHHHHCCCeEEEEEecCCCcEEEEEEeHHHHHHHHHHHHhhc
Confidence 789999999999999999999999999999999999999999999998864
No 145
>COG4747 ACT domain-containing protein [General function prediction only]
Probab=96.84 E-value=0.051 Score=48.06 Aligned_cols=119 Identities=19% Similarity=0.316 Sum_probs=84.1
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEEE---ecCce-eEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeec
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA---TSEVS-LSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNL 472 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Is---tSe~s-Is~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~ 472 (559)
.|++. ..+.||=++.+.+.|.++|||+...+ +++.. +.+.+++.+ +..+++++- ..+
T Consensus 5 QISvF---lENk~GRL~~~~~~L~eagINiRA~tiAdt~dFGIiRmvV~~~d-----------~A~~~Lee~----gF~- 65 (142)
T COG4747 5 QISVF---LENKPGRLASVANKLKEAGINIRAFTIADTGDFGIIRMVVDRPD-----------EAHSVLEEA----GFT- 65 (142)
T ss_pred EEEEE---ecCCcchHHHHHHHHHHcCCceEEEEeccccCcceEEEEcCChH-----------HHHHHHHHC----CcE-
Confidence 34554 34678889999999999999999886 55554 567787654 222333322 122
Q ss_pred ccceeEEEEEe-eccccchHHHHHHHHHHhCCCcEEEEEe-cCCceEEEEEEecccHHHHHHHHHHH
Q 008621 473 LQHRSIISLIG-NVQRSSLILEKAFRVLRRSGVNVQMISQ-GASKVNISLIVNDDEAEQCVRALHET 537 (559)
Q Consensus 473 ~~~~aiISIVG-~~~~~~gv~~ri~~~L~~~~InI~~Isq-gaSe~sIs~vV~~~d~~kAv~~LH~~ 537 (559)
+..=.+++ +|...||-+.++..+|..++||+.-|-. -.....-.++++-+|.+++.++|.+.
T Consensus 66 ---Vr~~dVlaVEmeD~PG~l~~I~~vl~d~diNldYiYAFv~ek~KAlli~r~ed~d~~~~aLed~ 129 (142)
T COG4747 66 ---VRETDVLAVEMEDVPGGLSRIAEVLGDADINLDYIYAFVTEKQKALLIVRVEDIDRAIKALEDA 129 (142)
T ss_pred ---EEeeeEEEEEecCCCCcHHHHHHHHhhcCcCceeeeeeeecCceEEEEEEhhHHHHHHHHHHHc
Confidence 12335666 4888999999999999999999864211 11346677889999999999999886
No 146
>PRK09084 aspartate kinase III; Validated
Probab=96.83 E-value=0.0033 Score=68.94 Aligned_cols=107 Identities=15% Similarity=0.215 Sum_probs=75.6
Q ss_pred HHHHHHHHHhCCCcEEEEEecCc--eeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeEEEEEee-cccc
Q 008621 412 LAKVFSTFEDLGISVDVVATSEV--SLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRS 488 (559)
Q Consensus 412 larIf~~L~~~gI~Vd~IstSe~--sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~aiISIVG~-~~~~ 488 (559)
..+-+....+++|++....+.+. .-++..+... .-..+..|+..+++++|++-|. |...
T Consensus 258 h~~~~~~~~~~~i~i~i~~~~~~~~~GT~I~~~~~------------------~~~~v~~it~~~~i~lItv~~~~~~~~ 319 (448)
T PRK09084 258 HPATLLPAVRSNIPVFVGSSKDPEAGGTWICNDTE------------------NPPLFRAIALRRNQTLLTLHSLNMLHA 319 (448)
T ss_pred CHHHHHHHHHcCCcEEEEeCCCCCCCceEEecCCC------------------CCCeeEEEEeeCCEEEEEEecCCCCcc
Confidence 34556677888998887764321 1233322110 0012456888899999999996 7788
Q ss_pred chHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccH-HHHHHHHHHHh
Q 008621 489 SLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEA-EQCVRALHETF 538 (559)
Q Consensus 489 ~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~-~kAv~~LH~~f 538 (559)
+|+++++|+.|++++|+|.||++ |+.+|+|.+++++. .++...+++++
T Consensus 320 ~g~~a~if~~l~~~~I~Vd~I~s--se~sIs~~i~~~~~~~~~~~~~~~~l 368 (448)
T PRK09084 320 RGFLAEVFGILARHKISVDLITT--SEVSVSLTLDTTGSTSTGDTLLTQAL 368 (448)
T ss_pred ccHHHHHHHHHHHcCCeEEEEec--cCcEEEEEEechhhhhhhhHHHHHHH
Confidence 99999999999999999999997 78999999999884 33443444443
No 147
>PRK05925 aspartate kinase; Provisional
Probab=96.76 E-value=0.012 Score=64.38 Aligned_cols=96 Identities=9% Similarity=0.149 Sum_probs=71.0
Q ss_pred HhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCcc----------ceeeEEeeecCeEEEEEEecCccchhhHHHHHH
Q 008621 347 PQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSK----------AVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVF 416 (559)
Q Consensus 347 p~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~----------~~It~Is~~~~ialItV~~~~m~~~~g~larIf 416 (559)
.+-++.+.++||++.+.++.. ... +...+..+... ..+..|...+++++|++.|.+|.+ +++.+++|
T Consensus 316 ~~if~~l~~~~I~vd~i~s~~-~si-s~~i~~~~~~~~~~~~l~~~l~~~~~i~~~~~~a~VsvVG~gm~~-~~v~~~~~ 392 (440)
T PRK05925 316 EDVLGILRSLGIVPGLVMAQN-LGV-YFTIDDDDISEEYPQHLTDALSAFGTVSCEGPLALITMIGAKLAS-WKVVRTFT 392 (440)
T ss_pred HHHHHHHHHcCCcEEEEeccC-CEE-EEEEechhccHHHHHHHHHHhcCCceEEEECCEEEEEEeCCCccc-ccHHHHHH
Confidence 467889999999985554331 111 11122111101 123457788999999999999987 78999999
Q ss_pred HHHHhCCCcEEEEEecCceeEEEeCCCch
Q 008621 417 STFEDLGISVDVVATSEVSLSLTLDPSKL 445 (559)
Q Consensus 417 ~~L~~~gI~Vd~IstSe~sIs~~v~~~~~ 445 (559)
+.|++.||++.++++|+.+|+|.|+.++.
T Consensus 393 ~aL~~~~Ini~~i~~s~~~is~vV~~~d~ 421 (440)
T PRK05925 393 EKLRGYQTPVFCWCQSDMALNLVVNEELA 421 (440)
T ss_pred HHHhhCCCCEEEEECCCceEEEEEehHHH
Confidence 99999999999999999999999987753
No 148
>KOG2436 consensus Acetylglutamate kinase/acetylglutamate synthase [Amino acid transport and metabolism]
Probab=96.70 E-value=0.0078 Score=65.21 Aligned_cols=123 Identities=16% Similarity=0.226 Sum_probs=82.7
Q ss_pred hhhHHHHHHHHHHHHHHcCCceEEecccceE--EEEec--------CCCC-ceeeecchHHHHHHHhhchhcCCcEEEEc
Q 008621 199 SFGECMSTRIFAAYLNKIGVKARQYDAFDIG--FITTD--------DFTN-ADILEATYPAVAKRLHGDWITDLAIPIVT 267 (559)
Q Consensus 199 s~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~--iit~~--------~~~~-a~i~~~~~~~i~~~l~~~l~~~~~ipVv~ 267 (559)
-+||.--. +...|++.|-.++..++...- +++.+ +|+. .++...+.+++. .+++.|.+|+++
T Consensus 170 ~~~E~n~~--lv~nL~~~g~~ar~~s~g~~v~~~f~a~~~~v~d~~~y~~~gei~~vd~d~i~-----~l~~~G~mp~L~ 242 (520)
T KOG2436|consen 170 VSLEANLN--LVINLSQLGTRARPSSSGVRVGNFFPADRNGVLDGEDYGLVGEIKKVDVDRIR-----HLLDAGSMPLLR 242 (520)
T ss_pred chhhhhhH--HHHHHHHhhceeccccccccccceeecccccccccceeeeecccceechhhhh-----hhhhCCCchheh
Confidence 34666433 345689999888887765421 23433 2222 233334444443 345688999998
Q ss_pred CCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCccccccCHHHHHHHHH
Q 008621 268 GFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAY 339 (559)
Q Consensus 268 Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~ 339 (559)
- .+.+ .+|+++|.+ +|..|+.+|.+|+++.+++.+|+.=+...+ .+.++.++.+|...+..
T Consensus 243 s-la~T-aSGqvlnvN---a~~~a~elA~~L~~~kli~l~d~g~~l~e~------ge~~S~l~l~~e~~~l~ 303 (520)
T KOG2436|consen 243 S-LAAT-ASGQVLNVN---ADEVAGELALALGPDKLILLMDKGRILKEN------GEDISSLILQEEDAGLR 303 (520)
T ss_pred h-hccc-CccceEEee---HHHHhhHHHhccCcceeEEecccccccccC------cccccccccchhHhhhh
Confidence 8 6767 489999999 999999999999999999999972233333 45567777777666554
No 149
>PRK08210 aspartate kinase I; Reviewed
Probab=96.60 E-value=0.0066 Score=65.67 Aligned_cols=100 Identities=20% Similarity=0.292 Sum_probs=75.3
Q ss_pred CcchHhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCcc--ce---e-eEEeeecCeEEEEEEecCccchhhHHHHHH
Q 008621 343 QVLHPQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMSK--AV---L-TSIVLKRNVTMLDIVSTRMLGQYGFLAKVF 416 (559)
Q Consensus 343 ~vlhp~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~~--~~---I-t~Is~~~~ialItV~~~~m~~~~g~larIf 416 (559)
+.+..+-+..+.++||++...+... + .++......+..+ .. . ..+...+++++|++.|.+|.+.+|+++++|
T Consensus 283 ~g~la~If~~L~~~~I~i~~i~~~~-~-~is~~v~~~~~~~a~~~l~~~~~~v~~~~~~a~isvvG~~~~~~~g~~~~i~ 360 (403)
T PRK08210 283 YDLQQEVFKALAEAGISVDFINIFP-T-EVVFTVSDEDSEKAKEILENLGLKPSVRENCAKVSIVGAGMAGVPGVMAKIV 360 (403)
T ss_pred chHHHHHHHHHHHcCCeEEEEEecC-c-eEEEEEcHHHHHHHHHHHHHhCCcEEEeCCcEEEEEEcCCcCCCccHHHHHH
Confidence 3455567788899999988765442 2 3444433221110 00 0 146678999999999999999999999999
Q ss_pred HHHHhCCCcEEEEEecCceeEEEeCCCc
Q 008621 417 STFEDLGISVDVVATSEVSLSLTLDPSK 444 (559)
Q Consensus 417 ~~L~~~gI~Vd~IstSe~sIs~~v~~~~ 444 (559)
+.|+++||++.++++|+.+++|.++.++
T Consensus 361 ~aL~~~~I~i~~~~~s~~~is~vv~~~~ 388 (403)
T PRK08210 361 TALSEEGIEILQSADSHTTIWVLVKEED 388 (403)
T ss_pred HHHHhCCCCEEEEecCCCEEEEEEcHHH
Confidence 9999999999999999999999998765
No 150
>cd04891 ACT_AK-LysC-DapG-like_1 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII and related proteins. This CD includes the N-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, as well as, the first and third, of four, ACT domains present in cyanobacteria AK. Also included are the N-terminal of the two ACT domains of the diaminopimelate-sensitive aspartokinase isoenzyme AKI found in Bacilli (Bacillus subtilis strain 168), Clostridia, and Actinobacteria bacterial species. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=96.48 E-value=0.01 Score=45.12 Aligned_cols=46 Identities=30% Similarity=0.484 Sum_probs=37.5
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecC-----ceeEEEeCCCc
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSE-----VSLSLTLDPSK 444 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe-----~sIs~~v~~~~ 444 (559)
+|++.+ +.+.+|+++++|+.|.++||++++++++. .+++|++++++
T Consensus 2 ~v~v~~--~~~~~~~~~~i~~~L~~~~i~i~~i~~~~~~~~~~~is~~v~~~~ 52 (61)
T cd04891 2 QVTIKG--VPDKPGVAAKIFSALAEAGINVDMIVQSVSRGGTTDISFTVPKSD 52 (61)
T ss_pred EEEEec--CCCCCcHHHHHHHHHHHcCCcEEEEEEcCCCCCcEEEEEEEeHHH
Confidence 466654 56789999999999999999999998753 56889997654
No 151
>PRK08841 aspartate kinase; Validated
Probab=96.35 E-value=0.012 Score=63.38 Aligned_cols=94 Identities=18% Similarity=0.220 Sum_probs=67.8
Q ss_pred HhHHHHHHhCCCCEEEecCCCCCCCCeEEecCCCCc---cceeeEEeeecCeEEEEEEecCccchhhHHHHHHHHHHhCC
Q 008621 347 PQSMRPAREGDIPVRVKNSYNPNAPGTLIRRSRDMS---KAVLTSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLG 423 (559)
Q Consensus 347 p~a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~~~---~~~It~Is~~~~ialItV~~~~m~~~~g~larIf~~L~~~g 423 (559)
++.+..+.++||++....... ..=+.+.+..+.. ......+...+++++|++.|.+ .+|+.+++|+.|.+++
T Consensus 269 ~~i~~~l~~~~i~v~~i~~~~--~~~~~~v~~~~~~~~~~~~~~~i~~~~~~a~vsvVG~~---~~gv~~~~~~aL~~~~ 343 (392)
T PRK08841 269 PSLTKQCQMLGIEVWNVIEEA--DRAQIVIKQDACAKLKLVFDDKIRNSESVSLLTLVGLE---ANGMVEHACNLLAQNG 343 (392)
T ss_pred HHHHHHHHHcCCCEEEEEecC--CcEEEEECHHHHHHHHHhCcccEEEeCCEEEEEEECCC---ChHHHHHHHHHHHhCC
Confidence 456677888999977765322 1112222222111 1112246778999999999975 4899999999999999
Q ss_pred CcEEEEEecCceeEEEeCCCch
Q 008621 424 ISVDVVATSEVSLSLTLDPSKL 445 (559)
Q Consensus 424 I~Vd~IstSe~sIs~~v~~~~~ 445 (559)
|++.++++|+.+|+|.++.++.
T Consensus 344 I~i~~i~~s~~~is~vv~~~~~ 365 (392)
T PRK08841 344 IDVRQCSTEPQSSMLVLDPANV 365 (392)
T ss_pred CCEEEEECCCcEEEEEEeHHHH
Confidence 9999999999999999987653
No 152
>cd04910 ACT_AK-Ectoine_1 ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the aspartokinase of the ectoine (1,4,5,6-tetrahydro-2-methyl pyrimidine-4-carboxylate) biosynthetic pathway found in Methylomicrobium alcaliphilum, Vibrio cholerae, and various other halotolerant or halophilic bacteria. Bacteria exposed to hyperosmotic stress accumulate organic solutes called 'compatible solutes' of which ectoine, a heterocyclic amino acid, is one. Apart from its osmotic function, ectoine also exhibits a protective effect on proteins, nucleic acids and membranes against a variety of stress factors. de novo synthesis of ectoine starts with the phosphorylation of L-aspartate and shares its first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: aspartokinase
Probab=96.14 E-value=0.023 Score=46.24 Aligned_cols=63 Identities=11% Similarity=0.090 Sum_probs=55.4
Q ss_pred EEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHHhcc
Q 008621 478 IISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHETFFE 540 (559)
Q Consensus 478 iISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~f~~ 540 (559)
.|-+-+. |...+|+..++|+.|+++++++.+..+.+.++++++..+.+..+++++.|.+.|-.
T Consensus 3 alevfdqdMvG~~g~d~~i~~~l~~~~v~ii~K~~nANtit~yl~~~~k~~~r~~~~Le~~~p~ 66 (71)
T cd04910 3 ALEVFDQDMVGEVGYDLEILELLQRFKVSIIAKDTNANTITHYLAGSLKTIKRLTEDLENRFPN 66 (71)
T ss_pred EEEEeCCCccCChhHHHHHHHHHHHcCCeEEEEecCCCeEEEEEEcCHHHHHHHHHHHHHhCcc
Confidence 4556675 77888999999999999999999999998999999888888999999999998853
No 153
>PRK08961 bifunctional aspartate kinase/diaminopimelate decarboxylase protein; Provisional
Probab=96.13 E-value=0.014 Score=69.18 Aligned_cols=108 Identities=16% Similarity=0.244 Sum_probs=80.0
Q ss_pred HHHHHHHHHhCCCcEEEEEecCc--eeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeEEEEEee-cccc
Q 008621 412 LAKVFSTFEDLGISVDVVATSEV--SLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSIISLIGN-VQRS 488 (559)
Q Consensus 412 larIf~~L~~~gI~Vd~IstSe~--sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~aiISIVG~-~~~~ 488 (559)
-.+-++...++||++....+... .=++..... . .-..+..|+..+|+++|++-|. |...
T Consensus 274 ~~~a~~~a~~~~i~i~v~~~~~~~~~gT~I~~~~--~----------------~~~~v~~It~~~~v~lItv~~~~~~~~ 335 (861)
T PRK08961 274 HPRSIKPCRDAGIPMAILDTERPDLSGTSIDGDA--E----------------PVPGVKAISRKNGIVLVSMETIGMWQQ 335 (861)
T ss_pred CHHHHHHHHHCCCCEEEEeCCCCCCCccEEeCCC--C----------------CCCcceeEEEECCEEEEEEecCCcccc
Confidence 35566778899999887765332 112222111 0 0012456888899999999996 7788
Q ss_pred chHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccH---HHHHHHHHHHhc
Q 008621 489 SLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEA---EQCVRALHETFF 539 (559)
Q Consensus 489 ~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~---~kAv~~LH~~f~ 539 (559)
+++++++|+.|++++|+|.||++ |+.+++|.+++.+. +++++.|..+|-
T Consensus 336 ~g~~a~if~~la~~~I~Vd~I~s--se~sis~~i~~~~~~~~~~~~~~l~~~l~ 387 (861)
T PRK08961 336 VGFLADVFTLFKKHGLSVDLISS--SETNVTVSLDPSENLVNTDVLAALSADLS 387 (861)
T ss_pred ccHHHHHHHHHHHcCCeEEEEEc--CCCEEEEEEccccccchHHHHHHHHHHHh
Confidence 99999999999999999999987 78999999999875 367777777764
No 154
>COG3603 Uncharacterized conserved protein [Function unknown]
Probab=96.07 E-value=0.025 Score=49.93 Aligned_cols=67 Identities=21% Similarity=0.326 Sum_probs=57.7
Q ss_pred ceeecccceeEEEEEeec-cccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHH
Q 008621 468 AIVNLLQHRSIISLIGNV-QRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHET 537 (559)
Q Consensus 468 ~~v~~~~~~aiISIVG~~-~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~ 537 (559)
..|+...+-+...+-|.. -.-+|+++.+.+.|+++||.|+.+|+-..+. ++|+++|.++|+++|.++
T Consensus 55 ~~V~~~~GW~~lk~~gpf~FgltGilasV~~pLsd~gigIFavStydtDh---iLVr~~dLekAv~~L~ea 122 (128)
T COG3603 55 DVVQIEKGWSCLKFEGPFDFGLTGILASVSQPLSDNGIGIFAVSTYDTDH---ILVREEDLEKAVKALEEA 122 (128)
T ss_pred cceEecCCeEEEEEeccccCCcchhhhhhhhhHhhCCccEEEEEeccCce---EEEehhhHHHHHHHHHHc
Confidence 356677788889999963 3568999999999999999999999976666 799999999999999865
No 155
>cd04913 ACT_AKii-LysC-BS-like_1 ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168 and related proteins. This CD includes the N-terminal of the two ACT domains of the lysine-sensitive aspartokinase isoenzyme AKII of Bacillus subtilis (BS) strain 168, and the lysine plus threonine-sensitive aspartokinase of Corynebacterium glutamicum, and related sequences. In B. subtilis 168, the regulation of the diaminopimelate (Dap)-lysine biosynthetic pathway involves dual control by Dap and lysine, effected through separate Dap- and lysine-sensitive aspartokinase isoenzymes. The B. subtilis 168 AKII is induced by methionine and repressed and inhibited by lysine. Although Corynebacterium glutamicum is known to contain a single aspartokinase, both the succinylase and dehydrogenase variant pathways of DAP-lysine synthesis operate simultaneously in this organism. In corynebacteria and other various Gram-positive bacteria, the DAP-lysine pathway is fee
Probab=95.95 E-value=0.03 Score=44.50 Aligned_cols=48 Identities=23% Similarity=0.425 Sum_probs=38.5
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecC-----ceeEEEeCCCch
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSE-----VSLSLTLDPSKL 445 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe-----~sIs~~v~~~~~ 445 (559)
++|++.+ +.+.+|+++++|+.|+++||+++++.++. .+++|+++.++.
T Consensus 2 ~~v~v~~--~~~~~g~~~~i~~~L~~~~I~i~~i~~~~~~~~~~~is~~v~~~d~ 54 (75)
T cd04913 2 AKITLRG--VPDKPGVAAKIFGALAEANINVDMIVQNVSRDGTTDISFTVPKSDL 54 (75)
T ss_pred eEEEECC--CCCCCcHHHHHHHHHHHcCCeEEEEEeCCCCCCcEEEEEEecHHHH
Confidence 5677754 56789999999999999999999998642 368899987653
No 156
>PF01842 ACT: ACT domain; InterPro: IPR002912 The ACT domain is found in a variety of contexts and is proposed to be a conserved regulatory binding fold. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. The archetypical ACT domain is the C-terminal regulatory domain of 3-phosphoglycerate dehydrogenase (3PGDH), which folds with a ferredoxin-like topology. A pair of ACT domains form an eight-stranded antiparallel sheet with two molecules of allosteric inhibitor serine bound in the interface. Biochemical exploration of a few other proteins containing ACT domains supports the suggestions that these domains contain the archetypical ACT structure [].; GO: 0016597 amino acid binding, 0008152 metabolic process; PDB: 3L76_B 2F06_B 3NRB_C 1Y7P_C 2QMX_A 2DT9_A 2ZHO_D 3K5P_A 3TVI_K 3C1M_C ....
Probab=95.76 E-value=0.028 Score=43.75 Aligned_cols=54 Identities=28% Similarity=0.424 Sum_probs=44.9
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCc-----eEEEEEEecccHHHHHHHHHHHh
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGASK-----VNISLIVNDDEAEQCVRALHETF 538 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe-----~sIs~vV~~~d~~kAv~~LH~~f 538 (559)
+.+.||+++++++.|+++|+||..+.+..+. ..+.+..+..+.+++++.|++.+
T Consensus 7 ~~drpG~l~~v~~~la~~~inI~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 65 (66)
T PF01842_consen 7 VPDRPGILADVTEILADHGINIDSISQSSDKDGVGIVFIVIVVDEEDLEKLLEELEALP 65 (66)
T ss_dssp EETSTTHHHHHHHHHHHTTEEEEEEEEEEESSTTEEEEEEEEEEGHGHHHHHHHHHHHT
T ss_pred cCCCCCHHHHHHHHHHHcCCCHHHeEEEecCCCceEEEEEEECCCCCHHHHHHHHHccc
Confidence 4578999999999999999999998887664 34666677888899999998753
No 157
>cd04888 ACT_PheB-BS C-terminal ACT domain of a small (~147 a.a.) putative phenylalanine biosynthetic pathway protein described in Bacillus subtilis (BS) PheB (PheB-BS) and related domains. This CD includes the C-terminal ACT domain of a small (~147 a.a.) putative phenylalanine biosynthetic pathway protein described in Bacillus subtilis (BS) PheB (PheB-BS) and other related ACT domains. In B. subtilis, the upstream gene of pheB, pheA encodes prephenate dehydratase (PDT). The presumed product of the pheB gene is chorismate mutase (CM). The deduced product of the B. subtilis pheB gene, however, has no significant homology to the CM portion of the bifunctional CM-PDT of Escherichia coli. The presence of an ACT domain lends support to the prediction that these proteins function as a phenylalanine-binding regulatory protein. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=94.51 E-value=0.23 Score=39.91 Aligned_cols=55 Identities=24% Similarity=0.422 Sum_probs=40.8
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEec---C--ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhc
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATS---E--VSLSLTLDPSKLWSRELIQQASELDHVVEELEKIA 468 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstS---e--~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~ 468 (559)
.+.+|.++++++.|+++|++++++.++ + ..++|+++-++.. ..++.+++.|+++.
T Consensus 8 ~d~~g~l~~I~~~la~~~inI~~i~~~~~~~~~~~i~~~v~v~~~~--------~~l~~l~~~L~~i~ 67 (76)
T cd04888 8 EHRPGVLSKVLNTIAQVRGNVLTINQNIPIHGRANVTISIDTSTMN--------GDIDELLEELREID 67 (76)
T ss_pred cCCCchHHHHHHHHHHcCCCEEEEEeCCCCCCeEEEEEEEEcCchH--------HHHHHHHHHHhcCC
Confidence 467999999999999999999999753 2 4578888765531 14666777777644
No 158
>PRK11589 gcvR glycine cleavage system transcriptional repressor; Provisional
Probab=93.83 E-value=1.1 Score=43.43 Aligned_cols=107 Identities=7% Similarity=0.111 Sum_probs=69.4
Q ss_pred cCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe----cCceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhh-
Q 008621 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT----SEVSLSLTLDPSKLWSRELIQQASELDHVVEELEKI- 467 (559)
Q Consensus 393 ~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist----Se~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~- 467 (559)
.+..+|++.|. ++||+.+++.+.|+++|.|+.-..+ ++....+.+..... ... .++..+..+...
T Consensus 6 ~~~lviTviG~---DrpGIVa~vs~~l~~~g~NI~ds~~t~lgg~Fa~i~lvs~~~~-~~~------~le~~L~~l~~~~ 75 (190)
T PRK11589 6 QHYLVITALGA---DRPGIVNTITRHVSSCGCNIEDSRLAMLGEEFTFIMLLSGSWN-AIT------LIESTLPLKGAEL 75 (190)
T ss_pred ccEEEEEEEcC---CCChHHHHHHHHHHHcCCCeeehhhHhhCCceEEEEEEeCChh-HHH------HHHHHHHhhhhhc
Confidence 35567888875 6899999999999999999887653 35566666644321 111 233333333211
Q ss_pred -ceeec-------ccc---eeEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEe
Q 008621 468 -AIVNL-------LQH---RSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQ 511 (559)
Q Consensus 468 -~~v~~-------~~~---~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isq 511 (559)
-.+.+ ... -..|+++| ...||++.++.+.|++.||||.-.++
T Consensus 76 ~L~i~v~~~~~~~~~~~~~~~~v~v~G--~DrPGIV~~vT~~la~~~iNI~~L~T 128 (190)
T PRK11589 76 DLLIVMKRTTARPRPAMPATVWVQVEV--ADSPHLIERFTALFDSHHMNIAELVS 128 (190)
T ss_pred CeEEEEEeccccccccCCceEEEEEEE--CCCCCHHHHHHHHHHHcCCChhheEE
Confidence 01111 011 14677777 46899999999999999999986544
No 159
>COG3830 ACT domain-containing protein [Signal transduction mechanisms]
Probab=93.60 E-value=0.16 Score=42.92 Aligned_cols=62 Identities=27% Similarity=0.360 Sum_probs=49.0
Q ss_pred eeEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC--CceEEEEEEecccHHHHHHHHHHHhc
Q 008621 476 RSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA--SKVNISLIVNDDEAEQCVRALHETFF 539 (559)
Q Consensus 476 ~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga--Se~sIs~vV~~~d~~kAv~~LH~~f~ 539 (559)
.++|+++| +..||+.+.++.+|+++|+||.-|+|.- .--++.++|+-.....-...+.++|-
T Consensus 3 ~avITV~G--kDr~GIva~is~vLAe~~vNIldisQtvm~~~ftm~~lV~~~~~~~d~~~lr~~l~ 66 (90)
T COG3830 3 RAVITVIG--KDRVGIVAAVSRVLAEHGVNILDISQTVMDGFFTMIMLVDISKEVVDFAALRDELA 66 (90)
T ss_pred eEEEEEEc--CCCCchhHHHHHHHHHcCCcEEEHHHHHHhhhceeeeEEcCChHhccHHHHHHHHH
Confidence 57899999 4678999999999999999999999865 34467777887766666666666654
No 160
>cd04888 ACT_PheB-BS C-terminal ACT domain of a small (~147 a.a.) putative phenylalanine biosynthetic pathway protein described in Bacillus subtilis (BS) PheB (PheB-BS) and related domains. This CD includes the C-terminal ACT domain of a small (~147 a.a.) putative phenylalanine biosynthetic pathway protein described in Bacillus subtilis (BS) PheB (PheB-BS) and other related ACT domains. In B. subtilis, the upstream gene of pheB, pheA encodes prephenate dehydratase (PDT). The presumed product of the pheB gene is chorismate mutase (CM). The deduced product of the B. subtilis pheB gene, however, has no significant homology to the CM portion of the bifunctional CM-PDT of Escherichia coli. The presence of an ACT domain lends support to the prediction that these proteins function as a phenylalanine-binding regulatory protein. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=93.51 E-value=0.49 Score=37.91 Aligned_cols=54 Identities=17% Similarity=0.268 Sum_probs=44.4
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecC---CceEEEEEEecccHHHHHHHHHHHhc
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGA---SKVNISLIVNDDEAEQCVRALHETFF 539 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~Isqga---Se~sIs~vV~~~d~~kAv~~LH~~f~ 539 (559)
...||.++++++.|++.++|+.++++.. ....++|.++..+.+..++.|.+.+-
T Consensus 8 ~d~~g~l~~I~~~la~~~inI~~i~~~~~~~~~~~i~~~v~v~~~~~~l~~l~~~L~ 64 (76)
T cd04888 8 EHRPGVLSKVLNTIAQVRGNVLTINQNIPIHGRANVTISIDTSTMNGDIDELLEELR 64 (76)
T ss_pred cCCCchHHHHHHHHHHcCCCEEEEEeCCCCCCeEEEEEEEEcCchHHHHHHHHHHHh
Confidence 4568999999999999999999998843 23568899998888877777777765
No 161
>PRK04435 hypothetical protein; Provisional
Probab=92.93 E-value=0.8 Score=42.60 Aligned_cols=63 Identities=19% Similarity=0.428 Sum_probs=44.1
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecC-----ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhc
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSE-----VSLSLTLDPSKLWSRELIQQASELDHVVEELEKIA 468 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe-----~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~ 468 (559)
.+.+.+. +.+.+|.++++++.|+++|+|++.+.++. .+++|+++-++.. ..++.++..|+.+.
T Consensus 69 ~vtL~i~---l~Dr~GlLs~Il~~IA~~~aNIltI~q~i~~~g~a~vs~tVevs~~~--------~~L~~Li~~L~~i~ 136 (147)
T PRK04435 69 IITLSLL---LEDRSGTLSKVLNVIAEAGGNILTINQSIPLQGRANVTISIDTSSME--------GDIDELLEKLRNLD 136 (147)
T ss_pred EEEEEEE---EecCCCHHHHHHHHHHHcCCCeEEEEEEcCCCCEEEEEEEEEeCChH--------HHHHHHHHHHHcCC
Confidence 3344554 34679999999999999999999997532 4578888765431 14666777776633
No 162
>cd04911 ACT_AKiii-YclM-BS_1 ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII. This CD includes the first of two ACT domains located C-terminal to the catalytic domain of the lysine plus threonine-sensitive aspartokinase isoenzyme AKIII, a monofunctional class enzyme found in Bacilli (Bacillus subtilis (BS) YclM) and Clostridia species. Aspartokinase is the first enzyme in the aspartate metabolic pathway and catalyzes the conversion of aspartate and ATP to aspartylphosphate and ADP. Bacillus subtilis YclM is reported to be a single polypeptide of 50 kD. AKIII from Bacillus subtilis strain 168 is induced by lysine and repressed by threonine and it is synergistically inhibited by lysine and threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=92.87 E-value=0.33 Score=40.02 Aligned_cols=60 Identities=17% Similarity=0.320 Sum_probs=45.4
Q ss_pred EEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccH-----HHHHHHHHHHhcc
Q 008621 479 ISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEA-----EQCVRALHETFFE 540 (559)
Q Consensus 479 ISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~-----~kAv~~LH~~f~~ 540 (559)
|.+--. |....|+..|+++.|+++||++..+.+ +.-++|+++++++. ++.++.|++++..
T Consensus 4 I~i~K~~Mn~evGF~rk~L~I~E~~~is~Eh~PS--GID~~Siii~~~~~~~~~~~~i~~~i~~~~~p 69 (76)
T cd04911 4 IYISKYLMNREVGFGRKLLSILEDNGISYEHMPS--GIDDISIIIRDNQLTDEKEQKILAEIKEELHP 69 (76)
T ss_pred EehhHhhccchhcHHHHHHHHHHHcCCCEeeecC--CCccEEEEEEccccchhhHHHHHHHHHHhcCC
Confidence 333344 556689999999999999999999987 46668899999944 3456677776544
No 163
>KOG0456 consensus Aspartate kinase [Amino acid transport and metabolism]
Probab=92.21 E-value=0.4 Score=50.79 Aligned_cols=70 Identities=17% Similarity=0.373 Sum_probs=59.7
Q ss_pred ceeecccceeEEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHH--HHH-HHHHHHhc
Q 008621 468 AIVNLLQHRSIISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAE--QCV-RALHETFF 539 (559)
Q Consensus 468 ~~v~~~~~~aiISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~--kAv-~~LH~~f~ 539 (559)
..|...+|+.++-|-.. |....|+++++|..|.+.||.|..|++ ||.+||+-.+..+.. +.+ +.||+.+.
T Consensus 385 TsI~lK~nv~mldI~Str~l~q~GFLAkvFti~ek~~isVDvvaT--SEV~iSltL~~~~~~sreliq~~l~~a~e 458 (559)
T KOG0456|consen 385 TSIVLKRNVTMLDIASTRMLGQHGFLAKVFTIFEKLGISVDVVAT--SEVSISLTLDPSKLDSRELIQGELDQAVE 458 (559)
T ss_pred eEEEEeccEEEEEecccchhhhhhHHHHHHHHHHHhCcEEEEEEe--eeEEEEEecChhhhhhHHHHHhhHHHHHH
Confidence 45777899999999997 888899999999999999999999998 899999999888665 333 67777664
No 164
>PF01842 ACT: ACT domain; InterPro: IPR002912 The ACT domain is found in a variety of contexts and is proposed to be a conserved regulatory binding fold. ACT domains are linked to a wide range of metabolic enzymes that are regulated by amino acid concentration. The archetypical ACT domain is the C-terminal regulatory domain of 3-phosphoglycerate dehydrogenase (3PGDH), which folds with a ferredoxin-like topology. A pair of ACT domains form an eight-stranded antiparallel sheet with two molecules of allosteric inhibitor serine bound in the interface. Biochemical exploration of a few other proteins containing ACT domains supports the suggestions that these domains contain the archetypical ACT structure [].; GO: 0016597 amino acid binding, 0008152 metabolic process; PDB: 3L76_B 2F06_B 3NRB_C 1Y7P_C 2QMX_A 2DT9_A 2ZHO_D 3K5P_A 3TVI_K 3C1M_C ....
Probab=91.47 E-value=0.78 Score=35.38 Aligned_cols=27 Identities=30% Similarity=0.500 Sum_probs=24.4
Q ss_pred ccchhhHHHHHHHHHHhCCCcEEEEEe
Q 008621 405 MLGQYGFLAKVFSTFEDLGISVDVVAT 431 (559)
Q Consensus 405 m~~~~g~larIf~~L~~~gI~Vd~Ist 431 (559)
+.+.||.++++++.|+++|+|+..+.+
T Consensus 7 ~~drpG~l~~v~~~la~~~inI~~~~~ 33 (66)
T PF01842_consen 7 VPDRPGILADVTEILADHGINIDSISQ 33 (66)
T ss_dssp EETSTTHHHHHHHHHHHTTEEEEEEEE
T ss_pred cCCCCCHHHHHHHHHHHcCCCHHHeEE
Confidence 457899999999999999999999864
No 165
>cd04908 ACT_Bt0572_1 N-terminal ACT domain of a novel protein composed almost entirely of two tandem ACT domains. Included in this CD is the N-terminal ACT domain of a novel protein composed almost entirely of two tandem ACT domains as seen in the uncharacterized structure (pdb 2F06) of the Bt0572 protein from Bacteroides thetaiotaomicron and related ACT domains. These tandem ACT domain proteins belong to the superfamily of ACT regulatory domains.
Probab=90.75 E-value=0.75 Score=36.24 Aligned_cols=53 Identities=17% Similarity=0.219 Sum_probs=39.2
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHHHHH
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRALHET 537 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~LH~~ 537 (559)
+.+.||.++++...|.++|+||.-+.....+....+.+..++.+++.+.|-+.
T Consensus 8 v~d~pG~La~v~~~l~~~~inI~~i~~~~~~~~~~~rl~~~~~~~~~~~L~~~ 60 (66)
T cd04908 8 LENKPGRLAAVTEILSEAGINIRALSIADTSEFGILRLIVSDPDKAKEALKEA 60 (66)
T ss_pred EcCCCChHHHHHHHHHHCCCCEEEEEEEecCCCCEEEEEECCHHHHHHHHHHC
Confidence 56789999999999999999997544322322466666667777888887654
No 166
>cd02116 ACT ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-p
Probab=89.98 E-value=1 Score=32.02 Aligned_cols=49 Identities=31% Similarity=0.509 Sum_probs=38.1
Q ss_pred ccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEecc-cHHHHHHHHH
Q 008621 487 RSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVNDD-EAEQCVRALH 535 (559)
Q Consensus 487 ~~~gv~~ri~~~L~~~~InI~~IsqgaS----e~sIs~vV~~~-d~~kAv~~LH 535 (559)
..++.+.++++.|.+.++++..+.+... ...+++.++.. +.+.+++.|+
T Consensus 7 ~~~~~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 60 (60)
T cd02116 7 DRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIVVDGDGDLEKLLEALE 60 (60)
T ss_pred CCCchHHHHHHHHHHCCCcEEEEEeEEcCCCCeEEEEEEEechHHHHHHHHHhC
Confidence 3578999999999999999999887543 36688888887 6666666553
No 167
>PRK13562 acetolactate synthase 1 regulatory subunit; Provisional
Probab=89.67 E-value=1.1 Score=37.68 Aligned_cols=52 Identities=17% Similarity=0.363 Sum_probs=39.6
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEecC------ceeEEEeC-CCchhhHHHHHHHHHHHHHHHHHhhh
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLD-PSKLWSRELIQQASELDHVVEELEKI 467 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstSe------~sIs~~v~-~~~~~~~~~~~~~~~l~~~~~~L~~~ 467 (559)
.+.||+++|+...|.+.|+|++.++.++ ..++++++ .++ ..++++.++|++.
T Consensus 10 eN~~GVL~Rit~lFsRRg~NI~SLtvg~Te~~~iSRmtivv~~~d~----------~~ieqI~kQL~Kl 68 (84)
T PRK13562 10 ADQVSTLNRITSAFVRLQYNIDTLHVTHSEQPGISNMEIQVDIQDD----------TSLHILIKKLKQQ 68 (84)
T ss_pred ECCCCHHHHHHHHHhccCcCeeeEEecccCCCCceEEEEEEeCCCH----------HHHHHHHHHHhCC
Confidence 3689999999999999999999997543 46788886 432 1456677778763
No 168
>PRK06737 acetolactate synthase 1 regulatory subunit; Validated
Probab=89.61 E-value=1.1 Score=36.99 Aligned_cols=52 Identities=19% Similarity=0.271 Sum_probs=39.1
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEecC------ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhh
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQASELDHVVEELEKI 467 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstSe------~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~ 467 (559)
.+.||+++|+...|.+.|+|++.++.++ ..+++++..++ ..++++.++|++.
T Consensus 10 ~n~pGVL~Ri~~lf~rRgfNI~Sl~vg~te~~~~sriti~~~~~~----------~~i~qi~kQL~KL 67 (76)
T PRK06737 10 HNDPSVLLRISGIFARRGYYISSLNLNERDTSGVSEMKLTAVCTE----------NEATLLVSQLKKL 67 (76)
T ss_pred ecCCCHHHHHHHHHhccCcceEEEEecccCCCCeeEEEEEEECCH----------HHHHHHHHHHhCC
Confidence 3689999999999999999999997542 34677765442 1466677788774
No 169
>PRK11152 ilvM acetolactate synthase 2 regulatory subunit; Provisional
Probab=88.46 E-value=2.4 Score=35.00 Aligned_cols=51 Identities=18% Similarity=0.320 Sum_probs=39.1
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEecC------ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhh
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQASELDHVVEELEKI 467 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstSe------~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~ 467 (559)
.+.||+++|+...|.+.|+|++.++.++ ..+++++..+. .++.+.++|++.
T Consensus 11 ~n~pGVL~Ri~~lf~rRGfnI~sl~v~~t~~~~~sriti~v~~~~-----------~i~ql~kQL~KL 67 (76)
T PRK11152 11 RFRPEVLERVLRVVRHRGFQVCSMNMTQNTDAQNINIELTVASER-----------PIDLLSSQLNKL 67 (76)
T ss_pred ECCccHHHHHHHHHhcCCeeeeeEEeeecCCCCEEEEEEEECCCc-----------hHHHHHHHHhcC
Confidence 3689999999999999999999997433 46788886321 456677788763
No 170
>PF13740 ACT_6: ACT domain; PDB: 1ZPV_A 3P96_A 1U8S_A.
Probab=87.95 E-value=2.3 Score=34.67 Aligned_cols=58 Identities=19% Similarity=0.340 Sum_probs=38.3
Q ss_pred eEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC--CceEEEEEEecccHHHHHHHHHHHh
Q 008621 477 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA--SKVNISLIVNDDEAEQCVRALHETF 538 (559)
Q Consensus 477 aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga--Se~sIs~vV~~~d~~kAv~~LH~~f 538 (559)
-+|+++|. ..||+++.++.+|++.|.|+.-+.|.. ..-++.+.|+-. +.....|.++|
T Consensus 3 ~vItv~G~--DrpGiv~~v~~~l~~~g~ni~d~~~~~~~~~f~~~~~v~~~--~~~~~~l~~~L 62 (76)
T PF13740_consen 3 LVITVVGP--DRPGIVAAVTGVLAEHGCNIEDSRQAVLGGRFTLIMLVSIP--EDSLERLESAL 62 (76)
T ss_dssp EEEEEEEE----TTHHHHHHHHHHCTT-EEEEEEEEEETTEEEEEEEEEES--HHHHHHHHHHH
T ss_pred EEEEEEec--CCCcHHHHHHHHHHHCCCcEEEEEEEEEcCeEEEEEEEEeC--cccHHHHHHHH
Confidence 46888884 579999999999999999998766544 444555555555 33444555544
No 171
>PRK08178 acetolactate synthase 1 regulatory subunit; Reviewed
Probab=87.56 E-value=1.7 Score=37.46 Aligned_cols=51 Identities=16% Similarity=0.337 Sum_probs=38.5
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEecC------ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhh
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQASELDHVVEELEKI 467 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstSe------~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~ 467 (559)
.+.||+++|+...|++.|.|++.++.++ ..+++++..++ .++++.++|++.
T Consensus 16 ~N~pGVL~RIaglFsRRgyNIeSLtvg~te~~~iSRmtivv~~~~-----------~i~Qi~kQL~KL 72 (96)
T PRK08178 16 RNHPGVMSHVCGLFARRAFNVEGILCLPIQDGDKSRIWLLVNDDQ-----------RLEQMISQIEKL 72 (96)
T ss_pred ECCcCHHHHHHHHHhcCCcCeeeEEEeecCCCCceEEEEEEcCch-----------HHHHHHHHHhCC
Confidence 3689999999999999999999996432 45777776321 456677788763
No 172
>COG4492 PheB ACT domain-containing protein [General function prediction only]
Probab=86.39 E-value=5.8 Score=36.06 Aligned_cols=65 Identities=20% Similarity=0.432 Sum_probs=48.5
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEec-----CceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceeecccceeEEE
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATS-----EVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVNLLQHRSIIS 480 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstS-----e~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~~~~~~aiIS 480 (559)
....|.++++++.+++.++||.-|.|+ -.++++.++.+.... ..+.++.+|++ .++++.|-
T Consensus 80 edr~G~LS~vLd~iA~~~~nvLTI~Q~ipl~g~Anvtlsi~~ssm~~--------~V~~ii~kl~k------~e~V~kVe 145 (150)
T COG4492 80 EDRVGILSDVLDVIAREEINVLTIHQTIPLQGRANVTLSIDTSSMEK--------DVDKIIEKLRK------VEGVEKVE 145 (150)
T ss_pred hhhhhhHHHHHHHHHHhCCcEEEEecccccCceeeEEEEEEchhhhh--------hHHHHHHHHhc------ccceeEEE
Confidence 467899999999999999999998754 356788887664321 56677777766 44667777
Q ss_pred EEee
Q 008621 481 LIGN 484 (559)
Q Consensus 481 IVG~ 484 (559)
++|.
T Consensus 146 ivgs 149 (150)
T COG4492 146 IVGS 149 (150)
T ss_pred Eeec
Confidence 7773
No 173
>cd04889 ACT_PDH-BS-like C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate. Included in this CD is the C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate, found in Bacillus subtilis (BS) and other Firmicutes, Deinococci, and Bacteroidetes. PDH is the first enzyme in the aromatic amino acid pathway specific for the biosynthesis of tyrosine. This enzyme is feedback inhibited by tyrosine in B. subtilis and other microorganisms. Both phenylalanine and tryptophan have been shown to be inhibitors of this activity in B. subtilis. Bifunctional chorismate mutase-PDH (TyrA) enzymes such as those seen in Escherichia coli do not contain an ACT domain. Also included in this CD is the N-terminal ACT domain of a novel protein composed almost entirely of two tandem A
Probab=86.23 E-value=2.6 Score=31.75 Aligned_cols=50 Identities=20% Similarity=0.226 Sum_probs=34.6
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCc-eEEEEEEecccHHHHHHHH
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGASK-VNISLIVNDDEAEQCVRAL 534 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe-~sIs~vV~~~d~~kAv~~L 534 (559)
+...||.++++.+.|.++|+||..+.....+ ..-.+.+.-++.++|.+.|
T Consensus 5 ~~d~~G~l~~i~~~l~~~~inI~~~~~~~~~~~~~~~~~~v~~~~~a~~~l 55 (56)
T cd04889 5 VENKPGRLAEVTEILAEAGINIKAISIAETRGEFGILRLIFSDPERAKEVL 55 (56)
T ss_pred eCCCCChHHHHHHHHHHcCCCEeeEEEEEccCCcEEEEEEECCHHHHHHHh
Confidence 4567999999999999999999654433322 2333444555577777765
No 174
>PRK13562 acetolactate synthase 1 regulatory subunit; Provisional
Probab=85.72 E-value=2.7 Score=35.38 Aligned_cols=52 Identities=15% Similarity=0.257 Sum_probs=40.1
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCce----EEEEEEe-cccH--HHHHHHHHHH
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGASKV----NISLIVN-DDEA--EQCVRALHET 537 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~----sIs~vV~-~~d~--~kAv~~LH~~ 537 (559)
.+.||++.|+...+.+.|+||..++.|.++. .+++++. .++. ++..+.|++-
T Consensus 10 eN~~GVL~Rit~lFsRRg~NI~SLtvg~Te~~~iSRmtivv~~~d~~~ieqI~kQL~Kl 68 (84)
T PRK13562 10 ADQVSTLNRITSAFVRLQYNIDTLHVTHSEQPGISNMEIQVDIQDDTSLHILIKKLKQQ 68 (84)
T ss_pred ECCCCHHHHHHHHHhccCcCeeeEEecccCCCCceEEEEEEeCCCHHHHHHHHHHHhCC
Confidence 5679999999999999999999999998765 5888886 4432 3555555543
No 175
>PRK11895 ilvH acetolactate synthase 3 regulatory subunit; Reviewed
Probab=85.60 E-value=19 Score=34.07 Aligned_cols=90 Identities=10% Similarity=0.218 Sum_probs=56.1
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEecC------ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhce---ee-----
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAI---VN----- 471 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstSe------~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~---v~----- 471 (559)
.+.||.++++...|+++|+|++.++.++ ..+++.++.++- .++++.++|++.-. +.
T Consensus 10 eN~pGvL~rI~~lf~rrg~NI~Sl~v~~te~~~~sriti~V~~~~~----------~i~qi~kQl~KLidV~~V~~~~~~ 79 (161)
T PRK11895 10 ENEPGVLSRVAGLFSRRGYNIESLTVGPTEDPGLSRMTIVTSGDEQ----------VIEQITKQLNKLIDVLKVVDLTEE 79 (161)
T ss_pred cCCCcHHHHHHHHHHhCCCcEEEEEeeecCCCCEEEEEEEEECCHH----------HHHHHHHHHhccccEEEEEecCCc
Confidence 4789999999999999999999876332 236777765421 45566777776321 11
Q ss_pred --cccceeEEEEEeeccccchHHHHHHHHHHhCCCcEEEE
Q 008621 472 --LLQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMI 509 (559)
Q Consensus 472 --~~~~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~I 509 (559)
+.+.++++-+...-.. -..+++...-.+-+|.-+
T Consensus 80 ~~v~rEl~LiKv~~~~~~----r~~i~~i~~~f~a~ivdv 115 (161)
T PRK11895 80 AHVERELALVKVRASGEN----RAEILRLADIFRAKIVDV 115 (161)
T ss_pred chhheEEEEEEEECCccc----HHHHHHHHHHhCCEEEEe
Confidence 1234677766653211 235555555555666555
No 176
>TIGR00119 acolac_sm acetolactate synthase, small subunit. acetohydroxyacid synthase is a synonym.
Probab=84.83 E-value=20 Score=33.72 Aligned_cols=90 Identities=11% Similarity=0.200 Sum_probs=55.3
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEecC------ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhce---ee-----
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAI---VN----- 471 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstSe------~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~---v~----- 471 (559)
.+.||.++++...|.++|+|++.+..++ ..+++.++.++ . .++++.++|++.-. +.
T Consensus 9 en~pGvL~rI~~lf~rrg~NI~Sl~v~~t~~~~~sriti~V~~d~----~------~i~qi~kQl~Kli~V~~V~~~~~~ 78 (157)
T TIGR00119 9 ENEPGVLSRVAGLFTRRGFNIESLTVGPTEDPDLSRMTIVVVGDD----K------VLEQITKQLNKLVDVIKVSDLTES 78 (157)
T ss_pred cCCCcHHHHHHHHHHhCCceEEEEEEeecCCCCEEEEEEEEECCH----H------HHHHHHHHHhcCccEEEEEecCCC
Confidence 4689999999999999999999875332 23677776532 1 45556667776321 11
Q ss_pred --cccceeEEEEEeeccccchHHHHHHHHHHhCCCcEEEE
Q 008621 472 --LLQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMI 509 (559)
Q Consensus 472 --~~~~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~I 509 (559)
+.+.+++|-+...- .--..+++...-.+-+|.-+
T Consensus 79 ~~v~rEl~LiKv~~~~----~~r~~i~~i~~~f~a~ivdv 114 (157)
T TIGR00119 79 AIVERELCLVKVSAPG----EGRDEIIRLTNIFRGRIVDV 114 (157)
T ss_pred cceeeEEEEEEEECCc----cCHHHHHHHHHHhCCEEEEe
Confidence 12345666665532 12245556655555565554
No 177
>PRK04435 hypothetical protein; Provisional
Probab=84.34 E-value=6.5 Score=36.52 Aligned_cols=55 Identities=22% Similarity=0.347 Sum_probs=42.5
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCC---ceEEEEEEecccHHHHHHHHHHHhc
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGAS---KVNISLIVNDDEAEQCVRALHETFF 539 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaS---e~sIs~vV~~~d~~kAv~~LH~~f~ 539 (559)
+...||+++++++.+++.|+||..|+|... ..+++|-++..+.+..++.|=+.+-
T Consensus 76 l~Dr~GlLs~Il~~IA~~~aNIltI~q~i~~~g~a~vs~tVevs~~~~~L~~Li~~L~ 133 (147)
T PRK04435 76 LEDRSGTLSKVLNVIAEAGGNILTINQSIPLQGRANVTISIDTSSMEGDIDELLEKLR 133 (147)
T ss_pred EecCCCHHHHHHHHHHHcCCCeEEEEEEcCCCCEEEEEEEEEeCChHHHHHHHHHHHH
Confidence 445689999999999999999999998542 2457888888877756666655553
No 178
>PF13710 ACT_5: ACT domain; PDB: 2FGC_A 2PC6_A 2F1F_B.
Probab=81.20 E-value=3.8 Score=32.36 Aligned_cols=51 Identities=20% Similarity=0.477 Sum_probs=36.6
Q ss_pred chhhHHHHHHHHHHhCCCcEEEEEecC------ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhh
Q 008621 407 GQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQASELDHVVEELEKI 467 (559)
Q Consensus 407 ~~~g~larIf~~L~~~gI~Vd~IstSe------~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~ 467 (559)
+.||.+.|+...|.+.|++++.++.++ ..++++++.++- .++.+.++|++.
T Consensus 1 n~~GvL~Ri~~vf~rRg~nI~sl~v~~~~~~~~~riti~v~~~~~----------~i~~l~~Ql~Kl 57 (63)
T PF13710_consen 1 NQPGVLNRITGVFRRRGFNIESLSVGPTEDPGISRITIVVSGDDR----------EIEQLVKQLEKL 57 (63)
T ss_dssp SSTTHHHHHHHHHHTTT-EECEEEEEE-SSTTEEEEEEEEES-CC----------HHHHHHHHHHCS
T ss_pred CCcHHHHHHHHHHhcCCeEEeeEEeeecCCCCEEEEEEEEeeCch----------hHHHHHHHHhcc
Confidence 368999999999999999999986432 457777766331 455677777764
No 179
>CHL00100 ilvH acetohydroxyacid synthase small subunit
Probab=80.65 E-value=8.5 Score=36.88 Aligned_cols=57 Identities=23% Similarity=0.407 Sum_probs=41.5
Q ss_pred EEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC----CceEEEEEEeccc--HHHHHHHHHHH
Q 008621 479 ISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA----SKVNISLIVNDDE--AEQCVRALHET 537 (559)
Q Consensus 479 ISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga----Se~sIs~vV~~~d--~~kAv~~LH~~ 537 (559)
+++++ .+.||++.|+...|++.|+||..++.+. ....++++++.++ .++..+.|++-
T Consensus 5 isvlv--~n~PGVL~RIt~lFsrRg~NIesLsv~~t~~~~~sr~TIvv~~~~~~ieqL~kQL~KL 67 (174)
T CHL00100 5 LSVLV--EDESGVLTRIAGLFARRGFNIESLAVGPAEQKGISRITMVVPGDDRTIEQLTKQLYKL 67 (174)
T ss_pred EEEEE--eCcCCHHHHHHHHHHhCCCCeeEEEeeEcCCCCccEEEEEEECCHHHHHHHHHHHHHH
Confidence 44554 4689999999999999999999988765 3445888898762 34444444443
No 180
>cd04882 ACT_Bt0572_2 C-terminal ACT domain of a novel protein composed of just two ACT domains. Included in this CD is the C-terminal ACT domain of a novel protein composed of just two ACT domains, as seen in the yet uncharacterized structure (pdb 2F06) of the Bt0572 protein from Bacteroides thetaiotaomicron and related proteins. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=80.12 E-value=5.9 Score=30.33 Aligned_cols=53 Identities=21% Similarity=0.332 Sum_probs=36.0
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCc--eEEEEEEecccHHHHHHHHHHH
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGASK--VNISLIVNDDEAEQCVRALHET 537 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe--~sIs~vV~~~d~~kAv~~LH~~ 537 (559)
+...||.++++.+.|+++|+||..+.+.... ....+.+.-++.+++.+.|-+.
T Consensus 6 ~~d~pG~L~~i~~~l~~~~~nI~~i~~~~~~~~~~~~v~~~ve~~~~~~~~L~~~ 60 (65)
T cd04882 6 VPDKPGGLHEILQILSEEGINIEYMYAFVEKKGGKALLIFRTEDIEKAIEVLQER 60 (65)
T ss_pred eCCCCcHHHHHHHHHHHCCCChhheEEEccCCCCeEEEEEEeCCHHHHHHHHHHC
Confidence 4578999999999999999999766543222 2233444444577777766543
No 181
>COG3830 ACT domain-containing protein [Signal transduction mechanisms]
Probab=78.95 E-value=2.3 Score=36.13 Aligned_cols=46 Identities=11% Similarity=0.300 Sum_probs=35.6
Q ss_pred CeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecC----ceeEEEeCC
Q 008621 394 NVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSE----VSLSLTLDP 442 (559)
Q Consensus 394 ~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe----~sIs~~v~~ 442 (559)
..++|||.|. +++|+.+.++..|+++|+|+.-|++.- .++-+.++-
T Consensus 2 ~~avITV~Gk---Dr~GIva~is~vLAe~~vNIldisQtvm~~~ftm~~lV~~ 51 (90)
T COG3830 2 MRAVITVIGK---DRVGIVAAVSRVLAEHGVNILDISQTVMDGFFTMIMLVDI 51 (90)
T ss_pred ceEEEEEEcC---CCCchhHHHHHHHHHcCCcEEEHHHHHHhhhceeeeEEcC
Confidence 3568899875 689999999999999999999887642 444455543
No 182
>PRK06737 acetolactate synthase 1 regulatory subunit; Validated
Probab=77.00 E-value=5.4 Score=32.90 Aligned_cols=40 Identities=10% Similarity=0.186 Sum_probs=32.2
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCce----EEEEEEecc
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGASKV----NISLIVNDD 525 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~----sIs~vV~~~ 525 (559)
.+.||+++|+...+++.|+||..++.|.++. .+.+++..+
T Consensus 10 ~n~pGVL~Ri~~lf~rRgfNI~Sl~vg~te~~~~sriti~~~~~ 53 (76)
T PRK06737 10 HNDPSVLLRISGIFARRGYYISSLNLNERDTSGVSEMKLTAVCT 53 (76)
T ss_pred ecCCCHHHHHHHHHhccCcceEEEEecccCCCCeeEEEEEEECC
Confidence 5689999999999999999999999986553 355665543
No 183
>PRK00194 hypothetical protein; Validated
Probab=76.58 E-value=5.1 Score=33.42 Aligned_cols=35 Identities=34% Similarity=0.381 Sum_probs=29.5
Q ss_pred eEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC
Q 008621 477 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA 513 (559)
Q Consensus 477 aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga 513 (559)
.++++.| ...||+++++.+.|+++|+||.-+++..
T Consensus 4 ~~ltv~g--~DrpGiva~vt~~la~~g~nI~~~~~~~ 38 (90)
T PRK00194 4 AIITVIG--KDKVGIIAGVSTVLAELNVNILDISQTI 38 (90)
T ss_pred EEEEEEc--CCCCCHHHHHHHHHHHcCCCEEehhhHh
Confidence 4677777 3579999999999999999999988754
No 184
>CHL00100 ilvH acetohydroxyacid synthase small subunit
Probab=76.28 E-value=47 Score=31.82 Aligned_cols=38 Identities=13% Similarity=0.342 Sum_probs=31.5
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEecC------ceeEEEeCCC
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPS 443 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstSe------~sIs~~v~~~ 443 (559)
.+.||+++++...|++.|+|++.++.++ ..++++++.+
T Consensus 10 ~n~PGVL~RIt~lFsrRg~NIesLsv~~t~~~~~sr~TIvv~~~ 53 (174)
T CHL00100 10 EDESGVLTRIAGLFARRGFNIESLAVGPAEQKGISRITMVVPGD 53 (174)
T ss_pred eCcCCHHHHHHHHHHhCCCCeeEEEeeEcCCCCccEEEEEEECC
Confidence 3689999999999999999999987432 4578888765
No 185
>cd04870 ACT_PSP_1 CT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). The ACT_PSP_1 CD includes the first of the two ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). PSPs belong to the L-2-haloacid dehalogenase-like protein superfamily. PSP is involved in serine metabolism; serine is synthesized from phosphoglycerate through sequential reactions catalyzed by 3-phosphoglycerate dehydrogenase (SerA), 3-phosphoserine aminotransferase (SerC), and SerB. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=76.21 E-value=4.4 Score=32.72 Aligned_cols=44 Identities=18% Similarity=0.330 Sum_probs=32.1
Q ss_pred EEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC--CceEEEEEEec
Q 008621 479 ISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA--SKVNISLIVND 524 (559)
Q Consensus 479 ISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga--Se~sIs~vV~~ 524 (559)
|+++| ...||+.+++.+.|++.|+||.-++|.. ....+.+.++-
T Consensus 2 vtv~G--~DrpGiv~~vt~~la~~~~nI~dl~~~~~~~~f~~~~~v~~ 47 (75)
T cd04870 2 ITVTG--PDRPGLTSALTEVLAAHGVRILDVGQAVIHGRLSLGILVQI 47 (75)
T ss_pred EEEEc--CCCCCHHHHHHHHHHHCCCCEEecccEEEcCeeEEEEEEEc
Confidence 56777 4679999999999999999998775432 23445555553
No 186
>cd04870 ACT_PSP_1 CT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). The ACT_PSP_1 CD includes the first of the two ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). PSPs belong to the L-2-haloacid dehalogenase-like protein superfamily. PSP is involved in serine metabolism; serine is synthesized from phosphoglycerate through sequential reactions catalyzed by 3-phosphoglycerate dehydrogenase (SerA), 3-phosphoserine aminotransferase (SerC), and SerB. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=75.89 E-value=12 Score=30.12 Aligned_cols=30 Identities=10% Similarity=0.247 Sum_probs=25.9
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 398 ItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
+++.|. ++||+.+++.+.|+++|+|+.-++
T Consensus 2 vtv~G~---DrpGiv~~vt~~la~~~~nI~dl~ 31 (75)
T cd04870 2 ITVTGP---DRPGLTSALTEVLAAHGVRILDVG 31 (75)
T ss_pred EEEEcC---CCCCHHHHHHHHHHHCCCCEEecc
Confidence 567764 689999999999999999998774
No 187
>PF13291 ACT_4: ACT domain; PDB: 2KO1_B 3IBW_A.
Probab=75.52 E-value=11 Score=30.46 Aligned_cols=62 Identities=23% Similarity=0.425 Sum_probs=40.4
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecC------ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhcee
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIV 470 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe------~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v 470 (559)
.|.|.. .+.+|.+++|.+.+++.|+++..+.... ..+.|.+.-.+. ..++.++..|+++..|
T Consensus 8 ~l~i~~---~dr~GlL~dI~~~i~~~~~nI~~i~~~~~~~~~~~~~~l~v~V~d~---------~~L~~ii~~L~~i~~V 75 (80)
T PF13291_consen 8 RLRIEA---EDRPGLLADITSVISENGVNIRSINARTNKDDGTARITLTVEVKDL---------EHLNQIIRKLRQIPGV 75 (80)
T ss_dssp EEEEEE---E--TTHHHHHHHHHHCSSSEEEEEEEEE--ETTEEEEEEEEEESSH---------HHHHHHHHHHCTSTTE
T ss_pred EEEEEE---EcCCCHHHHHHHHHHHCCCCeEEEEeEEeccCCEEEEEEEEEECCH---------HHHHHHHHHHHCCCCe
Confidence 445553 4689999999999999999999885322 234455443332 2577788888775443
No 188
>cd04883 ACT_AcuB C-terminal ACT domain of the Bacillus subtilis acetoin utilization protein, AcuB. This CD includes the C-terminal ACT domain of the Bacillus subtilis acetoin utilization protein, AcuB. AcuB is putatively involved in the anaerobic catabolism of acetoin, and related proteins. Studies report the induction of AcuB by nitrate respiration and also by fermentation. Since acetoin can be secreted and later serve as a source of carbon, it has been proposed that, during anaerobic growth when other carbon sources are exhausted, the induction of the AcuB protein results in acetoin catabolism. AcuB-like proteins have two N-terminal tandem CBS domains and a single C-terminal ACT domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=75.30 E-value=14 Score=29.01 Aligned_cols=53 Identities=15% Similarity=0.158 Sum_probs=39.5
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEecccHHHHHHHHHHH
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVNDDEAEQCVRALHET 537 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaS----e~sIs~vV~~~d~~kAv~~LH~~ 537 (559)
+...||.+.++.+.|+++|+||.-+..... ...+.+-++..+.+++.+.|-+.
T Consensus 8 ~~d~pG~l~~i~~~l~~~~inI~~i~~~~~~~~~~~~v~i~v~~~~~~~~~~~L~~~ 64 (72)
T cd04883 8 VPDRPGQLADIAAIFKDRGVNIVSVLVYPSKEEDNKILVFRVQTMNPRPIIEDLRRA 64 (72)
T ss_pred ECCCCCHHHHHHHHHHHcCCCEEEEEEeccCCCCeEEEEEEEecCCHHHHHHHHHHC
Confidence 567889999999999999999987653322 33366666766777788777665
No 189
>cd04893 ACT_GcvR_1 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. This CD includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR int
Probab=73.37 E-value=12 Score=30.46 Aligned_cols=34 Identities=26% Similarity=0.338 Sum_probs=28.3
Q ss_pred EEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC
Q 008621 478 IISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA 513 (559)
Q Consensus 478 iISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga 513 (559)
+|++.| ...||+.+++.+.|+++|.||.-++|-.
T Consensus 3 iltv~g--~Dr~GiVa~vs~~la~~g~nI~d~~q~~ 36 (77)
T cd04893 3 VISALG--TDRPGILNELTRAVSESGCNILDSRMAI 36 (77)
T ss_pred EEEEEe--CCCChHHHHHHHHHHHcCCCEEEceeeE
Confidence 567777 4578999999999999999999877643
No 190
>cd04909 ACT_PDH-BS C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH). The C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate, found in Bacillus subtilis (BS) and other Firmicutes, Deinococci, and Bacteroidetes. PDH is the first enzyme in the aromatic amino acid pathway specific for the biosynthesis of tyrosine. This enzyme is feedback-inhibited by tyrosine in B. subtilis and other microorganisms. Both phenylalanine and tryptophan have been shown to be inhibitors of this activity in B. subtilis. Bifunctional chorismate mutase-PDH (TyrA) enzymes such as those seen in Escherichia coli do not contain an ACT domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=71.34 E-value=12 Score=29.17 Aligned_cols=52 Identities=13% Similarity=0.229 Sum_probs=35.6
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEec-ccHHHHHHHHHH
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVND-DEAEQCVRALHE 536 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaS----e~sIs~vV~~-~d~~kAv~~LH~ 536 (559)
+...||.++++.+.|+++|+|+..+.+... ...+.+.++. ++.+++.+.|.+
T Consensus 8 ~~d~~G~L~~l~~~l~~~~i~i~~~~~~~~~~~~~~~~~i~v~~~~~~~~~~~~L~~ 64 (69)
T cd04909 8 VPDEPGVIAEVTQILGDAGISIKNIEILEIREGIGGILRISFKTQEDRERAKEILKE 64 (69)
T ss_pred cCCCCCHHHHHHHHHHHcCCCceeeEeEEeecCCcEEEEEEECCHHHHHHHHHHHHH
Confidence 567899999999999999999986543322 3345566642 355666666554
No 191
>PRK13011 formyltetrahydrofolate deformylase; Reviewed
Probab=70.88 E-value=1.3e+02 Score=31.19 Aligned_cols=34 Identities=15% Similarity=0.213 Sum_probs=29.2
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEec
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS 432 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstS 432 (559)
..+++.|. ++||+.+++.+.|+++|+|+.-+++.
T Consensus 8 ~vitv~G~---DrpGIVa~VT~~La~~~vNI~dls~~ 41 (286)
T PRK13011 8 FVLTLSCP---SAAGIVAAVTGFLAEHGCYITELHSF 41 (286)
T ss_pred EEEEEEeC---CCCCHHHHHHHHHHhCCCCEEEeeee
Confidence 46788874 68999999999999999999988763
No 192
>COG2150 Predicted regulator of amino acid metabolism, contains ACT domain [General function prediction only]
Probab=70.04 E-value=27 Score=32.96 Aligned_cols=80 Identities=19% Similarity=0.289 Sum_probs=54.8
Q ss_pred HHHHHHHHHHhhh---ceeecccceeEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC----CceEEEEEEecccH
Q 008621 455 SELDHVVEELEKI---AIVNLLQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA----SKVNISLIVNDDEA 527 (559)
Q Consensus 455 ~~l~~~~~~L~~~---~~v~~~~~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga----Se~sIs~vV~~~d~ 527 (559)
++|..++..|+.. ..+...-+..+|.+.=.-...||+++.+++.+++.||+|+.+.... .+..+.++.+..--
T Consensus 69 ~~L~~if~nl~P~a~l~~vA~~lG~gViei~~~~~~~pgi~A~V~~~iak~gi~Irqi~~~dpe~~~e~~l~IVte~~iP 148 (167)
T COG2150 69 EELRRIFENLEPVASLADVAPLLGLGVIEIYPEDARYPGILAGVASLIAKRGISIRQIISEDPELQEEPKLTIVTERPIP 148 (167)
T ss_pred HHHHHHHHhccchhhHHHHHHhcCCeEEEEEeccCCCccHHHHHHHHHHHcCceEEEEecCCcccCCCceEEEEEeccCC
Confidence 4566666666643 2334444667777777666789999999999999999999865422 24457777777665
Q ss_pred HHHHHHH
Q 008621 528 EQCVRAL 534 (559)
Q Consensus 528 ~kAv~~L 534 (559)
.+.+..|
T Consensus 149 ~~li~el 155 (167)
T COG2150 149 GDLIDEL 155 (167)
T ss_pred HHHHHHH
Confidence 5555544
No 193
>cd04878 ACT_AHAS N-terminal ACT domain of the Escherichia coli IlvH-like regulatory subunit of acetohydroxyacid synthase (AHAS). ACT_AHAS: N-terminal ACT domain of the Escherichia coli IlvH-like regulatory subunit of acetohydroxyacid synthase (AHAS). AHAS catalyses the first common step in the biosynthesis of the three branched-chain amino acids. The first step involves the condensation of either pyruvate or 2-ketobutyrate with the two-carbon hydroxyethyl fragment derived from another pyruvate molecule, covalently bound to the coenzyme thiamine diphosphate. Bacterial AHASs generally consist of regulatory and catalytic subunits. The effector (valine) binding sites are proposed to be located in two symmetrically related positions in the interface between a pair of N-terminal ACT domains with the C-terminal domain of IlvH contacting the catalytic dimer. Plants Arabidopsis and Oryza have tandem IlvH subunits; both the first and second ACT domain sequences are present in this CD. Members of
Probab=69.19 E-value=32 Score=26.23 Aligned_cols=53 Identities=13% Similarity=0.370 Sum_probs=36.0
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEecC------ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhc
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQASELDHVVEELEKIA 468 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstSe------~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~ 468 (559)
.+.+|.++++...|+++++++..+.... ..+.|.++..+ . .++.++.+|+++.
T Consensus 8 ~d~~g~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~---------~~~~l~~~l~~~~ 66 (72)
T cd04878 8 ENEPGVLNRISGLFARRGFNIESLTVGPTEDPGISRITIVVEGDD-D---------VIEQIVKQLNKLV 66 (72)
T ss_pred cCCCcHHHHHHHHHHhCCCCEEEEEeeecCCCCeEEEEEEEECCH-H---------HHHHHHHHHhCCc
Confidence 4678999999999999999999875432 23566665321 1 3555666776544
No 194
>TIGR01693 UTase_glnD [Protein-PII] uridylyltransferase. This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family.
Probab=68.86 E-value=2.1e+02 Score=34.21 Aligned_cols=125 Identities=22% Similarity=0.232 Sum_probs=73.2
Q ss_pred cCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEE--EecCcee---EEEeCCCc---hhhH---HHHHHHHHHHHHH
Q 008621 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSEVSL---SLTLDPSK---LWSR---ELIQQASELDHVV 461 (559)
Q Consensus 393 ~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~I--stSe~sI---s~~v~~~~---~~~~---~~~~~~~~l~~~~ 461 (559)
.+.+.|.|... +.+|.++++...|+.+|++|... .++.... +|+|...+ .... +.+++ .+...+
T Consensus 666 ~~~t~i~V~~~---DrpgLla~i~~~L~~~~l~I~~A~I~tt~~g~~lD~F~V~~~~g~~~~~~~~~~~i~~--~L~~~L 740 (850)
T TIGR01693 666 SGGTEVFIYAP---DQPGLFAKVAGALAMLSLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVFQELLQ--GLVDVL 740 (850)
T ss_pred CCeEEEEEEeC---CCCcHHHHHHHHHHHCCCeEEEEEEEEecCCEEEEEEEEECCCCCCCCcHHHHHHHHH--HHHHHH
Confidence 45667788753 68999999999999999999764 3232221 55553322 1111 11221 222222
Q ss_pred HHHhh--------------------hceeecc----cceeEEEEEeeccccchHHHHHHHHHHhCCCcEEE--EEecCCc
Q 008621 462 EELEK--------------------IAIVNLL----QHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASK 515 (559)
Q Consensus 462 ~~L~~--------------------~~~v~~~----~~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~--IsqgaSe 515 (559)
..... -..|.+. ++.++|.|+| ...||++.++.++|.+.|++|.. |++....
T Consensus 741 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~~d~~~s~~~t~~~v~~--~DrpGll~~i~~~l~~~~~~i~~a~i~t~~~~ 818 (850)
T TIGR01693 741 AGLAKDPDTISARRARRRRLQHFAVPPRVTILNTASRKATIMEVRA--LDRPGLLARVGRTLEELGLSIQSAKITTFGEK 818 (850)
T ss_pred cCCCccccccccccCCcccccCCCCCCeEEEccCCCCCeEEEEEEE--CCccHHHHHHHHHHHHCCCeEEEEEEEecCcc
Confidence 11000 0123332 2457777777 46799999999999999999986 4443333
Q ss_pred eEEEEEEec
Q 008621 516 VNISLIVND 524 (559)
Q Consensus 516 ~sIs~vV~~ 524 (559)
.-=.|.|..
T Consensus 819 ~~d~F~v~~ 827 (850)
T TIGR01693 819 AEDVFYVTD 827 (850)
T ss_pred ceeEEEEEC
Confidence 333455554
No 195
>PRK05007 PII uridylyl-transferase; Provisional
Probab=68.52 E-value=2e+02 Score=34.71 Aligned_cols=126 Identities=19% Similarity=0.229 Sum_probs=74.7
Q ss_pred cCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEE--EecCcee---EEEeCCCchh--hHH---HHHHHHHHHHHHH
Q 008621 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSEVSL---SLTLDPSKLW--SRE---LIQQASELDHVVE 462 (559)
Q Consensus 393 ~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~I--stSe~sI---s~~v~~~~~~--~~~---~~~~~~~l~~~~~ 462 (559)
.+.+.|.|.. .+.+|+++++...|+.+|++|... .++.... +|.|.+.+-. ..+ .+++ .+.+.+.
T Consensus 699 ~~~t~V~V~a---~DrpGLfa~Ia~~La~~~L~I~~A~I~T~~dg~alD~F~V~d~~g~~~~~~~~~~I~~--~L~~aL~ 773 (884)
T PRK05007 699 RGGTEIFIWS---PDRPYLFAAVCAELDRRNLSVHDAQIFTSRDGMAMDTFIVLEPDGSPLSQDRHQVIRK--ALEQALT 773 (884)
T ss_pred CCeEEEEEEe---cCCcCHHHHHHHHHHHCCCEEEEEEEEEcCCCeEEEEEEEECCCCCCCCHHHHHHHHH--HHHHHHc
Confidence 3566778775 468999999999999999999764 3443322 3665332210 111 1111 2222221
Q ss_pred HH------h-------h----hceeecc----cceeEEEEEeeccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEE
Q 008621 463 EL------E-------K----IAIVNLL----QHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNIS 519 (559)
Q Consensus 463 ~L------~-------~----~~~v~~~----~~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~--IsqgaSe~sIs 519 (559)
.- . + -..|.+. ++.++|.|.. ...||++.++.++|.+.|++|.. |++-....-=+
T Consensus 774 ~~~~~~~~~~~~~~~~~~~~~~~~V~~d~~~s~~~TvlEV~a--~DRpGLL~~I~~~l~~~~l~I~~AkI~T~gera~Dv 851 (884)
T PRK05007 774 QSSPQPPKPRRLPAKLRHFNVPTEVSFLPTHTDRRSYMELIA--LDQPGLLARVGKIFADLGISLHGARITTIGERVEDL 851 (884)
T ss_pred CCCCCcccccccccccCCCCCCCEEEEccCCCCCeEEEEEEe--CCchHHHHHHHHHHHHCCcEEEEEEEeccCceEEEE
Confidence 10 0 0 0123333 2345666655 56799999999999999999987 76655555455
Q ss_pred EEEecc
Q 008621 520 LIVNDD 525 (559)
Q Consensus 520 ~vV~~~ 525 (559)
|+|...
T Consensus 852 FyV~~~ 857 (884)
T PRK05007 852 FILATA 857 (884)
T ss_pred EEEEcC
Confidence 666543
No 196
>PRK08178 acetolactate synthase 1 regulatory subunit; Reviewed
Probab=68.40 E-value=12 Score=32.37 Aligned_cols=38 Identities=21% Similarity=0.208 Sum_probs=31.7
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCce----EEEEEEe
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGASKV----NISLIVN 523 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~----sIs~vV~ 523 (559)
.+.||++.|+...+++.|+||..++.|.++. .+++++.
T Consensus 16 ~N~pGVL~RIaglFsRRgyNIeSLtvg~te~~~iSRmtivv~ 57 (96)
T PRK08178 16 RNHPGVMSHVCGLFARRAFNVEGILCLPIQDGDKSRIWLLVN 57 (96)
T ss_pred ECCcCHHHHHHHHHhcCCcCeeeEEEeecCCCCceEEEEEEc
Confidence 4679999999999999999999998777643 3677776
No 197
>cd04908 ACT_Bt0572_1 N-terminal ACT domain of a novel protein composed almost entirely of two tandem ACT domains. Included in this CD is the N-terminal ACT domain of a novel protein composed almost entirely of two tandem ACT domains as seen in the uncharacterized structure (pdb 2F06) of the Bt0572 protein from Bacteroides thetaiotaomicron and related ACT domains. These tandem ACT domain proteins belong to the superfamily of ACT regulatory domains.
Probab=67.92 E-value=10 Score=29.61 Aligned_cols=26 Identities=23% Similarity=0.386 Sum_probs=22.9
Q ss_pred ccchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 405 MLGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 405 m~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
+.+.||.++++.+.|.++|+||..+.
T Consensus 8 v~d~pG~La~v~~~l~~~~inI~~i~ 33 (66)
T cd04908 8 LENKPGRLAAVTEILSEAGINIRALS 33 (66)
T ss_pred EcCCCChHHHHHHHHHHCCCCEEEEE
Confidence 45789999999999999999998664
No 198
>cd04869 ACT_GcvR_2 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. This CD includes the second of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR in
Probab=67.76 E-value=29 Score=27.87 Aligned_cols=33 Identities=15% Similarity=0.370 Sum_probs=26.9
Q ss_pred EEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC
Q 008621 479 ISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA 513 (559)
Q Consensus 479 ISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga 513 (559)
|++.| ...||+++++.+.|++.|+||.-+++..
T Consensus 2 l~v~g--~D~~Giv~~it~~l~~~~~nI~~~~~~~ 34 (81)
T cd04869 2 VEVVG--NDRPGIVHEVTQFLAQRNINIEDLSTET 34 (81)
T ss_pred EEEEe--CCCCCHHHHHHHHHHHcCCCeEEeEeee
Confidence 45556 3478999999999999999999887743
No 199
>PRK11895 ilvH acetolactate synthase 3 regulatory subunit; Reviewed
Probab=67.51 E-value=14 Score=34.90 Aligned_cols=54 Identities=19% Similarity=0.418 Sum_probs=40.3
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCc----eEEEEEEecc--cHHHHHHHHHHHh
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGASK----VNISLIVNDD--EAEQCVRALHETF 538 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe----~sIs~vV~~~--d~~kAv~~LH~~f 538 (559)
..+.||+++++...+++.|+||..++.+.++ ..+.+.++.+ ..++..+.|++-.
T Consensus 9 veN~pGvL~rI~~lf~rrg~NI~Sl~v~~te~~~~sriti~V~~~~~~i~qi~kQl~KLi 68 (161)
T PRK11895 9 VENEPGVLSRVAGLFSRRGYNIESLTVGPTEDPGLSRMTIVTSGDEQVIEQITKQLNKLI 68 (161)
T ss_pred EcCCCcHHHHHHHHHHhCCCcEEEEEeeecCCCCEEEEEEEEECCHHHHHHHHHHHhccc
Confidence 4578999999999999999999987777654 2377888753 3456666666544
No 200
>PRK11152 ilvM acetolactate synthase 2 regulatory subunit; Provisional
Probab=67.28 E-value=13 Score=30.61 Aligned_cols=51 Identities=25% Similarity=0.414 Sum_probs=37.9
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCc----eEEEEEEecccHHHHHHHHHHHh
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGASK----VNISLIVNDDEAEQCVRALHETF 538 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe----~sIs~vV~~~d~~kAv~~LH~~f 538 (559)
..+.||+++|+...+++.|.||..++-|..+ ..|++++.. ++.+..|-+.+
T Consensus 10 v~n~pGVL~Ri~~lf~rRGfnI~sl~v~~t~~~~~sriti~v~~---~~~i~ql~kQL 64 (76)
T PRK11152 10 ARFRPEVLERVLRVVRHRGFQVCSMNMTQNTDAQNINIELTVAS---ERPIDLLSSQL 64 (76)
T ss_pred EECCccHHHHHHHHHhcCCeeeeeEEeeecCCCCEEEEEEEECC---CchHHHHHHHH
Confidence 3578999999999999999999999887732 457778752 44444444444
No 201
>cd04887 ACT_MalLac-Enz ACT_MalLac-Enz CD includes the N-terminal ACT domain of putative NAD-dependent malic enzyme 1, Bacillus subtilis YqkI and related domains. The ACT_MalLac-Enz CD includes the N-terminal ACT domain of putative NAD-dependent malic enzyme 1, Bacillus subtilis YqkI, a malolactic enzyme (MalLac-Enz) which converts malate to lactate, and other related ACT domains. The yqkJ product is predicted to convert malate directly to lactate, as opposed to related malic enzymes that convert malate to pyruvate. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=67.24 E-value=26 Score=27.58 Aligned_cols=57 Identities=14% Similarity=0.250 Sum_probs=37.7
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEec-----CceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhceee
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATS-----EVSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIVN 471 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstS-----e~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v~ 471 (559)
.+.+|.++++.+.+++.|+++.-+... ...+.|.+.-.+. ..++.++..|+.+..|.
T Consensus 7 ~d~~g~L~~i~~~i~~~~~nI~~v~~~~~~~~~~~~~~~vev~~~---------~~l~~i~~~L~~i~gV~ 68 (74)
T cd04887 7 PNRPGMLGRVTTAIGEAGGDIGAIDLVEQGRDYTVRDITVDAPSE---------EHAETIVAAVRALPEVK 68 (74)
T ss_pred CCCCchHHHHHHHHHHcCCcEEEEEEEEecCCEEEEEEEEEcCCH---------HHHHHHHHHHhcCCCeE
Confidence 468999999999999999999876532 1224555543332 14666777776654443
No 202
>cd04877 ACT_TyrR N-terminal ACT domain of the TyrR protein. ACT_TyrR: N-terminal ACT domain of the TyrR protein. The TyrR protein of Escherichia coli controls the expression of a group of transcription units (TyrR regulon) whose gene products are involved in the biosynthesis or transport of the aromatic amino acids. Binding to specific DNA sequences known as TyrR boxes, the TyrR protein can either activate or repress transcription at different sigma70 promoters. Its regulatory activity occurs in response to intracellular levels of tyrosine, phenylalanine and tryptophan. The TyrR protein consists of an N-terminal region important for transcription activation with an ATP-independent aromatic amino acid binding site (contained within the ACT domain) and is involved in dimerization; a central region with an ATP binding site, an ATP-dependent aromatic amino acid binding site and is involved in hexamerization; and a helix turn helix DNA binding C-terminal region. In solution, in the absence
Probab=66.82 E-value=21 Score=28.60 Aligned_cols=55 Identities=13% Similarity=0.241 Sum_probs=38.1
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEecC-ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhce
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATSE-VSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAI 469 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstSe-~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~ 469 (559)
.+.+|.++++.+.+++.++++..+.... ..+.|.+.-.+. ..++.+++.|+++..
T Consensus 8 ~dr~Gll~dI~~~i~~~~~nI~~~~~~~~~~i~l~i~v~~~---------~~L~~li~~L~~i~g 63 (74)
T cd04877 8 EDRLGITQEVLDLLVEHNIDLRGIEIDPKGRIYLNFPTIEF---------EKLQTLMPEIRRIDG 63 (74)
T ss_pred EccchHHHHHHHHHHHCCCceEEEEEecCCeEEEEeEecCH---------HHHHHHHHHHhCCCC
Confidence 3578999999999999999999886433 225555543332 146777778876443
No 203
>cd04903 ACT_LSD C-terminal ACT domain of the L-serine dehydratase (LSD), iron-sulfur-dependent, beta subunit. The C-terminal ACT domain of the L-serine dehydratase (LSD), iron-sulfur-dependent, beta subunit, found in various bacterial anaerobes such as Clostridium, Bacillis, and Treponema species. These enzymes catalyze the deamination of L-serine, producing pyruvate and ammonia. Unlike the eukaryotic L-serine dehydratase, which requires the pyridoxal-5'-phosphate (PLP) cofactor, the prokaryotic L-serine dehydratase contains an [4Fe-4S] cluster instead of a PLP active site. The LSD alpha and beta subunits of the 'clostridial' enzyme are encoded by the sdhA and sdhB genes. The single subunit bacterial homologs of L-serine dehydratase (LSD1, LSD2, TdcG) present in Escherichia coli, and other enterobacterials, lack the ACT domain described here. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=66.61 E-value=18 Score=27.59 Aligned_cols=51 Identities=12% Similarity=0.228 Sum_probs=36.1
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecC----CceEEEEEEecccHHHHHHHHHH
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGA----SKVNISLIVNDDEAEQCVRALHE 536 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~Isqga----Se~sIs~vV~~~d~~kAv~~LH~ 536 (559)
...+|+++++...|+++|+++..+.+.. ....+.+.++..+.+++++.|.+
T Consensus 7 ~d~~g~l~~i~~~l~~~~~~I~~~~~~~~~~~~~~~i~i~v~~~~~~~~i~~l~~ 61 (71)
T cd04903 7 KDKPGAIAKVTSVLADHEINIAFMRVSRKEKGDQALMVIEVDQPIDEEVIEEIKK 61 (71)
T ss_pred CCCCChHHHHHHHHHHcCcCeeeeEEEeccCCCeEEEEEEeCCCCCHHHHHHHHc
Confidence 4578999999999999999998775433 12235566666666666666553
No 204
>COG3603 Uncharacterized conserved protein [Function unknown]
Probab=65.35 E-value=36 Score=30.55 Aligned_cols=57 Identities=19% Similarity=0.276 Sum_probs=45.2
Q ss_pred eEEeeecCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCceeEEEeCCCc
Q 008621 387 TSIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVSLSLTLDPSK 444 (559)
Q Consensus 387 t~Is~~~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~sIs~~v~~~~ 444 (559)
..|...++-..+++++.--.+..|+++.+.+.|+++||.|-.+++....- +.|.+++
T Consensus 55 ~~V~~~~GW~~lk~~gpf~FgltGilasV~~pLsd~gigIFavStydtDh-iLVr~~d 111 (128)
T COG3603 55 DVVQIEKGWSCLKFEGPFDFGLTGILASVSQPLSDNGIGIFAVSTYDTDH-ILVREED 111 (128)
T ss_pred cceEecCCeEEEEEeccccCCcchhhhhhhhhHhhCCccEEEEEeccCce-EEEehhh
Confidence 35667788889999987667889999999999999999999998766443 3444443
No 205
>cd04875 ACT_F4HF-DF N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase). This CD includes the N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase) which catalyzes the hydrolysis of 10-formyltetrahydrofolate (formyl-FH4) to FH4 and formate. Formyl-FH4 hydrolase generates the formate that is used by purT-encoded 5'-phosphoribosylglycinamide transformylase for step three of de novo purine nucleotide synthesis. Formyl-FH4 hydrolase, a hexamer which is activated by methionine and inhibited by glycine, is proposed to regulate the balance FH4 and C1-FH4 in response to changing growth conditions. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=64.94 E-value=18 Score=28.82 Aligned_cols=32 Identities=19% Similarity=0.087 Sum_probs=27.2
Q ss_pred EEEEeeccccchHHHHHHHHHHhCCCcEEEEEec
Q 008621 479 ISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQG 512 (559)
Q Consensus 479 ISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqg 512 (559)
|++.| ...||+++++.+.|++.|+||.-+++.
T Consensus 2 i~v~g--~D~~Giv~~it~~l~~~g~nI~~~~~~ 33 (74)
T cd04875 2 LTLSC--PDRPGIVAAVSGFLAEHGGNIVESDQF 33 (74)
T ss_pred EEEEc--CCCCCHHHHHHHHHHHcCCCEEeeeee
Confidence 56666 357899999999999999999988775
No 206
>TIGR00119 acolac_sm acetolactate synthase, small subunit. acetohydroxyacid synthase is a synonym.
Probab=64.67 E-value=19 Score=33.93 Aligned_cols=53 Identities=15% Similarity=0.439 Sum_probs=39.8
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCCc---e-EEEEEEecccHHHHHHHHHHHhc
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGASK---V-NISLIVNDDEAEQCVRALHETFF 539 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe---~-sIs~vV~~~d~~kAv~~LH~~f~ 539 (559)
..+.||+++++...+++.|+||..++.+.++ . .+++.++.+ ++.++.|.+.+.
T Consensus 8 ven~pGvL~rI~~lf~rrg~NI~Sl~v~~t~~~~~sriti~V~~d--~~~i~qi~kQl~ 64 (157)
T TIGR00119 8 VENEPGVLSRVAGLFTRRGFNIESLTVGPTEDPDLSRMTIVVVGD--DKVLEQITKQLN 64 (157)
T ss_pred EcCCCcHHHHHHHHHHhCCceEEEEEEeecCCCCEEEEEEEEECC--HHHHHHHHHHHh
Confidence 4568999999999999999999987776554 2 367777763 556666666654
No 207
>PRK03381 PII uridylyl-transferase; Provisional
Probab=64.51 E-value=2.7e+02 Score=33.04 Aligned_cols=138 Identities=17% Similarity=0.263 Sum_probs=81.3
Q ss_pred cCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEE--EecC--ceeEEEeCCCchh--hHHHHHHHHHHHHHHHH---
Q 008621 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSE--VSLSLTLDPSKLW--SRELIQQASELDHVVEE--- 463 (559)
Q Consensus 393 ~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~I--stSe--~sIs~~v~~~~~~--~~~~~~~~~~l~~~~~~--- 463 (559)
.+.+.|+|.+. ..||+.+++...|..+|+||.-. .+.. .--+|.|...+-. ..+.+++ .+.+++..
T Consensus 597 ~~~~~V~V~~~---DrpGLfa~i~~vL~~~glnI~dA~i~t~dg~~ld~F~V~~~~~~~~~~~~l~~--~L~~~L~~~~~ 671 (774)
T PRK03381 597 PHMVEVTVVAP---DRRGLLSKAAGVLALHRLRVRSASVRSHDGVAVLEFVVSPRFGSPPDAALLRQ--DLRRALDGDLD 671 (774)
T ss_pred CCeEEEEEEec---CCccHHHHHHHHHHHCCCeEEEeEEEecCCEEEEEEEEECCCCCcchHHHHHH--HHHHHHcCCCc
Confidence 46677888764 68999999999999999998754 2321 1234555432211 1111221 22222211
Q ss_pred ----Hhhh--c-------------eeecc----cceeEEEEEeeccccchHHHHHHHHHHhCCCcEEE--EEecCCceEE
Q 008621 464 ----LEKI--A-------------IVNLL----QHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNI 518 (559)
Q Consensus 464 ----L~~~--~-------------~v~~~----~~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~--IsqgaSe~sI 518 (559)
+... . .+... .+.++|.|.+ ...||+++++..+|...|+||.. |++.....-=
T Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~t~i~V~a--~DrpGLla~Ia~~L~~~~lnI~~AkI~T~g~~a~D 749 (774)
T PRK03381 672 VLARLAAREAAAAAVPVRRPAAPPRVLWLDGASPDATVLEVRA--ADRPGLLARLARALERAGVDVRWARVATLGADVVD 749 (774)
T ss_pred hhhhhhcccccccccccccCCCCcEEEEEECCCCCeEEEEEEe--CCchhHHHHHHHHHHHCCCeEEEEEEeecCCeEEE
Confidence 0000 0 12111 2457777777 35799999999999999999986 6655444445
Q ss_pred EEEEecccH----HHHHHHHHHHh
Q 008621 519 SLIVNDDEA----EQCVRALHETF 538 (559)
Q Consensus 519 s~vV~~~d~----~kAv~~LH~~f 538 (559)
+|.|...+. +. .+.|.+.+
T Consensus 750 ~F~V~d~~g~~~~~~-~~~l~~~L 772 (774)
T PRK03381 750 VFYVTGAAGGPLADA-RAAVEQAV 772 (774)
T ss_pred EEEEECCCCCcCchH-HHHHHHHh
Confidence 677765543 23 55565554
No 208
>PF13740 ACT_6: ACT domain; PDB: 1ZPV_A 3P96_A 1U8S_A.
Probab=63.40 E-value=34 Score=27.68 Aligned_cols=33 Identities=15% Similarity=0.326 Sum_probs=25.6
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist 431 (559)
.+|++.|. ++||+.+++++.|+++|.|+.-+.+
T Consensus 3 ~vItv~G~---DrpGiv~~v~~~l~~~g~ni~d~~~ 35 (76)
T PF13740_consen 3 LVITVVGP---DRPGIVAAVTGVLAEHGCNIEDSRQ 35 (76)
T ss_dssp EEEEEEEE-----TTHHHHHHHHHHCTT-EEEEEEE
T ss_pred EEEEEEec---CCCcHHHHHHHHHHHCCCcEEEEEE
Confidence 46788874 6899999999999999999887753
No 209
>cd04886 ACT_ThrD-II-like C-terminal ACT domain of biodegradative (catabolic) threonine dehydratase II (ThrD-II) and other related ACT domains. This CD includes the C-terminal ACT domain of biodegradative (catabolic) threonine dehydratase II (ThrD-II) and other related ACT domains. The Escherichia coli tdcB gene product, ThrD-II, anaerobically catalyzes the pyridoxal phosphate-dependent dehydration of L-threonine and L-serine to ammonia and to alpha-ketobutyrate and pyruvate, respectively. Tetrameric ThrD-II is subject to allosteric activation by AMP, inhibition by alpha-keto acids, and catabolite inactivation by several metabolites of glycolysis and the citric acid cycle. Also included in this CD are N-terminal ACT domains present in smaller (~170 a.a.) archaeal proteins of unknown function. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=63.27 E-value=38 Score=25.84 Aligned_cols=51 Identities=24% Similarity=0.361 Sum_probs=33.9
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC-------ceEEEEEEeccc---HHHHHHHHHH
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGAS-------KVNISLIVNDDE---AEQCVRALHE 536 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaS-------e~sIs~vV~~~d---~~kAv~~LH~ 536 (559)
...||.++++++.+++.|++|..+.+... ...+.+-+.-.+ .+..++.|.+
T Consensus 6 ~d~~G~L~~i~~~i~~~~~nI~~i~~~~~~~~~~~~~~~~~i~v~~~~~~~l~~l~~~l~~ 66 (73)
T cd04886 6 PDRPGQLAKLLAVIAEAGANIIEVSHDRAFKTLPLGEVEVELTLETRGAEHIEEIIAALRE 66 (73)
T ss_pred CCCCChHHHHHHHHHHcCCCEEEEEEEeccCCCCCceEEEEEEEEeCCHHHHHHHHHHHHH
Confidence 46799999999999999999987665432 233444444443 3355555544
No 210
>cd04881 ACT_HSDH-Hom ACT_HSDH_Hom CD includes the C-terminal ACT domain of the NAD(P)H-dependent, homoserine dehydrogenase (HSDH) and related domains. The ACT_HSDH_Hom CD includes the C-terminal ACT domain of the NAD(P)H-dependent, homoserine dehydrogenase (HSDH) encoded by the hom gene of Bacillus subtilis and other related sequences. HSDH reduces aspartate semi-aldehyde to the amino acid homoserine, one that is required for the biosynthesis of Met, Thr, and Ile from Asp. Neither the enzyme nor the aspartate pathway is found in the animal kingdom. This mostly bacterial HSDH group has a C-terminal ACT domain and is believed to be involved in enzyme regulation. A C-terminal deletion in the Corynebacterium glutamicum HSDH abolished allosteric inhibition by L-threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=62.69 E-value=49 Score=25.68 Aligned_cols=56 Identities=23% Similarity=0.386 Sum_probs=37.3
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEecC------ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhcee
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAIV 470 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstSe------~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~v 470 (559)
.+.+|.++++.+.|+++++++.-+.+.. ..+.+.+...+. ..++.+++.|++...|
T Consensus 8 ~d~~g~l~~i~~~l~~~~i~I~~~~~~~~~~~~~~~~~i~~~~~~~---------~~l~~~i~~L~~~~~V 69 (79)
T cd04881 8 KDKPGVLAKITGILAEHGISIESVIQKEADGGETAPVVIVTHETSE---------AALNAALAEIEALDAV 69 (79)
T ss_pred CCCCcHHHHHHHHHHHcCCCeEEEEEcccCCCCceeEEEEEccCCH---------HHHHHHHHHHHcCccc
Confidence 3678999999999999999998875321 235555544331 1466677777764433
No 211
>cd02116 ACT ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. Members of this CD belong to the superfamily of ACT regulatory domains. Pairs of ACT domains are commonly involved in specifically binding an amino acid or other small ligand leading to regulation of the enzyme. The ACT domain has been detected in a number of diverse proteins; some of these proteins are involved in amino acid and purine biosynthesis, phenylalanine hydroxylation, regulation of bacterial metabolism and transcription, and many remain to be characterized. ACT domain-containing enzymes involved in amino acid and purine synthesis are in many cases allosteric enzymes with complex regulation enforced by the binding of ligands. The ACT domain is commonly involved in the binding of a small regulatory molecule, such as the amino acids L-Ser and L-Phe in the case of D-3-phosphoglycerate dehydrogenase and the bifunctional chorismate mutase-p
Probab=62.51 E-value=25 Score=24.36 Aligned_cols=37 Identities=24% Similarity=0.478 Sum_probs=28.3
Q ss_pred chhhHHHHHHHHHHhCCCcEEEEEecC------ceeEEEeCCC
Q 008621 407 GQYGFLAKVFSTFEDLGISVDVVATSE------VSLSLTLDPS 443 (559)
Q Consensus 407 ~~~g~larIf~~L~~~gI~Vd~IstSe------~sIs~~v~~~ 443 (559)
+.+|.+.++++.|+++++++..+..+. ..+++.++..
T Consensus 7 ~~~~~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 49 (60)
T cd02116 7 DRPGLLAKVLSVLAEAGINITSIEQRTSGDGGEADIFIVVDGD 49 (60)
T ss_pred CCCchHHHHHHHHHHCCCcEEEEEeEEcCCCCeEEEEEEEech
Confidence 468899999999999999999886432 3466666543
No 212
>PRK00194 hypothetical protein; Validated
Probab=61.96 E-value=38 Score=28.08 Aligned_cols=33 Identities=12% Similarity=0.409 Sum_probs=27.8
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist 431 (559)
.++++.+. +.||+++++.+.|+++|+||.-+.+
T Consensus 4 ~~ltv~g~---DrpGiva~vt~~la~~g~nI~~~~~ 36 (90)
T PRK00194 4 AIITVIGK---DKVGIIAGVSTVLAELNVNILDISQ 36 (90)
T ss_pred EEEEEEcC---CCCCHHHHHHHHHHHcCCCEEehhh
Confidence 46777764 5899999999999999999988753
No 213
>cd04872 ACT_1ZPV ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein. This CD, ACT_1ZPV, includes those single ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein (pdb structure 1ZPV). Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=61.27 E-value=16 Score=30.29 Aligned_cols=34 Identities=26% Similarity=0.302 Sum_probs=29.0
Q ss_pred EEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC
Q 008621 478 IISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA 513 (559)
Q Consensus 478 iISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga 513 (559)
+|++.| ...||+++++.+.|++.|+||.-++|..
T Consensus 3 vl~i~g--~D~pGiva~vt~~la~~g~nI~~~~~~~ 36 (88)
T cd04872 3 VITVVG--KDRVGIVAGVSTKLAELNVNILDISQTI 36 (88)
T ss_pred EEEEEc--CCCCCHHHHHHHHHHHcCCCEEechhHh
Confidence 567777 3579999999999999999999988765
No 214
>cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=60.45 E-value=90 Score=25.41 Aligned_cols=54 Identities=19% Similarity=0.158 Sum_probs=40.3
Q ss_pred cccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEEEEeccc-----HHHHHHHHHHHhc
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISLIVNDDE-----AEQCVRALHETFF 539 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~--IsqgaSe~sIs~vV~~~d-----~~kAv~~LH~~f~ 539 (559)
...||.+.++.++|.+.|++|.. |++-....-=.|.|...+ -++.++.|.+++.
T Consensus 9 ~DRpGLL~~i~~~l~~~gl~I~~AkIsT~Gerv~DvFyV~d~~g~kl~d~~~~~~l~~~L~ 69 (72)
T cd04895 9 ARKPGILLEAVQVLTDLDLCITKAYISSDGGWFMDVFHVTDQLGNKLTDDSLIAYIEKSLG 69 (72)
T ss_pred CCcCCHHHHHHHHHHHCCcEEEEEEEeecCCeEEEEEEEECCCCCCCCCHHHHHHHHHHhc
Confidence 46799999999999999999996 666555555667776654 2455667776654
No 215
>PRK05092 PII uridylyl-transferase; Provisional
Probab=60.04 E-value=3.6e+02 Score=32.71 Aligned_cols=124 Identities=13% Similarity=0.183 Sum_probs=71.2
Q ss_pred CeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEE--Eec--Ccee-EEEeCCCch---hh---HHHHHHHHHHHHHHH
Q 008621 394 NVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATS--EVSL-SLTLDPSKL---WS---RELIQQASELDHVVE 462 (559)
Q Consensus 394 ~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~I--stS--e~sI-s~~v~~~~~---~~---~~~~~~~~~l~~~~~ 462 (559)
+.+.|+|.+. +.+|.++++...|+.+|.||.-. .++ ...+ +|.|...+- .. .+.+++ .+..++.
T Consensus 731 ~~t~v~I~~~---Dr~GLfa~i~~~L~~~glnI~~A~I~t~~dg~alD~F~V~~~~g~~~~~~~~~~~l~~--~L~~~l~ 805 (931)
T PRK05092 731 GVTEVTVLAA---DHPGLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWIQDAFGRDEDEPRRLARLAK--AIEDALS 805 (931)
T ss_pred CeEEEEEEeC---CCCcHHHHHHHHHHHCCCcEEEEEEEEecCCeEEEEEEEECCCCCCCCCHHHHHHHHH--HHHHHHc
Confidence 5667788764 58999999999999999998753 232 2233 366632211 11 111221 2222221
Q ss_pred H-H--h-----h-hc-----------eeec----ccceeEEEEEeeccccchHHHHHHHHHHhCCCcEEE--EEecCCce
Q 008621 463 E-L--E-----K-IA-----------IVNL----LQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKV 516 (559)
Q Consensus 463 ~-L--~-----~-~~-----------~v~~----~~~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~--IsqgaSe~ 516 (559)
. . . + .. .|.+ ..+.+.|.|++ ...||+++++..+|.+.|++|.. |++.....
T Consensus 806 ~~~~~~~~~~~r~~~~~~~~~~~~~~~V~~~~~~s~~~t~i~I~~--~DrpGLl~~I~~~l~~~gl~I~~A~I~T~~~~~ 883 (931)
T PRK05092 806 GEVRLPEALAKRTKPKKRARAFHVPPRVTIDNEASNRFTVIEVNG--RDRPGLLYDLTRALSDLNLNIASAHIATYGERA 883 (931)
T ss_pred CCCCCccccccccCccccccCCCCCCEEEEeeCCCCCeEEEEEEE--CCcCcHHHHHHHHHHHCCceEEEEEEEEcCCEE
Confidence 0 0 0 0 00 0111 12445666666 45799999999999999999986 55543333
Q ss_pred EEEEEEec
Q 008621 517 NISLIVND 524 (559)
Q Consensus 517 sIs~vV~~ 524 (559)
-=.|.|..
T Consensus 884 ~D~F~v~d 891 (931)
T PRK05092 884 VDVFYVTD 891 (931)
T ss_pred EEEEEEeC
Confidence 34566644
No 216
>PRK13010 purU formyltetrahydrofolate deformylase; Reviewed
Probab=59.95 E-value=1.3e+02 Score=31.23 Aligned_cols=33 Identities=15% Similarity=0.214 Sum_probs=28.7
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist 431 (559)
.+|++.|. +++|+.+++.+.|+++|+||.-+++
T Consensus 10 ~iitv~G~---Dr~GIVA~Vs~~Lae~g~NI~disq 42 (289)
T PRK13010 10 YVLTLACP---SAPGIVAAVSGFLAEKGCYIVELTQ 42 (289)
T ss_pred EEEEEECC---CCCCcHHHHHHHHHHCCCCEEeccc
Confidence 46788874 6899999999999999999988876
No 217
>PRK03059 PII uridylyl-transferase; Provisional
Probab=59.74 E-value=3.7e+02 Score=32.39 Aligned_cols=123 Identities=20% Similarity=0.234 Sum_probs=70.2
Q ss_pred CeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEE--EecCcee---EEEeCC-Cch-hh---HHHHHHHHHHHHHHHH
Q 008621 394 NVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSEVSL---SLTLDP-SKL-WS---RELIQQASELDHVVEE 463 (559)
Q Consensus 394 ~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~I--stSe~sI---s~~v~~-~~~-~~---~~~~~~~~~l~~~~~~ 463 (559)
+.+-|.|.. .+.+|..+++...|+.+|+||.-. .++.... +|.|.+ ... .. .+.+++ .+...+..
T Consensus 677 ~~~~v~i~~---~d~~gLFa~i~g~l~~~~l~I~~A~i~t~~~g~~ld~f~V~~~~~~~~~~~~~~~i~~--~l~~~l~~ 751 (856)
T PRK03059 677 EGLQVMVYT---PDQPDLFARICGYFDRAGFSILDARVHTTRHGYALDTFQVLDPEEDVHYRDIINLVEH--ELAERLAE 751 (856)
T ss_pred CeEEEEEEe---cCCCcHHHHHHHHHHHCCCceeeeEEEEcCCCeEEEEEEEeCCCCCCChHHHHHHHHH--HHHHHHcC
Confidence 556677764 468999999999999999999643 2333221 455522 111 11 111111 22221110
Q ss_pred ---Hh----h--------h---ceeecc----cceeEEEEEeeccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEE
Q 008621 464 ---LE----K--------I---AIVNLL----QHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNIS 519 (559)
Q Consensus 464 ---L~----~--------~---~~v~~~----~~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~--IsqgaSe~sIs 519 (559)
+. + . ..|.+. .+.+.|.|++. ..||+++++..+|...|++|.. |++-....-=+
T Consensus 752 ~~~~~~~~~~~~~~~~~~~~~~~~V~~~~~~~~~~T~i~V~a~--DrpGLLa~Ia~~L~~~~l~I~~AkI~T~~~~v~Dv 829 (856)
T PRK03059 752 QAPLPEPSKGRLSRQVKHFPITPRVDLRPDERGQYYILSVSAN--DRPGLLYAIARVLAEHRVSVHTAKINTLGERVEDT 829 (856)
T ss_pred CCCcchhhcccccccccCCCCCceEEEEEcCCCCEEEEEEEeC--CcchHHHHHHHHHHHCCCeEEEEEEeecCCEEEEE
Confidence 00 0 0 012221 24566666663 6799999999999999999996 66543333345
Q ss_pred EEEe
Q 008621 520 LIVN 523 (559)
Q Consensus 520 ~vV~ 523 (559)
|.|.
T Consensus 830 F~V~ 833 (856)
T PRK03059 830 FLID 833 (856)
T ss_pred EEEc
Confidence 6664
No 218
>cd04874 ACT_Af1403 N-terminal ACT domain of the yet uncharacterized, small (~133 a.a.), putative amino acid binding protein, Af1403, and related domains. This CD includes the N-terminal ACT domain of the yet uncharacterized, small (~133 a.a.), putative amino acid binding protein, Af1403, from Archaeoglobus fulgidus and other related archeal ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=59.56 E-value=33 Score=26.24 Aligned_cols=25 Identities=12% Similarity=0.174 Sum_probs=22.0
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
.+.+|.++++.+.|+++++++.-+.
T Consensus 8 ~d~~g~l~~i~~~l~~~~~~i~~~~ 32 (72)
T cd04874 8 EDKPGVLRDLTGVIAEHGGNITYTQ 32 (72)
T ss_pred CCCCChHHHHHHHHHhCCCCEEEEE
Confidence 4688999999999999999998664
No 219
>COG4747 ACT domain-containing protein [General function prediction only]
Probab=58.96 E-value=26 Score=31.44 Aligned_cols=66 Identities=15% Similarity=0.233 Sum_probs=45.1
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEec--CCceEEEEEEecccHHHHHHHHHHHhcc---CccccccccccC
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQG--ASKVNISLIVNDDEAEQCVRALHETFFE---SDLANLDCVCGS 552 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~Isqg--aSe~sIs~vV~~~d~~kAv~~LH~~f~~---~~~~~~~~~~~~ 552 (559)
..+.||-++.+.+.|.++|||++..+-. +.---|-.+|++. +.|-++||++=|- ++....+.++.+
T Consensus 10 lENk~GRL~~~~~~L~eagINiRA~tiAdt~dFGIiRmvV~~~--d~A~~~Lee~gF~Vr~~dVlaVEmeD~P 80 (142)
T COG4747 10 LENKPGRLASVANKLKEAGINIRAFTIADTGDFGIIRMVVDRP--DEAHSVLEEAGFTVRETDVLAVEMEDVP 80 (142)
T ss_pred ecCCcchHHHHHHHHHHcCCceEEEEeccccCcceEEEEcCCh--HHHHHHHHHCCcEEEeeeEEEEEecCCC
Confidence 3467899999999999999999985542 2223366777766 5678889988553 344444444443
No 220
>PRK08577 hypothetical protein; Provisional
Probab=58.46 E-value=33 Score=31.17 Aligned_cols=35 Identities=17% Similarity=0.365 Sum_probs=28.0
Q ss_pred cCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 393 ~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
++.+.+++.. .+.+|.++++.+.|+++++++..+.
T Consensus 54 k~~~~I~V~~---~Dr~GvLa~I~~~l~~~~inI~~i~ 88 (136)
T PRK08577 54 KKLVEIELVV---EDRPGVLAKITGLLAEHGVDILATE 88 (136)
T ss_pred ccEEEEEEEE---cCCCCHHHHHHHHHHHCCCCEEEEE
Confidence 3456677764 4688999999999999999998664
No 221
>cd04872 ACT_1ZPV ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein. This CD, ACT_1ZPV, includes those single ACT domain proteins similar to the yet uncharacterized Streptococcus pneumoniae ACT domain protein (pdb structure 1ZPV). Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=58.38 E-value=51 Score=27.30 Aligned_cols=32 Identities=16% Similarity=0.400 Sum_probs=27.1
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist 431 (559)
++++.+. +.||+++++.+.|+++|+|+.-+.+
T Consensus 3 vl~i~g~---D~pGiva~vt~~la~~g~nI~~~~~ 34 (88)
T cd04872 3 VITVVGK---DRVGIVAGVSTKLAELNVNILDISQ 34 (88)
T ss_pred EEEEEcC---CCCCHHHHHHHHHHHcCCCEEechh
Confidence 5677764 5899999999999999999988753
No 222
>cd04880 ACT_AAAH-PDT-like ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH). ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH): Phenylalanine hydroxylases (PAH), tyrosine hydroxylases (TH) and tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. This family of enzymes shares a common catalytic mechanism, in which dioxygen is used by an active site containing a single, reduced iron atom to hydroxylate an unactivated aromatic substrate, concomitant with a two-electron oxidation of tetrahydropterin (BH4) cofactor to its quinonoid dihydropterin form. Eukaryotic AAAHs have an N-terminal ACT (regulatory) domain, a middle catalytic domain and a C-terminal domain which is responsible for the oligomeric state of the enzyme forming a domain-swapped tetrameric coiled-coil. The PAH, TH, and TPH enzymes contain highly conserved catalytic domains but distinct N-terminal ACT domains and differ in their mech
Probab=58.19 E-value=30 Score=27.56 Aligned_cols=26 Identities=27% Similarity=0.493 Sum_probs=23.0
Q ss_pred chhhHHHHHHHHHHhCCCcEEEEEec
Q 008621 407 GQYGFLAKVFSTFEDLGISVDVVATS 432 (559)
Q Consensus 407 ~~~g~larIf~~L~~~gI~Vd~IstS 432 (559)
+.||.++++++.|+++|+|+..|.+.
T Consensus 8 d~pG~L~~vL~~f~~~~vni~~I~Sr 33 (75)
T cd04880 8 NKPGALAKALKVFAERGINLTKIESR 33 (75)
T ss_pred CcCCHHHHHHHHHHHCCCCEEEEEee
Confidence 57999999999999999999998543
No 223
>cd04869 ACT_GcvR_2 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. This CD includes the second of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR in
Probab=58.18 E-value=67 Score=25.72 Aligned_cols=30 Identities=13% Similarity=0.348 Sum_probs=25.1
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 398 ItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
+++.+. ..+|.++++.+.|+++|+++.-+.
T Consensus 2 l~v~g~---D~~Giv~~it~~l~~~~~nI~~~~ 31 (81)
T cd04869 2 VEVVGN---DRPGIVHEVTQFLAQRNINIEDLS 31 (81)
T ss_pred EEEEeC---CCCCHHHHHHHHHHHcCCCeEEeE
Confidence 455653 589999999999999999998875
No 224
>cd04879 ACT_3PGDH-like ACT_3PGDH-like CD includes the C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH). ACT_3PGDH-like: The ACT_3PGDH-like CD includes the C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH), with or without an extended C-terminal (xct) region found in various bacteria, archaea, fungi, and plants. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In bacteria, 3PGDH is feedback controlled by the end product L-serine in an allosteric manner. In the Escherichia coli homotetrameric enzyme, the interface at adjacent ACT (regulatory) domains couples to create an extended beta-sheet. Each regulatory interface forms two serine-binding sites. The mechanism by which serine transmits inhibition to the active
Probab=57.72 E-value=28 Score=26.38 Aligned_cols=25 Identities=20% Similarity=0.315 Sum_probs=22.1
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
.+.+|.++++.+.|+++|+++..+.
T Consensus 7 ~d~~g~l~~i~~~l~~~~~nI~~~~ 31 (71)
T cd04879 7 KDVPGVIGKVGTILGEHGINIAAMQ 31 (71)
T ss_pred cCCCCHHHHHHHHHHhcCCCeeeEE
Confidence 4678999999999999999998774
No 225
>cd04875 ACT_F4HF-DF N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase). This CD includes the N-terminal ACT domain of formyltetrahydrofolate deformylase (F4HF-DF; formyltetrahydrofolate hydrolase) which catalyzes the hydrolysis of 10-formyltetrahydrofolate (formyl-FH4) to FH4 and formate. Formyl-FH4 hydrolase generates the formate that is used by purT-encoded 5'-phosphoribosylglycinamide transformylase for step three of de novo purine nucleotide synthesis. Formyl-FH4 hydrolase, a hexamer which is activated by methionine and inhibited by glycine, is proposed to regulate the balance FH4 and C1-FH4 in response to changing growth conditions. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=57.44 E-value=59 Score=25.83 Aligned_cols=31 Identities=16% Similarity=0.190 Sum_probs=26.2
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe
Q 008621 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (559)
Q Consensus 398 ItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist 431 (559)
|++.+. +++|+++++.+.|+++|+++.-+.+
T Consensus 2 i~v~g~---D~~Giv~~it~~l~~~g~nI~~~~~ 32 (74)
T cd04875 2 LTLSCP---DRPGIVAAVSGFLAEHGGNIVESDQ 32 (74)
T ss_pred EEEEcC---CCCCHHHHHHHHHHHcCCCEEeeee
Confidence 566653 6899999999999999999988854
No 226
>cd04874 ACT_Af1403 N-terminal ACT domain of the yet uncharacterized, small (~133 a.a.), putative amino acid binding protein, Af1403, and related domains. This CD includes the N-terminal ACT domain of the yet uncharacterized, small (~133 a.a.), putative amino acid binding protein, Af1403, from Archaeoglobus fulgidus and other related archeal ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=57.33 E-value=48 Score=25.33 Aligned_cols=41 Identities=17% Similarity=0.158 Sum_probs=29.4
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCC---ceEEEEEEecc
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGAS---KVNISLIVNDD 525 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaS---e~sIs~vV~~~ 525 (559)
+...+|.++++.+.|+++++++..+.+... ...+.+.++..
T Consensus 7 ~~d~~g~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~i~~~~~ 50 (72)
T cd04874 7 AEDKPGVLRDLTGVIAEHGGNITYTQQFIEREGKARIYMELEGV 50 (72)
T ss_pred eCCCCChHHHHHHHHHhCCCCEEEEEEeccCCCeEEEEEEEecc
Confidence 346789999999999999999987655432 23355566554
No 227
>cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=55.98 E-value=95 Score=24.87 Aligned_cols=45 Identities=24% Similarity=0.283 Sum_probs=32.8
Q ss_pred EEEEEeeccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEEEEec
Q 008621 478 IISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISLIVND 524 (559)
Q Consensus 478 iISIVG~~~~~~gv~~ri~~~L~~~~InI~~--IsqgaSe~sIs~vV~~ 524 (559)
+|.+.|. ..||+++++..+|++.|+||.. |.+-....--+|.|..
T Consensus 2 ~~~v~~~--Dr~gLl~~i~~~l~~~~lnI~~A~i~t~~~~~~d~f~V~d 48 (74)
T cd04925 2 AIELTGT--DRPGLLSEVFAVLADLHCNVVEARAWTHNGRLACVIYVRD 48 (74)
T ss_pred EEEEEEC--CCCCHHHHHHHHHHHCCCcEEEEEEEEECCEEEEEEEEEc
Confidence 4566664 5799999999999999999986 4443344556666653
No 228
>PF13710 ACT_5: ACT domain; PDB: 2FGC_A 2PC6_A 2F1F_B.
Probab=55.18 E-value=20 Score=28.21 Aligned_cols=39 Identities=28% Similarity=0.515 Sum_probs=29.5
Q ss_pred ccchHHHHHHHHHHhCCCcEEEEEecC----CceEEEEEEecc
Q 008621 487 RSSLILEKAFRVLRRSGVNVQMISQGA----SKVNISLIVNDD 525 (559)
Q Consensus 487 ~~~gv~~ri~~~L~~~~InI~~Isqga----Se~sIs~vV~~~ 525 (559)
+.||++.|+...+.+.|+||..++.+. .-..+++.++.+
T Consensus 1 n~~GvL~Ri~~vf~rRg~nI~sl~v~~~~~~~~~riti~v~~~ 43 (63)
T PF13710_consen 1 NQPGVLNRITGVFRRRGFNIESLSVGPTEDPGISRITIVVSGD 43 (63)
T ss_dssp SSTTHHHHHHHHHHTTT-EECEEEEEE-SSTTEEEEEEEEES-
T ss_pred CCcHHHHHHHHHHhcCCeEEeeEEeeecCCCCEEEEEEEEeeC
Confidence 368999999999999999999877665 234577777764
No 229
>cd04905 ACT_CM-PDT C-terminal ACT domain of the bifunctional chorismate mutase-prephenate dehydratase (CM-PDT) enzyme and the prephenate dehydratase (PDT) enzyme. The C-terminal ACT domain of the bifunctional chorismate mutase-prephenate dehydratase (CM-PDT) enzyme and the prephenate dehydratase (PDT) enzyme, found in plants, fungi, bacteria, and archaea. The P-protein of E. coli (CM-PDT, PheA) catalyzes the conversion of chorismate to prephenate and then the decarboxylation and dehydration to form phenylpyruvate. These are the first two steps in the biosynthesis of L-Phe and L-Tyr via the shikimate pathway in microorganisms and plants. The E. coli P-protein (CM-PDT) has three domains with an N-terminal domain with chorismate mutase activity, a middle domain with prephenate dehydratase activity, and an ACT regulatory C-terminal domain. The prephenate dehydratase enzyme has a PDT and ACT domain. The ACT domain is essential to bring about the negative allosteric regulation by L-Phe bindi
Probab=55.05 E-value=80 Score=25.50 Aligned_cols=53 Identities=13% Similarity=0.222 Sum_probs=36.3
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCC---ceEEEEEEecc------cHHHHHHHHHHH
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGAS---KVNISLIVNDD------EAEQCVRALHET 537 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaS---e~sIs~vV~~~------d~~kAv~~LH~~ 537 (559)
+...||.++++++.++++|||+..+..-.. ...+.|.|+-+ +.+++++.|.+.
T Consensus 8 ~~d~~G~L~~il~~f~~~~ini~~i~s~p~~~~~~~~~f~vd~~~~~~~~~~~~~l~~l~~~ 69 (80)
T cd04905 8 LPNKPGALYDVLGVFAERGINLTKIESRPSKGGLWEYVFFIDFEGHIEDPNVAEALEELKRL 69 (80)
T ss_pred ECCCCCHHHHHHHHHHHCCcCEEEEEEEEcCCCCceEEEEEEEECCCCCHHHHHHHHHHHHh
Confidence 345789999999999999999987644332 33456666533 345666666653
No 230
>cd04886 ACT_ThrD-II-like C-terminal ACT domain of biodegradative (catabolic) threonine dehydratase II (ThrD-II) and other related ACT domains. This CD includes the C-terminal ACT domain of biodegradative (catabolic) threonine dehydratase II (ThrD-II) and other related ACT domains. The Escherichia coli tdcB gene product, ThrD-II, anaerobically catalyzes the pyridoxal phosphate-dependent dehydration of L-threonine and L-serine to ammonia and to alpha-ketobutyrate and pyruvate, respectively. Tetrameric ThrD-II is subject to allosteric activation by AMP, inhibition by alpha-keto acids, and catabolite inactivation by several metabolites of glycolysis and the citric acid cycle. Also included in this CD are N-terminal ACT domains present in smaller (~170 a.a.) archaeal proteins of unknown function. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=53.86 E-value=42 Score=25.61 Aligned_cols=25 Identities=24% Similarity=0.345 Sum_probs=22.1
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
.+.||.++++++.|+++|+++.-+.
T Consensus 6 ~d~~G~L~~i~~~i~~~~~nI~~i~ 30 (73)
T cd04886 6 PDRPGQLAKLLAVIAEAGANIIEVS 30 (73)
T ss_pred CCCCChHHHHHHHHHHcCCCEEEEE
Confidence 4689999999999999999998664
No 231
>PRK11589 gcvR glycine cleavage system transcriptional repressor; Provisional
Probab=53.49 E-value=38 Score=32.92 Aligned_cols=60 Identities=13% Similarity=0.264 Sum_probs=42.2
Q ss_pred ceeEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC--CceEEEEEEecccHHHHHHHHHHHh
Q 008621 475 HRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA--SKVNISLIVNDDEAEQCVRALHETF 538 (559)
Q Consensus 475 ~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga--Se~sIs~vV~~~d~~kAv~~LH~~f 538 (559)
...+|+++| ...||+++++.+.|.++|.|+.-.++.- .+-.+.++|.... ..+..|...|
T Consensus 7 ~~lviTviG--~DrpGIVa~vs~~l~~~g~NI~ds~~t~lgg~Fa~i~lvs~~~--~~~~~le~~L 68 (190)
T PRK11589 7 HYLVITALG--ADRPGIVNTITRHVSSCGCNIEDSRLAMLGEEFTFIMLLSGSW--NAITLIESTL 68 (190)
T ss_pred cEEEEEEEc--CCCChHHHHHHHHHHHcCCCeeehhhHhhCCceEEEEEEeCCh--hHHHHHHHHH
Confidence 457899999 3579999999999999999998766643 3445666665443 2444444444
No 232
>TIGR00655 PurU formyltetrahydrofolate deformylase. This model describes formyltetrahydrofolate deformylases. The enzyme is a homohexamer. Sequences from a related enzyme formyl tetrahydrofolate-specific enzyme, phosphoribosylglycinamide formyltransferase, serve as an outgroup for phylogenetic analysis. Putative members of this family, scoring below the trusted cutoff, include a sequence from Rhodobacter capsulatus that lacks an otherwise conserved C-terminal region.
Probab=53.46 E-value=31 Score=35.61 Aligned_cols=34 Identities=12% Similarity=0.132 Sum_probs=29.5
Q ss_pred EEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC
Q 008621 478 IISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA 513 (559)
Q Consensus 478 iISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga 513 (559)
+|+++| ...||+.+++.+.|+++|+||.-++|.-
T Consensus 2 ~itv~g--~D~~GIVA~Vt~~La~~g~NI~d~sq~~ 35 (280)
T TIGR00655 2 ILLVSC--PDQKGLVAAISTFIAKHGANIISNDQHT 35 (280)
T ss_pred EEEEEC--CCCCChHHHHHHHHHHCCCCEEeeeEEE
Confidence 567777 4578999999999999999999998865
No 233
>cd04905 ACT_CM-PDT C-terminal ACT domain of the bifunctional chorismate mutase-prephenate dehydratase (CM-PDT) enzyme and the prephenate dehydratase (PDT) enzyme. The C-terminal ACT domain of the bifunctional chorismate mutase-prephenate dehydratase (CM-PDT) enzyme and the prephenate dehydratase (PDT) enzyme, found in plants, fungi, bacteria, and archaea. The P-protein of E. coli (CM-PDT, PheA) catalyzes the conversion of chorismate to prephenate and then the decarboxylation and dehydration to form phenylpyruvate. These are the first two steps in the biosynthesis of L-Phe and L-Tyr via the shikimate pathway in microorganisms and plants. The E. coli P-protein (CM-PDT) has three domains with an N-terminal domain with chorismate mutase activity, a middle domain with prephenate dehydratase activity, and an ACT regulatory C-terminal domain. The prephenate dehydratase enzyme has a PDT and ACT domain. The ACT domain is essential to bring about the negative allosteric regulation by L-Phe bindi
Probab=53.46 E-value=57 Score=26.41 Aligned_cols=37 Identities=19% Similarity=0.269 Sum_probs=27.4
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEec-----CceeEEEeCC
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATS-----EVSLSLTLDP 442 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstS-----e~sIs~~v~~ 442 (559)
.+.+|.++++++.|+++|||+..+.+. ...+.|.++-
T Consensus 9 ~d~~G~L~~il~~f~~~~ini~~i~s~p~~~~~~~~~f~vd~ 50 (80)
T cd04905 9 PNKPGALYDVLGVFAERGINLTKIESRPSKGGLWEYVFFIDF 50 (80)
T ss_pred CCCCCHHHHHHHHHHHCCcCEEEEEEEEcCCCCceEEEEEEE
Confidence 357999999999999999999877432 2335666543
No 234
>PRK05788 cobalamin biosynthesis protein CbiG; Validated
Probab=53.08 E-value=2.7e+02 Score=29.30 Aligned_cols=141 Identities=19% Similarity=0.233 Sum_probs=74.1
Q ss_pred CCcEEEEcCCCcccCCCCcee--eec--CCcchhHHHHHHHHcCcCcE-EEeeCCcccccCCCCCCCCCccccccCHHHH
Q 008621 260 DLAIPIVTGFLGKAWRTCAIT--TLG--RGGSDLTATTIGKALGLQEI-QVWKDVDGVLTCDPNIHPHAKPVPYLTFDEA 334 (559)
Q Consensus 260 ~~~ipVv~Gfig~~~~~G~~~--tlg--RgGSD~tAa~lA~~L~A~~l-~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea 334 (559)
++.|.|+ |+ .|+.. .|+ .||.+..|-.||..|||.-+ +=-||+.|.+.-|
T Consensus 78 DPaVvvv------De-~G~~vIsLLsGH~GGAN~LA~~iA~~lga~pVITTAtd~~g~~avD------------------ 132 (315)
T PRK05788 78 DPAVVVV------DE-KGKFVISLLSGHHGGANELARDLAKILGAVPVITTATDVNGKAAVD------------------ 132 (315)
T ss_pred CCCEEEE------eC-CCCEEEEcccCCcccHHHHHHHHHHHhCCEEEEeCCccccCCccHH------------------
Confidence 4456666 42 56542 343 68999999999999999765 5667888887644
Q ss_pred HHHH-HcCCCcchHh---HHHHHHhCCCCEEEecCCCCCCCCeEEecCCC-CccceeeEEeeecCeEEEEEEecCccchh
Q 008621 335 AELA-YFGAQVLHPQ---SMRPAREGDIPVRVKNSYNPNAPGTLIRRSRD-MSKAVLTSIVLKRNVTMLDIVSTRMLGQY 409 (559)
Q Consensus 335 ~eLa-~~Ga~vlhp~---a~~~a~~~~Ipv~I~n~~~p~~~GT~I~~~~~-~~~~~It~Is~~~~ialItV~~~~m~~~~ 409 (559)
.++ .+|..+-.|+ .+.-++-.|=||.+..- +..+..+..... ........+.+......+-|-...-....
T Consensus 133 -~la~~~g~~i~~~~~~k~i~a~ll~g~~v~~~~~---~~~~~i~i~~~~~~~~~~~~~l~l~P~~l~vGIGcrrg~~~e 208 (315)
T PRK05788 133 -TIAKQLNAKIVNRESTKKVNAALVNGEKVGLWGD---ELDPVIRVSLRNDVPELPKVTVKLRPKNVVLGIGCRKGVSAE 208 (315)
T ss_pred -HHHHhcCCEecCHHHHHHHHHHHHCCCceEEEcc---CCCceEEEeccccccCCCCceEEEecCeEEEeeccCCCCCHH
Confidence 111 1344444433 23334445555555321 112233322211 00000112333333333333333323345
Q ss_pred hHHHHHHHHHHhCCCcEEEE
Q 008621 410 GFLAKVFSTFEDLGISVDVV 429 (559)
Q Consensus 410 g~larIf~~L~~~gI~Vd~I 429 (559)
.+...+.+.|+++|++++-+
T Consensus 209 ~i~~ai~~~L~~~~i~~~~i 228 (315)
T PRK05788 209 EIAEAVERALEALNIDPRAV 228 (315)
T ss_pred HHHHHHHHHHHHcCCCHHHc
Confidence 57788889999999976543
No 235
>cd04819 PA_2 PA_2: Protease-associated (PA) domain subgroup 2. A subgroup of PA-domain containing proteins. The PA domain is an insert domain in a diverse fraction of proteases. The significance of the PA domain to many of the proteins in which it is inserted is undetermined. It may be a protein-protein interaction domain. At peptidase active sites, the PA domain may participate in substrate binding and/or promoting conformational changes, which influence the stability and accessibility of the site to substrate. Proteins in this group contain a C-terminal RING-finger domain. Proteins into which the PA domain is inserted include the following: i) various signal peptide peptidases: such as hSPPL2a and 2b, ii) various E3 ubiquitin ligases similar to human GRAIL (gene related to anergy in lymphocytes) protein, iii) various proteins containing a RING finger motif such as Arabidopsis ReMembR-H2 protein, iv) EDEM3 (ER-degradation-enhancing mannosidase-like 3 protein), v) various plant vacuola
Probab=52.97 E-value=76 Score=28.43 Aligned_cols=76 Identities=18% Similarity=0.177 Sum_probs=46.3
Q ss_pred CCceeeecCCcc-hh--HHHHHHHHcCcCcEEEeeCCcccccCCCCC-----CCCCccccccCHHHHHHHHHcCCCcchH
Q 008621 276 TCAITTLGRGGS-DL--TATTIGKALGLQEIQVWKDVDGVLTCDPNI-----HPHAKPVPYLTFDEAAELAYFGAQVLHP 347 (559)
Q Consensus 276 ~G~~~tlgRgGS-D~--tAa~lA~~L~A~~l~i~TDV~GV~taDP~~-----v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp 347 (559)
.|.+..+.||+. +. --...|...||.-++++.+.+|.+..-|.. .+..-+.=.|+.++..+|..
T Consensus 44 ~GkIvlv~~g~~~~~~~~k~~~A~~~GA~avi~~~~~~g~~~~~~~~~~~~~~~~~IP~v~Is~edg~~L~~-------- 115 (127)
T cd04819 44 EGKIAVVKRDDPDVDRKEKYAKAVAAGAAAFVVVNTVPGVLPATGDEGTEDGPPSPIPAASVSGEDGLRLAR-------- 115 (127)
T ss_pred CCeEEEEEcCCCchhHHHHHHHHHHCCCEEEEEEeCCCCcCcccccccccCCCCCCCCEEEEeHHHHHHHHH--------
Confidence 577777777765 22 357788999999999999999865311110 01122233566777776643
Q ss_pred hHHHHHHhCCCCEEEec
Q 008621 348 QSMRPAREGDIPVRVKN 364 (559)
Q Consensus 348 ~a~~~a~~~~Ipv~I~n 364 (559)
+++.|-++.+|+
T Consensus 116 -----~l~~g~~~~~~~ 127 (127)
T cd04819 116 -----VAERNDTLVLRV 127 (127)
T ss_pred -----HHhcCCceEeeC
Confidence 234466666653
No 236
>PRK03670 competence damage-inducible protein A; Provisional
Probab=52.07 E-value=45 Score=33.89 Aligned_cols=70 Identities=19% Similarity=0.256 Sum_probs=45.1
Q ss_pred HHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeec
Q 008621 204 MSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG 283 (559)
Q Consensus 204 lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlg 283 (559)
-|+..++..|.+.|++..... ++.++ ...+.+.+...+.+...+.|++|-+|.+.
T Consensus 20 tN~~~la~~L~~~G~~v~~~~-----iV~Dd-----------~~~I~~~l~~a~~~~~DlVIttGGlGpt~--------- 74 (252)
T PRK03670 20 SNSAFIAQKLTEKGYWVRRIT-----TVGDD-----------VEEIKSVVLEILSRKPEVLVISGGLGPTH--------- 74 (252)
T ss_pred hhHHHHHHHHHHCCCEEEEEE-----EcCCC-----------HHHHHHHHHHHhhCCCCEEEECCCccCCC---------
Confidence 466778889999999864432 23221 23455555433222347888888676552
Q ss_pred CCcchhHHHHHHHHcCcC
Q 008621 284 RGGSDLTATTIGKALGLQ 301 (559)
Q Consensus 284 RgGSD~tAa~lA~~L~A~ 301 (559)
-|.|.-.+|.+++-+
T Consensus 75 ---dD~T~eava~a~g~~ 89 (252)
T PRK03670 75 ---DDVTMLAVAEALGRE 89 (252)
T ss_pred ---CCchHHHHHHHhCCC
Confidence 588999999999854
No 237
>cd04881 ACT_HSDH-Hom ACT_HSDH_Hom CD includes the C-terminal ACT domain of the NAD(P)H-dependent, homoserine dehydrogenase (HSDH) and related domains. The ACT_HSDH_Hom CD includes the C-terminal ACT domain of the NAD(P)H-dependent, homoserine dehydrogenase (HSDH) encoded by the hom gene of Bacillus subtilis and other related sequences. HSDH reduces aspartate semi-aldehyde to the amino acid homoserine, one that is required for the biosynthesis of Met, Thr, and Ile from Asp. Neither the enzyme nor the aspartate pathway is found in the animal kingdom. This mostly bacterial HSDH group has a C-terminal ACT domain and is believed to be involved in enzyme regulation. A C-terminal deletion in the Corynebacterium glutamicum HSDH abolished allosteric inhibition by L-threonine. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=51.92 E-value=75 Score=24.57 Aligned_cols=51 Identities=10% Similarity=0.298 Sum_probs=34.1
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEecccH---HHHHHHHHH
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVNDDEA---EQCVRALHE 536 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaS----e~sIs~vV~~~d~---~kAv~~LH~ 536 (559)
.+.+|.++++.+.|++.++++.-+.+... ...+.+.+...+. +++++.|.+
T Consensus 8 ~d~~g~l~~i~~~l~~~~i~I~~~~~~~~~~~~~~~~~i~~~~~~~~~l~~~i~~L~~ 65 (79)
T cd04881 8 KDKPGVLAKITGILAEHGISIESVIQKEADGGETAPVVIVTHETSEAALNAALAEIEA 65 (79)
T ss_pred CCCCcHHHHHHHHHHHcCCCeEEEEEcccCCCCceeEEEEEccCCHHHHHHHHHHHHc
Confidence 45789999999999999999998765432 2335565554443 345555543
No 238
>cd04884 ACT_CBS C-terminal ACT domain of the cystathionine beta-synthase (CBS) domain protein found in Thermotoga maritima, Tm0935, and delta proteobacteria. This CD includes the C-terminal ACT domain of the cystathionine beta-synthase (CBS) domain protein found in Thermotoga maritima, Tm0935, and delta proteobacteria. This protein has two N-terminal tandem CBS domains and a single C-terminal ACT domain. The CBS domain is found in a wide range of proteins, often in tandem arrangements and together with a variety of other functional domains. It has been proposed that the CBS domain may play a regulatory role, although its exact function is unknown. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=51.62 E-value=63 Score=25.44 Aligned_cols=29 Identities=14% Similarity=0.119 Sum_probs=24.6
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecC
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGA 513 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~Isqga 513 (559)
+...||.++++.+.|+++|+||..+.+..
T Consensus 6 ~~d~pG~L~~l~~~i~~~g~nI~~i~~~~ 34 (72)
T cd04884 6 LEDKPGTLKPVVDTLREFNARIISILTAF 34 (72)
T ss_pred ecCCCccHHHHHHHHHHCCCeEEEEEecc
Confidence 56789999999999999999998765543
No 239
>cd04879 ACT_3PGDH-like ACT_3PGDH-like CD includes the C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH). ACT_3PGDH-like: The ACT_3PGDH-like CD includes the C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH), with or without an extended C-terminal (xct) region found in various bacteria, archaea, fungi, and plants. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In bacteria, 3PGDH is feedback controlled by the end product L-serine in an allosteric manner. In the Escherichia coli homotetrameric enzyme, the interface at adjacent ACT (regulatory) domains couples to create an extended beta-sheet. Each regulatory interface forms two serine-binding sites. The mechanism by which serine transmits inhibition to the active
Probab=50.74 E-value=52 Score=24.85 Aligned_cols=50 Identities=18% Similarity=0.286 Sum_probs=32.2
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEecccHHHHHHHHH
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVNDDEAEQCVRALH 535 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaS----e~sIs~vV~~~d~~kAv~~LH 535 (559)
...+|.++++.+.|++.++||..+..... ...+.+-++....++.++.|.
T Consensus 7 ~d~~g~l~~i~~~l~~~~~nI~~~~~~~~~~~~~~~~~~~v~~~~~~~l~~~l~ 60 (71)
T cd04879 7 KDVPGVIGKVGTILGEHGINIAAMQVGRKEKGGIAYMVLDVDSPVPEEVLEELK 60 (71)
T ss_pred cCCCCHHHHHHHHHHhcCCCeeeEEEeccCCCCEEEEEEEcCCCCCHHHHHHHH
Confidence 45789999999999999999987655432 222445554444334444443
No 240
>PRK01759 glnD PII uridylyl-transferase; Provisional
Probab=50.46 E-value=2.9e+02 Score=33.18 Aligned_cols=126 Identities=18% Similarity=0.157 Sum_probs=73.7
Q ss_pred cCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEE--EecC--ce-eEEEeCCCchh--hHH---HHHHHHHHHHHHH
Q 008621 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSE--VS-LSLTLDPSKLW--SRE---LIQQASELDHVVE 462 (559)
Q Consensus 393 ~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~I--stSe--~s-Is~~v~~~~~~--~~~---~~~~~~~l~~~~~ 462 (559)
.+.+.|.|.. .+.+|.++++...|+.+|++|..- .+.. .. =+|.|.+.+-. ..+ .+++ .+...+.
T Consensus 675 ~~~t~V~V~~---~DrpGLfa~Ia~~L~~~~L~I~~A~I~T~~~g~alD~F~V~d~~g~~~~~~~~~~l~~--~L~~aL~ 749 (854)
T PRK01759 675 RGGTEIFIYC---QDQANLFLKVVSTIGAKKLSIHDAQIITSQDGYVLDSFIVTELNGKLLEFDRRRQLEQ--ALTKALN 749 (854)
T ss_pred CCeEEEEEEe---cCCccHHHHHHHHHHHCCCeEEEEEEEEccCCEEEEEEEEeCCCCCCCCHHHHHHHHH--HHHHHHc
Confidence 3566777775 468999999999999999999763 3322 12 14555322210 111 1111 2222211
Q ss_pred HHh---h-------------hceeeccc----ceeEEEEEeeccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEE
Q 008621 463 ELE---K-------------IAIVNLLQ----HRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISL 520 (559)
Q Consensus 463 ~L~---~-------------~~~v~~~~----~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~--IsqgaSe~sIs~ 520 (559)
.-. . -..|.+.+ +.++|.|.. ...||.++++.++|.+.|++|.. |++-....-=.|
T Consensus 750 ~~~~~~~~~~~~~~~~~~~~~~~V~~dn~~s~~~T~iev~a--~DrpGLL~~I~~~l~~~~l~i~~AkI~T~gerv~D~F 827 (854)
T PRK01759 750 TNKLKKLNLEENHKLQHFHVKTEVRFLNEEKQEQTEMELFA--LDRAGLLAQVSQVFSELNLNLLNAKITTIGEKAEDFF 827 (854)
T ss_pred CCCCcchhccccccccCCCCCCEEEEccCCCCCeEEEEEEe--CCchHHHHHHHHHHHHCCCEEEEEEEcccCceEEEEE
Confidence 000 0 01233332 345555544 56799999999999999999997 666555554556
Q ss_pred EEecc
Q 008621 521 IVNDD 525 (559)
Q Consensus 521 vV~~~ 525 (559)
+|...
T Consensus 828 yv~~~ 832 (854)
T PRK01759 828 ILTNQ 832 (854)
T ss_pred EEECC
Confidence 66544
No 241
>PRK13010 purU formyltetrahydrofolate deformylase; Reviewed
Probab=49.88 E-value=34 Score=35.53 Aligned_cols=35 Identities=14% Similarity=0.150 Sum_probs=30.7
Q ss_pred eeEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEec
Q 008621 476 RSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQG 512 (559)
Q Consensus 476 ~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqg 512 (559)
..+|+++| ...||+.+++.+.|+++|+||.-++|-
T Consensus 9 ~~iitv~G--~Dr~GIVA~Vs~~Lae~g~NI~disq~ 43 (289)
T PRK13010 9 SYVLTLAC--PSAPGIVAAVSGFLAEKGCYIVELTQF 43 (289)
T ss_pred CEEEEEEC--CCCCCcHHHHHHHHHHCCCCEEecccc
Confidence 35789988 457899999999999999999999984
No 242
>cd04882 ACT_Bt0572_2 C-terminal ACT domain of a novel protein composed of just two ACT domains. Included in this CD is the C-terminal ACT domain of a novel protein composed of just two ACT domains, as seen in the yet uncharacterized structure (pdb 2F06) of the Bt0572 protein from Bacteroides thetaiotaomicron and related proteins. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=49.85 E-value=18 Score=27.59 Aligned_cols=26 Identities=15% Similarity=0.335 Sum_probs=22.7
Q ss_pred ccchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 405 MLGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 405 m~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
+.+.||.++++++.|+++|+|+..+.
T Consensus 6 ~~d~pG~L~~i~~~l~~~~~nI~~i~ 31 (65)
T cd04882 6 VPDKPGGLHEILQILSEEGINIEYMY 31 (65)
T ss_pred eCCCCcHHHHHHHHHHHCCCChhheE
Confidence 35789999999999999999998664
No 243
>cd04931 ACT_PAH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, phenylalanine hydroxylases (PAH). ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, phenylalanine hydroxylases (PAH). PAH catalyzes the hydroxylation of L-Phe to L-Tyr, the first step in the catabolic degradation of L-Phe. In PAH, an autoregulatory sequence, N-terminal of the ACT domain, extends across the catalytic domain active site and regulates the enzyme by intrasteric regulation. It appears that the activation by L-Phe induces a conformational change that converts the enzyme to a high-affinity and high-activity state. Modulation of activity is achieved through inhibition by BH4 and activation by phosphorylation of serine residues of the autoregulatory region. The molecular basis for the cooperative activation process is not fully understood yet. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=49.47 E-value=84 Score=26.65 Aligned_cols=59 Identities=22% Similarity=0.384 Sum_probs=40.4
Q ss_pred EEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCceE---EEEEEecc-----cHHHHHHHHHHHh
Q 008621 480 SLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVN---ISLIVNDD-----EAEQCVRALHETF 538 (559)
Q Consensus 480 SIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~s---Is~vV~~~-----d~~kAv~~LH~~f 538 (559)
+++=.+...||-+.++++.++++|||+.-|..-.+... -.|+|+-+ ..+++++.|.+.+
T Consensus 16 slif~l~~~pGsL~~vL~~Fa~~~INLt~IeSRP~~~~~~~Y~FfVDieg~~~~~~~~~l~~L~~~~ 82 (90)
T cd04931 16 SLIFSLKEEVGALAKVLRLFEEKDINLTHIESRPSRLNKDEYEFFINLDKKSAPALDPIIKSLRNDI 82 (90)
T ss_pred EEEEEcCCCCcHHHHHHHHHHHCCCCEEEEEeccCCCCCceEEEEEEEEcCCCHHHHHHHHHHHHHh
Confidence 33333455799999999999999999998876554322 45666633 3346777776644
No 244
>cd04902 ACT_3PGDH-xct C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH). The C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH), with an extended C-terminal (xct) region from bacteria, archaea, fungi, and plants. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In bacteria, 3PGDH is feedback-controlled by the end product L-serine in an allosteric manner. Some 3PGDH enzymes have an additional domain formed by an extended C-terminal region. This additional domain introduces significant asymmetry to the homotetramer. Adjacent ACT (regulatory) domains interact, creating two serine-binding sites, however, this asymmetric arrangement results in the formation of two different and distinct domain interfaces between iden
Probab=49.07 E-value=36 Score=26.49 Aligned_cols=50 Identities=14% Similarity=0.272 Sum_probs=31.6
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEE--ec--CCceEEEEEEecccHHHHHHHH
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMIS--QG--ASKVNISLIVNDDEAEQCVRAL 534 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~Is--qg--aSe~sIs~vV~~~d~~kAv~~L 534 (559)
+...||.++++.+.|+++|+||..+. .. .....+.+-++.......++.|
T Consensus 6 ~~d~~G~l~~i~~~l~~~~inI~~~~~~~~~~~~~~~~~i~v~~~~~~~~~~~l 59 (73)
T cd04902 6 NTDRPGVIGKVGTILGEAGINIAGMQVGRDEPGGEALMVLSVDEPVPDEVLEEL 59 (73)
T ss_pred eCCCCCHHHHHHHHHHHcCcChhheEeeccCCCCEEEEEEEeCCCCCHHHHHHH
Confidence 35678999999999999999996432 21 1233355555554433444444
No 245
>cd04878 ACT_AHAS N-terminal ACT domain of the Escherichia coli IlvH-like regulatory subunit of acetohydroxyacid synthase (AHAS). ACT_AHAS: N-terminal ACT domain of the Escherichia coli IlvH-like regulatory subunit of acetohydroxyacid synthase (AHAS). AHAS catalyses the first common step in the biosynthesis of the three branched-chain amino acids. The first step involves the condensation of either pyruvate or 2-ketobutyrate with the two-carbon hydroxyethyl fragment derived from another pyruvate molecule, covalently bound to the coenzyme thiamine diphosphate. Bacterial AHASs generally consist of regulatory and catalytic subunits. The effector (valine) binding sites are proposed to be located in two symmetrically related positions in the interface between a pair of N-terminal ACT domains with the C-terminal domain of IlvH contacting the catalytic dimer. Plants Arabidopsis and Oryza have tandem IlvH subunits; both the first and second ACT domain sequences are present in this CD. Members of
Probab=48.95 E-value=70 Score=24.22 Aligned_cols=40 Identities=20% Similarity=0.458 Sum_probs=29.9
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC----ceEEEEEEecc
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGAS----KVNISLIVNDD 525 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaS----e~sIs~vV~~~ 525 (559)
...+|++.++...|++.++++..+.+... ...+.+.++..
T Consensus 8 ~d~~g~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 51 (72)
T cd04878 8 ENEPGVLNRISGLFARRGFNIESLTVGPTEDPGISRITIVVEGD 51 (72)
T ss_pred cCCCcHHHHHHHHHHhCCCCEEEEEeeecCCCCeEEEEEEEECC
Confidence 46789999999999999999998776432 23366666653
No 246
>TIGR00655 PurU formyltetrahydrofolate deformylase. This model describes formyltetrahydrofolate deformylases. The enzyme is a homohexamer. Sequences from a related enzyme formyl tetrahydrofolate-specific enzyme, phosphoribosylglycinamide formyltransferase, serve as an outgroup for phylogenetic analysis. Putative members of this family, scoring below the trusted cutoff, include a sequence from Rhodobacter capsulatus that lacks an otherwise conserved C-terminal region.
Probab=48.84 E-value=2.5e+02 Score=28.91 Aligned_cols=33 Identities=15% Similarity=0.198 Sum_probs=27.8
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEec
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATS 432 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstS 432 (559)
.|++.|. +++|+.+++.+.|+++|+||.-+++.
T Consensus 2 ~itv~g~---D~~GIVA~Vt~~La~~g~NI~d~sq~ 34 (280)
T TIGR00655 2 ILLVSCP---DQKGLVAAISTFIAKHGANIISNDQH 34 (280)
T ss_pred EEEEECC---CCCChHHHHHHHHHHCCCCEEeeeEE
Confidence 4677764 68999999999999999999888754
No 247
>cd04889 ACT_PDH-BS-like C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate. Included in this CD is the C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate, found in Bacillus subtilis (BS) and other Firmicutes, Deinococci, and Bacteroidetes. PDH is the first enzyme in the aromatic amino acid pathway specific for the biosynthesis of tyrosine. This enzyme is feedback inhibited by tyrosine in B. subtilis and other microorganisms. Both phenylalanine and tryptophan have been shown to be inhibitors of this activity in B. subtilis. Bifunctional chorismate mutase-PDH (TyrA) enzymes such as those seen in Escherichia coli do not contain an ACT domain. Also included in this CD is the N-terminal ACT domain of a novel protein composed almost entirely of two tandem A
Probab=48.30 E-value=23 Score=26.43 Aligned_cols=26 Identities=23% Similarity=0.415 Sum_probs=22.9
Q ss_pred ccchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 405 MLGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 405 m~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
+.+.||.++++++.|.++|+|+..+.
T Consensus 5 ~~d~~G~l~~i~~~l~~~~inI~~~~ 30 (56)
T cd04889 5 VENKPGRLAEVTEILAEAGINIKAIS 30 (56)
T ss_pred eCCCCChHHHHHHHHHHcCCCEeeEE
Confidence 45789999999999999999998764
No 248
>PRK00275 glnD PII uridylyl-transferase; Provisional
Probab=47.46 E-value=5.9e+02 Score=30.81 Aligned_cols=125 Identities=15% Similarity=0.215 Sum_probs=71.6
Q ss_pred CeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEE--EecCce--e-EEEeCCCchh----hHHH---HHHHHHHHHHH
Q 008621 394 NVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSEVS--L-SLTLDPSKLW----SREL---IQQASELDHVV 461 (559)
Q Consensus 394 ~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~I--stSe~s--I-s~~v~~~~~~----~~~~---~~~~~~l~~~~ 461 (559)
+.+.|.|... +.+|..+++...|+..|+||.-- .++... + +|.|.+.+-. ..+. +++ .+...+
T Consensus 703 ~~t~V~V~~~---DrpgLFa~i~g~L~~~~lnI~~A~I~Tt~dg~alD~F~V~d~~g~~~~~~~~r~~~i~~--~L~~~L 777 (895)
T PRK00275 703 GGTQIFIYAP---DQHDFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGEPIGDNPARIEQIRE--GLTEAL 777 (895)
T ss_pred CeEEEEEEeC---CCCcHHHHHHHHHHHCCCeEEEEEEEEcCCCeEEEEEEEeCCCCCCccchHHHHHHHHH--HHHHHH
Confidence 5667777754 68999999999999999999653 233322 1 4555322211 1111 111 222211
Q ss_pred H-------HHhhh-----------ceeec----ccceeEEEEEeeccccchHHHHHHHHHHhCCCcEEE--EEecCCceE
Q 008621 462 E-------ELEKI-----------AIVNL----LQHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVN 517 (559)
Q Consensus 462 ~-------~L~~~-----------~~v~~----~~~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~--IsqgaSe~s 517 (559)
. .+... ..|.+ ..+.+.|.|.+ ...||+++++..+|.+.|++|.. |++.....-
T Consensus 778 ~~~~~~~~~~~~~~~~~~~~~~~~~~V~i~~~~~~~~T~i~V~a--~DrpGLLa~I~~~L~~~~l~I~~AkI~T~g~~v~ 855 (895)
T PRK00275 778 RNPDDYPTIIQRRVPRQLKHFAFPTQVTISNDAQRPVTVLEIIA--PDRPGLLARIGRIFLEFDLSLQNAKIATLGERVE 855 (895)
T ss_pred cCCCccchhhhhhhhhhccCCCCCCEEEEEECCCCCeEEEEEEE--CCCCCHHHHHHHHHHHCCCEEEEeEEEecCCEEE
Confidence 0 00000 01111 12456666666 35799999999999999999986 555433344
Q ss_pred EEEEEecc
Q 008621 518 ISLIVNDD 525 (559)
Q Consensus 518 Is~vV~~~ 525 (559)
=+|.|...
T Consensus 856 D~F~V~d~ 863 (895)
T PRK00275 856 DVFFITDA 863 (895)
T ss_pred EEEEEECC
Confidence 45666543
No 249
>cd04901 ACT_3PGDH C-terminal ACT (regulatory) domain of D-3-Phosphoglycerate Dehydrogenase (3PGDH) found in fungi and bacteria. The C-terminal ACT (regulatory) domain of D-3-Phosphoglycerate Dehydrogenase (3PGDH) found in fungi and bacteria. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In Escherichia coli, the SerA 3PGDH is feedback-controlled by the end product L-serine in an allosteric manner. In the homotetrameric enzyme, the interface at adjacent ACT (regulatory) domains couples to create an extended beta-sheet. Each regulatory interface forms two serine-binding sites. The mechanism by which serine transmits inhibition to the active site is postulated to involve the tethering of the regulatory domains together to create a rigid quaternary structure with a solvent-
Probab=47.16 E-value=18 Score=28.05 Aligned_cols=52 Identities=12% Similarity=0.154 Sum_probs=36.4
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecCC--ceEEEEEEecccHHHHHHHHHH
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGAS--KVNISLIVNDDEAEQCVRALHE 536 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~IsqgaS--e~sIs~vV~~~d~~kAv~~LH~ 536 (559)
....||+++++.+.+++.|+|+..+...+. ...+.+-++..+.+..++.|.+
T Consensus 6 ~~d~~g~l~~i~~~l~~~~~nI~~~~~~~~~~~a~~~~~~~~~~l~~li~~l~~ 59 (69)
T cd04901 6 HKNVPGVLGQINTILAEHNINIAAQYLQTRGEIGYVVIDIDSEVSEELLEALRA 59 (69)
T ss_pred ecCCCcHHHHHHHHHHHcCCCHHHHhccCCCCEEEEEEEcCCCCCHHHHHHHHc
Confidence 346789999999999999999976655432 2224455666666667666654
No 250
>cd04887 ACT_MalLac-Enz ACT_MalLac-Enz CD includes the N-terminal ACT domain of putative NAD-dependent malic enzyme 1, Bacillus subtilis YqkI and related domains. The ACT_MalLac-Enz CD includes the N-terminal ACT domain of putative NAD-dependent malic enzyme 1, Bacillus subtilis YqkI, a malolactic enzyme (MalLac-Enz) which converts malate to lactate, and other related ACT domains. The yqkJ product is predicted to convert malate directly to lactate, as opposed to related malic enzymes that convert malate to pyruvate. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=47.09 E-value=94 Score=24.29 Aligned_cols=50 Identities=10% Similarity=0.113 Sum_probs=35.5
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecC---CceEEEEEEecccHHHHHHHHH
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGA---SKVNISLIVNDDEAEQCVRALH 535 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~Isqga---Se~sIs~vV~~~d~~kAv~~LH 535 (559)
...||.++++.+++++.|+||.-+.... ....+.|.+.-.+.+.+-+.++
T Consensus 7 ~d~~g~L~~i~~~i~~~~~nI~~v~~~~~~~~~~~~~~~vev~~~~~l~~i~~ 59 (74)
T cd04887 7 PNRPGMLGRVTTAIGEAGGDIGAIDLVEQGRDYTVRDITVDAPSEEHAETIVA 59 (74)
T ss_pred CCCCchHHHHHHHHHHcCCcEEEEEEEEecCCEEEEEEEEEcCCHHHHHHHHH
Confidence 4678999999999999999998766533 2233566677666665555444
No 251
>COG3602 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=46.89 E-value=16 Score=32.33 Aligned_cols=48 Identities=19% Similarity=0.251 Sum_probs=36.8
Q ss_pred EEeeecCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEecCce
Q 008621 388 SIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVATSEVS 435 (559)
Q Consensus 388 ~Is~~~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~IstSe~s 435 (559)
|+.+.--+.+|++.-..-+...|+.+.+-..|+++||+..+++..-..
T Consensus 63 Gl~~~~~~~lITL~VhSsLeaVGltAA~ataLa~aGis~NvvaayyHD 110 (134)
T COG3602 63 GLSYSAVCRLITLNVHSSLEAVGLTAAFATALAEAGISCNVVAAYYHD 110 (134)
T ss_pred CCCccceeeeEEeehhhhhhhhhHHHHHHHHHHHcCcccchhhhhhcc
Confidence 455555667777765556778999999999999999999988754433
No 252
>PF09413 DUF2007: Domain of unknown function (DUF2007); InterPro: IPR018551 This is a family of proteins with unknown function. ; PDB: 2HFV_A.
Probab=46.37 E-value=54 Score=25.60 Aligned_cols=44 Identities=18% Similarity=0.266 Sum_probs=25.3
Q ss_pred HHHHHHHHhCCCcEEEEEecCCce--------EEEEEEecccHHHHHHHHHH
Q 008621 493 EKAFRVLRRSGVNVQMISQGASKV--------NISLIVNDDEAEQCVRALHE 536 (559)
Q Consensus 493 ~ri~~~L~~~~InI~~IsqgaSe~--------sIs~vV~~~d~~kAv~~LH~ 536 (559)
.-+-..|.++||+...-....+.. -+.+.|+++|.++|.+.|++
T Consensus 13 ~~i~~~L~~~gI~~~v~~~~~~~~~g~~g~~~~~~v~V~~~d~~~A~~il~~ 64 (67)
T PF09413_consen 13 ELIKGLLEENGIPAFVKNEHMSGYAGEPGTGGQVEVYVPEEDYERAREILEE 64 (67)
T ss_dssp HHHHHHHHHTT--EE--S----SS---S--SSSEEEEEEGGGHHHHHHHHHH
T ss_pred HHHHHHHHhCCCcEEEECCccchhhcccCccCceEEEECHHHHHHHHHHHHH
Confidence 344455666666655432222221 17899999999999999875
No 253
>cd04883 ACT_AcuB C-terminal ACT domain of the Bacillus subtilis acetoin utilization protein, AcuB. This CD includes the C-terminal ACT domain of the Bacillus subtilis acetoin utilization protein, AcuB. AcuB is putatively involved in the anaerobic catabolism of acetoin, and related proteins. Studies report the induction of AcuB by nitrate respiration and also by fermentation. Since acetoin can be secreted and later serve as a source of carbon, it has been proposed that, during anaerobic growth when other carbon sources are exhausted, the induction of the AcuB protein results in acetoin catabolism. AcuB-like proteins have two N-terminal tandem CBS domains and a single C-terminal ACT domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=46.17 E-value=1.1e+02 Score=23.78 Aligned_cols=26 Identities=27% Similarity=0.420 Sum_probs=22.9
Q ss_pred ccchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 405 MLGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 405 m~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
+.+.+|.+.++.+.|+++|+++..+.
T Consensus 8 ~~d~pG~l~~i~~~l~~~~inI~~i~ 33 (72)
T cd04883 8 VPDRPGQLADIAAIFKDRGVNIVSVL 33 (72)
T ss_pred ECCCCCHHHHHHHHHHHcCCCEEEEE
Confidence 45788999999999999999998774
No 254
>PRK13581 D-3-phosphoglycerate dehydrogenase; Provisional
Probab=46.09 E-value=1.2e+02 Score=34.21 Aligned_cols=85 Identities=16% Similarity=0.195 Sum_probs=50.3
Q ss_pred HhHHHHHHhCCCCEEEecCC-CCCCCCeEEec-CCCCccceeeEEeeecC-eEEEEEEe-------cC------ccchhh
Q 008621 347 PQSMRPAREGDIPVRVKNSY-NPNAPGTLIRR-SRDMSKAVLTSIVLKRN-VTMLDIVS-------TR------MLGQYG 410 (559)
Q Consensus 347 p~a~~~a~~~~Ipv~I~n~~-~p~~~GT~I~~-~~~~~~~~It~Is~~~~-ialItV~~-------~~------m~~~~g 410 (559)
+.|.+.|++.||.+...... .+.+|.|.-.. ..+.....+.|.+.-.+ +-++.|.+ .+ ..+.||
T Consensus 385 ~nA~~iA~e~GI~~~~~~~~~~~~hpNtv~i~l~~~~~~~~v~G~s~ggg~~~I~~ing~~v~~~~~~~~li~~~~D~pG 464 (526)
T PRK13581 385 VNAPLLAKERGIEVEESKSEESPDYSNLITVTVTTDDGERSVAGTVFGDGEPRIVEIDGYRVDAKPEGHMLIIRNRDRPG 464 (526)
T ss_pred cCHHHHHHHcCCEEEEEEecCCCCCCCEEEEEEEeCCeEEEEEEEEecCCceEEEEECCEEEEeeCCceEEEEEeCCcCC
Confidence 45889999999998765432 33456664322 11111223444433222 22323322 11 246899
Q ss_pred HHHHHHHHHHhCCCcEEEEEe
Q 008621 411 FLAKVFSTFEDLGISVDVVAT 431 (559)
Q Consensus 411 ~larIf~~L~~~gI~Vd~Ist 431 (559)
.++++.+.|.+++|||..+..
T Consensus 465 ~I~~v~~~L~~~~iNIa~m~~ 485 (526)
T PRK13581 465 VIGKVGTLLGEAGINIAGMQL 485 (526)
T ss_pred hhHHHHHHHhhcCCCchhcEe
Confidence 999999999999999987754
No 255
>PF13291 ACT_4: ACT domain; PDB: 2KO1_B 3IBW_A.
Probab=46.08 E-value=74 Score=25.58 Aligned_cols=55 Identities=20% Similarity=0.335 Sum_probs=36.2
Q ss_pred EEEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCc----eEEEEEEecccHHHHHHHHH
Q 008621 479 ISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASK----VNISLIVNDDEAEQCVRALH 535 (559)
Q Consensus 479 ISIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe----~sIs~vV~~~d~~kAv~~LH 535 (559)
+.+.+ ...+|+++.+.+++++.++||..++..... ..+.+-+.-.+.+..-+.++
T Consensus 9 l~i~~--~dr~GlL~dI~~~i~~~~~nI~~i~~~~~~~~~~~~~~l~v~V~d~~~L~~ii~ 67 (80)
T PF13291_consen 9 LRIEA--EDRPGLLADITSVISENGVNIRSINARTNKDDGTARITLTVEVKDLEHLNQIIR 67 (80)
T ss_dssp EEEEE--E--TTHHHHHHHHHHCSSSEEEEEEEEE--ETTEEEEEEEEEESSHHHHHHHHH
T ss_pred EEEEE--EcCCCHHHHHHHHHHHCCCCeEEEEeEEeccCCEEEEEEEEEECCHHHHHHHHH
Confidence 44444 457899999999999999999987775532 24556666666665444443
No 256
>cd04877 ACT_TyrR N-terminal ACT domain of the TyrR protein. ACT_TyrR: N-terminal ACT domain of the TyrR protein. The TyrR protein of Escherichia coli controls the expression of a group of transcription units (TyrR regulon) whose gene products are involved in the biosynthesis or transport of the aromatic amino acids. Binding to specific DNA sequences known as TyrR boxes, the TyrR protein can either activate or repress transcription at different sigma70 promoters. Its regulatory activity occurs in response to intracellular levels of tyrosine, phenylalanine and tryptophan. The TyrR protein consists of an N-terminal region important for transcription activation with an ATP-independent aromatic amino acid binding site (contained within the ACT domain) and is involved in dimerization; a central region with an ATP binding site, an ATP-dependent aromatic amino acid binding site and is involved in hexamerization; and a helix turn helix DNA binding C-terminal region. In solution, in the absence
Probab=45.62 E-value=1e+02 Score=24.53 Aligned_cols=44 Identities=16% Similarity=0.116 Sum_probs=32.6
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHH
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQC 530 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kA 530 (559)
...+|+++.+.+.+++.++|+..+...+. ..+.+-+.-.+.+..
T Consensus 8 ~dr~Gll~dI~~~i~~~~~nI~~~~~~~~-~~i~l~i~v~~~~~L 51 (74)
T cd04877 8 EDRLGITQEVLDLLVEHNIDLRGIEIDPK-GRIYLNFPTIEFEKL 51 (74)
T ss_pred EccchHHHHHHHHHHHCCCceEEEEEecC-CeEEEEeEecCHHHH
Confidence 35678999999999999999999887553 225555555555543
No 257
>cd04903 ACT_LSD C-terminal ACT domain of the L-serine dehydratase (LSD), iron-sulfur-dependent, beta subunit. The C-terminal ACT domain of the L-serine dehydratase (LSD), iron-sulfur-dependent, beta subunit, found in various bacterial anaerobes such as Clostridium, Bacillis, and Treponema species. These enzymes catalyze the deamination of L-serine, producing pyruvate and ammonia. Unlike the eukaryotic L-serine dehydratase, which requires the pyridoxal-5'-phosphate (PLP) cofactor, the prokaryotic L-serine dehydratase contains an [4Fe-4S] cluster instead of a PLP active site. The LSD alpha and beta subunits of the 'clostridial' enzyme are encoded by the sdhA and sdhB genes. The single subunit bacterial homologs of L-serine dehydratase (LSD1, LSD2, TdcG) present in Escherichia coli, and other enterobacterials, lack the ACT domain described here. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=45.17 E-value=54 Score=24.89 Aligned_cols=25 Identities=28% Similarity=0.339 Sum_probs=22.0
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
.+.+|.++++.+.|+++|+++..+.
T Consensus 7 ~d~~g~l~~i~~~l~~~~~~I~~~~ 31 (71)
T cd04903 7 KDKPGAIAKVTSVLADHEINIAFMR 31 (71)
T ss_pred CCCCChHHHHHHHHHHcCcCeeeeE
Confidence 4678999999999999999998774
No 258
>cd04893 ACT_GcvR_1 ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. This CD includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein, and other related domains. The glycine cleavage enzyme system in Escherichia coli provides one-carbon units for cellular methylation reactions. This enzyme system, encoded by the gcvTHP operon and lpd gene, catalyzes the cleavage of glycine into CO2 + NH3 and transfers a one-carbon unit to tetrahydrofolate, producing 5,10-methylenetetrahydrofolate. The gcvTHP operon is activated by the GcvA protein in response to glycine and repressed by a GcvA/GcvR interaction in the absence of glycine. It has been proposed that the co-activator glycine acts through a mechanism of de-repression by binding to GcvR and preventing GcvR from interacting with GcvA to block GcvA's activator function. Evidence also suggests that GcvR int
Probab=45.04 E-value=39 Score=27.43 Aligned_cols=32 Identities=13% Similarity=0.222 Sum_probs=27.0
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist 431 (559)
+|++.+. ++||+.+++.+.|+++|.|+.-+.+
T Consensus 3 iltv~g~---Dr~GiVa~vs~~la~~g~nI~d~~q 34 (77)
T cd04893 3 VISALGT---DRPGILNELTRAVSESGCNILDSRM 34 (77)
T ss_pred EEEEEeC---CCChHHHHHHHHHHHcCCCEEEcee
Confidence 5677764 6899999999999999999987753
No 259
>cd04880 ACT_AAAH-PDT-like ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH). ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH): Phenylalanine hydroxylases (PAH), tyrosine hydroxylases (TH) and tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. This family of enzymes shares a common catalytic mechanism, in which dioxygen is used by an active site containing a single, reduced iron atom to hydroxylate an unactivated aromatic substrate, concomitant with a two-electron oxidation of tetrahydropterin (BH4) cofactor to its quinonoid dihydropterin form. Eukaryotic AAAHs have an N-terminal ACT (regulatory) domain, a middle catalytic domain and a C-terminal domain which is responsible for the oligomeric state of the enzyme forming a domain-swapped tetrameric coiled-coil. The PAH, TH, and TPH enzymes contain highly conserved catalytic domains but distinct N-terminal ACT domains and differ in their mech
Probab=44.78 E-value=62 Score=25.71 Aligned_cols=51 Identities=20% Similarity=0.342 Sum_probs=34.9
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCC---ceEEEEEEecc------cHHHHHHHHHH
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGAS---KVNISLIVNDD------EAEQCVRALHE 536 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaS---e~sIs~vV~~~------d~~kAv~~LH~ 536 (559)
...||.++++++.++++|+|+..|..-.. .....|+|+-+ +.+++++.|.+
T Consensus 7 ~d~pG~L~~vL~~f~~~~vni~~I~Srp~~~~~~~~~f~id~~~~~~~~~~~~~l~~l~~ 66 (75)
T cd04880 7 KNKPGALAKALKVFAERGINLTKIESRPSRKGLWEYEFFVDFEGHIDDPDVKEALEELKR 66 (75)
T ss_pred CCcCCHHHHHHHHHHHCCCCEEEEEeeecCCCCceEEEEEEEECCCCCHHHHHHHHHHHH
Confidence 45799999999999999999999855432 22345555433 34456666654
No 260
>cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains. This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=43.96 E-value=1.5e+02 Score=23.45 Aligned_cols=28 Identities=11% Similarity=0.167 Sum_probs=23.3
Q ss_pred EEEEeeccccchHHHHHHHHHHhCCCcEEE
Q 008621 479 ISLIGNVQRSSLILEKAFRVLRRSGVNVQM 508 (559)
Q Consensus 479 ISIVG~~~~~~gv~~ri~~~L~~~~InI~~ 508 (559)
|.|.+ ...||+++++..+|+..|++|..
T Consensus 4 i~v~~--~Dr~gLl~~i~~~l~~~~l~I~~ 31 (73)
T cd04900 4 VFIYT--PDRPGLFARIAGALDQLGLNILD 31 (73)
T ss_pred EEEEe--cCCCCHHHHHHHHHHHCCCCeEE
Confidence 34444 36899999999999999999987
No 261
>cd04929 ACT_TPH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. TPH catalyses the hydroxylation of L-Trp to 5-hydroxytryptophan, the rate limiting step in the biosynthesis of 5-hydroxytryptamine (serotonin) and the first reaction in the synthesis of melatonin. Very little is known about the role of the ACT domain in TPH, which appears to be regulated by phosphorylation but not by its substrate or cofactor. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=43.71 E-value=1e+02 Score=25.04 Aligned_cols=52 Identities=23% Similarity=0.313 Sum_probs=36.5
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCceE---EEEEEec----ccHHHHHHHHHHH
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGASKVN---ISLIVND----DEAEQCVRALHET 537 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~s---Is~vV~~----~d~~kAv~~LH~~ 537 (559)
...||-+.++++.++.+|||+.-|..-++... ..|+|+- ++.+++++.|++.
T Consensus 8 ~~~~g~L~~iL~~f~~~~inl~~IeSRP~~~~~~~y~F~id~e~~~~~i~~~l~~l~~~ 66 (74)
T cd04929 8 KNEVGGLAKALKLFQELGINVVHIESRKSKRRSSEFEIFVDCECDQRRLDELVQLLKRE 66 (74)
T ss_pred CCCCcHHHHHHHHHHHCCCCEEEEEeccCCCCCceEEEEEEEEcCHHHHHHHHHHHHHh
Confidence 45689999999999999999998876554333 4455553 3455666666553
No 262
>PRK13011 formyltetrahydrofolate deformylase; Reviewed
Probab=43.50 E-value=99 Score=32.00 Aligned_cols=34 Identities=12% Similarity=0.121 Sum_probs=30.0
Q ss_pred eEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEec
Q 008621 477 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQG 512 (559)
Q Consensus 477 aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqg 512 (559)
..|+++| ...||+++++.+.|++.|+||.-++|.
T Consensus 8 ~vitv~G--~DrpGIVa~VT~~La~~~vNI~dls~~ 41 (286)
T PRK13011 8 FVLTLSC--PSAAGIVAAVTGFLAEHGCYITELHSF 41 (286)
T ss_pred EEEEEEe--CCCCCHHHHHHHHHHhCCCCEEEeeee
Confidence 5688888 467999999999999999999998884
No 263
>COG1058 CinA Predicted nucleotide-utilizing enzyme related to molybdopterin-biosynthesis enzyme MoeA [General function prediction only]
Probab=43.50 E-value=1.1e+02 Score=31.19 Aligned_cols=68 Identities=28% Similarity=0.382 Sum_probs=46.5
Q ss_pred HHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecC
Q 008621 205 STRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGR 284 (559)
Q Consensus 205 sa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgR 284 (559)
|+.-++..|.++|++..... .+ +| +...+.+.+... .+..++.|++|-+|-+.
T Consensus 22 Na~~la~~L~~~G~~v~~~~-----~V--gD---------~~~~I~~~l~~a-~~r~D~vI~tGGLGPT~---------- 74 (255)
T COG1058 22 NAAFLADELTELGVDLARIT-----TV--GD---------NPDRIVEALREA-SERADVVITTGGLGPTH---------- 74 (255)
T ss_pred hHHHHHHHHHhcCceEEEEE-----ec--CC---------CHHHHHHHHHHH-HhCCCEEEECCCcCCCc----------
Confidence 56778999999999875543 12 11 223455555443 34567889999888652
Q ss_pred CcchhHHHHHHHHcCcC
Q 008621 285 GGSDLTATTIGKALGLQ 301 (559)
Q Consensus 285 gGSD~tAa~lA~~L~A~ 301 (559)
-|.|+=.+|++||-+
T Consensus 75 --DDiT~e~vAka~g~~ 89 (255)
T COG1058 75 --DDLTAEAVAKALGRP 89 (255)
T ss_pred --cHhHHHHHHHHhCCC
Confidence 488899999999954
No 264
>PF00994 MoCF_biosynth: Probable molybdopterin binding domain; InterPro: IPR001453 Eukaryotic and prokaryotic molybdoenzymes require a molybdopterin cofactor (MoCF) for their activity. The biosynthesis of this cofactor involves a complex multistep enzymatic pathway. One of the eukaryotic proteins involved in this pathway is the Drosophila protein cinnamon [] which is highly similar to gephyrin, a rat microtubule-associated protein which was thought to anchor the glycine receptor to subsynaptic microtubules. Cinnamon and gephyrin are evolutionary related, in their N-terminal half, to the Escherichia coli MoCF biosynthesis proteins mog/chlG and moaB/chlA2 and, in their C-terminal half, to E. coli moeA/chlE.; GO: 0006777 Mo-molybdopterin cofactor biosynthetic process; PDB: 3TCR_B 1O8O_B 1O8Q_G 1EAV_D 1O8N_C 1UUX_A 1UUY_A 2G2C_A 2G4R_C 3K6A_F ....
Probab=42.66 E-value=88 Score=28.39 Aligned_cols=69 Identities=22% Similarity=0.303 Sum_probs=45.9
Q ss_pred HHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeee
Q 008621 203 CMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTL 282 (559)
Q Consensus 203 ~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tl 282 (559)
--|+..++++|++.|+...... ++.+ +...+.+.+.. ++++.++.|++|-.|.+.
T Consensus 16 d~n~~~l~~~l~~~G~~v~~~~-----~v~D-----------d~~~i~~~l~~-~~~~~D~VittGG~g~~~-------- 70 (144)
T PF00994_consen 16 DSNGPFLAALLEELGIEVIRYG-----IVPD-----------DPDAIKEALRR-ALDRADLVITTGGTGPGP-------- 70 (144)
T ss_dssp BHHHHHHHHHHHHTTEEEEEEE-----EEES-----------SHHHHHHHHHH-HHHTTSEEEEESSSSSST--------
T ss_pred EhHHHHHHHHHHHcCCeeeEEE-----EECC-----------CHHHHHHHHHh-hhccCCEEEEcCCcCccc--------
Confidence 3477888999999998764432 3332 23456666643 345668888888555431
Q ss_pred cCCcchhHHHHHHHHcCc
Q 008621 283 GRGGSDLTATTIGKALGL 300 (559)
Q Consensus 283 gRgGSD~tAa~lA~~L~A 300 (559)
.|++.-.++.+.+-
T Consensus 71 ----~D~t~~a~~~~~~~ 84 (144)
T PF00994_consen 71 ----DDVTPEALAEAGGR 84 (144)
T ss_dssp ----TCHHHHHHHHHSSE
T ss_pred ----CCcccHHHHHhcCc
Confidence 68999988888764
No 265
>TIGR00177 molyb_syn molybdenum cofactor synthesis domain. The Drosophila protein cinnamon, the Arabidopsis protein cnx1, and rat protein gephyrin each have one domain like MoeA and one like MoaB and Mog. These domains are, however, distantly related to each other, as captured by this model. Gephyrin is unusual in that it seems to be a tubulin-binding neuroprotein involved in the clustering of both blycine receptors and GABA receptors, rather than a protein of molybdenum cofactor biosynthesis.
Probab=42.10 E-value=1.1e+02 Score=28.02 Aligned_cols=65 Identities=17% Similarity=0.265 Sum_probs=41.1
Q ss_pred HHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecC
Q 008621 205 STRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGR 284 (559)
Q Consensus 205 sa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgR 284 (559)
|..++++.|++.|++..... ++.++ ...+.+.+.+ +.+..++.|++|-.|.+
T Consensus 28 n~~~l~~~l~~~G~~v~~~~-----~v~Dd-----------~~~i~~~l~~-~~~~~DliIttGG~g~g----------- 79 (144)
T TIGR00177 28 NGPLLAALLEEAGFNVSRLG-----IVPDD-----------PEEIREILRK-AVDEADVVLTTGGTGVG----------- 79 (144)
T ss_pred cHHHHHHHHHHCCCeEEEEe-----ecCCC-----------HHHHHHHHHH-HHhCCCEEEECCCCCCC-----------
Confidence 55677888999998764432 33222 2345555544 34456788888844432
Q ss_pred CcchhHHHHHHHHc
Q 008621 285 GGSDLTATTIGKAL 298 (559)
Q Consensus 285 gGSD~tAa~lA~~L 298 (559)
.-|++...++.+.
T Consensus 80 -~~D~t~~ai~~~g 92 (144)
T TIGR00177 80 -PRDVTPEALEELG 92 (144)
T ss_pred -CCccHHHHHHHhC
Confidence 2699999999876
No 266
>PRK06027 purU formyltetrahydrofolate deformylase; Reviewed
Probab=41.64 E-value=91 Score=32.23 Aligned_cols=62 Identities=18% Similarity=0.147 Sum_probs=41.5
Q ss_pred eeEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC----CceEEEEEEec-------ccHHHHHHHHHHHhc
Q 008621 476 RSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA----SKVNISLIVND-------DEAEQCVRALHETFF 539 (559)
Q Consensus 476 ~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga----Se~sIs~vV~~-------~d~~kAv~~LH~~f~ 539 (559)
..+|+++| ...||+++++.+.|++.|+||.-+++.. ..-.+.+.++. ++.+++++.|-+++-
T Consensus 6 ~~vitv~G--~DrpGIVa~Vt~~La~~g~NI~d~s~~~~~~~g~F~m~i~v~~~~~~~~~~~L~~~L~~l~~~l~ 78 (286)
T PRK06027 6 RYVLTLSC--PDRPGIVAAVSNFLYEHGGNIVDADQFVDPETGRFFMRVEFEGDGLIFNLETLRADFAALAEEFE 78 (286)
T ss_pred eEEEEEEC--CCCCcHHHHHHHHHHHCCCCEEEceeEEcCCCCeEEEEEEEEeCCCCCCHHHHHHHHHHHHHHhC
Confidence 35788888 3578999999999999999999877643 12233344443 234455555555554
No 267
>cd04904 ACT_AAAH ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH). ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH): Phenylalanine hydroxylases (PAH), tyrosine hydroxylases (TH) and tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. This family of enzymes shares a common catalytic mechanism, in which dioxygen is used by an active site containing a single, reduced iron atom to hydroxylate an unactivated aromatic substrate, concomitant with a two-electron oxidation of tetrahydropterin (BH4) cofactor to its quinonoid dihydropterin form. PAH catalyzes the hydroxylation of L-Phe to L-Tyr, the first step in the catabolic degradation of L-Phe; TH catalyses the hydroxylation of L-Tyr to 3,4-dihydroxyphenylalanine, the rate limiting step in the biosynthesis of catecholamines; and TPH catalyses the hydroxylation of L-Trp to 5-hydroxytryptophan, the rate limiting step in the biosynthesis of 5-hydroxy
Probab=41.25 E-value=1.2e+02 Score=24.40 Aligned_cols=51 Identities=22% Similarity=0.382 Sum_probs=35.3
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCceE---EEEEEecc----cHHHHHHHHHH
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGASKVN---ISLIVNDD----EAEQCVRALHE 536 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~s---Is~vV~~~----d~~kAv~~LH~ 536 (559)
...||-+.++++.++.+|||+.-|..-.+... -.|.|+-+ +.+++++.|.+
T Consensus 8 ~~~pG~L~~vL~~f~~~~iNlt~IeSRP~~~~~~~y~Ffvd~~~~~~~~~~~l~~L~~ 65 (74)
T cd04904 8 KEEVGALARALKLFEEFGVNLTHIESRPSRRNGSEYEFFVDCEVDRGDLDQLISSLRR 65 (74)
T ss_pred CCCCcHHHHHHHHHHHCCCcEEEEECCCCCCCCceEEEEEEEEcChHHHHHHHHHHHH
Confidence 45689999999999999999998866544432 44555533 34456666654
No 268
>cd00885 cinA Competence-damaged protein. CinA is the first gene in the competence- inducible (cin) operon and is thought to be specifically required at some stage in the process of transformation. This domain is closely related to a domain, found in a variety of proteins involved in biosynthesis of molybdopterin cofactor, where the domain is presumed to bind molybdopterin.
Probab=40.90 E-value=1.1e+02 Score=28.93 Aligned_cols=69 Identities=23% Similarity=0.337 Sum_probs=44.9
Q ss_pred HHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeec
Q 008621 204 MSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG 283 (559)
Q Consensus 204 lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlg 283 (559)
-|+..++..|++.|++..... ++.+ +...+.+.+... ++...+.|++|-.|.+.
T Consensus 19 ~n~~~l~~~L~~~G~~v~~~~-----~v~D-----------d~~~I~~~l~~~-~~~~dlVIttGG~G~t~--------- 72 (170)
T cd00885 19 TNAAFLAKELAELGIEVYRVT-----VVGD-----------DEDRIAEALRRA-SERADLVITTGGLGPTH--------- 72 (170)
T ss_pred hHHHHHHHHHHHCCCEEEEEE-----EeCC-----------CHHHHHHHHHHH-HhCCCEEEECCCCCCCC---------
Confidence 356778889999998764421 2322 223455555443 34557888888565441
Q ss_pred CCcchhHHHHHHHHcCcC
Q 008621 284 RGGSDLTATTIGKALGLQ 301 (559)
Q Consensus 284 RgGSD~tAa~lA~~L~A~ 301 (559)
-|.|--.++.+++-+
T Consensus 73 ---~D~t~ea~~~~~~~~ 87 (170)
T cd00885 73 ---DDLTREAVAKAFGRP 87 (170)
T ss_pred ---CChHHHHHHHHhCCC
Confidence 699999999999854
No 269
>cd04871 ACT_PSP_2 ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). The ACT_PSP_2 CD includes the second of the two ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). PSPs belong to the L-2-haloacid dehalogenase-like protein superfamily. PSP is involved in serine metabolism; serine is synthesized from phosphoglycerate through sequential reactions catalyzed by 3-phosphoglycerate dehydrogenase (SerA), 3-phosphoserine aminotransferase (SerC), and SerB. Members of this CD belong to the superfamily of ACT regulatory domains
Probab=40.83 E-value=20 Score=29.83 Aligned_cols=58 Identities=22% Similarity=0.399 Sum_probs=38.4
Q ss_pred EEEEEee-ccccchHHHHHHHHHHhCCCcEEEEEecCC-----------ceEEEEEEecccHHHHHHHHHHHhc
Q 008621 478 IISLIGN-VQRSSLILEKAFRVLRRSGVNVQMISQGAS-----------KVNISLIVNDDEAEQCVRALHETFF 539 (559)
Q Consensus 478 iISIVG~-~~~~~gv~~ri~~~L~~~~InI~~IsqgaS-----------e~sIs~vV~~~d~~kAv~~LH~~f~ 539 (559)
+|+++|. + +.+.++++.+.|+++|+||.-|++=+. ...+.|-++... .-...|.++|.
T Consensus 1 ivtvlg~~~--~a~~ia~Vs~~lA~~~~NI~~I~~l~~~~~~~~~~~~~~~~~e~~v~~~~--~~~~~lr~~L~ 70 (84)
T cd04871 1 IVTLLGRPL--TAEQLAAVTRVVADQGLNIDRIRRLSGRVPLEEQDDSPKACVEFSVRGQP--ADLEALRAALL 70 (84)
T ss_pred CEEEEcCcC--CHHHHHHHHHHHHHcCCCHHHHHHhhccccccccCCCCcEEEEEEEeCCC--CCHHHHHHHHH
Confidence 4788885 3 568999999999999999987766321 234566666443 23444555544
No 270
>COG2150 Predicted regulator of amino acid metabolism, contains ACT domain [General function prediction only]
Probab=40.34 E-value=1.2e+02 Score=28.82 Aligned_cols=37 Identities=27% Similarity=0.326 Sum_probs=28.4
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEec------CceeEEEeCC
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATS------EVSLSLTLDP 442 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstS------e~sIs~~v~~ 442 (559)
...+|+++.++..++++||++..+... +..+++..+.
T Consensus 103 ~~~pgi~A~V~~~iak~gi~Irqi~~~dpe~~~e~~l~IVte~ 145 (167)
T COG2150 103 ARYPGILAGVASLIAKRGISIRQIISEDPELQEEPKLTIVTER 145 (167)
T ss_pred CCCccHHHHHHHHHHHcCceEEEEecCCcccCCCceEEEEEec
Confidence 357899999999999999999988533 3455666544
No 271
>PRK06027 purU formyltetrahydrofolate deformylase; Reviewed
Probab=39.51 E-value=2.8e+02 Score=28.62 Aligned_cols=34 Identities=15% Similarity=0.130 Sum_probs=28.6
Q ss_pred eEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe
Q 008621 395 VTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (559)
Q Consensus 395 ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist 431 (559)
...+++.|. ++||+.+++.+.|+++|+|+.-+++
T Consensus 6 ~~vitv~G~---DrpGIVa~Vt~~La~~g~NI~d~s~ 39 (286)
T PRK06027 6 RYVLTLSCP---DRPGIVAAVSNFLYEHGGNIVDADQ 39 (286)
T ss_pred eEEEEEECC---CCCcHHHHHHHHHHHCCCCEEEcee
Confidence 356788875 6899999999999999999987753
No 272
>cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=39.36 E-value=56 Score=26.59 Aligned_cols=31 Identities=19% Similarity=0.359 Sum_probs=26.2
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEE
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV 429 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~I 429 (559)
++|.|.. .+.||.+.++.+.|.++|++|..-
T Consensus 2 Tviev~a---~DRpGLL~~i~~~l~~~gl~I~~A 32 (72)
T cd04895 2 TLVKVDS---ARKPGILLEAVQVLTDLDLCITKA 32 (72)
T ss_pred EEEEEEE---CCcCCHHHHHHHHHHHCCcEEEEE
Confidence 4566664 478999999999999999999875
No 273
>cd05014 SIS_Kpsf KpsF-like protein. KpsF is an arabinose-5-phosphate isomerase which contains SIS (Sugar ISomerase) domains. SIS domains are found in many phosphosugar isomerases and phosphosugar binding proteins. KpsF catalyzes the reversible reaction of ribulose 5-phosphate to arabinose 5-phosphate. This is the second step in the CMP-Kdo biosynthesis pathway.
Probab=38.49 E-value=1.3e+02 Score=26.30 Aligned_cols=79 Identities=13% Similarity=0.084 Sum_probs=43.7
Q ss_pred CceeeecCCcchhHHHHHHHHcCc--CcEEEeeCCcccccCCCCCCCCCccccccCHHHHHHHHHcCCCcchHhHHHHHH
Q 008621 277 CAITTLGRGGSDLTATTIGKALGL--QEIQVWKDVDGVLTCDPNIHPHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAR 354 (559)
Q Consensus 277 G~~~tlgRgGSD~tAa~lA~~L~A--~~l~i~TDV~GV~taDP~~v~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~ 354 (559)
|++..+|+|+|...|-.++..|.. ..+..+.|...++. ++....+...+=-+| +.|..----++++.|+
T Consensus 1 ~~I~i~G~G~S~~~a~~~~~~l~~~g~~~~~~~~~~~~~~-~~~~~~~~d~vi~iS--------~sG~t~~~~~~~~~a~ 71 (128)
T cd05014 1 GKVVVTGVGKSGHIARKIAATLSSTGTPAFFLHPTEALHG-DLGMVTPGDVVIAIS--------NSGETDELLNLLPHLK 71 (128)
T ss_pred CeEEEEeCcHhHHHHHHHHHHhhcCCCceEEcccchhhcc-ccCcCCCCCEEEEEe--------CCCCCHHHHHHHHHHH
Confidence 457889999999999999998852 23444444332322 111111111111222 2232222335688899
Q ss_pred hCCCCEEEec
Q 008621 355 EGDIPVRVKN 364 (559)
Q Consensus 355 ~~~Ipv~I~n 364 (559)
+.|+|+....
T Consensus 72 ~~g~~vi~iT 81 (128)
T cd05014 72 RRGAPIIAIT 81 (128)
T ss_pred HCCCeEEEEe
Confidence 9999966553
No 274
>TIGR00719 sda_beta L-serine dehydratase, iron-sulfur-dependent, beta subunit. This family of enzymes is not homologous to the pyridoxal phosphate-dependent threonine deaminases and eukaryotic serine deaminases.
Probab=38.20 E-value=2e+02 Score=28.16 Aligned_cols=25 Identities=16% Similarity=0.357 Sum_probs=22.4
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
.+.||++.++-+.|.+++|||-.+.
T Consensus 156 ~D~PG~Ig~vg~~Lg~~~iNIa~m~ 180 (208)
T TIGR00719 156 NDKFGTIAGVANLLAGFEINIEHLE 180 (208)
T ss_pred CCCCChHHHHHHHHHhCCccEEEEE
Confidence 4689999999999999999997775
No 275
>PF13511 DUF4124: Domain of unknown function (DUF4124)
Probab=37.84 E-value=28 Score=26.67 Aligned_cols=29 Identities=17% Similarity=0.299 Sum_probs=21.7
Q ss_pred HHHHHHHcCcCcEEEeeCCcc--cccCCCCC
Q 008621 291 ATTIGKALGLQEIQVWKDVDG--VLTCDPNI 319 (559)
Q Consensus 291 Aa~lA~~L~A~~l~i~TDV~G--V~taDP~~ 319 (559)
+.+++....+..+.-|+|-+| +|++.|.-
T Consensus 3 ll~l~~~a~aa~vYk~~D~~G~v~ysd~P~~ 33 (60)
T PF13511_consen 3 LLLLAASAAAAEVYKWVDENGVVHYSDTPPP 33 (60)
T ss_pred HHHHhHHHhhccEEEEECCCCCEEECccCCC
Confidence 344455555678999999999 68888864
No 276
>COG0440 IlvH Acetolactate synthase, small (regulatory) subunit [Amino acid transport and metabolism]
Probab=37.48 E-value=47 Score=31.51 Aligned_cols=38 Identities=13% Similarity=0.303 Sum_probs=30.6
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEEec------CceeEEEeCCC
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVATS------EVSLSLTLDPS 443 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~IstS------e~sIs~~v~~~ 443 (559)
.+.+|.++++...|++.|.|++.++.. ...+++.+..+
T Consensus 12 ~ne~GvLsRv~glfsrRG~NIeSltv~~tE~~~~SRiTivv~g~ 55 (163)
T COG0440 12 ENEPGVLSRVTGLFSRRGYNIESLTVGPTETPGLSRITIVVSGD 55 (163)
T ss_pred ECCCCeeehhhHHHHhcCcccceEEEEecCCCCceEEEEEEcCC
Confidence 368999999999999999999998632 25577887763
No 277
>COG1707 ACT domain-containing protein [General function prediction only]
Probab=37.20 E-value=2.8e+02 Score=26.54 Aligned_cols=112 Identities=16% Similarity=0.265 Sum_probs=66.5
Q ss_pred chhhHHHHHHHHHHhCCCcEEEEEec-C-----ceeEEEeCCCchhhHHHHHHHHHHHHHHHHHhhhce---eecccce-
Q 008621 407 GQYGFLAKVFSTFEDLGISVDVVATS-E-----VSLSLTLDPSKLWSRELIQQASELDHVVEELEKIAI---VNLLQHR- 476 (559)
Q Consensus 407 ~~~g~larIf~~L~~~gI~Vd~IstS-e-----~sIs~~v~~~~~~~~~~~~~~~~l~~~~~~L~~~~~---v~~~~~~- 476 (559)
+.||.+.++...+++.|.|+....+. + -.|.+-+..- . ..+.++++++.... +...+.+
T Consensus 11 nk~GvL~~ltgiiae~ggNIt~~q~~~~~~g~~~~iYmEiEgi--~---------d~e~l~~~lks~d~v~ev~i~~sle 79 (218)
T COG1707 11 NKPGVLRDLTGIIAEEGGNITYAQQFLEKDGEKALIYMEIEGI--D---------DFEKLLERLKSFDYVIEVEIHRSLE 79 (218)
T ss_pred cCccHHHHHHHHHHhcCCceEeeehhhhccCceEEEEEEeeCC--C---------CHHHHHHHhhccceEEEeeecchHH
Confidence 57999999999999999999877542 1 1234444321 1 24445566665322 2222211
Q ss_pred ----eEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCceEEEEEEecccHHHHHHHH
Q 008621 477 ----SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVNISLIVNDDEAEQCVRAL 534 (559)
Q Consensus 477 ----aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~sIs~vV~~~d~~kAv~~L 534 (559)
--|-++|...+.++++.-..+-..++||.=.-||. +.. =+|-+++..+|+++.
T Consensus 80 ~iyGKRvIiiGGGAqVsqVA~GAIsEADRHNiRGERISv--DTi---PlVGEE~laEAVkAV 136 (218)
T COG1707 80 EIYGKRVIIIGGGAQVSQVARGAISEADRHNIRGERISV--DTI---PLVGEEELAEAVKAV 136 (218)
T ss_pred HHhCcEEEEECCchhHHHHHHhhcchhhhcccccceeee--ecc---cccChHHHHHHHHHH
Confidence 12446666666677777777777778777666765 222 245666655555543
No 278
>cd04876 ACT_RelA-SpoT ACT domain found C-terminal of the RelA/SpoT domains. ACT_RelA-SpoT: the ACT domain found C-terminal of the RelA/SpoT domains. Enzymes of the Rel/Spo family enable bacteria to survive prolonged periods of nutrient limitation by controlling guanosine-3'-diphosphate-5'-(tri)diphosphate ((p)ppGpp) production and subsequent rRNA repression (stringent response). Both the synthesis of (p)ppGpp from ATP and GDP(GTP), and its hydrolysis to GDP(GTP) and pyrophosphate, are catalyzed by Rel/Spo proteins. In Escherichia coli and its close relatives, the metabolism of (p)ppGpp is governed by two homologous proteins, RelA and SpoT. The RelA protein catalyzes (p)ppGpp synthesis in a reaction requiring its binding to ribosomes bearing codon-specified uncharged tRNA. The major role of the SpoT protein is the breakdown of (p)ppGpp by a manganese-dependent (p)ppGpp pyrophosphohydrolase activity. Although the stringent response appears to be tightly regulated by these two enzymes i
Probab=36.96 E-value=1e+02 Score=22.37 Aligned_cols=24 Identities=21% Similarity=0.311 Sum_probs=21.0
Q ss_pred chhhHHHHHHHHHHhCCCcEEEEE
Q 008621 407 GQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 407 ~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
+.+|.++++.+.|.++++++.-+.
T Consensus 7 ~~~~~l~~i~~~l~~~~~~i~~~~ 30 (71)
T cd04876 7 DRPGLLADITTVIAEEKINILSVN 30 (71)
T ss_pred ccCcHHHHHHHHHHhCCCCEEEEE
Confidence 568899999999999999998764
No 279
>COG0462 PrsA Phosphoribosylpyrophosphate synthetase [Nucleotide transport and metabolism / Amino acid transport and metabolism]
Probab=36.54 E-value=3.1e+02 Score=28.92 Aligned_cols=144 Identities=20% Similarity=0.198 Sum_probs=74.8
Q ss_pred HHHHhhhHHHHHHHHHHHHHHcCCceEEecccceEEEEecC-------CCCceeeec-chHHHHHHHhhchhcCCcEEEE
Q 008621 195 DYLVSFGECMSTRIFAAYLNKIGVKARQYDAFDIGFITTDD-------FTNADILEA-TYPAVAKRLHGDWITDLAIPIV 266 (559)
Q Consensus 195 d~ils~GE~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~-------~~~a~i~~~-~~~~i~~~l~~~l~~~~~ipVv 266 (559)
|..-.-||.+++++++..|+..|++- ++|-|- |-+-.+... ..+.+.+.+.... ......|+
T Consensus 99 Dk~~~~repIsaklvA~lL~~aG~dr---------v~TvDlH~~qiqgfFdipvdnl~a~p~l~~~~~~~~-~~~d~vVV 168 (314)
T COG0462 99 DKAFKPREPISAKLVANLLETAGADR---------VLTVDLHAPQIQGFFDIPVDNLYAAPLLAEYIREKY-DLDDPVVV 168 (314)
T ss_pred CcccCCCCCEeHHHHHHHHHHcCCCe---------EEEEcCCchhhcccCCCccccccchHHHHHHHHHhc-CCCCcEEE
Confidence 43435699999999999999999874 344332 211111111 2233333333211 11135566
Q ss_pred cCCCcccCCCCceeeecCCcchhHHHHHHHHcCcCcEEEeeCCcccccCCCCCCC-----------CCcccccc-----C
Q 008621 267 TGFLGKAWRTCAITTLGRGGSDLTATTIGKALGLQEIQVWKDVDGVLTCDPNIHP-----------HAKPVPYL-----T 330 (559)
Q Consensus 267 ~Gfig~~~~~G~~~tlgRgGSD~tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~-----------~a~~i~~l-----s 330 (559)
++- .|- =--|..+|..|+++--.|.+.=+ .+|+.+. ++-.+..| |
T Consensus 169 SPD------~Gg---------v~RAr~~A~~L~~~~a~i~K~R~----~~~~~v~~~~~~gdV~gk~~iiVDDiIdTgGT 229 (314)
T COG0462 169 SPD------KGG---------VKRARALADRLGAPLAIIDKRRD----SSPNVVEVMNLIGDVEGKDVVIVDDIIDTGGT 229 (314)
T ss_pred CCC------ccH---------HHHHHHHHHHhCCCEEEEEEeec----CCCCeEEEeecccccCCCEEEEEeccccccHH
Confidence 552 232 22388899999987555555431 0111111 12222221 1
Q ss_pred HHH-HHHHHHcCCC-----cchH----hHHHHHHhCCCC-EEEecCCC
Q 008621 331 FDE-AAELAYFGAQ-----VLHP----QSMRPAREGDIP-VRVKNSYN 367 (559)
Q Consensus 331 ~~E-a~eLa~~Ga~-----vlhp----~a~~~a~~~~Ip-v~I~n~~~ 367 (559)
.-+ |..|-..||+ .-|| .+.+.+....+. |.+.||-.
T Consensus 230 i~~Aa~~Lk~~GAk~V~a~~tH~vfs~~a~~~l~~~~i~~vivTnTi~ 277 (314)
T COG0462 230 IAKAAKALKERGAKKVYAAATHGVFSGAALERLEASAIDEVIVTDTIP 277 (314)
T ss_pred HHHHHHHHHHCCCCeEEEEEEchhhChHHHHHHhcCCCCEEEEeCCcc
Confidence 233 4455667986 3455 466666655575 77877643
No 280
>cd04897 ACT_ACR_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=36.22 E-value=2.4e+02 Score=23.10 Aligned_cols=49 Identities=10% Similarity=0.134 Sum_probs=35.7
Q ss_pred eEEEEEeeccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEEEEecccH
Q 008621 477 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISLIVNDDEA 527 (559)
Q Consensus 477 aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~--IsqgaSe~sIs~vV~~~d~ 527 (559)
++|.|.+ ...||.+.++..+|.+.|++|.. |++-....-=.|.|...+.
T Consensus 2 TvveV~~--~DRpGLL~~i~~~l~~~~l~I~~A~I~T~gera~D~FyV~d~~g 52 (75)
T cd04897 2 SVVTVQC--RDRPKLLFDVVCTLTDMDYVVFHATIDTDGDDAHQEYYIRHKDG 52 (75)
T ss_pred EEEEEEe--CCcCcHHHHHHHHHHhCCeEEEEEEEeecCceEEEEEEEEcCCC
Confidence 3444544 56799999999999999999986 6665555555677765543
No 281
>cd04896 ACT_ACR-like_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=35.31 E-value=2.4e+02 Score=23.17 Aligned_cols=30 Identities=27% Similarity=0.401 Sum_probs=25.0
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEE
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV 429 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~I 429 (559)
++.|.. .++||.+.++...|.+.|++|...
T Consensus 2 vlev~a---~DRpGLL~~i~~~l~~~~l~i~~A 31 (75)
T cd04896 2 LLQIRC---VDQKGLLYDILRTSKDCNIQISYG 31 (75)
T ss_pred EEEEEe---CCcccHHHHHHHHHHHCCeEEEEE
Confidence 455554 468999999999999999999875
No 282
>TIGR02726 phenyl_P_delta phenylphosphate carboxylase, delta subunit. Members of this protein family are the alpha subunit of phenylphosphate carboxylase. Phenol (methyl-benzene) is converted to phenylphosphate, then para-carboxylated by this four-subunit enzyme, with the release of phosphate, to 4-hydroxybenzoate. The enzyme contains neither biotin nor thiamin pyrophosphate. This delta subunit belongs to HAD family hydrolases.
Probab=35.06 E-value=23 Score=33.67 Aligned_cols=49 Identities=22% Similarity=0.172 Sum_probs=29.0
Q ss_pred EEeeCCcccccCCCCCC--CCCccccccCHHHHHHHHHcCCCcchHhHHHHHHhCCCCEEEecCC
Q 008621 304 QVWKDVDGVLTCDPNIH--PHAKPVPYLTFDEAAELAYFGAQVLHPQSMRPAREGDIPVRVKNSY 366 (559)
Q Consensus 304 ~i~TDV~GV~taDP~~v--~~a~~i~~ls~~Ea~eLa~~Ga~vlhp~a~~~a~~~~Ipv~I~n~~ 366 (559)
.+.+|+|||+|++ ++. +.....+..+..+ . -++..+++.|+++.|.++.
T Consensus 9 ~~v~d~dGv~tdg-~~~~~~~g~~~~~~~~~D--~-----------~~~~~L~~~Gi~laIiT~k 59 (169)
T TIGR02726 9 LVILDVDGVMTDG-RIVINDEGIESRNFDIKD--G-----------MGVIVLQLCGIDVAIITSK 59 (169)
T ss_pred EEEEeCceeeECC-eEEEcCCCcEEEEEecch--H-----------HHHHHHHHCCCEEEEEECC
Confidence 4678999999854 322 1222223222221 1 2467778899998887643
No 283
>COG0440 IlvH Acetolactate synthase, small (regulatory) subunit [Amino acid transport and metabolism]
Probab=34.96 E-value=52 Score=31.17 Aligned_cols=63 Identities=17% Similarity=0.361 Sum_probs=47.9
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCce----EEEEEEec--ccHHHHHHHHHHHhccCccccccc
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGASKV----NISLIVND--DEAEQCVRALHETFFESDLANLDC 548 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~----sIs~vV~~--~d~~kAv~~LH~~f~~~~~~~~~~ 548 (559)
.+.||++.|+...+++-|.|+..++-+..+. .+.+++.. ...++..+.||+-.--.+..++..
T Consensus 12 ~ne~GvLsRv~glfsrRG~NIeSltv~~tE~~~~SRiTivv~g~~~~~EQi~kQL~kLidV~kV~d~~~ 80 (163)
T COG0440 12 ENEPGVLSRVTGLFSRRGYNIESLTVGPTETPGLSRITIVVSGDEQVLEQIIKQLNKLIDVLKVLDLTS 80 (163)
T ss_pred ECCCCeeehhhHHHHhcCcccceEEEEecCCCCceEEEEEEcCCcchHHHHHHHHHhhccceeEEEcCC
Confidence 4679999999999999999999988776553 47788877 337888888887665545555443
No 284
>cd04909 ACT_PDH-BS C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH). The C-terminal ACT domain of the monofunctional, NAD dependent, prephenate dehydrogenase (PDH) enzyme that catalyzes the formation of 4-hydroxyphenylpyruvate from prephenate, found in Bacillus subtilis (BS) and other Firmicutes, Deinococci, and Bacteroidetes. PDH is the first enzyme in the aromatic amino acid pathway specific for the biosynthesis of tyrosine. This enzyme is feedback-inhibited by tyrosine in B. subtilis and other microorganisms. Both phenylalanine and tryptophan have been shown to be inhibitors of this activity in B. subtilis. Bifunctional chorismate mutase-PDH (TyrA) enzymes such as those seen in Escherichia coli do not contain an ACT domain. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=34.72 E-value=65 Score=24.95 Aligned_cols=26 Identities=27% Similarity=0.436 Sum_probs=22.7
Q ss_pred ccchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 405 MLGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 405 m~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
+.+.||.++++.+.|+++|+++.-+.
T Consensus 8 ~~d~~G~L~~l~~~l~~~~i~i~~~~ 33 (69)
T cd04909 8 VPDEPGVIAEVTQILGDAGISIKNIE 33 (69)
T ss_pred cCCCCCHHHHHHHHHHHcCCCceeeE
Confidence 45789999999999999999997663
No 285
>PRK01215 competence damage-inducible protein A; Provisional
Probab=34.69 E-value=1.2e+02 Score=30.99 Aligned_cols=70 Identities=23% Similarity=0.355 Sum_probs=46.3
Q ss_pred HHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeee
Q 008621 203 CMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTL 282 (559)
Q Consensus 203 ~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tl 282 (559)
--|+..++..|++.|++..... ++.++ ...+.+.+... ++..++.|++|-+|.+.
T Consensus 22 dtn~~~l~~~L~~~G~~v~~~~-----~v~Dd-----------~~~I~~~l~~a-~~~~DlVIttGG~g~t~-------- 76 (264)
T PRK01215 22 NTNASWIARRLTYLGYTVRRIT-----VVMDD-----------IEEIVSAFREA-IDRADVVVSTGGLGPTY-------- 76 (264)
T ss_pred EhhHHHHHHHHHHCCCeEEEEE-----EeCCC-----------HHHHHHHHHHH-hcCCCEEEEeCCCcCCh--------
Confidence 3466778899999999864432 23221 23455555543 44557888888665442
Q ss_pred cCCcchhHHHHHHHHcCcC
Q 008621 283 GRGGSDLTATTIGKALGLQ 301 (559)
Q Consensus 283 gRgGSD~tAa~lA~~L~A~ 301 (559)
-|+|.-.++.+++-+
T Consensus 77 ----dD~t~eaia~~~g~~ 91 (264)
T PRK01215 77 ----DDKTNEGFAKALGVE 91 (264)
T ss_pred ----hhhHHHHHHHHhCCC
Confidence 699999999999854
No 286
>cd04884 ACT_CBS C-terminal ACT domain of the cystathionine beta-synthase (CBS) domain protein found in Thermotoga maritima, Tm0935, and delta proteobacteria. This CD includes the C-terminal ACT domain of the cystathionine beta-synthase (CBS) domain protein found in Thermotoga maritima, Tm0935, and delta proteobacteria. This protein has two N-terminal tandem CBS domains and a single C-terminal ACT domain. The CBS domain is found in a wide range of proteins, often in tandem arrangements and together with a variety of other functional domains. It has been proposed that the CBS domain may play a regulatory role, although its exact function is unknown. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=34.27 E-value=49 Score=26.11 Aligned_cols=26 Identities=15% Similarity=0.247 Sum_probs=22.9
Q ss_pred ccchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 405 MLGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 405 m~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
+.+.||-++++.+.|+++|+|+..+.
T Consensus 6 ~~d~pG~L~~l~~~i~~~g~nI~~i~ 31 (72)
T cd04884 6 LEDKPGTLKPVVDTLREFNARIISIL 31 (72)
T ss_pred ecCCCccHHHHHHHHHHCCCeEEEEE
Confidence 45789999999999999999997664
No 287
>PRK08198 threonine dehydratase; Provisional
Probab=34.22 E-value=1.7e+02 Score=31.49 Aligned_cols=45 Identities=18% Similarity=0.285 Sum_probs=35.7
Q ss_pred eccccchHHHHHHHHHHhCCCcEEEEEecC-------CceEEEEEEecccHH
Q 008621 484 NVQRSSLILEKAFRVLRRSGVNVQMISQGA-------SKVNISLIVNDDEAE 528 (559)
Q Consensus 484 ~~~~~~gv~~ri~~~L~~~~InI~~Isqga-------Se~sIs~vV~~~d~~ 528 (559)
.+...||.++++++.+++.|.||.-|.|.- ....+++.++-.+.+
T Consensus 333 ~l~D~PG~L~~ll~~i~~~g~NI~~i~~~~~~~~~~~~~~~v~v~ie~~~~~ 384 (404)
T PRK08198 333 RLPDRPGQLAKLLSIIAELGANVIDVDHDRFSPDLRLGEVEVELTLETRGPE 384 (404)
T ss_pred EeCCCCCHHHHHHHHHhhCCCceEEEEEEEccCCCCCceEEEEEEEEeCCHH
Confidence 567889999999999999999999888852 346677777766533
No 288
>cd04873 ACT_UUR-ACR-like ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD. This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted t
Probab=32.56 E-value=1.7e+02 Score=22.22 Aligned_cols=41 Identities=20% Similarity=0.234 Sum_probs=29.3
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecC--CceEEEEEEeccc
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGA--SKVNISLIVNDDE 526 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~Isqga--Se~sIs~vV~~~d 526 (559)
...+|+++++...|.+.+++|..+.... ......|.+...+
T Consensus 8 ~d~~g~l~~i~~~l~~~~~~I~~~~~~~~~~~~~~~~~v~~~~ 50 (70)
T cd04873 8 PDRPGLLADITRVLADLGLNIHDARISTTGERALDVFYVTDSD 50 (70)
T ss_pred CCCCCHHHHHHHHHHHCCCeEEEEEEeecCCEEEEEEEEECCC
Confidence 4578999999999999999997644332 2444566665544
No 289
>PRK03673 hypothetical protein; Provisional
Probab=31.95 E-value=1.6e+02 Score=32.03 Aligned_cols=69 Identities=20% Similarity=0.238 Sum_probs=46.3
Q ss_pred HHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeec
Q 008621 204 MSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG 283 (559)
Q Consensus 204 lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlg 283 (559)
-|+..++..|++.|++..... .+.| +...+.+.+... ++..++.|++|-+|.+.
T Consensus 21 tN~~~la~~L~~~G~~v~~~~-----~v~D-----------~~~~i~~~l~~a-~~~~DlVI~tGGlGpt~--------- 74 (396)
T PRK03673 21 TNAAWLADFFFHQGLPLSRRN-----TVGD-----------NLDALVAILRER-SQHADVLIVNGGLGPTS--------- 74 (396)
T ss_pred hHHHHHHHHHHHCCCEEEEEE-----EcCC-----------CHHHHHHHHHHH-hccCCEEEEcCCCCCCC---------
Confidence 377788899999999864432 2222 234455555543 34567888888666442
Q ss_pred CCcchhHHHHHHHHcCcC
Q 008621 284 RGGSDLTATTIGKALGLQ 301 (559)
Q Consensus 284 RgGSD~tAa~lA~~L~A~ 301 (559)
-|+|.-.+|.++|-.
T Consensus 75 ---dD~t~~avA~a~g~~ 89 (396)
T PRK03673 75 ---DDLSALAAATAAGEG 89 (396)
T ss_pred ---cccHHHHHHHHcCCC
Confidence 599999999999954
No 290
>cd04902 ACT_3PGDH-xct C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH). The C-terminal ACT (regulatory) domain of D-3-phosphoglycerate dehydrogenase (3PGDH), with an extended C-terminal (xct) region from bacteria, archaea, fungi, and plants. 3PGDH is an enzyme that belongs to the D-isomer specific, 2-hydroxyacid dehydrogenase family and catalyzes the oxidation of D-3-phosphoglycerate to 3- phosphohydroxypyruvate, which is the first step in the biosynthesis of L-serine, using NAD+ as the oxidizing agent. In bacteria, 3PGDH is feedback-controlled by the end product L-serine in an allosteric manner. Some 3PGDH enzymes have an additional domain formed by an extended C-terminal region. This additional domain introduces significant asymmetry to the homotetramer. Adjacent ACT (regulatory) domains interact, creating two serine-binding sites, however, this asymmetric arrangement results in the formation of two different and distinct domain interfaces between iden
Probab=31.74 E-value=1e+02 Score=23.74 Aligned_cols=25 Identities=20% Similarity=0.329 Sum_probs=21.7
Q ss_pred cchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 406 LGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 406 ~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
.+.+|.++++.+.|+++|+++..+.
T Consensus 7 ~d~~G~l~~i~~~l~~~~inI~~~~ 31 (73)
T cd04902 7 TDRPGVIGKVGTILGEAGINIAGMQ 31 (73)
T ss_pred CCCCCHHHHHHHHHHHcCcChhheE
Confidence 4689999999999999999997553
No 291
>PRK04374 PII uridylyl-transferase; Provisional
Probab=30.93 E-value=1e+03 Score=28.74 Aligned_cols=126 Identities=17% Similarity=0.262 Sum_probs=73.5
Q ss_pred cCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEE--EecCce--e-EEEeCCCchh---hHHHHHHHHHHHHHHHH-
Q 008621 393 RNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV--ATSEVS--L-SLTLDPSKLW---SRELIQQASELDHVVEE- 463 (559)
Q Consensus 393 ~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~I--stSe~s--I-s~~v~~~~~~---~~~~~~~~~~l~~~~~~- 463 (559)
.+.+-|.|.. .+.+|..+++...|+.+|+||.-. .+.... + +|.|.+.+-. ..+.+++ .+...+..
T Consensus 688 ~~~~~v~v~~---~d~~gLFa~i~g~l~~~~lnI~~A~i~t~~~g~~ld~f~V~~~~~~~~~~~~~i~~--~l~~~l~~~ 762 (869)
T PRK04374 688 NDALEVFVYS---PDRDGLFAAIVATLDRKGYGIHRARVLDAPHDAIFDVFEVLPQDTYADGDPQRLAA--ALRQVLAGD 762 (869)
T ss_pred CCeEEEEEEe---CCCccHHHHHHHHHHHCCCeEEEEEEEEcCCCEEEEEEEEeCCCCCChHHHHHHHH--HHHHHHcCC
Confidence 3566777775 368999999999999999998643 333222 1 4444332211 1111221 22222211
Q ss_pred Hh-----hh------------ceeecc----cceeEEEEEeeccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEE
Q 008621 464 LE-----KI------------AIVNLL----QHRSIISLIGNVQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISL 520 (559)
Q Consensus 464 L~-----~~------------~~v~~~----~~~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~--IsqgaSe~sIs~ 520 (559)
.. +- ..|.+. .+.+.|.|+. ...||+++++..+|...|++|.. |++-....-=+|
T Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~V~~~~~~~~~~t~leI~a--~DrpGLLa~Ia~~l~~~~l~I~~AkI~T~g~~a~D~F 840 (869)
T PRK04374 763 LQKVRPARRAVPRQLRHFRFAPRVEFSESAGGRRTRISLVA--PDRPGLLADVAHVLRMQHLRVHDARIATFGERAEDQF 840 (869)
T ss_pred CCccccccccCcccccCCCCCCeEEEeecCCCCeEEEEEEe--CCcCcHHHHHHHHHHHCCCeEEEeEEEecCCEEEEEE
Confidence 00 00 112222 2456666666 35799999999999999999986 666544444566
Q ss_pred EEecc
Q 008621 521 IVNDD 525 (559)
Q Consensus 521 vV~~~ 525 (559)
.|...
T Consensus 841 ~V~d~ 845 (869)
T PRK04374 841 QITDE 845 (869)
T ss_pred EEECC
Confidence 77543
No 292
>smart00852 MoCF_biosynth Probable molybdopterin binding domain. This domain is found a variety of proteins involved in biosynthesis of molybdopterin cofactor. The domain is presumed to bind molybdopterin. The structure of this domain is known, and it forms an alpha/beta structure. In the known structure of Gephyrin this domain mediates trimerisation.
Probab=30.20 E-value=1.8e+02 Score=25.93 Aligned_cols=69 Identities=23% Similarity=0.365 Sum_probs=43.4
Q ss_pred HHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeee
Q 008621 203 CMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTL 282 (559)
Q Consensus 203 ~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tl 282 (559)
..|..++++.|++.|.+..... ++. | +...+.+.+.. +.+..++.|++|-.|.+
T Consensus 17 d~~~~~l~~~l~~~G~~~~~~~-----~v~-D----------d~~~I~~~l~~-~~~~~dliittGG~g~g--------- 70 (135)
T smart00852 17 DSNGPALAELLTELGIEVTRYV-----IVP-D----------DKEAIKEALRE-ALERADLVITTGGTGPG--------- 70 (135)
T ss_pred cCcHHHHHHHHHHCCCeEEEEE-----EeC-C----------CHHHHHHHHHH-HHhCCCEEEEcCCCCCC---------
Confidence 4466778889999998764432 332 1 22345555544 33456788888854433
Q ss_pred cCCcchhHHHHHHHHcCc
Q 008621 283 GRGGSDLTATTIGKALGL 300 (559)
Q Consensus 283 gRgGSD~tAa~lA~~L~A 300 (559)
--|++-..++.+++.
T Consensus 71 ---~~D~t~~~l~~~~~~ 85 (135)
T smart00852 71 ---PDDVTPEAVAEALGK 85 (135)
T ss_pred ---CCcCcHHHHHHHhCC
Confidence 258889999888864
No 293
>TIGR01327 PGDH D-3-phosphoglycerate dehydrogenase. This model represents a long form of D-3-phosphoglycerate dehydrogenase, the serA gene of one pathway of serine biosynthesis. Shorter forms, scoring between trusted and noise cutoff, include SerA from E. coli.
Probab=30.09 E-value=1.3e+02 Score=33.83 Aligned_cols=84 Identities=19% Similarity=0.232 Sum_probs=50.6
Q ss_pred HhHHHHHHhCCCCEEEecCCC-CCCCCeEEec-CCCCccceeeEEeeec-CeEEEEEEecC-------------ccchhh
Q 008621 347 PQSMRPAREGDIPVRVKNSYN-PNAPGTLIRR-SRDMSKAVLTSIVLKR-NVTMLDIVSTR-------------MLGQYG 410 (559)
Q Consensus 347 p~a~~~a~~~~Ipv~I~n~~~-p~~~GT~I~~-~~~~~~~~It~Is~~~-~ialItV~~~~-------------m~~~~g 410 (559)
+.|...|++.||.+....... +.++.|.-.. ..+.....+.|.+.-. .+-++.|.+.. ..+.||
T Consensus 384 ~nA~~iA~e~GI~v~~~~~~~~~~hpNtv~i~l~~~~~~~~v~G~s~gGg~~~I~~ing~~v~~~~~~~~li~~~~D~pG 463 (525)
T TIGR01327 384 VNAPAVAKERGITVEESKSESSPDYKNYLSVTVTGDSGTVSVAGTVFGGFSPRIVEIDGFHVDLEPEGIMLIILHLDKPG 463 (525)
T ss_pred cCHHHHHHHcCCEEEEEEccCCCCCCCEEEEEEEeCCcEEEEEEEEecCCcEEEEEECCEEEEEecCccEEEEEecCcCC
Confidence 458899999999986654332 3456663322 1111222355554432 23333333211 236799
Q ss_pred HHHHHHHHHHhCCCcEEEEE
Q 008621 411 FLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 411 ~larIf~~L~~~gI~Vd~Is 430 (559)
.++++.+.|.+++||+-.+.
T Consensus 464 ~I~~v~~~L~~~~iNIa~m~ 483 (525)
T TIGR01327 464 VIGKVGTLLGTAGINIASMQ 483 (525)
T ss_pred cchHHHhHHhhcCCChHHcE
Confidence 99999999999999997665
No 294
>cd04899 ACT_ACR-UUR-like_2 C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains. This ACT domain family, ACT_ACR-UUR-like_2, includes the second of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the second and fourth ACT domains of a novel protein composed almost entirely of ACT domain repeats, the ACR protein. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=29.91 E-value=83 Score=24.25 Aligned_cols=31 Identities=26% Similarity=0.564 Sum_probs=25.0
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
++.|.. .+.+|.++++...|+++++++.-+.
T Consensus 2 ~l~v~~---~d~~gll~~i~~~l~~~~~~I~~~~ 32 (70)
T cd04899 2 VLELTA---LDRPGLLADVTRVLAELGLNIHSAK 32 (70)
T ss_pred EEEEEE---cCCccHHHHHHHHHHHCCCeEEEEE
Confidence 456654 4689999999999999999997653
No 295
>cd04876 ACT_RelA-SpoT ACT domain found C-terminal of the RelA/SpoT domains. ACT_RelA-SpoT: the ACT domain found C-terminal of the RelA/SpoT domains. Enzymes of the Rel/Spo family enable bacteria to survive prolonged periods of nutrient limitation by controlling guanosine-3'-diphosphate-5'-(tri)diphosphate ((p)ppGpp) production and subsequent rRNA repression (stringent response). Both the synthesis of (p)ppGpp from ATP and GDP(GTP), and its hydrolysis to GDP(GTP) and pyrophosphate, are catalyzed by Rel/Spo proteins. In Escherichia coli and its close relatives, the metabolism of (p)ppGpp is governed by two homologous proteins, RelA and SpoT. The RelA protein catalyzes (p)ppGpp synthesis in a reaction requiring its binding to ribosomes bearing codon-specified uncharged tRNA. The major role of the SpoT protein is the breakdown of (p)ppGpp by a manganese-dependent (p)ppGpp pyrophosphohydrolase activity. Although the stringent response appears to be tightly regulated by these two enzymes i
Probab=29.24 E-value=2.2e+02 Score=20.48 Aligned_cols=39 Identities=13% Similarity=0.190 Sum_probs=27.1
Q ss_pred cccchHHHHHHHHHHhCCCcEEEEEecCCc---eEEEEEEec
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQMISQGASK---VNISLIVND 524 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~IsqgaSe---~sIs~vV~~ 524 (559)
...++.+.++.+.|.+.++++.-+.+..++ ..+.+.+..
T Consensus 6 ~~~~~~l~~i~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 47 (71)
T cd04876 6 IDRPGLLADITTVIAEEKINILSVNTRTDDDGLATIRLTLEV 47 (71)
T ss_pred eccCcHHHHHHHHHHhCCCCEEEEEeEECCCCEEEEEEEEEE
Confidence 356789999999999999999876554332 234444443
No 296
>COG4492 PheB ACT domain-containing protein [General function prediction only]
Probab=29.22 E-value=3e+02 Score=25.31 Aligned_cols=61 Identities=26% Similarity=0.365 Sum_probs=42.1
Q ss_pred eEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecC---CceEEEEEEecccHHHHHHHHHHH
Q 008621 477 SIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGA---SKVNISLIVNDDEAEQCVRALHET 537 (559)
Q Consensus 477 aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~Isqga---Se~sIs~vV~~~d~~kAv~~LH~~ 537 (559)
-++++.=.+....|.++++++++++.++||+.|.|.- ..-++.+.++.+-.+.-+..+-.+
T Consensus 71 ri~TL~l~ledr~G~LS~vLd~iA~~~~nvLTI~Q~ipl~g~Anvtlsi~~ssm~~~V~~ii~k 134 (150)
T COG4492 71 RIITLSLSLEDRVGILSDVLDVIAREEINVLTIHQTIPLQGRANVTLSIDTSSMEKDVDKIIEK 134 (150)
T ss_pred eEEEEEEEEhhhhhhHHHHHHHHHHhCCcEEEEecccccCceeeEEEEEEchhhhhhHHHHHHH
Confidence 3555555566778999999999999999999999853 234566666655444444444333
No 297
>cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=29.11 E-value=72 Score=25.59 Aligned_cols=30 Identities=27% Similarity=0.481 Sum_probs=25.3
Q ss_pred EEEEEecCccchhhHHHHHHHHHHhCCCcEEEE
Q 008621 397 MLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV 429 (559)
Q Consensus 397 lItV~~~~m~~~~g~larIf~~L~~~gI~Vd~I 429 (559)
++++.+. +.||+++++...|+++|++|...
T Consensus 2 ~~~v~~~---Dr~gLl~~i~~~l~~~~lnI~~A 31 (74)
T cd04925 2 AIELTGT---DRPGLLSEVFAVLADLHCNVVEA 31 (74)
T ss_pred EEEEEEC---CCCCHHHHHHHHHHHCCCcEEEE
Confidence 5667654 68999999999999999998864
No 298
>TIGR02667 moaB_proteo molybdenum cofactor biosynthesis protein B, proteobacterial. This model represents the MoaB protein molybdopterin biosynthesis regions in Proteobacteria. This crystallized but incompletely characterized protein is thought to be involved in, though not required for, early steps in molybdopterin biosynthesis. It may bind a molybdopterin precursor. A distinctive conserved motif PCN near the C-terminus helps distinguish this clade from other homologs, including sets of proteins designated MogA.
Probab=29.01 E-value=1.6e+02 Score=27.69 Aligned_cols=69 Identities=16% Similarity=0.224 Sum_probs=42.9
Q ss_pred HHHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhch-hcCCcEEEEcCCCcccCCCCceee
Q 008621 203 CMSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDW-ITDLAIPIVTGFLGKAWRTCAITT 281 (559)
Q Consensus 203 ~lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l-~~~~~ipVv~Gfig~~~~~G~~~t 281 (559)
--|...+++.|++.|++...+ +++.++ ...+.+.+.+.+ .+..++.|++|-.|.+
T Consensus 21 d~n~~~l~~~L~~~G~~v~~~-----~iv~Dd-----------~~~i~~~l~~~~~~~~~DlVIttGGtg~g-------- 76 (163)
T TIGR02667 21 DTSGQYLVERLTEAGHRLADR-----AIVKDD-----------IYQIRAQVSAWIADPDVQVILITGGTGFT-------- 76 (163)
T ss_pred CCcHHHHHHHHHHCCCeEEEE-----EEcCCC-----------HHHHHHHHHHHHhcCCCCEEEECCCcCCC--------
Confidence 346667888899999876443 244322 234555555422 1345788888855433
Q ss_pred ecCCcchhHHHHHHHHcC
Q 008621 282 LGRGGSDLTATTIGKALG 299 (559)
Q Consensus 282 lgRgGSD~tAa~lA~~L~ 299 (559)
.-|++.-.++..++
T Consensus 77 ----~~D~t~eal~~l~~ 90 (163)
T TIGR02667 77 ----GRDVTPEALEPLFD 90 (163)
T ss_pred ----CCCCcHHHHHHHHC
Confidence 25888888888776
No 299
>cd04896 ACT_ACR-like_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=28.71 E-value=2.3e+02 Score=23.29 Aligned_cols=38 Identities=18% Similarity=0.295 Sum_probs=28.2
Q ss_pred cccchHHHHHHHHHHhCCCcEEE--EE--e-cCCceEEEEEEec
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQM--IS--Q-GASKVNISLIVND 524 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~--Is--q-gaSe~sIs~vV~~ 524 (559)
...||.+.++.++|.+.|++|.. |+ + |..... +|+|+.
T Consensus 8 ~DRpGLL~~i~~~l~~~~l~i~~AkI~~~T~Gerv~D-~Fyv~~ 50 (75)
T cd04896 8 VDQKGLLYDILRTSKDCNIQISYGRFSSKVKGYREVD-LFIVQS 50 (75)
T ss_pred CCcccHHHHHHHHHHHCCeEEEEEEEecCcccCEEEE-EEEEeC
Confidence 46799999999999999999986 66 3 333343 456644
No 300
>cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=27.77 E-value=1.7e+02 Score=23.19 Aligned_cols=40 Identities=25% Similarity=0.307 Sum_probs=28.0
Q ss_pred ccccchHHHHHHHHHHhCCCcEEE--EEecCCceEEEEEEec
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQM--ISQGASKVNISLIVND 524 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~--IsqgaSe~sIs~vV~~ 524 (559)
+...+|.++++..+|++.|+||.. +.......-.+|.|..
T Consensus 8 ~~D~~Gll~~i~~~l~~~~lnI~sa~i~t~~~~~~d~f~v~~ 49 (72)
T cd04926 8 TEDRVGLLSDVTRVFRENGLTVTRAEISTQGDMAVNVFYVTD 49 (72)
T ss_pred ECCccCHHHHHHHHHHHCCcEEEEEEEecCCCeEEEEEEEEC
Confidence 346799999999999999999964 3332223345666644
No 301
>PRK08577 hypothetical protein; Provisional
Probab=27.58 E-value=2.1e+02 Score=25.79 Aligned_cols=50 Identities=20% Similarity=0.213 Sum_probs=32.8
Q ss_pred eeEEEEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCc----eEEEEEEecccH
Q 008621 476 RSIISLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASK----VNISLIVNDDEA 527 (559)
Q Consensus 476 ~aiISIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe----~sIs~vV~~~d~ 527 (559)
...+.+.+ .+.+|+++++.+.|++.++++..+.+.... ..+.+.++-++.
T Consensus 56 ~~~I~V~~--~Dr~GvLa~I~~~l~~~~inI~~i~~~~~~~~~~~~i~l~vev~~~ 109 (136)
T PRK08577 56 LVEIELVV--EDRPGVLAKITGLLAEHGVDILATECEELKRGELAECVIIVDLSKS 109 (136)
T ss_pred EEEEEEEE--cCCCCHHHHHHHHHHHCCCCEEEEEEEEecCCCEEEEEEEEEeCCc
Confidence 34455554 457899999999999999999876543322 234555554443
No 302
>cd04931 ACT_PAH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, phenylalanine hydroxylases (PAH). ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, phenylalanine hydroxylases (PAH). PAH catalyzes the hydroxylation of L-Phe to L-Tyr, the first step in the catabolic degradation of L-Phe. In PAH, an autoregulatory sequence, N-terminal of the ACT domain, extends across the catalytic domain active site and regulates the enzyme by intrasteric regulation. It appears that the activation by L-Phe induces a conformational change that converts the enzyme to a high-affinity and high-activity state. Modulation of activity is achieved through inhibition by BH4 and activation by phosphorylation of serine residues of the autoregulatory region. The molecular basis for the cooperative activation process is not fully understood yet. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=27.14 E-value=2e+02 Score=24.37 Aligned_cols=35 Identities=23% Similarity=0.380 Sum_probs=26.8
Q ss_pred chhhHHHHHHHHHHhCCCcEEEEEecC-----ceeEEEeC
Q 008621 407 GQYGFLAKVFSTFEDLGISVDVVATSE-----VSLSLTLD 441 (559)
Q Consensus 407 ~~~g~larIf~~L~~~gI~Vd~IstSe-----~sIs~~v~ 441 (559)
..+|-+.++++.|+++|||+..|.+.. -...|.|+
T Consensus 23 ~~pGsL~~vL~~Fa~~~INLt~IeSRP~~~~~~~Y~FfVD 62 (90)
T cd04931 23 EEVGALAKVLRLFEEKDINLTHIESRPSRLNKDEYEFFIN 62 (90)
T ss_pred CCCcHHHHHHHHHHHCCCCEEEEEeccCCCCCceEEEEEE
Confidence 468999999999999999999886432 22455554
No 303
>cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=27.08 E-value=1.2e+02 Score=24.14 Aligned_cols=25 Identities=24% Similarity=0.425 Sum_probs=21.6
Q ss_pred ccchhhHHHHHHHHHHhCCCcEEEE
Q 008621 405 MLGQYGFLAKVFSTFEDLGISVDVV 429 (559)
Q Consensus 405 m~~~~g~larIf~~L~~~gI~Vd~I 429 (559)
+.+.+|.++++...|+++|++|...
T Consensus 8 ~~D~~Gll~~i~~~l~~~~lnI~sa 32 (72)
T cd04926 8 TEDRVGLLSDVTRVFRENGLTVTRA 32 (72)
T ss_pred ECCccCHHHHHHHHHHHCCcEEEEE
Confidence 3468999999999999999999654
No 304
>cd00886 MogA_MoaB MogA_MoaB family. Members of this family are involved in biosynthesis of the molybdenum cofactor (MoCF) an essential cofactor of a diverse group of redox enzymes. MoCF biosynthesis is an evolutionarily conserved pathway present in eubacteria, archaea, and eukaryotes. MoCF contains a tricyclic pyranopterin, termed molybdopterin (MPT). MogA, together with MoeA, is responsible for the metal incorporation into MPT, the third step in MoCF biosynthesis. The plant homolog Cnx1 is a MoeA-MogA fusion protein. The mammalian homolog gephyrin is a MogA-MoeA fusion protein, that plays a critical role in postsynaptic anchoring of inhibitory glycine receptors and major GABAa receptor subtypes. In contrast, MoaB shows high similarity to MogA, but little is known about its physiological role. All well studied members of this family form highly stable trimers.
Probab=26.78 E-value=2.1e+02 Score=26.28 Aligned_cols=66 Identities=20% Similarity=0.236 Sum_probs=41.4
Q ss_pred HHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhc--CCcEEEEcCCCcccCCCCceeee
Q 008621 205 STRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWIT--DLAIPIVTGFLGKAWRTCAITTL 282 (559)
Q Consensus 205 sa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~--~~~ipVv~Gfig~~~~~G~~~tl 282 (559)
|..+++++|++.|++.... +++.++ ...+.+.+... .+ ..++.|++|-.+.+ .
T Consensus 21 n~~~l~~~l~~~G~~v~~~-----~~v~Dd-----------~~~i~~~l~~~-~~~~~~DlVittGG~s~g----~---- 75 (152)
T cd00886 21 SGPALVELLEEAGHEVVAY-----EIVPDD-----------KDEIREALIEW-ADEDGVDLILTTGGTGLA----P---- 75 (152)
T ss_pred hHHHHHHHHHHcCCeeeeE-----EEcCCC-----------HHHHHHHHHHH-HhcCCCCEEEECCCcCCC----C----
Confidence 5567888999999875433 233222 23455555443 34 45788888855543 2
Q ss_pred cCCcchhHHHHHHHHcC
Q 008621 283 GRGGSDLTATTIGKALG 299 (559)
Q Consensus 283 gRgGSD~tAa~lA~~L~ 299 (559)
-|++...++..++
T Consensus 76 ----~D~t~~al~~~~~ 88 (152)
T cd00886 76 ----RDVTPEATRPLLD 88 (152)
T ss_pred ----CcCcHHHHHHHhC
Confidence 5888988888874
No 305
>cd04906 ACT_ThrD-I_1 First of two tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase). This CD includes the first of two tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase) which catalyzes the committed step in branched chain amino acid biosynthesis in plants and microorganisms, the pyridoxal 5'-phosphate (PLP)-dependent dehydration/deamination of L-threonine (or L-serine) to 2-ketobutyrate (or pyruvate). ThrD-I is a cooperative, feedback-regulated (isoleucine and valine) allosteric enzyme that forms a tetramer and contains four pyridoxal phosphate moieties. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=26.39 E-value=3.1e+02 Score=22.46 Aligned_cols=51 Identities=8% Similarity=0.089 Sum_probs=35.5
Q ss_pred eccccchHHHHHHHHHHhCCCcEEEEEec---CCceEEEEEEeccc----HHHHHHHHHH
Q 008621 484 NVQRSSLILEKAFRVLRRSGVNVQMISQG---ASKVNISLIVNDDE----AEQCVRALHE 536 (559)
Q Consensus 484 ~~~~~~gv~~ri~~~L~~~~InI~~Isqg---aSe~sIs~vV~~~d----~~kAv~~LH~ 536 (559)
.+...||-+.++.+.|...+|+ -+.+. .....+.+.+.-.+ .+++++.|-+
T Consensus 7 ~ipD~PG~L~~ll~~l~~anI~--~~~y~~~~~~~~~v~i~ie~~~~~~~~~~i~~~L~~ 64 (85)
T cd04906 7 TIPERPGSFKKFCELIGPRNIT--EFNYRYADEKDAHIFVGVSVANGAEELAELLEDLKS 64 (85)
T ss_pred ecCCCCcHHHHHHHHhCCCcee--EEEEEccCCCeeEEEEEEEeCCcHHHHHHHHHHHHH
Confidence 3678899999999999966555 33332 14555777778555 6677777765
No 306
>cd04871 ACT_PSP_2 ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). The ACT_PSP_2 CD includes the second of the two ACT domains found N-terminal of phosphoserine phosphatase (PSP, SerB). PSPs belong to the L-2-haloacid dehalogenase-like protein superfamily. PSP is involved in serine metabolism; serine is synthesized from phosphoglycerate through sequential reactions catalyzed by 3-phosphoglycerate dehydrogenase (SerA), 3-phosphoserine aminotransferase (SerC), and SerB. Members of this CD belong to the superfamily of ACT regulatory domains
Probab=25.66 E-value=62 Score=26.87 Aligned_cols=31 Identities=19% Similarity=0.342 Sum_probs=24.7
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 398 ItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
|++-|..+ ..|.++++-+.|+++|+||+-|.
T Consensus 2 vtvlg~~~--~a~~ia~Vs~~lA~~~~NI~~I~ 32 (84)
T cd04871 2 VTLLGRPL--TAEQLAAVTRVVADQGLNIDRIR 32 (84)
T ss_pred EEEEcCcC--CHHHHHHHHHHHHHcCCCHHHHH
Confidence 45665432 67899999999999999999775
No 307
>PF11760 CbiG_N: Cobalamin synthesis G N-terminal; InterPro: IPR021744 Members of this family are involved in cobalamin synthesis. The gene encoded by P72862 from SWISSPROT has been designated cbiH but in fact represents a fusion between cbiH and cbiG. As other multi-functional proteins involved in cobalamin biosynthesis catalyse adjacent steps in the pathway, including CysG, CobL (CbiET), CobIJ and CobA-HemD, it is therefore possible that CbiG catalyses a reaction step adjacent to CbiH. In the anaerobic pathway such a step could be the formation of a gamma lactone, which is thought to help to mediate the anaerobic ring contraction process []. Within the cobalamin synthesis pathway CbiG catalyses the both the opening of the lactone ring and the extrusion of the two-carbon fragment of cobalt-precorrin-5A from C-20 and its associated methyl group (deacylation) to give cobalt-precorrin-5B. The N-terminal of the enzyme is conserved in this family, and the C-terminal and the mid-sections are conserved independently in other families, CbiG_C and CbiG_mid, although the distinct function of each region is unclear. ; PDB: 3EEQ_B.
Probab=25.63 E-value=1.4e+02 Score=25.19 Aligned_cols=28 Identities=36% Similarity=0.552 Sum_probs=17.9
Q ss_pred CCce--eeec--CCcchhHHHHHHHHcCcCcE
Q 008621 276 TCAI--TTLG--RGGSDLTATTIGKALGLQEI 303 (559)
Q Consensus 276 ~G~~--~tlg--RgGSD~tAa~lA~~L~A~~l 303 (559)
+|+. ..|| +||.+..|-.+|..|++.-+
T Consensus 47 ~g~~vIplL~GH~GGan~lA~~iA~~lga~~V 78 (84)
T PF11760_consen 47 DGRFVIPLLGGHRGGANELARQIAELLGAQPV 78 (84)
T ss_dssp T--EEEEEE-TTTT-HHHHHHHHHHHTT-EE-
T ss_pred CCCEEEEeccCCcchHHHHHHHHHHHhCCEEE
Confidence 5654 3354 89999999999999999643
No 308
>PRK00549 competence damage-inducible protein A; Provisional
Probab=25.59 E-value=2.2e+02 Score=31.02 Aligned_cols=69 Identities=22% Similarity=0.281 Sum_probs=45.6
Q ss_pred HHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeec
Q 008621 204 MSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG 283 (559)
Q Consensus 204 lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlg 283 (559)
-|+..++..|++.|++..... ++.++ ...+.+.+... .+..++.|++|-+|.+.
T Consensus 20 tN~~~L~~~L~~~G~~v~~~~-----~v~Dd-----------~~~I~~~l~~a-~~~~DlVItTGGlGpt~--------- 73 (414)
T PRK00549 20 TNAQFLSEKLAELGIDVYHQT-----VVGDN-----------PERLLSALEIA-EERSDLIITTGGLGPTK--------- 73 (414)
T ss_pred hhHHHHHHHHHHCCCeEEEEE-----EeCCC-----------HHHHHHHHHHh-ccCCCEEEECCCCCCCC---------
Confidence 466778889999999864432 33221 23345555432 34557889988666442
Q ss_pred CCcchhHHHHHHHHcCcC
Q 008621 284 RGGSDLTATTIGKALGLQ 301 (559)
Q Consensus 284 RgGSD~tAa~lA~~L~A~ 301 (559)
-|+|.-.++.+++.+
T Consensus 74 ---dD~t~ea~a~~~g~~ 88 (414)
T PRK00549 74 ---DDLTKETVAKFLGRE 88 (414)
T ss_pred ---CccHHHHHHHHhCCC
Confidence 589999999999864
No 309
>cd04897 ACT_ACR_3 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the third ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=25.14 E-value=1.3e+02 Score=24.75 Aligned_cols=31 Identities=16% Similarity=0.184 Sum_probs=26.4
Q ss_pred EEEEEEecCccchhhHHHHHHHHHHhCCCcEEEE
Q 008621 396 TMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVV 429 (559)
Q Consensus 396 alItV~~~~m~~~~g~larIf~~L~~~gI~Vd~I 429 (559)
++|.|.. .+.||.+.++...|.+.|++|..-
T Consensus 2 TvveV~~---~DRpGLL~~i~~~l~~~~l~I~~A 32 (75)
T cd04897 2 SVVTVQC---RDRPKLLFDVVCTLTDMDYVVFHA 32 (75)
T ss_pred EEEEEEe---CCcCcHHHHHHHHHHhCCeEEEEE
Confidence 5677775 468999999999999999999875
No 310
>PHA01735 hypothetical protein
Probab=24.95 E-value=1.9e+02 Score=23.43 Aligned_cols=34 Identities=18% Similarity=0.243 Sum_probs=22.6
Q ss_pred HHHHHhhhHHHHHHHHH--HHHHHcCCceEEecccce
Q 008621 194 RDYLVSFGECMSTRIFA--AYLNKIGVKARQYDAFDI 228 (559)
Q Consensus 194 ~d~ils~GE~lsa~ll~--~~L~~~Gi~a~~l~~~~~ 228 (559)
..+|.+ ||--++.|=+ ..|++++|.++..++..+
T Consensus 22 ~~Riks-geATtaDL~AA~d~Lk~NdItgv~~~gspl 57 (76)
T PHA01735 22 LSRIKS-GEATTADLRAACDWLKSNDITGVAVDGSPL 57 (76)
T ss_pred HHHHhc-CcccHHHHHHHHHHHHHCCCceeeCCCCHH
Confidence 344444 6665655544 468999999988887653
No 311
>cd00758 MoCF_BD MoCF_BD: molybdenum cofactor (MoCF) binding domain (BD). This domain is found a variety of proteins involved in biosynthesis of molybdopterin cofactor, like MoaB, MogA, and MoeA. The domain is presumed to bind molybdopterin.
Probab=24.71 E-value=2.7e+02 Score=24.93 Aligned_cols=66 Identities=14% Similarity=0.174 Sum_probs=41.5
Q ss_pred HHHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeec
Q 008621 204 MSTRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLG 283 (559)
Q Consensus 204 lsa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlg 283 (559)
-|..++.+.|++.|.+..... ++.+ +...+.+.+.+. +++.++.|++|-.|.+
T Consensus 19 ~n~~~l~~~l~~~G~~v~~~~-----~v~D-----------d~~~i~~~i~~~-~~~~DlvittGG~g~g---------- 71 (133)
T cd00758 19 TNGPALEALLEDLGCEVIYAG-----VVPD-----------DADSIRAALIEA-SREADLVLTTGGTGVG---------- 71 (133)
T ss_pred chHHHHHHHHHHCCCEEEEee-----ecCC-----------CHHHHHHHHHHH-HhcCCEEEECCCCCCC----------
Confidence 366778888999997754331 2221 234455555543 4456788888855543
Q ss_pred CCcchhHHHHHHHHc
Q 008621 284 RGGSDLTATTIGKAL 298 (559)
Q Consensus 284 RgGSD~tAa~lA~~L 298 (559)
--|++.-.++...
T Consensus 72 --~~D~t~~ai~~~g 84 (133)
T cd00758 72 --RRDVTPEALAELG 84 (133)
T ss_pred --CCcchHHHHHHhc
Confidence 2688888888865
No 312
>cd04873 ACT_UUR-ACR-like ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD. This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted t
Probab=24.33 E-value=1.4e+02 Score=22.67 Aligned_cols=30 Identities=20% Similarity=0.458 Sum_probs=24.2
Q ss_pred EEEEecCccchhhHHHHHHHHHHhCCCcEEEEE
Q 008621 398 LDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVA 430 (559)
Q Consensus 398 ItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Is 430 (559)
+.|.. .+.+|.++++...|.++|+++..+.
T Consensus 3 l~i~~---~d~~g~l~~i~~~l~~~~~~I~~~~ 32 (70)
T cd04873 3 VEVYA---PDRPGLLADITRVLADLGLNIHDAR 32 (70)
T ss_pred EEEEe---CCCCCHHHHHHHHHHHCCCeEEEEE
Confidence 44543 4689999999999999999997663
No 313
>PRK08198 threonine dehydratase; Provisional
Probab=24.33 E-value=2.1e+02 Score=30.81 Aligned_cols=41 Identities=27% Similarity=0.304 Sum_probs=31.3
Q ss_pred EEeeecCeEEEEEEecCccchhhHHHHHHHHHHhCCCcEEEEEe
Q 008621 388 SIVLKRNVTMLDIVSTRMLGQYGFLAKVFSTFEDLGISVDVVAT 431 (559)
Q Consensus 388 ~Is~~~~ialItV~~~~m~~~~g~larIf~~L~~~gI~Vd~Ist 431 (559)
+.........+.+. +.+.||.++++++.+.++|.||.-|..
T Consensus 320 gl~~~gr~~~l~v~---l~D~PG~L~~ll~~i~~~g~NI~~i~~ 360 (404)
T PRK08198 320 GLVAAGRYLKLRVR---LPDRPGQLAKLLSIIAELGANVIDVDH 360 (404)
T ss_pred hhhhcCCEEEEEEE---eCCCCCHHHHHHHHHhhCCCceEEEEE
Confidence 33344555666665 567899999999999999999987653
No 314
>cd04930 ACT_TH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tyrosine hydroxylases (TH). ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tyrosine hydroxylases (TH). TH catalyses the hydroxylation of L-Tyr to 3,4-dihydroxyphenylalanine, the rate limiting step in the biosynthesis of catecholamines (dopamine, noradrenaline and adrenaline), functioning as hormones and neurotransmitters. The enzyme is not regulated by its amino acid substrate, but instead by phosphorylation at several serine residues located N-terminal of the ACT domain, and by feedback inhibition by catecholamines at the active site. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=23.84 E-value=3.1e+02 Score=24.31 Aligned_cols=57 Identities=12% Similarity=0.269 Sum_probs=37.0
Q ss_pred EEEeeccccchHHHHHHHHHHhCCCcEEEEEecCCceE---EEEEEecc----cHHHHHHHHHH
Q 008621 480 SLIGNVQRSSLILEKAFRVLRRSGVNVQMISQGASKVN---ISLIVNDD----EAEQCVRALHE 536 (559)
Q Consensus 480 SIVG~~~~~~gv~~ri~~~L~~~~InI~~IsqgaSe~s---Is~vV~~~----d~~kAv~~LH~ 536 (559)
|++=.+...||.+.++++.++.+|||+.-|..-++... -.|+|+-+ +..++++.|.+
T Consensus 43 Slifsl~~~pGsL~~iL~~Fa~~gINLt~IESRP~~~~~~eY~FfIdieg~~~~~~~aL~~L~~ 106 (115)
T cd04930 43 TLLFSLKEGFSSLSRILKVFETFEAKIHHLESRPSRKEGGDLEVLVRCEVHRSDLLQLISSLRQ 106 (115)
T ss_pred EEEEEeCCCCcHHHHHHHHHHHCCCCEEEEECCcCCCCCceEEEEEEEEeCHHHHHHHHHHHHH
Confidence 33333455789999999999999999999876554222 35555533 33445555543
No 315
>cd04885 ACT_ThrD-I Tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase). This CD includes each of two tandem C-terminal ACT domains of threonine dehydratase I (ThrD-I; L-threonine hydrolyase) which catalyzes the committed step in branched chain amino acid biosynthesis in plants and microorganisms, the pyridoxal 5'-phosphate (PLP)-dependent dehydration/deamination of L-threonine (or L-serine) to 2-ketobutyrate (or pyruvate). ThrD-I is a cooperative, feedback-regulated (isoleucine and valine) allosteric enzyme that forms a tetramer and contains four pyridoxal phosphate moieties. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=22.38 E-value=3.7e+02 Score=20.81 Aligned_cols=42 Identities=10% Similarity=0.078 Sum_probs=31.3
Q ss_pred ccccchHHHHHHHHHHhCCCcEEEEEecC---CceEEEEEEecccH
Q 008621 485 VQRSSLILEKAFRVLRRSGVNVQMISQGA---SKVNISLIVNDDEA 527 (559)
Q Consensus 485 ~~~~~gv~~ri~~~L~~~~InI~~Isqga---Se~sIs~vV~~~d~ 527 (559)
+...||-+.++.+.+++ +.||..+.+.- ....+.+.+.-.+.
T Consensus 5 ipdkPG~l~~~~~~i~~-~~nI~~~~~~~~~~~~~~v~v~ie~~~~ 49 (68)
T cd04885 5 FPERPGALKKFLELLGP-PRNITEFHYRNQGGDEARVLVGIQVPDR 49 (68)
T ss_pred CCCCCCHHHHHHHHhCC-CCcEEEEEEEcCCCCceEEEEEEEeCCH
Confidence 45689999999999998 99999888753 34446666665443
No 316
>cd04904 ACT_AAAH ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH). ACT domain of the nonheme iron-dependent, aromatic amino acid hydroxylases (AAAH): Phenylalanine hydroxylases (PAH), tyrosine hydroxylases (TH) and tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. This family of enzymes shares a common catalytic mechanism, in which dioxygen is used by an active site containing a single, reduced iron atom to hydroxylate an unactivated aromatic substrate, concomitant with a two-electron oxidation of tetrahydropterin (BH4) cofactor to its quinonoid dihydropterin form. PAH catalyzes the hydroxylation of L-Phe to L-Tyr, the first step in the catabolic degradation of L-Phe; TH catalyses the hydroxylation of L-Tyr to 3,4-dihydroxyphenylalanine, the rate limiting step in the biosynthesis of catecholamines; and TPH catalyses the hydroxylation of L-Trp to 5-hydroxytryptophan, the rate limiting step in the biosynthesis of 5-hydroxy
Probab=22.27 E-value=1.2e+02 Score=24.33 Aligned_cols=25 Identities=24% Similarity=0.592 Sum_probs=22.4
Q ss_pred chhhHHHHHHHHHHhCCCcEEEEEe
Q 008621 407 GQYGFLAKVFSTFEDLGISVDVVAT 431 (559)
Q Consensus 407 ~~~g~larIf~~L~~~gI~Vd~Ist 431 (559)
+.||-+.++++.|+++|||+-.|-+
T Consensus 9 ~~pG~L~~vL~~f~~~~iNlt~IeS 33 (74)
T cd04904 9 EEVGALARALKLFEEFGVNLTHIES 33 (74)
T ss_pred CCCcHHHHHHHHHHHCCCcEEEEEC
Confidence 4689999999999999999998854
No 317
>cd02129 PA_hSPPL_like PA_hSPPL_like: Protease-associated domain containing human signal peptide peptidase-like (hSPPL)-like. This group contains various PA domain-containing proteins similar to hSPPL2a and 2b. These SPPLs are GxGD aspartic proteases. SPPL2a is sorted to the late endosomes, SPPL2b to the plasma membrane. In activated dendritic cells, hSPPL2a and 2b catalyze the intramembrane proteolysis of tumor necrosis factor alpha triggering IL-12 production. hSPPL2a and 2b may have a broad substrate spectrum. The significance of the PA domain to these SPPLs has not been ascertained. It may be a protein-protein interaction domain. At peptidase active sites, the PA domain may participate in substrate binding and/or promoting conformational changes, which influence the stability and accessibility of the site to substrate.
Probab=22.16 E-value=3.5e+02 Score=24.27 Aligned_cols=63 Identities=13% Similarity=0.228 Sum_probs=40.0
Q ss_pred CCceeeecCCcchh-HHHHHHHHcCcCcEEEeeCCcccccCCCCCCCCCc--cccccCHHHHHHHH
Q 008621 276 TCAITTLGRGGSDL-TATTIGKALGLQEIQVWKDVDGVLTCDPNIHPHAK--PVPYLTFDEAAELA 338 (559)
Q Consensus 276 ~G~~~tlgRgGSD~-tAa~lA~~L~A~~l~i~TDV~GV~taDP~~v~~a~--~i~~ls~~Ea~eLa 338 (559)
.|.+..+-||+-.+ .=+..|...||..++|+-|.+++...+..-.+..- +.-.|++++...|.
T Consensus 44 ~gkIaLV~RG~CsF~~K~~~Aq~aGA~aVII~nn~~~~~~~~~~~~~~~v~IP~v~Is~~dG~~i~ 109 (120)
T cd02129 44 KGKAVVVMRGNCTFYEKARLAQSLGAEGLLIVSRERLVPPSGNRSEYEKIDIPVALLSYKDMLDIQ 109 (120)
T ss_pred CCeEEEEECCCcCHHHHHHHHHHCCCCEEEEEECCCCCCCCCCCCCCcCCcccEEEEeHHHHHHHH
Confidence 47778888987543 23677999999999999998864211111001122 33467888877773
No 318
>cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=22.01 E-value=3.8e+02 Score=21.49 Aligned_cols=26 Identities=15% Similarity=0.197 Sum_probs=22.6
Q ss_pred cccchHHHHHHHHHHhCCCcEEE--EEe
Q 008621 486 QRSSLILEKAFRVLRRSGVNVQM--ISQ 511 (559)
Q Consensus 486 ~~~~gv~~ri~~~L~~~~InI~~--Isq 511 (559)
...||+++++..+|++.|++|.. |.+
T Consensus 8 ~Dr~gLfa~i~~~l~~~~l~I~~A~I~T 35 (76)
T cd04927 8 SDRKGLLHDVTEVLYELELTIERVKVST 35 (76)
T ss_pred CCCCCHHHHHHHHHHHCCCeEEEEEEEE
Confidence 36799999999999999999986 554
No 319
>TIGR00200 cinA_nterm competence/damage-inducible protein CinA N-terminal domain. cinA is a DNA damage- or competence-inducible protein that is polycistronic with recA in a number of species
Probab=20.97 E-value=3.4e+02 Score=29.64 Aligned_cols=68 Identities=22% Similarity=0.237 Sum_probs=44.8
Q ss_pred HHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecC
Q 008621 205 STRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGR 284 (559)
Q Consensus 205 sa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgR 284 (559)
|+..++..|++.|++..... ++.+ +...+.+.+... .+..++.|++|-+|.+.
T Consensus 21 N~~~l~~~L~~~G~~v~~~~-----~v~D-----------d~~~i~~~l~~a-~~~~DlVIttGGlgpt~---------- 73 (413)
T TIGR00200 21 NAQWLADFLAHQGLPLSRRT-----TVGD-----------NPERLKTIIRIA-SERADVLIFNGGLGPTS---------- 73 (413)
T ss_pred hHHHHHHHHHHCCCeEEEEE-----EeCC-----------CHHHHHHHHHHH-hcCCCEEEEcCCCCCCC----------
Confidence 56678888999999865432 2222 123455555543 35567888888666442
Q ss_pred CcchhHHHHHHHHcCcC
Q 008621 285 GGSDLTATTIGKALGLQ 301 (559)
Q Consensus 285 gGSD~tAa~lA~~L~A~ 301 (559)
-|++.-.++.+++-+
T Consensus 74 --dD~t~eava~~~g~~ 88 (413)
T TIGR00200 74 --DDLTAETIATAKGEP 88 (413)
T ss_pred --cccHHHHHHHHhCCC
Confidence 589999999999854
No 320
>cd04929 ACT_TPH ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. ACT domain of the nonheme iron-dependent aromatic amino acid hydroxylase, tryptophan hydroxylases (TPH), both peripheral (TPH1) and neuronal (TPH2) enzymes. TPH catalyses the hydroxylation of L-Trp to 5-hydroxytryptophan, the rate limiting step in the biosynthesis of 5-hydroxytryptamine (serotonin) and the first reaction in the synthesis of melatonin. Very little is known about the role of the ACT domain in TPH, which appears to be regulated by phosphorylation but not by its substrate or cofactor. Members of this CD belong to the superfamily of ACT regulatory domains.
Probab=20.32 E-value=1.4e+02 Score=24.15 Aligned_cols=25 Identities=36% Similarity=0.573 Sum_probs=22.3
Q ss_pred chhhHHHHHHHHHHhCCCcEEEEEe
Q 008621 407 GQYGFLAKVFSTFEDLGISVDVVAT 431 (559)
Q Consensus 407 ~~~g~larIf~~L~~~gI~Vd~Ist 431 (559)
..+|-++++++.|+++|||+-.|-+
T Consensus 9 ~~~g~L~~iL~~f~~~~inl~~IeS 33 (74)
T cd04929 9 NEVGGLAKALKLFQELGINVVHIES 33 (74)
T ss_pred CCCcHHHHHHHHHHHCCCCEEEEEe
Confidence 4688999999999999999998864
No 321
>COG0303 MoeA Molybdopterin biosynthesis enzyme [Coenzyme metabolism]
Probab=20.23 E-value=2.7e+02 Score=30.37 Aligned_cols=72 Identities=18% Similarity=0.346 Sum_probs=47.9
Q ss_pred HHHHHHHHHHHcCCceEEecccceEEEEecCCCCceeeecchHHHHHHHhhchhcCCcEEEEcCCCcccCCCCceeeecC
Q 008621 205 STRIFAAYLNKIGVKARQYDAFDIGFITTDDFTNADILEATYPAVAKRLHGDWITDLAIPIVTGFLGKAWRTCAITTLGR 284 (559)
Q Consensus 205 sa~ll~~~L~~~Gi~a~~l~~~~~~iit~~~~~~a~i~~~~~~~i~~~l~~~l~~~~~ipVv~Gfig~~~~~G~~~tlgR 284 (559)
|...++++|++.|.....+ |++.++ ...+++.+.+. .++.++.|++|-... |+
T Consensus 204 N~~~l~a~l~~~G~e~~~~-----giv~Dd-----------~~~l~~~i~~a-~~~~DviItsGG~Sv----G~------ 256 (404)
T COG0303 204 NSYMLAALLERAGGEVVDL-----GIVPDD-----------PEALREAIEKA-LSEADVIITSGGVSV----GD------ 256 (404)
T ss_pred CHHHHHHHHHHcCCceeec-----cccCCC-----------HHHHHHHHHHh-hhcCCEEEEeCCccC----cc------
Confidence 5567888999999875443 344332 34455556554 344578888883321 33
Q ss_pred CcchhHHHHHHHHcCcCcEEEee
Q 008621 285 GGSDLTATTIGKALGLQEIQVWK 307 (559)
Q Consensus 285 gGSD~tAa~lA~~L~A~~l~i~T 307 (559)
.|++-.++...+| ++.+|.
T Consensus 257 --~D~v~~~l~~~lG--~v~~~g 275 (404)
T COG0303 257 --ADYVKAALERELG--EVLFHG 275 (404)
T ss_pred --hHhHHHHHHhcCC--cEEEEe
Confidence 6999999998888 788875
Done!